data_5kqb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5kqb _Structure_validation_residue.Date_analyzed 2017-07-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -98.56 25.06 6.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.74 -162.65 11.86 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.872 -1.143 . . . . 0.0 114.824 -173.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.53 134.85 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.415 2.286 . . . . 0.0 108.833 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -109.67 91.73 3.76 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.93 106.78 11.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 125.87 26.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.045 0.839 . . . . 0.0 110.337 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.7 mt -137.14 151.4 71.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.66 0.784 . . . . 0.0 112.094 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.55 138.65 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.582 2.188 . . . . 0.0 111.528 165.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.63 128.77 38.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.442 0.697 . . . . 0.0 110.978 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.49 63.98 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.047 1.308 . . . . 0.0 115.285 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.3 m -57.72 126.38 75.83 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-N 119.583 1.692 . . . . 0.0 112.714 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -69.26 133.27 26.06 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.211 1.941 . . . . 0.0 112.412 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -89.58 130.0 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.561 1.944 . . . . 0.0 107.964 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -102.75 152.73 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.665 1.586 . . . . 0.0 109.834 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.49 124.0 90.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.936 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.39 -40.3 19.33 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.083 2.522 . . . . 0.0 112.456 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.3 p -130.23 164.12 25.22 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.543 1.937 . . . . 0.0 110.382 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.27 137.61 50.89 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 166.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.08 -161.93 17.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.576 0.608 . . . . 0.0 113.167 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -145.72 144.5 30.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 112.008 174.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.81 129.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -40.06 8.62 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -157.76 146.49 19.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.144 1.378 . . . . 0.0 111.007 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.7 mt -141.13 120.31 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.85 1.26 . . . . 0.0 109.425 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 p90 . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.236 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 mttm . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.99 123.26 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.35 131.86 48.71 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.341 1.456 . . . . 0.0 110.187 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.13 125.44 53.78 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.114 1.365 . . . . 0.0 111.384 171.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.7 mt -121.39 149.26 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.241 1.416 . . . . 0.0 111.807 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.05 139.84 48.35 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 111.376 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 124.529 1.132 . . . . 0.0 113.363 176.134 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -117.87 159.44 23.08 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.651 1.98 . . . . 0.0 111.907 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -143.45 104.4 4.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.951 2.1 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 148.52 24.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.34 0.656 . . . . 0.0 112.503 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -136.17 89.76 2.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.586 2.355 . . . . 0.0 109.92 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.01 160.51 16.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.666 1.186 . . . . 0.0 111.216 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 62.44 57.1 1.96 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.559 1.944 . . . . 0.0 114.032 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.85 145.46 26.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.322 1.049 . . . . 0.0 111.555 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -87.44 -43.72 11.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.108 1.363 . . . . 0.0 108.045 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -147.45 144.77 28.86 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.186 1.794 . . . . 0.0 112.473 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -86.83 149.71 24.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.146 0.978 . . . . 0.0 111.927 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -117.18 -4.43 11.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.243 1.017 . . . . 0.0 112.607 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.25 162.82 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.179 1.392 . . . . 0.0 111.529 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -111.66 161.52 16.16 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.583 1.153 . . . . 0.0 111.29 168.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.39 128.04 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.123 1.369 . . . . 0.0 107.641 170.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.66 16.05 66.8 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.179 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -87.23 123.52 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.067 1.434 . . . . 0.0 112.871 167.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -69.02 137.8 53.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.199 0.523 . . . . 0.0 111.718 160.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.83 164.14 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.011 2.125 . . . . 0.0 110.67 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -133.83 142.32 47.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.882 1.273 . . . . 0.0 108.677 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.38 132.35 10.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.337 1.055 . . . . 0.0 113.392 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.88 -7.54 81.83 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.446 1.974 . . . . 0.0 115.011 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -77.37 140.92 40.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.1 1.45 . . . . 0.0 113.148 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.9 mm -67.78 129.4 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.76 -0.587 . . . . 0.0 110.997 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.0 pt -114.45 -20.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.762 1.225 . . . . 0.0 113.304 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.02 -177.07 2.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.137 1.775 . . . . 0.0 110.415 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -132.3 130.85 41.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.4 t -79.05 146.39 33.32 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.559 0.695 . . . . 0.0 112.645 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 C-N-CA 124.758 1.17 . . . . 0.0 111.108 -179.893 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.7 p80 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.15 115.32 8.3 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 109.663 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -95.16 99.88 11.78 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.739 0.816 . . . . 0.0 110.24 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 51.8 t80 -89.09 114.44 25.69 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.025 1.33 . . . . 0.0 114.508 172.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -118.21 116.83 27.61 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.708 1.203 . . . . 0.0 111.908 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.3 ttt-85 -100.64 124.74 46.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.909 1.684 . . . . 0.0 111.567 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 32.9 mtm -130.44 157.27 43.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.96 1.304 . . . . 0.0 112.338 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -131.5 135.96 47.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.403 1.481 . . . . 0.0 111.52 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.7 -7.66 57.83 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 126.368 1.937 . . . . 0.0 115.363 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 171.14 -166.65 39.79 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.689 2.566 . . . . 0.0 109.806 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.57 131.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 122.483 1.135 . . . . 0.0 110.555 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.43 168.98 14.89 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 128.466 2.936 . . . . 0.0 109.896 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -56.22 -41.96 76.5 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.849 1.325 . . . . 0.0 112.852 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.69 64.91 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.055 -1.028 . . . . 0.0 112.505 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.0 -15.1 58.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.954 1.301 . . . . 0.0 113.44 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.88 56.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.927 0.891 . . . . 0.0 112.763 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.96 -85.57 0.55 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.635 1.174 . . . . 0.0 113.66 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -166.97 126.89 1.14 Allowed Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 127.386 2.274 . . . . 0.0 106.109 167.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.0 -28.71 8.94 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.277 2.652 . . . . 0.0 114.601 171.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -53.24 -53.51 55.22 Favored Pre-proline 0 N--CA 1.478 0.971 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.53 -19.5 32.39 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.704 2.936 . . . . 0.0 112.584 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -72.36 -44.87 61.96 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 24.2 mt -66.68 -29.43 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.432 0.693 . . . . 0.0 111.056 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.86 -15.8 5.48 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.85 -3.23 9.71 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.437 1.495 . . . . 0.0 114.27 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.61 147.62 98.03 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.088 0.955 . . . . 0.0 112.097 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -51.35 -44.72 41.61 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.747 3.631 . . . . 0.0 114.626 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -111.71 12.96 21.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.898 1.279 . . . . 0.0 113.686 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.04 -135.39 46.07 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 120.821 -1.174 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.12 -25.85 64.2 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.308 -1.113 . . . . 0.0 113.319 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -70.18 -5.77 29.62 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.563 -1.336 . . . . 0.0 113.373 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.9 m -77.98 -4.05 45.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.987 0.812 . . . . 0.0 111.991 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.51 -15.55 12.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.735 1.614 . . . . 0.0 113.825 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -148.95 158.14 43.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 121.635 2.016 . . . . 0.0 115.037 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -110.06 79.42 1.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.47 0.544 0 C-N-CA 124.584 1.154 . . . . 0.0 109.523 174.516 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 97.8 m-85 -120.54 25.21 9.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -168.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.81 -178.63 25.83 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.97 -1.081 . . . . 0.0 113.354 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.37 146.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.823 1.649 . . . . 0.0 108.109 163.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.8 142.06 48.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.987 0.812 . . . . 0.0 112.177 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -116.43 122.6 45.27 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.338 1.455 . . . . 0.0 114.538 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.79 114.6 17.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.026 0.93 . . . . 0.0 110.864 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.3 mt -126.66 151.26 73.0 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.77 136.9 47.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.612 2.208 . . . . 0.0 110.373 152.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -54.22 138.65 38.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.802 1.241 . . . . 0.0 110.847 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.18 -1.62 84.4 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.589 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 36.2 m -50.25 124.94 18.7 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 119.938 1.869 . . . . 0.0 111.273 166.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.31 129.32 15.78 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.798 1.665 . . . . 0.0 110.896 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.34 131.46 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 108.738 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -106.13 155.74 19.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.119 1.367 . . . . 0.0 110.224 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.96 75.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 O-C-N 121.521 -0.737 . . . . 0.0 111.707 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.51 -36.79 10.78 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.283 2.655 . . . . 0.0 113.24 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 p -134.62 163.18 30.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.148 1.779 . . . . 0.0 107.05 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.66 139.69 53.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.73 22.74 Favored Glycine 0 N--CA 1.467 0.702 0 O-C-N 121.433 -0.792 . . . . 0.0 113.219 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -148.02 144.87 28.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.372 1.069 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.51 128.22 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.3 -38.81 7.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.203 1.001 . . . . 0.0 112.045 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -148.62 141.35 24.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.49 1.516 . . . . 0.0 111.778 -168.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -139.76 127.29 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.142 1.377 . . . . 0.0 110.381 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 p90 . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -178.833 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.79 137.18 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.885 2.474 . . . . 0.0 113.394 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.68 135.92 53.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.016 1.326 . . . . 0.0 110.237 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 124.6 44.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.11 147.1 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 125.187 1.395 . . . . 0.0 111.796 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.98 138.13 51.2 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.34 2.256 . . . . 0.0 111.764 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.735 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 39.6 m-85 . . . . . 0 C--O 1.235 0.305 0 N-CA-C 118.28 2.696 . . . . 0.0 118.28 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -130.0 150.36 51.31 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.154 1.781 . . . . 0.0 111.847 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -118.61 131.84 56.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.846 1.658 . . . . 0.0 108.763 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -105.43 150.69 25.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.377 1.071 . . . . 0.0 111.856 157.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -135.19 112.56 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.585 1.954 . . . . 0.0 106.35 171.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -106.7 159.9 15.87 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 111.25 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 68.74 55.3 0.47 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.484 1.913 . . . . 0.0 113.282 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.82 158.03 16.27 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 111.382 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -40.42 5.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.638 1.175 . . . . 0.0 112.557 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -144.64 147.9 33.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.034 1.734 . . . . 0.0 111.782 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -94.32 145.99 24.36 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.037 1.335 . . . . 0.0 112.397 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -106.73 -16.44 14.49 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.47 1.108 . . . . 0.0 112.012 170.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.35 167.21 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.149 1.38 . . . . 0.0 111.499 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -124.19 165.4 17.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 111.939 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.5 t -56.22 123.78 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.36 1.064 . . . . 0.0 108.931 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.34 61.01 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.209 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -97.92 135.83 39.09 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.032 1.916 . . . . 0.0 109.419 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -76.49 145.17 39.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.456 1.102 . . . . 0.0 113.254 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.99 161.04 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 127.013 2.125 . . . . 0.0 111.293 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -123.93 144.09 49.99 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.498 2.319 . . . . 0.0 108.552 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -45.44 112.73 0.49 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.014 1.326 . . . . 0.0 112.308 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.39 -3.2 34.76 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.946 1.736 . . . . 0.0 115.51 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.15 144.54 26.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.2 mm -70.9 130.82 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.763 0.71 . . . . 0.0 111.924 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.6 pt -115.96 -22.94 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.712 1.205 . . . . 0.0 113.298 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.44 -178.33 2.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.938 1.295 . . . . 0.0 111.278 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -129.73 135.44 48.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.68 146.65 53.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.933 0.893 . . . . 0.0 112.27 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 CA-C-O 121.52 0.511 . . . . 0.0 112.751 176.03 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 115.77 12.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.482 0.713 . . . . 0.0 110.478 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -92.12 98.78 11.75 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.79 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.288 50.6 t80 -89.07 109.67 20.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.66 117.49 33.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.447 1.099 . . . . 0.0 111.467 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -102.53 126.37 49.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.012 1.325 . . . . 0.0 111.059 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.5 mtm -129.49 149.11 51.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.573 1.549 . . . . 0.0 111.451 -170.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -124.32 131.08 53.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.47 1.508 . . . . 0.0 110.759 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.25 -1.27 35.18 Favored Glycine 0 CA--C 1.545 1.914 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.42 -169.74 41.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.997 1.284 . . . . 0.0 112.521 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.76 115.73 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.28 1.432 . . . . 0.0 112.781 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.52 15.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.395 1.95 . . . . 0.0 111.347 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -57.84 -40.5 80.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.607 1.204 . . . . 0.0 112.832 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.49 -17.61 64.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -88.65 -11.8 44.31 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 151.09 34.08 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -130.57 -89.12 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.517 1.527 . . . . 0.0 113.98 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -160.22 95.89 1.53 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -167.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.4 -34.94 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.15 1.9 . . . . 0.0 114.206 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -54.95 -55.36 39.7 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 121.098 1.772 . . . . 0.0 115.53 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.46 -26.51 40.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.362 2.708 . . . . 0.0 112.099 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.17 -38.3 81.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.44 -40.8 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.887 0.475 . . . . 0.0 110.861 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.45 -5.05 13.09 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -114.12 -4.79 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.018 2.127 . . . . 0.0 113.225 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.84 156.04 48.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.53 1.132 . . . . 0.0 112.327 171.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.65 -49.51 16.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.868 3.045 . . . . 0.0 113.148 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.41 5.21 36.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.454 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.37 -143.76 47.61 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.033 -1.042 . . . . 0.0 112.181 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.44 61.93 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -64.7 -10.08 24.57 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -86.72 5.46 36.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 171.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.1 -18.56 9.35 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.624 1.57 . . . . 0.0 112.709 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -149.1 157.73 43.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.363 -1.461 . . . . 0.0 111.701 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.69 89.02 2.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.241 0.65 0 C-N-CA 124.978 1.311 . . . . 0.0 110.796 173.126 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.49 22.63 11.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.571 1.548 . . . . 0.0 114.675 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.59 -158.05 8.93 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 121.206 -0.934 . . . . 0.0 113.56 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.92 133.31 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.867 2.067 . . . . 0.0 108.796 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.45 96.08 5.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.48 110.44 14.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 114.17 4.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.267 0.94 . . . . 0.0 111.351 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -129.82 147.27 64.76 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.22 0.608 . . . . 0.0 112.057 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.47 135.43 49.58 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.04 1.827 . . . . 0.0 110.346 162.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -60.67 130.3 45.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.769 0.827 . . . . 0.0 111.129 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.58 -7.92 68.56 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.737 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -51.32 126.65 28.75 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-N 120.121 1.961 . . . . 0.0 113.101 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -67.73 136.07 37.73 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.638 2.226 . . . . 0.0 112.151 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.67 127.6 44.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.484 1.514 . . . . 0.0 107.888 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -96.91 148.8 22.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.087 1.355 . . . . 0.0 109.643 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.1 125.06 88.5 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.692 -0.671 . . . . 0.0 110.277 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.64 -39.93 14.58 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.314 2.676 . . . . 0.0 111.72 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.2 p -120.34 166.44 13.52 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.736 2.414 . . . . 0.0 110.089 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -67.36 144.92 55.56 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 154.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.95 -157.68 16.18 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.407 1.003 . . . . 0.0 114.345 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.14 143.96 25.38 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.044 1.738 . . . . 0.0 112.09 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.32 127.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -42.7 8.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 -159.19 143.72 15.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.2 1.0 . . . . 0.0 110.85 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.422 HG22 ' CE2' ' A' ' 129' ' ' TYR . 53.1 mt -141.78 122.31 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.486 1.514 . . . . 0.0 109.101 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -177.316 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 mttm . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.4 139.36 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.656 1.982 . . . . 0.0 114.208 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.298 1.439 . . . . 0.0 109.821 171.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 126.5 55.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.391 0.676 . . . . 0.0 112.57 171.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.14 145.18 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.829 1.252 . . . . 0.0 112.218 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.94 132.25 52.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.701 2.4 . . . . 0.0 112.182 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.422 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.264 50.0 m-85 . . . . . 0 C--O 1.238 0.468 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -126.48 155.71 41.85 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.646 2.378 . . . . 0.0 111.332 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -137.8 105.3 5.54 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.473 1.909 . . . . 0.0 110.625 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -88.52 146.03 25.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.156 0.582 . . . . 0.0 111.225 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -132.21 109.52 9.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.689 1.596 . . . . 0.0 108.218 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.08 162.49 12.9 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.939 1.296 . . . . 0.0 111.112 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 59.32 61.76 1.97 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.203 2.201 . . . . 0.0 112.798 -174.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.03 140.49 36.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.973 1.309 . . . . 0.0 111.998 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -80.86 -48.75 11.97 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 0.0 108.716 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -152.42 149.21 28.34 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.536 1.935 . . . . 0.0 111.152 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.422 ' CE2' HG22 ' A' ' 100' ' ' ILE . 97.9 m-85 -98.06 143.27 28.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.728 1.211 . . . . 0.0 113.032 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -103.45 -29.36 11.23 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.524 -0.735 . . . . 0.0 111.812 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.6 m -111.03 172.61 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.737 1.615 . . . . 0.0 112.208 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -128.55 162.94 26.08 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.734 1.614 . . . . 0.0 111.681 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -56.04 130.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 122.37 1.081 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.29 5.42 67.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.476 1.512 . . . . 0.0 114.995 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -95.21 136.8 35.11 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.24 1.52 . . . . 0.0 114.061 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.1 mmm-85 -86.49 133.93 33.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.94 159.21 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.423 1.489 . . . . 0.0 110.863 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.19 143.54 51.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.216 1.806 . . . . 0.0 108.462 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.65 128.99 13.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.23 1.012 . . . . 0.0 113.06 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.45 -2.69 78.22 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.33 1.443 . . . . 0.0 114.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -79.31 139.74 37.74 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.754 1.277 . . . . 0.0 113.692 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.6 mm -69.82 126.81 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 118.846 0.748 . . . . 0.0 111.544 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -108.8 -26.06 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.125 1.37 . . . . 0.0 113.133 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.11 -176.81 2.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 110.389 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.47 136.34 41.21 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -82.48 143.87 30.83 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 C-N-CA 124.601 1.096 . . . . 0.0 113.27 -176.111 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.0 p80 . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.08 118.08 19.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.857 0.753 . . . . 0.0 110.587 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -94.95 100.91 12.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.51 113.14 25.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.015 1.326 . . . . 0.0 113.953 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -117.7 112.41 20.44 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 110.088 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 ttt-85 -99.93 127.26 46.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.122 0.969 . . . . 0.0 110.603 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.1 mtm -127.37 154.09 45.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.622 1.569 . . . . 0.0 111.731 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -130.07 131.92 45.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.419 1.087 . . . . 0.0 112.246 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.54 6.11 75.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.053 0.835 . . . . 0.0 114.68 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.83 -161.1 31.23 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.116 1.817 . . . . 0.0 111.374 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.48 135.6 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.63 1.172 . . . . 0.0 111.838 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 138.71 171.72 12.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.084 1.802 . . . . 0.0 112.578 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -54.23 -51.29 64.96 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.75 1.22 . . . . 0.0 113.569 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.15 -17.12 63.17 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.712 -1.243 . . . . 0.0 114.279 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -80.23 -18.2 50.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.07 145.87 55.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.667 0.787 . . . . 0.0 111.602 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -122.8 -81.0 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -166.92 97.37 0.68 Allowed Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.27 -26.35 5.13 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.127 1.884 . . . . 0.0 114.51 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -51.91 77.18 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-N 121.622 2.01 . . . . 0.0 113.821 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.48 -25.75 24.95 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.512 2.141 . . . . 0.0 112.379 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.67 -32.7 74.26 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -80.71 -26.37 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.341 0.657 . . . . 0.0 111.717 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -59.46 -10.44 3.29 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -117.39 -5.84 11.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.887 2.075 . . . . 0.0 113.616 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.04 148.76 91.91 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.367 -0.833 . . . . 0.0 111.8 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -36.95 52.87 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.306 2.671 . . . . 0.0 114.066 -166.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -109.64 0.13 18.9 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.265 -0.897 . . . . 0.0 110.864 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 78.3 -143.2 26.96 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.613 1.097 . . . . 0.0 112.083 -164.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.54 -25.97 64.96 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.916 -1.344 . . . . 0.0 114.14 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -63.25 -8.88 9.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.01 1.324 . . . . 0.0 114.485 173.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -83.05 -5.44 59.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.397 1.079 . . . . 0.0 112.952 170.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -104.2 -14.61 15.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.903 1.681 . . . . 0.0 113.184 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -143.51 160.16 41.11 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.834 1.652 . . . . 0.0 114.7 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -108.07 78.16 1.16 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 124.315 1.046 . . . . 0.0 112.354 -176.693 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.279 69.9 m-85 -90.07 43.76 1.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.56 -175.91 38.44 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.506 -1.371 . . . . 0.0 115.055 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.32 146.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.152 1.781 . . . . 0.0 107.866 165.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 137.44 50.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.518 1.054 . . . . 0.0 113.13 167.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.08 118.96 38.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.005 1.722 . . . . 0.0 113.93 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.82 110.47 4.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.585 0.754 . . . . 0.0 110.199 171.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.7 mt -125.34 150.42 67.35 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 111.466 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.6 138.21 73.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.637 2.225 . . . . 0.0 110.578 161.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -56.76 121.61 10.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.185 1.394 . . . . 0.0 111.291 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.37 1.65 66.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.1 m -52.18 125.46 33.38 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 120.407 2.104 . . . . 0.0 112.436 166.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -68.22 135.66 35.04 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.095 1.863 . . . . 0.0 111.841 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.3 mm -91.51 130.51 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.716 1.606 . . . . 0.0 107.428 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -101.25 150.19 23.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.995 1.318 . . . . 0.0 109.246 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 93.13 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.936 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.03 -30.53 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.317 2.678 . . . . 0.0 113.345 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.7 p -132.43 163.73 28.12 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.724 2.41 . . . . 0.0 112.225 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.54 135.94 42.14 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.71 -159.26 11.54 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.403 1.001 . . . . 0.0 114.057 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -150.9 145.55 25.71 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.681 1.593 . . . . 0.0 111.174 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.59 125.66 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.83 -41.35 7.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.822 1.249 . . . . 0.0 111.075 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -149.32 142.93 25.46 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.724 1.21 . . . . 0.0 111.654 -166.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.9 mt -140.99 134.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.446 1.098 . . . . 0.0 109.386 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.5 p90 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -134.53 138.89 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.137 1.775 . . . . 0.0 113.851 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -115.21 134.27 55.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.566 1.946 . . . . 0.0 109.784 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.44 123.62 46.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.755 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.2 mt -119.48 142.67 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 0.0 111.373 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.09 138.93 37.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.534 1.934 . . . . 0.0 110.89 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 112.241 169.779 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.296 38.5 m-85 . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -131.8 150.38 52.17 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.387 1.075 . . . . 0.0 112.598 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -125.53 121.4 33.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.693 1.997 . . . . 0.0 108.184 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -97.49 150.41 21.1 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.27 91.77 2.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.829 2.452 . . . . 0.0 108.823 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.47 162.91 13.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.472 0.709 . . . . 0.0 111.838 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 65.26 53.63 1.29 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.352 1.861 . . . . 0.0 111.721 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.7 mt -96.75 140.95 30.58 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.266 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.53 -50.83 12.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.376 1.87 . . . . 0.0 107.802 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -147.78 146.84 29.33 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.884 1.673 . . . . 0.0 111.322 -163.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -91.09 151.03 21.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.059 0.543 . . . . 0.0 111.728 171.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -118.12 -7.11 10.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.437 1.095 . . . . 0.0 112.657 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.81 166.8 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.294 1.838 . . . . 0.0 111.219 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -122.16 165.96 15.31 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.718 1.607 . . . . 0.0 111.135 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.5 t -52.64 125.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.782 1.233 . . . . 0.0 107.993 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.1 13.72 61.65 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.42 126.37 35.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.749 1.774 . . . . 0.0 112.603 168.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -71.2 135.22 47.43 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.981 0.512 . . . . 0.0 111.371 167.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.51 156.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.91 1.684 . . . . 0.0 110.348 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -136.13 140.73 43.89 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.988 1.715 . . . . 0.0 109.336 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.25 131.62 16.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.265 1.031 . . . . 0.0 113.488 -171.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.22 -6.68 83.31 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.861 2.172 . . . . 0.0 115.128 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -79.23 140.75 37.58 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.036 1.418 . . . . 0.0 114.017 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.0 mm -70.42 129.63 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.688 0.795 . . . . 0.0 111.603 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -115.5 -23.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.966 1.307 . . . . 0.0 113.089 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.67 -175.92 1.67 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.879 1.672 . . . . 0.0 110.386 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -136.85 138.18 40.48 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.5 t -79.92 143.24 34.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.048 0.84 . . . . 0.0 113.236 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 C-N-CA 124.953 1.264 . . . . 0.0 112.977 -176.213 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.65 117.09 13.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.082 0.953 . . . . 0.0 110.702 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -90.9 106.07 18.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.219 0.918 . . . . 0.0 111.865 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.251 41.5 t80 -95.28 115.04 26.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.409 1.484 . . . . 0.0 114.563 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -113.85 120.43 40.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.822 0.849 . . . . 0.0 111.755 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -92.95 124.0 36.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.078 1.751 . . . . 0.0 111.35 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.3 mtm -126.07 161.32 27.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.984 1.714 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -134.16 141.96 47.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 111.353 169.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.35 -5.26 60.52 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.252 1.406 . . . . 0.0 115.867 167.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.59 -175.12 47.45 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.751 2.596 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.25 121.76 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.637 1.175 . . . . 0.0 112.544 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.93 163.75 10.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.28 1.419 . . . . 0.0 112.356 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -48.23 -46.13 35.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.736 1.214 . . . . 0.0 113.468 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.34 69.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -81.46 -14.24 57.26 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.1 131.83 49.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.614 1.166 . . . . 0.0 112.119 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -103.28 -80.48 0.52 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.778 0.831 . . . . 0.0 112.681 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -166.78 101.34 0.66 Allowed Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.397 1.479 . . . . 0.0 114.046 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.02 -32.29 1.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.866 1.711 . . . . 0.0 114.097 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -57.83 -53.84 61.55 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 120.976 1.717 . . . . 0.0 115.475 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.24 -25.97 49.6 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.241 2.627 . . . . 0.0 112.122 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -61.13 -27.56 68.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 166.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.21 -31.52 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.836 0.854 . . . . 0.0 111.998 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.4 -4.7 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -114.81 -5.75 12.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.807 2.043 . . . . 0.0 113.652 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.9 mt -77.72 148.1 75.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.743 1.217 . . . . 0.0 112.532 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.65 -21.31 22.13 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.811 3.007 . . . . 0.0 115.2 -164.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -119.01 9.44 11.86 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.106 1.363 . . . . 0.0 113.921 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.02 -141.24 34.1 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.252 0.93 . . . . 0.0 112.975 -169.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.63 -25.25 52.8 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.313 -1.11 . . . . 0.0 113.414 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -64.89 -9.11 18.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 113.753 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.3 m -81.74 -7.96 59.65 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.08 0.952 . . . . 0.0 112.76 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.36 -18.69 14.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.624 1.17 . . . . 0.0 113.346 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -144.17 159.42 42.68 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.378 -1.451 . . . . 0.0 113.441 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -104.78 93.11 4.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.241 0.631 0 C-N-CA 123.658 0.783 . . . . 0.0 111.824 177.196 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 121.454 0.645 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.453 68.5 m-85 -93.41 28.07 2.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.43 -168.97 23.09 Favored Glycine 0 CA--C 1.532 1.097 0 O-C-N 121.109 -0.994 . . . . 0.0 114.766 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.27 144.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.977 2.111 . . . . 0.0 108.859 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -123.47 129.88 51.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -102.62 118.77 37.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.106 1.762 . . . . 0.0 113.804 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 157' ' ' HIS . . . -72.76 78.14 1.12 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.356 1.062 . . . . 0.0 112.421 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.6 mt -95.77 150.17 37.02 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.099 0.959 . . . . 0.0 112.484 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.07 151.52 83.6 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.864 2.376 . . . . 0.0 112.214 162.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -54.74 139.68 38.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.325 1.45 . . . . 0.0 111.054 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.77 -9.56 59.21 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.028 -1.429 . . . . 0.0 115.818 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 m -50.62 122.47 16.19 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.707 1.754 . . . . 0.0 113.938 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -67.31 129.3 20.03 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.165 1.243 . . . . 0.0 111.662 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -87.94 127.68 40.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.267 1.827 . . . . 0.0 107.771 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -99.25 154.38 18.2 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.482 1.513 . . . . 0.0 109.77 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.9 123.95 90.16 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.939 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -35.79 51.61 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.148 2.565 . . . . 0.0 112.716 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -138.58 154.89 48.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.725 1.61 . . . . 0.0 107.137 -169.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.29 134.33 55.65 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.494 0.718 . . . . 0.0 110.926 169.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.01 -157.92 11.58 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.937 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 146.47 25.65 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.438 1.895 . . . . 0.0 111.911 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.03 129.23 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 -44.91 7.09 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -158.62 143.73 16.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.049 1.34 . . . . 0.0 111.104 -166.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -141.1 118.75 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.761 1.224 . . . . 0.0 109.637 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.0 p90 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.577 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.8 mttp . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.81 140.93 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 127.005 2.122 . . . . 0.0 114.451 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.86 132.53 56.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.302 1.841 . . . . 0.0 108.683 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.99 124.49 51.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.586 1.155 . . . . 0.0 110.403 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.76 144.43 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.455 1.102 . . . . 0.0 111.153 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.76 127.09 53.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.362 1.865 . . . . 0.0 110.35 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 . . . . . 0 N--CA 1.473 0.689 0 O-C-N 121.006 -1.059 . . . . 0.0 111.428 169.328 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.312 35.1 m-85 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -120.13 155.32 33.28 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.316 2.246 . . . . 0.0 110.843 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -140.97 103.17 4.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.245 1.818 . . . . 0.0 109.994 -168.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -85.06 142.72 29.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.685 0.394 . . . . 0.0 111.38 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -130.78 89.94 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.872 2.469 . . . . 0.0 109.979 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mp -93.27 157.06 16.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.342 0.657 . . . . 0.0 111.346 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 71.18 58.56 0.19 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.269 1.827 . . . . 0.0 113.187 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -103.72 148.86 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.024 1.33 . . . . 0.0 111.288 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.42 -52.68 6.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.412 1.885 . . . . 0.0 107.618 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -150.98 157.79 43.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 127.168 2.187 . . . . 0.0 110.921 -165.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -98.77 154.29 18.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.94 0.896 . . . . 0.0 112.076 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -117.18 -14.28 10.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.677 1.191 . . . . 0.0 112.934 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.93 163.17 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.067 1.347 . . . . 0.0 110.397 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -117.88 163.84 15.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.4 t -54.52 135.43 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.57 3.72 83.7 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.561 1.077 . . . . 0.0 115.263 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -79.67 124.57 28.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 119.326 1.563 . . . . 0.0 111.863 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -74.19 140.95 45.46 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.77 160.92 40.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.617 1.567 . . . . 0.0 110.298 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -129.2 145.06 51.41 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.605 1.562 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.0 116.56 2.05 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.558 1.143 . . . . 0.0 112.732 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.68 -1.33 42.19 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 126.203 1.859 . . . . 0.0 115.305 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -86.34 142.58 28.39 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.407 1.883 . . . . 0.0 114.958 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.4 mm -69.01 129.05 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.109 0.868 . . . . 0.0 112.01 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.77 -23.97 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.707 1.603 . . . . 0.0 113.312 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.77 3.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.469 1.108 . . . . 0.0 110.54 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.66 132.08 46.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.6 t -69.06 137.52 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.704 1.601 . . . . 0.0 110.43 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.502 0 CA-C-O 122.893 1.274 . . . . 0.0 115.027 -169.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 82' ' ' ALA . 25.1 m170 . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.48 128.53 36.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.292 1.437 . . . . 0.0 112.089 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -106.23 105.9 16.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.798 0.839 . . . . 0.0 112.109 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.287 33.7 t80 -95.4 111.98 23.77 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.882 1.673 . . . . 0.0 114.941 175.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -116.7 114.0 23.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.621 1.168 . . . . 0.0 111.282 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.94 122.63 43.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.415 1.486 . . . . 0.0 110.808 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.0 mtm -128.64 156.46 43.38 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.618 1.567 . . . . 0.0 111.415 -172.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -127.76 128.29 45.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 110.669 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.3 -15.2 12.7 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 125.886 1.708 . . . . 0.0 116.623 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.53 40.31 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.049 1.309 . . . . 0.0 112.179 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.93 91.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 173.03 173.21 39.28 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.872 1.701 . . . . 0.0 112.86 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -48.58 -48.65 38.77 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.1 -14.62 62.74 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.19 -16.34 38.12 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 143.49 52.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.564 1.146 . . . . 0.0 112.823 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -125.23 -79.94 0.61 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -164.79 110.51 0.84 Allowed Pre-proline 0 N--CA 1.47 0.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -29.99 4.13 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.257 1.971 . . . . 0.0 114.151 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -51.35 -59.98 6.72 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.6 -28.62 69.73 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.689 2.926 . . . . 0.0 111.695 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -66.72 -39.17 87.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.22 -34.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.775 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.51 -16.84 17.12 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.93 1.12 11.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.144 1.778 . . . . 0.0 114.692 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.23 154.39 87.36 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.44 1.096 . . . . 0.0 111.848 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -47.2 -54.69 4.7 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.921 3.748 . . . . 0.0 114.028 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -106.99 10.84 30.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.272 1.029 . . . . 0.0 112.727 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.32 -139.1 30.15 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.711 -1.243 . . . . 0.0 112.332 -169.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.97 -26.4 62.28 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.706 -1.467 . . . . 0.0 112.807 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -69.55 -3.37 14.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.983 1.313 . . . . 0.0 113.067 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.6 m -80.54 -8.04 59.44 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.31 1.044 . . . . 0.0 113.013 166.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.57 -13.47 15.05 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.854 1.662 . . . . 0.0 112.687 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.16 161.47 42.67 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -106.04 90.15 3.29 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.849 1.26 . . . . 0.0 109.806 170.272 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.96 23.0 14.27 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -170.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.0 -166.97 14.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 120.696 -1.252 . . . . 0.0 114.579 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.01 130.36 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.828 2.051 . . . . 0.0 109.291 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -109.64 89.15 2.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.15 108.1 12.4 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.17 126.83 30.43 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.417 1.008 . . . . 0.0 111.776 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.45 159.17 71.64 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.137 0.975 . . . . 0.0 113.325 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.19 145.8 73.91 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.234 2.623 . . . . 0.0 111.22 161.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -65.87 131.71 46.91 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.345 -0.847 . . . . 0.0 111.149 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.27 84.24 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.586 -1.675 . . . . 0.0 115.415 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -47.72 121.93 8.58 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.923 1.862 . . . . 0.0 112.459 171.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -68.2 129.25 18.94 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.424 1.416 . . . . 0.0 111.589 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -86.23 128.1 39.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.73 1.612 . . . . 0.0 108.482 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -100.4 149.81 23.27 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 109.644 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.76 133.37 90.46 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 121.777 -0.577 . . . . 0.0 110.861 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.59 -32.39 6.11 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.193 2.595 . . . . 0.0 112.667 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.3 p -140.22 160.92 38.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.34 2.256 . . . . 0.0 107.847 -170.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -74.64 136.78 41.94 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.772 -1.205 . . . . 0.0 109.326 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.56 -159.11 11.81 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.973 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.09 144.68 25.89 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.913 1.285 . . . . 0.0 113.108 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.65 127.26 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.06 -41.95 5.69 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.614 1.166 . . . . 0.0 111.939 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -147.06 140.43 25.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.697 1.199 . . . . 0.0 110.915 -165.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 mt -144.82 110.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.512 1.525 . . . . 0.0 109.42 -173.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 p90 . . . . . 0 N--CA 1.48 1.074 0 C-N-CA 123.461 0.704 . . . . 0.0 112.545 -169.617 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.25 134.79 62.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.528 1.531 . . . . 0.0 115.087 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -111.35 134.97 52.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.135 1.374 . . . . 0.0 109.574 168.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.4 124.34 44.28 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 177.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 55.6 mt -119.85 139.91 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.557 1.143 . . . . 0.0 111.193 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.33 131.27 40.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.852 2.061 . . . . 0.0 110.118 166.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.611 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 . . . . . 0 C--O 1.236 0.394 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -121.9 152.77 39.27 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.536 1.534 . . . . 0.0 112.54 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.38 138.95 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.586 1.954 . . . . 0.0 109.153 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -114.0 148.65 36.59 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.977 1.311 . . . . 0.0 112.827 161.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -133.7 99.63 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.896 1.679 . . . . 0.0 106.964 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.41 163.67 13.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.695 1.198 . . . . 0.0 110.508 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 66.25 40.15 3.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.154 2.181 . . . . 0.0 114.937 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -83.98 154.22 23.44 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.312 -1.493 . . . . 0.0 112.827 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.36 -46.75 7.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.799 1.239 . . . . 0.0 108.955 171.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -152.82 160.27 43.09 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -104.0 148.64 25.98 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.646 1.578 . . . . 0.0 111.911 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -107.33 -8.61 16.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.662 1.585 . . . . 0.0 112.25 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 175.39 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.772 1.629 . . . . 0.0 111.464 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -130.82 169.21 16.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.438 1.495 . . . . 0.0 111.424 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.29 132.47 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 122.225 1.012 . . . . 0.0 108.983 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.69 9.16 69.08 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.511 1.053 . . . . 0.0 115.128 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -86.27 124.61 32.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.727 1.264 . . . . 0.0 113.33 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -75.87 139.68 41.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.514 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.4 164.6 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.214 1.805 . . . . 0.0 112.676 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.05 140.14 48.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.254 1.822 . . . . 0.0 110.218 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.1 125.68 3.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.875 1.27 . . . . 0.0 113.402 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.94 -10.14 72.33 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.0 1.762 . . . . 0.0 114.995 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -80.74 145.0 31.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.179 1.489 . . . . 0.0 114.667 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.82 135.06 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.225 0.61 . . . . 0.0 111.817 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 42.1 pt -121.22 -20.52 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.493 1.117 . . . . 0.0 113.321 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.7 -176.03 1.19 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.896 1.678 . . . . 0.0 111.388 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -132.82 134.46 44.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.2 t -71.01 143.65 50.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.179 0.591 . . . . 0.0 112.231 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.15 0 C-N-CA 124.554 1.073 . . . . 0.0 113.185 -178.016 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 120.727 0.298 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.42 120.88 41.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.167 1.387 . . . . 0.0 110.887 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -98.45 99.41 10.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.301 1.04 . . . . 0.0 110.583 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.283 36.8 t80 -88.75 116.66 27.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -122.29 116.95 24.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.323 1.049 . . . . 0.0 111.886 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -95.29 131.39 41.42 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.747 1.619 . . . . 0.0 110.93 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.8 mtm -132.43 155.09 49.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.681 1.593 . . . . 0.0 111.498 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -128.76 136.7 50.91 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.304 1.442 . . . . 0.0 111.235 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.39 2.75 43.85 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.75 -175.81 43.78 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.6 2.048 . . . . 0.0 111.0 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.56 123.29 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 122.438 1.114 . . . . 0.0 108.266 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.07 159.58 9.94 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.724 2.583 . . . . 0.0 110.685 -165.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.61 -46.68 83.78 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.774 1.287 . . . . 0.0 113.534 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.72 -15.98 63.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -76.28 -15.07 60.08 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.27 152.31 42.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.51 1.124 . . . . 0.0 113.861 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -119.97 -90.49 0.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.37 1.468 . . . . 0.0 112.409 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -160.91 118.13 1.44 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.371 1.469 . . . . 0.0 108.385 165.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -20.9 29.96 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.096 2.531 . . . . 0.0 115.512 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -50.86 -55.32 28.28 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.98 -28.2 42.09 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.905 3.07 . . . . 0.0 112.873 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.46 -34.51 78.46 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.2 mt -79.14 -32.66 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.107 0.563 . . . . 0.0 111.37 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.81 -5.59 2.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -117.45 -9.05 10.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.964 1.706 . . . . 0.0 113.804 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 58.7 mt -63.98 152.53 87.15 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.198 1.399 . . . . 0.0 113.078 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.97 -32.71 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.539 2.826 . . . . 0.0 114.603 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.64 13.43 19.93 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.108 1.363 . . . . 0.0 113.09 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.06 -135.73 48.67 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.98 0.8 . . . . 0.0 112.197 -167.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.23 -26.92 53.07 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.91 -10.28 56.29 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.7 t -78.66 0.62 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.211 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.7 mt -111.13 -16.23 13.51 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.726 1.61 . . . . 0.0 112.834 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -146.24 153.87 41.08 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.771 1.623 . . . . 0.0 114.558 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -107.75 76.53 1.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.399 1.095 . . . . 0.0 113.317 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 C--O 1.239 0.543 0 C-N-CA 124.464 1.105 . . . . 0.0 109.454 169.065 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -122.47 27.22 7.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.155 0.982 . . . . 0.0 113.627 -166.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.99 -169.47 17.5 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.888 -1.132 . . . . 0.0 113.588 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.68 132.8 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.995 2.118 . . . . 0.0 108.617 173.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.96 93.76 4.61 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -79.82 111.19 15.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 121.55 17.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.729 0.695 . . . . 0.0 111.307 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.8 mt -135.99 156.78 76.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.373 1.469 . . . . 0.0 110.653 -173.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.29 137.68 67.11 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.56 2.174 . . . . 0.0 110.774 160.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -60.21 133.37 56.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 0.0 111.063 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.29 5.25 89.02 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.24 -1.311 . . . . 0.0 115.07 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.5 m -55.12 125.55 57.75 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.179 1.99 . . . . 0.0 110.506 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -68.02 132.31 26.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.968 1.779 . . . . 0.0 111.851 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.46 126.22 41.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.208 1.803 . . . . 0.0 107.665 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -95.99 153.61 17.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.216 1.007 . . . . 0.0 110.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.32 123.71 89.44 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.727 -0.608 . . . . 0.0 110.672 172.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.19 -40.19 20.58 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.992 2.461 . . . . 0.0 111.475 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.1 p -134.82 165.02 26.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.079 2.552 . . . . 0.0 111.309 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -70.94 136.03 48.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.493 1.117 . . . . 0.0 112.056 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.54 -157.32 13.22 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.521 1.058 . . . . 0.0 114.629 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.68 150.42 31.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.557 1.943 . . . . 0.0 110.19 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 t -66.01 133.26 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -41.74 8.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 176.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -158.88 145.64 17.17 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.069 1.748 . . . . 0.0 109.372 -169.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.6 mt -137.32 129.87 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.901 1.28 . . . . 0.0 108.864 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.6 p90 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.51 137.01 56.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.607 1.563 . . . . 0.0 114.823 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.4 tp -115.95 123.44 48.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.21 125.47 48.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.276 1.03 . . . . 0.0 109.753 171.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.1 mt -121.45 147.46 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.588 1.155 . . . . 0.0 111.606 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.87 136.95 49.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.692 1.997 . . . . 0.0 110.812 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 123.876 0.87 . . . . 0.0 112.773 171.336 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.295 52.4 m-85 . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -115.16 151.86 33.64 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.376 1.87 . . . . 0.0 110.746 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.89 102.85 4.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.123 1.769 . . . . 0.0 110.206 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -85.31 139.83 31.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.384 0.274 . . . . 0.0 111.193 170.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -126.25 91.36 3.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.532 2.333 . . . . 0.0 109.436 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.55 158.36 16.49 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.961 1.304 . . . . 0.0 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 63.54 56.34 1.62 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.503 1.921 . . . . 0.0 114.124 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.2 mt -96.49 147.37 23.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 111.332 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -84.42 -48.49 9.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.63 148.11 30.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.062 1.745 . . . . 0.0 112.076 -169.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -93.66 144.62 25.22 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.938 1.295 . . . . 0.0 113.153 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -104.36 -10.97 17.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.605 0.762 . . . . 0.0 112.288 166.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.53 164.31 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.97 1.708 . . . . 0.0 113.191 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.45 164.37 14.98 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.016 2.126 . . . . 0.0 110.515 168.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.73 128.12 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.74 7.9 74.16 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.634 1.111 . . . . 0.0 115.747 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.27 133.32 35.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.044 1.922 . . . . 0.0 107.276 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -70.5 146.24 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.016 0.527 . . . . 0.0 111.8 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.6 m -129.33 154.06 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 110.007 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -133.5 140.59 47.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.954 1.702 . . . . 0.0 108.736 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.26 125.68 11.39 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.264 1.031 . . . . 0.0 112.751 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.63 -1.37 66.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.829 1.68 . . . . 0.0 115.46 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -88.54 142.29 27.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.125 1.37 . . . . 0.0 114.031 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.1 mm -67.3 132.12 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.084 0.856 . . . . 0.0 111.774 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 44.2 pt -116.57 -23.17 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.826 1.25 . . . . 0.0 113.211 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -172.54 -175.49 1.35 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.623 1.969 . . . . 0.0 110.665 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.38 139.14 46.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 0.0 107.505 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.11 144.37 50.29 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.64 0.776 . . . . 0.0 112.126 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 C-N-CA 123.664 0.649 . . . . 0.0 113.004 -175.858 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.54 117.37 14.13 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.08 0.952 . . . . 0.0 111.138 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -92.68 101.54 13.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.713 0.805 . . . . 0.0 110.784 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.281 52.9 t80 -93.28 115.65 28.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 170.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -117.62 116.08 26.36 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.632 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -92.24 121.85 34.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.72 1.608 . . . . 0.0 110.426 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.6 mtm -125.67 153.18 44.22 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.341 1.456 . . . . 0.0 110.756 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.12 128.92 46.97 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.654 1.181 . . . . 0.0 110.817 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.61 1.71 83.53 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.285 1.421 . . . . 0.0 115.812 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.51 -174.7 43.85 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.031 1.777 . . . . 0.0 111.846 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.8 125.3 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.618 1.167 . . . . 0.0 114.126 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 151.81 171.5 19.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.648 1.594 . . . . 0.0 113.037 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -65.06 -34.93 79.6 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.343 -1.093 . . . . 0.0 112.15 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.35 67.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.462 1.505 . . . . 0.0 113.58 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -92.94 -14.85 27.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.77 144.61 57.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.537 1.135 . . . . 0.0 112.329 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -116.24 -82.9 0.63 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.048 0.939 . . . . 0.0 112.24 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -170.4 129.02 0.81 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 128.125 2.57 . . . . 0.0 106.111 160.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -71.58 -24.48 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.948 2.432 . . . . 0.0 114.539 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -54.05 -55.08 40.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -171.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.88 -31.09 48.28 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.688 2.925 . . . . 0.0 112.082 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -65.1 -41.62 94.77 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.9 mt -71.58 -35.78 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.391 0.541 . . . . 0.0 111.303 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 44.3 m-20 -63.68 -2.85 1.9 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -126.53 -7.59 6.29 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.096 2.158 . . . . 0.0 115.01 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.76 151.12 55.05 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.14 0.976 . . . . 0.0 112.484 170.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.41 -32.87 49.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.537 2.824 . . . . 0.0 114.947 -168.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.98 10.2 24.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.534 1.133 . . . . 0.0 109.61 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.68 -136.26 44.32 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.548 -1.345 . . . . 0.0 111.915 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.7 -25.28 68.08 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.934 -1.333 . . . . 0.0 113.939 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -68.41 -3.28 10.7 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.9 m -77.3 -6.69 54.12 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 111.94 166.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.06 -12.92 12.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.779 1.632 . . . . 0.0 113.854 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.13 161.52 38.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -114.81 87.01 2.55 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 122.228 1.013 . . . . 0.0 111.904 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.203 1.401 . . . . 0.0 110.915 177.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.66 21.29 7.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.17 -172.08 13.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.703 1.144 . . . . 0.0 113.903 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.78 136.8 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.342 2.257 . . . . 0.0 108.549 173.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.07 100.88 7.82 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.49 130.61 36.22 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.32 34.22 0.13 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.968 2.107 . . . . 0.0 115.901 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 148.74 90.33 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.727 -1.233 . . . . 0.0 111.835 -168.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.43 146.54 85.59 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.213 1.942 . . . . 0.0 111.982 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.12 129.0 33.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.967 0.907 . . . . 0.0 110.331 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.62 63.06 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.707 1.146 . . . . 0.0 115.523 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -58.87 126.5 80.97 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-N 119.612 1.706 . . . . 0.0 113.15 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -69.66 130.31 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.27 1.98 . . . . 0.0 112.317 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 mm -85.13 129.6 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.974 1.71 . . . . 0.0 108.532 170.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -100.78 151.98 21.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.164 . . . . 0.0 110.39 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.75 88.98 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.367 0.667 . . . . 0.0 111.621 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.71 -26.02 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.176 3.251 . . . . 0.0 113.249 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.9 p -133.27 164.33 27.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 127.306 2.242 . . . . 0.0 110.263 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.98 145.39 46.32 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.169 -0.957 . . . . 0.0 108.479 151.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.83 -163.92 24.67 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.144 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -147.28 143.75 28.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.58 1.152 . . . . 0.0 111.917 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.16 128.11 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.33 -43.88 7.83 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.426 1.491 . . . . 0.0 114.947 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -159.21 144.1 15.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.048 0.939 . . . . 0.0 110.992 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -140.75 114.85 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.674 1.19 . . . . 0.0 109.88 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 p90 . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -167.339 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.7 mttm . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.13 137.45 55.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 tp -115.95 131.5 56.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.719 2.007 . . . . 0.0 108.582 167.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 125.81 53.54 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.59 1.156 . . . . 0.0 110.316 173.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.17 144.46 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.27 1.028 . . . . 0.0 111.552 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.36 136.27 41.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.654 1.982 . . . . 0.0 110.793 171.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 123.628 0.771 . . . . 0.0 111.619 170.422 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.73 159.08 31.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.556 2.742 . . . . 0.0 112.117 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.62 105.26 4.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.184 2.194 . . . . 0.0 110.96 -171.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -85.79 144.33 27.8 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.472 0.709 . . . . 0.0 112.314 171.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.42 87.12 2.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.136 2.574 . . . . 0.0 108.887 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.39 159.55 19.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.044 1.338 . . . . 0.0 110.918 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 62.87 50.41 3.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.754 2.021 . . . . 0.0 114.455 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.9 mt -89.79 158.41 17.51 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.672 -1.267 . . . . 0.0 112.419 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -98.76 -46.61 5.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 0.0 109.13 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -150.14 149.41 30.21 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.207 1.803 . . . . 0.0 111.888 -171.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -103.39 134.52 46.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 112.108 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -87.43 -27.51 22.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.125 0.57 . . . . 0.0 111.791 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -112.93 166.72 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.023 1.729 . . . . 0.0 112.521 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -116.69 162.22 18.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.801 2.04 . . . . 0.0 111.283 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.2 t -55.99 126.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.401 1.081 . . . . 0.0 109.189 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.34 12.14 61.79 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.453 1.501 . . . . 0.0 115.389 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -96.4 133.69 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.764 1.782 . . . . 0.0 107.657 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -72.97 146.75 45.79 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.011 0.924 . . . . 0.0 111.413 167.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.86 167.12 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.343 1.857 . . . . 0.0 111.879 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.85 134.16 44.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.427 1.891 . . . . 0.0 110.055 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.55 121.78 3.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.045 1.338 . . . . 0.0 112.851 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.81 4.69 69.35 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.523 1.535 . . . . 0.0 115.412 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -90.25 148.97 22.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 114.649 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.8 mm -70.12 139.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.63 0.729 . . . . 0.0 111.469 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.53 -23.06 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.507 1.123 . . . . 0.0 112.544 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.15 -179.01 2.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.026 1.33 . . . . 0.0 111.368 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.97 138.14 54.76 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 80.0 p -66.43 135.99 55.08 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.651 1.18 . . . . 0.0 112.104 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.038 0 CA-C-O 122.389 0.994 . . . . 0.0 113.318 -176.452 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.19 116.11 16.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.487 -1.383 . . . . 0.0 111.082 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -94.62 102.04 13.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.855 0.752 . . . . 0.0 111.774 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.275 43.9 t80 -93.9 116.81 29.3 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.381 1.473 . . . . 0.0 114.77 171.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -124.6 116.61 22.69 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.757 1.223 . . . . 0.0 111.654 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -101.1 127.08 47.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.517 1.127 . . . . 0.0 111.409 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.2 mtm -128.44 157.33 41.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.792 1.637 . . . . 0.0 111.65 -173.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -136.09 137.17 40.79 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.177 1.391 . . . . 0.0 111.243 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.78 -18.61 8.72 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.167 1.365 . . . . 0.0 115.031 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -176.83 -168.74 37.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.152 1.834 . . . . 0.0 111.273 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.59 112.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 156.49 169.36 20.45 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.895 1.712 . . . . 0.0 111.557 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -61.14 -40.64 94.59 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.361 -1.082 . . . . 0.0 113.245 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.47 -26.95 67.17 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.51 -11.86 55.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.55 141.82 51.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.734 1.214 . . . . 0.0 112.651 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -106.03 -80.09 0.56 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -174.51 123.93 0.38 Allowed Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 128.37 2.668 . . . . 0.0 106.147 160.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.42 -29.49 11.09 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.054 2.503 . . . . 0.0 114.715 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -52.84 71.17 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.58 -30.69 70.93 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.926 2.417 . . . . 0.0 111.881 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.17 -45.75 93.32 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 166.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.7 mt -69.53 -32.12 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.767 -1.208 . . . . 0.0 111.719 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.08 0.42 1.95 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.061 1.744 . . . . 0.0 115.07 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -124.74 -8.52 7.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 114.303 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.59 151.31 88.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.927 -1.108 . . . . 0.0 112.82 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.5 -35.2 39.87 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.743 2.962 . . . . 0.0 114.806 -165.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -112.13 16.4 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.923 1.289 . . . . 0.0 112.16 166.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.38 -134.72 48.04 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 121.076 -1.015 . . . . 0.0 112.441 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.34 -22.7 65.16 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.419 -1.048 . . . . 0.0 112.544 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.6 mtt-85 -72.3 -3.36 23.31 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.632 -1.293 . . . . 0.0 112.564 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 75.5 m -84.54 -7.53 59.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.501 1.12 . . . . 0.0 113.054 163.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.94 -19.88 15.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.777 1.631 . . . . 0.0 111.671 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -147.41 160.21 42.82 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -104.9 86.24 2.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.472 0.655 0 C-N-CA 124.604 1.162 . . . . 0.0 109.666 173.5 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -112.71 93.96 4.68 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.78 -172.47 26.45 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.198 0.904 . . . . 0.0 113.444 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.23 134.62 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.705 2.002 . . . . 0.0 108.862 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -110.53 92.29 3.99 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -78.37 106.18 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.72 120.24 10.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.341 0.973 . . . . 0.0 110.744 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.8 mt -129.83 152.32 79.67 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 124.012 0.925 . . . . 0.0 111.106 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.58 135.52 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.476 -1.009 . . . . 0.0 109.476 160.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.4 tttt -58.67 139.04 56.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.846 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 -6.46 76.29 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.111 -1.383 . . . . 0.0 115.881 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.4 m -51.76 127.53 34.4 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.693 2.247 . . . . 0.0 112.964 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.42 131.26 22.79 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.852 1.701 . . . . 0.0 112.084 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.2 132.2 32.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.152 1.781 . . . . 0.0 107.824 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -104.52 155.65 18.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 109.492 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.04 129.59 82.65 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.263 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.13 -31.87 22.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.382 2.721 . . . . 0.0 113.472 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -140.21 159.97 41.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.957 2.103 . . . . 0.0 107.546 -171.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -77.01 138.48 39.62 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.93 -1.106 . . . . 0.0 111.764 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.7 -157.05 10.05 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.075 1.322 . . . . 0.0 113.651 -173.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.91 146.86 25.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.428 1.491 . . . . 0.0 113.005 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.21 129.3 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -43.11 6.92 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -159.41 141.65 13.61 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.694 1.198 . . . . 0.0 110.983 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 55.5 mt -142.6 113.83 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.785 1.234 . . . . 0.0 110.965 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.8 p90 . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 124.493 1.117 . . . . 0.0 111.823 -168.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.2 mttm . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.13 137.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.777 1.631 . . . . 0.0 115.051 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.9 tp -117.87 126.68 52.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.042 2.137 . . . . 0.0 108.955 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.01 126.38 52.13 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.819 1.248 . . . . 0.0 110.256 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.97 147.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.998 1.319 . . . . 0.0 111.45 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.04 137.3 47.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.696 1.998 . . . . 0.0 110.144 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 . . . . . 0 N--CA 1.472 0.665 0 O-C-N 121.223 -0.923 . . . . 0.0 113.443 175.335 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.297 42.1 m-85 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -123.22 161.21 24.98 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 112.141 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -143.84 104.13 4.13 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.252 2.221 . . . . 0.0 110.955 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -84.81 145.8 27.68 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 167.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -130.72 93.33 3.4 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.604 2.362 . . . . 0.0 109.837 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.39 157.37 15.92 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.663 1.185 . . . . 0.0 110.839 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.266 94.1 m-70 69.76 49.79 0.51 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.072 2.149 . . . . 0.0 114.484 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.84 143.82 25.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.873 0.869 . . . . 0.0 111.485 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.11 -43.32 15.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.402 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -154.48 151.11 28.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.016 2.526 . . . . 0.0 110.847 -169.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -96.96 159.33 14.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.744 0.818 . . . . 0.0 111.238 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -109.67 -28.58 8.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.448 1.099 . . . . 0.0 112.385 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.78 168.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.165 1.786 . . . . 0.0 110.667 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -128.12 172.1 11.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 111.358 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.98 130.8 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.275 1.03 . . . . 0.0 109.224 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.15 3.46 72.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.783 1.182 . . . . 0.0 115.323 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.75 126.14 31.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.015 1.407 . . . . 0.0 111.877 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.24 124.89 28.19 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.803 0.441 . . . . 0.0 111.488 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -106.94 157.03 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.858 1.663 . . . . 0.0 110.46 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.36 140.54 52.11 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.656 1.582 . . . . 0.0 109.307 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -44.02 123.31 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.446 1.098 . . . . 0.0 112.992 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.96 6.95 86.21 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.246 1.403 . . . . 0.0 115.362 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -91.63 145.88 24.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.374 1.469 . . . . 0.0 112.858 170.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.2 mm -70.12 137.93 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.081 0.855 . . . . 0.0 112.114 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -123.58 -24.05 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.19 -173.17 1.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.45 1.023 . . . . 0.0 111.629 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.55 137.05 41.64 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.161 1.385 . . . . 0.0 107.3 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.8 t -75.56 142.62 42.72 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 C-N-CA 124.268 0.937 . . . . 0.0 113.157 177.755 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 121.105 0.479 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.81 121.56 42.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 110.485 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -96.11 102.4 14.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.92 0.888 . . . . 0.0 110.524 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.76 112.86 24.8 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.371 1.468 . . . . 0.0 114.65 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.44 118.62 35.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.19 0.596 . . . . 0.0 112.155 174.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -93.84 127.56 39.65 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.639 1.576 . . . . 0.0 111.55 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.1 mtm -132.16 162.43 30.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.475 1.91 . . . . 0.0 111.593 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -132.5 128.91 38.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.39 1.076 . . . . 0.0 112.796 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.87 6.93 74.32 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.254 1.261 . . . . 0.0 116.254 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.63 -179.6 44.04 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 126.439 1.971 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.72 128.9 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.282 1.433 . . . . 0.0 112.336 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.62 156.79 6.97 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.786 1.66 . . . . 0.0 112.056 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -48.2 -42.51 30.15 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.23 62.41 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -92.28 -13.41 30.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.628 1.571 . . . . 0.0 114.537 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.54 148.18 34.26 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.314 1.045 . . . . 0.0 113.508 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -116.99 -96.78 0.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.714 1.606 . . . . 0.0 111.826 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -159.51 118.24 1.65 Allowed Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.603 1.961 . . . . 0.0 113.114 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -85.35 -30.97 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.913 1.742 . . . . 0.0 114.296 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -52.37 -55.71 29.25 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 121.169 1.804 . . . . 0.0 114.697 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.01 -26.75 21.34 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.778 2.985 . . . . 0.0 112.225 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -67.26 -37.48 83.54 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.05 -44.95 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.093 0.557 . . . . 0.0 110.572 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -67.52 -0.89 4.2 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -173.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -111.92 -9.57 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.212 1.805 . . . . 0.0 113.52 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.28 159.15 42.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.243 1.417 . . . . 0.0 113.378 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.35 -48.06 24.02 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.73 3.62 . . . . 0.0 114.062 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -114.08 8.85 17.13 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.446 1.099 . . . . 0.0 113.356 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.51 -135.79 27.41 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.562 1.077 . . . . 0.0 111.961 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.18 -28.83 19.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.605 1.162 . . . . 0.0 113.6 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -70.72 -7.84 47.78 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.055 -1.028 . . . . 0.0 113.31 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.4 m -81.49 -3.86 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.802 0.841 . . . . 0.0 112.27 167.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.1 mp -111.11 -14.83 13.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.993 1.717 . . . . 0.0 113.322 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -145.03 161.88 38.31 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.234 -1.541 . . . . 0.0 113.76 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -110.14 82.75 1.64 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.015 0.912 . . . . 0.0 113.134 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 125.316 1.446 . . . . 0.0 111.061 174.22 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 . . . . . 0 CA--C 1.538 0.49 0 CA-C-O 120.592 0.234 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.357 83.2 m-85 -108.12 23.43 14.5 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -170.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.28 -164.51 13.44 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.332 0.968 . . . . 0.0 113.266 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.48 133.71 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 126.609 1.963 . . . . 0.0 108.953 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -110.43 96.48 6.22 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -78.64 123.88 27.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.49 56.59 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.703 2.001 . . . . 0.0 113.847 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.6 149.0 63.55 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.288 -0.883 . . . . 0.0 111.112 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.45 146.28 93.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.05 1.833 . . . . 0.0 111.777 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -54.58 135.48 46.26 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 110.678 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.95 68.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.737 1.161 . . . . 0.0 115.63 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 m -52.71 126.14 39.78 Favored Pre-proline 0 N--CA 1.478 0.936 0 CA-C-N 118.75 1.275 . . . . 0.0 112.238 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -69.49 129.28 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.09 1.86 . . . . 0.0 111.998 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -85.86 130.59 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 108.468 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -103.35 149.94 24.27 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 109.764 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.54 83.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.879 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.4 -46.86 4.96 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.47 2.78 . . . . 0.0 111.574 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -113.98 172.81 6.77 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 128.487 2.715 . . . . 0.0 109.703 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -68.98 149.97 48.22 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.245 -0.91 . . . . 0.0 110.017 155.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 -154.64 12.45 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.475 0.56 . . . . 0.0 114.159 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -151.24 145.84 25.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.574 1.549 . . . . 0.0 111.021 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -66.0 128.12 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.04 -41.34 9.61 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -159.37 145.67 16.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.001 1.72 . . . . 0.0 109.543 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.0 mt -137.99 127.64 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 109.365 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.517 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.4 mttp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.14 143.16 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.861 1.665 . . . . 0.0 114.421 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 tt -122.76 136.6 54.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.803 1.641 . . . . 0.0 109.416 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.52 125.83 52.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.311 0.644 . . . . 0.0 111.935 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.02 147.92 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.883 1.273 . . . . 0.0 111.813 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -112.54 141.45 46.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 111.726 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 124.769 1.228 . . . . 0.0 113.062 173.187 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 C--O 1.235 0.328 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -121.14 142.97 49.36 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.954 1.702 . . . . 0.0 111.31 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -123.93 103.68 8.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.762 2.025 . . . . 0.0 110.426 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -86.68 144.01 27.33 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.566 0.346 . . . . 0.0 111.62 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -128.7 97.67 4.75 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.427 1.891 . . . . 0.0 106.892 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.28 151.59 22.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 109.844 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 71.56 63.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.937 2.095 . . . . 0.0 113.95 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.4 mt -101.67 155.7 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.512 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.45 -43.3 6.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.738 1.215 . . . . 0.0 110.939 167.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -145.14 150.29 36.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.614 1.566 . . . . 0.0 112.38 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -92.54 158.31 16.07 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.57 1.148 . . . . 0.0 112.441 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -122.2 -10.63 8.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.05 0.94 . . . . 0.0 113.205 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.3 160.81 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.56 1.144 . . . . 0.0 112.341 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -120.26 155.33 33.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.29 1.836 . . . . 0.0 112.841 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.1 t -55.11 123.14 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 0.0 109.413 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.08 0.7 61.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.078 1.323 . . . . 0.0 115.528 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -88.28 128.95 35.49 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.966 1.883 . . . . 0.0 113.3 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -74.55 139.97 44.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.064 0.546 . . . . 0.0 111.998 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.31 159.86 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 110.373 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -126.67 148.3 49.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.407 1.483 . . . . 0.0 108.658 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.42 121.74 4.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.363 1.065 . . . . 0.0 111.984 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.23 10.25 58.55 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.732 1.158 . . . . 0.0 114.971 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.33 134.75 34.09 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.966 1.306 . . . . 0.0 112.676 167.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.4 mm -65.57 131.41 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 118.888 0.767 . . . . 0.0 110.372 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.4 pt -114.98 -21.96 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.479 1.112 . . . . 0.0 113.231 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.44 -179.82 1.96 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 110.904 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -129.63 135.0 48.0 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t -80.27 144.54 32.77 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.217 0 C-N-CA 125.312 1.434 . . . . 0.0 112.361 -179.076 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.0 p80 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.85 115.49 19.47 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.159 170.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -93.75 101.29 13.41 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.29 0.636 . . . . 0.0 110.943 172.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.66 117.21 29.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.948 1.299 . . . . 0.0 114.128 171.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -122.6 114.44 20.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.348 1.059 . . . . 0.0 111.888 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -92.51 121.94 34.46 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.208 1.803 . . . . 0.0 110.828 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.1 mtm -127.38 160.86 30.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.238 1.815 . . . . 0.0 111.189 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -140.26 133.96 30.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.11 6.96 81.21 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.722 1.153 . . . . 0.0 115.125 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.29 179.46 38.48 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 127.57 2.51 . . . . 0.0 110.086 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.1 125.07 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.76 168.86 15.45 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.607 1.575 . . . . 0.0 112.875 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -60.3 -36.9 78.95 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.184 -1.186 . . . . 0.0 113.523 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.08 -17.36 63.22 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.795 -1.191 . . . . 0.0 114.05 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.23 -12.55 43.43 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.47 137.11 52.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.567 1.147 . . . . 0.0 112.986 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -103.13 -89.86 0.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -161.91 115.9 1.23 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.575 2.35 . . . . 0.0 113.585 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 -31.76 2.08 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.103 1.869 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -54.37 -53.39 59.93 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.78 -22.56 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.886 3.058 . . . . 0.0 112.052 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -65.52 -42.67 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 167.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 49.0 mt -72.21 -25.62 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.297 -0.877 . . . . 0.0 112.206 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -59.76 -14.2 13.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -118.13 -1.14 11.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.431 1.092 . . . . 0.0 113.641 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.89 148.65 92.23 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.517 0.727 . . . . 0.0 112.632 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.58 -26.45 23.71 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.609 2.873 . . . . 0.0 114.932 -168.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -112.82 -7.86 13.76 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.83 -137.81 13.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.413 1.482 . . . . 0.0 112.535 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -55.09 -30.78 60.39 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.727 1.263 . . . . 0.0 111.694 170.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.0 mtp-105 -63.97 -12.25 36.04 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.476 1.51 . . . . 0.0 113.899 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 71.6 m -79.77 -7.85 58.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.472 1.033 . . . . 0.0 112.565 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.06 -14.0 15.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.106 1.363 . . . . 0.0 112.948 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -149.98 162.3 40.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -111.72 80.57 1.34 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--O 1.24 0.555 0 C-N-CA 124.888 1.275 . . . . 0.0 110.123 173.59 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 121.739 0.781 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.526 12.1 m-30 -90.74 39.44 0.98 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -173.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.91 -179.55 26.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.82 1.2 . . . . 0.0 112.897 170.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.58 127.48 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.687 1.595 . . . . 0.0 109.501 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -99.26 90.0 4.41 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -74.1 107.24 6.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.97 123.95 20.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.056 0.844 . . . . 0.0 110.294 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 mt -138.35 151.98 70.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.61 0.764 . . . . 0.0 111.228 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.2 136.5 44.26 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.36 2.04 . . . . 0.0 110.033 162.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.02 134.61 52.58 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.207 1.003 . . . . 0.0 109.949 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.32 -8.35 79.32 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.237 -1.313 . . . . 0.0 115.824 -175.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.6 m -53.77 123.81 40.23 Favored Pre-proline 0 N--CA 1.481 1.114 0 CA-C-N 120.219 2.009 . . . . 0.0 112.331 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.03 130.85 19.71 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.726 1.617 . . . . 0.0 111.161 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -85.74 131.2 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.463 1.505 . . . . 0.0 108.216 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -101.32 149.8 23.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.31 1.044 . . . . 0.0 109.84 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.19 130.85 87.45 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.76 -0.588 . . . . 0.0 110.835 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.62 -27.42 15.33 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.923 3.082 . . . . 0.0 112.724 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 p -129.94 161.67 30.36 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.039 2.535 . . . . 0.0 112.905 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -63.92 138.83 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 157.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.52 -155.95 11.37 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -151.99 148.78 28.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.187 1.395 . . . . 0.0 111.584 171.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.66 129.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -41.92 7.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.003 1.721 . . . . 0.0 115.244 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -157.9 143.25 16.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.467 1.107 . . . . 0.0 111.464 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.4 mt -136.42 125.73 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.381 1.072 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.8 p90 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.967 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 mttm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 111.649 0.241 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.42 138.39 53.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.689 1.595 . . . . 0.0 114.743 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -119.46 127.09 52.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.959 2.104 . . . . 0.0 108.605 171.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 126.76 52.22 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.365 1.066 . . . . 0.0 110.464 171.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.8 mt -123.12 147.78 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.952 1.301 . . . . 0.0 111.927 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.22 141.96 42.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.201 2.2 . . . . 0.0 111.737 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 173.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 42.4 m-85 . . . . . 0 C--O 1.237 0.447 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -125.81 152.51 45.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.541 1.936 . . . . 0.0 111.431 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.74 104.03 6.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.846 2.059 . . . . 0.0 109.986 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.95 139.99 29.95 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.527 0.331 . . . . 0.0 111.63 170.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -125.57 92.93 3.71 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.621 2.368 . . . . 0.0 108.759 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.23 163.29 14.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.889 1.276 . . . . 0.0 110.914 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 64.71 38.08 7.15 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.489 1.916 . . . . 0.0 114.966 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.54 154.25 27.62 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.496 -1.378 . . . . 0.0 112.848 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.53 -49.43 6.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.73 1.612 . . . . 0.0 109.272 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -152.18 149.33 28.63 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.641 1.976 . . . . 0.0 111.387 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -94.47 141.35 28.69 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.503 1.121 . . . . 0.0 111.913 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -95.43 -15.51 22.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.058 0.943 . . . . 0.0 111.878 167.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.94 165.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.27 1.828 . . . . 0.0 113.154 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -120.79 164.34 16.76 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.744 2.018 . . . . 0.0 111.2 172.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.07 129.72 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.32 4.58 68.28 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.531 1.062 . . . . 0.0 115.713 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.62 130.27 35.22 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.623 1.712 . . . . 0.0 112.912 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -65.0 143.87 57.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.407 0.622 . . . . 0.0 110.795 163.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 161.62 21.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.514 1.526 . . . . 0.0 110.535 167.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -133.86 143.29 48.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.576 1.55 . . . . 0.0 109.88 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.14 117.61 2.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.966 0.889 . . . . 0.0 111.904 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.83 74.88 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.547 1.546 . . . . 0.0 115.205 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -85.36 145.14 27.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.519 1.66 . . . . 0.0 114.487 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.9 mm -70.82 136.46 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.854 0.835 . . . . 0.0 111.969 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 49.1 pt -122.79 -23.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.69 1.196 . . . . 0.0 112.903 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.32 -176.57 1.91 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.527 1.531 . . . . 0.0 110.853 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -129.44 136.63 50.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.8 t -66.08 137.07 56.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.981 0 C-N-CA 125.575 1.56 . . . . 0.0 111.885 179.169 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.46 123.13 47.38 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.588 1.555 . . . . 0.0 109.812 165.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -98.38 103.62 15.58 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.472 0.709 . . . . 0.0 110.867 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.272 36.0 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 172.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -116.26 115.28 25.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.436 1.094 . . . . 0.0 111.851 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -95.31 125.25 39.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.804 1.642 . . . . 0.0 111.149 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.9 mtm -131.0 153.0 49.69 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.494 1.518 . . . . 0.0 111.372 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.24 130.51 52.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.227 1.411 . . . . 0.0 111.898 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.99 36.15 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.39 -179.73 48.0 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.549 2.023 . . . . 0.0 111.9 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 125.9 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.579 1.552 . . . . 0.0 112.891 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.98 164.85 10.08 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.888 . . . . 0.0 112.325 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -56.79 -36.95 70.47 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.038 -1.272 . . . . 0.0 113.155 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.45 -12.37 56.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -97.59 -8.82 28.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.29 142.12 55.65 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.212 1.405 . . . . 0.0 113.087 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.13 -79.7 0.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.354 1.062 . . . . 0.0 112.335 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -170.07 123.57 0.64 Allowed Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.843 2.057 . . . . 0.0 113.054 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.25 -35.4 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.535 2.156 . . . . 0.0 114.102 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -54.41 -54.69 45.53 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.11 -18.9 39.83 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.879 3.053 . . . . 0.0 113.14 -175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.06 -44.18 66.27 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.76 -31.25 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.707 0.803 . . . . 0.0 111.634 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.82 -3.77 3.69 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -123.53 -1.99 8.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.685 1.594 . . . . 0.0 114.374 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.7 mt -69.25 151.22 97.07 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.292 1.037 . . . . 0.0 112.292 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.08 -36.17 71.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.174 2.583 . . . . 0.0 115.063 -165.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -111.51 9.59 21.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.896 0.878 . . . . 0.0 113.366 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 71.51 -134.06 22.16 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.026 -1.046 . . . . 0.0 112.241 -171.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.69 -26.0 65.23 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.341 -1.094 . . . . 0.0 112.94 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -70.91 -3.9 21.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.407 1.483 . . . . 0.0 114.171 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 68.9 m -82.13 -6.08 58.92 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.14 0.976 . . . . 0.0 113.122 165.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.85 -13.25 14.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.307 1.443 . . . . 0.0 113.114 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.92 163.1 36.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.448 1.476 . . . . 0.0 113.896 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -111.35 89.67 3.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 124.531 1.132 . . . . 0.0 110.682 170.987 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.285 97.1 m-85 -107.14 15.33 25.28 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -170.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.96 -164.77 12.26 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.12 -0.987 . . . . 0.0 115.027 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.21 137.09 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 127.477 2.311 . . . . 0.0 109.384 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.9 97.17 5.49 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -77.67 108.49 10.91 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.03 117.95 5.71 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.313 1.045 . . . . 0.0 111.051 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -133.93 148.76 69.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.147 0.979 . . . . 0.0 111.089 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.36 139.46 65.44 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.234 1.956 . . . . 0.0 110.635 163.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -51.92 136.73 28.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 110.184 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.86 -4.73 78.67 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.537 -1.702 . . . . 0.0 116.19 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 m -53.1 123.5 34.15 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 120.431 2.116 . . . . 0.0 112.343 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.46 127.95 16.47 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.654 1.569 . . . . 0.0 110.907 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 mm -84.38 129.01 38.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.876 1.27 . . . . 0.0 107.797 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -99.03 152.41 19.85 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.656 1.183 . . . . 0.0 109.983 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.01 124.72 90.25 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 118.39 -0.815 . . . . 0.0 110.085 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.26 -36.42 21.17 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.582 2.855 . . . . 0.0 112.835 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.573 2.349 . . . . 0.0 108.989 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.97 147.73 49.8 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.058 -1.026 . . . . 0.0 108.988 155.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.15 -159.4 19.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.916 0.77 . . . . 0.0 113.607 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -148.35 144.46 27.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.874 1.27 . . . . 0.0 112.397 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.21 125.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.91 -44.87 8.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.942 1.697 . . . . 0.0 115.101 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -157.06 147.48 21.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.012 1.325 . . . . 0.0 111.105 -168.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.406 HG23 ' CE1' ' A' ' 129' ' ' TYR . 47.0 mt -140.79 118.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.716 1.206 . . . . 0.0 109.513 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 p90 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.724 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 t -131.92 137.18 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 126.188 1.795 . . . . 0.0 114.61 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.66 137.52 51.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.75 1.62 . . . . 0.0 109.618 165.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.53 125.28 51.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.676 0.79 . . . . 0.0 112.266 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.69 153.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.295 1.438 . . . . 0.0 111.906 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.63 55.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.857 2.063 . . . . 0.0 111.636 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 124.587 1.155 . . . . 0.0 113.016 177.619 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.273 55.5 m-85 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -104.23 157.08 17.38 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.465 1.906 . . . . 0.0 111.139 170.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -138.36 105.13 5.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.098 2.159 . . . . 0.0 110.501 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -85.81 147.74 26.16 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.19 109.78 8.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.947 1.699 . . . . 0.0 107.875 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.8 157.02 17.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.809 1.643 . . . . 0.0 110.562 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 67.1 59.11 0.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.113 1.765 . . . . 0.0 113.253 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 mt -104.82 151.23 24.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.691 1.597 . . . . 0.0 111.058 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.75 -42.67 6.4 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.487 . . . . 0.0 111.298 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -146.58 147.08 30.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.652 1.581 . . . . 0.0 112.265 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.406 ' CE1' HG23 ' A' ' 100' ' ' ILE . 90.1 m-85 -94.04 141.69 28.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 112.647 176.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -106.89 -5.77 18.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.808 1.243 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.29 166.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.341 1.456 . . . . 0.0 110.225 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -122.19 165.17 16.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.05 1.34 . . . . 0.0 110.265 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.69 131.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.978 0.911 . . . . 0.0 108.771 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.87 8.14 73.34 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.929 1.252 . . . . 0.0 115.278 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -84.19 119.22 24.75 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.01 1.405 . . . . 0.0 112.862 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -65.83 142.02 58.08 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.231 163.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.99 159.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.307 1.843 . . . . 0.0 109.195 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.66 142.7 50.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.449 1.9 . . . . 0.0 108.848 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.58 123.01 4.56 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.948 0.899 . . . . 0.0 113.326 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.39 3.73 64.74 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.582 1.087 . . . . 0.0 114.804 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.88 133.61 38.09 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.666 1.186 . . . . 0.0 112.487 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.7 mm -67.73 129.31 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.721 0.691 . . . . 0.0 109.992 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.1 pt -112.87 -22.09 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.201 1.001 . . . . 0.0 113.266 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.93 -179.18 2.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.429 1.491 . . . . 0.0 110.322 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.18 132.17 45.91 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.0 t -77.24 146.53 36.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.094 0 C-N-CA 124.98 1.276 . . . . 0.0 111.448 -179.757 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.15 114.07 7.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.173 0.989 . . . . 0.0 110.744 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -91.9 99.04 11.97 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.597 0.759 . . . . 0.0 111.343 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 43.3 t80 -90.97 120.07 31.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.153 1.381 . . . . 0.0 114.679 172.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -130.0 108.36 10.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.987 1.315 . . . . 0.0 111.01 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -96.45 135.78 37.85 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.144 1.378 . . . . 0.0 111.386 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 41.0 mtm -136.11 143.22 44.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.332 1.453 . . . . 0.0 112.065 -166.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -111.62 132.62 54.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.948 1.299 . . . . 0.0 112.988 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.66 1.0 64.95 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.575 1.56 . . . . 0.0 115.17 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 161.64 -169.99 37.25 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 127.856 2.646 . . . . 0.0 109.438 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.87 138.26 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 122.269 1.033 . . . . 0.0 111.006 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.59 161.69 10.67 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 128.757 3.075 . . . . 0.0 109.595 -171.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -57.51 -42.29 82.51 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.704 -1.468 . . . . 0.0 113.44 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.16 -20.63 66.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -78.33 -16.0 58.16 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.8 147.46 45.47 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.36 1.064 . . . . 0.0 112.353 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.36 -61.35 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.409 1.084 . . . . 0.0 113.825 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.4 t0 178.42 123.07 0.2 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 130.557 3.543 . . . . 0.0 108.309 160.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.6 -21.63 21.91 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.78 2.986 . . . . 0.0 116.099 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -51.9 -56.22 23.47 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 120.658 1.572 . . . . 0.0 114.699 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.87 -24.89 60.58 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.618 2.879 . . . . 0.0 112.937 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.275 3.5 t80 -64.26 -45.11 89.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 169.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.5 mt -66.63 -28.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.854 -1.154 . . . . 0.0 111.357 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.22 -4.4 10.39 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -118.09 -10.15 10.39 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.1 mt -66.31 149.66 97.71 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.371 1.068 . . . . 0.0 112.423 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.75 -41.68 10.36 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.789 2.326 . . . . 0.0 113.597 -166.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.67 9.91 34.99 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.11 -133.98 45.93 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 120.866 -1.146 . . . . 0.0 112.441 -172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -54.21 -30.87 51.53 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.907 -0.76 . . . . 0.0 112.772 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -71.43 -5.47 33.04 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.09 1.356 . . . . 0.0 112.456 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.7 m -83.67 -6.91 59.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.968 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.9 -14.81 15.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.992 1.317 . . . . 0.0 113.0 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -146.41 159.12 43.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.535 1.516 . . . . 0.0 115.018 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -104.13 96.42 6.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 122.363 1.078 . . . . 0.0 112.777 -179.444 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.358 93.7 m-85 -106.08 18.96 21.28 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -169.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.72 -172.25 19.03 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.032 -1.042 . . . . 0.0 113.788 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.63 132.92 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.44 1.896 . . . . 0.0 109.039 172.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -111.01 102.01 10.52 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -85.23 115.82 23.22 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 76.1 4.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.862 1.665 . . . . 0.0 112.267 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.49 152.8 41.23 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.37 142.72 91.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.523 2.149 . . . . 0.0 111.001 158.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -59.98 136.3 57.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.935 1.294 . . . . 0.0 110.28 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.68 1.78 90.3 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -57.14 124.67 67.26 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.597 1.698 . . . . 0.0 111.654 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.28 125.31 11.22 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.037 1.158 . . . . 0.0 110.031 176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.8 mm -80.76 129.38 37.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.356 1.462 . . . . 0.0 107.577 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -101.35 152.8 20.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.689 1.196 . . . . 0.0 109.954 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.62 131.54 87.89 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.766 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.75 -34.56 18.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.328 2.685 . . . . 0.0 112.833 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.0 p -129.59 163.4 26.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.547 1.939 . . . . 0.0 108.587 -173.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.93 141.84 58.09 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 121.256 -0.903 . . . . 0.0 108.988 158.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.12 -159.98 21.51 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.068 0.842 . . . . 0.0 113.418 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -151.05 140.91 21.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.228 1.514 . . . . 0.0 111.267 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 t -55.1 137.87 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.108 0.963 . . . . 0.0 113.419 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.97 -44.14 5.58 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -159.27 148.49 18.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.681 1.593 . . . . 0.0 109.776 -167.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.2 mt -139.8 128.0 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.447 1.099 . . . . 0.0 108.391 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.299 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 t -134.82 137.79 50.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 126.268 1.827 . . . . 0.0 114.616 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.1 tp -117.39 133.04 56.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.138 1.775 . . . . 0.0 108.819 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.27 125.65 53.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.778 1.231 . . . . 0.0 110.279 172.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.78 141.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.552 1.141 . . . . 0.0 110.809 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.52 137.82 36.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.021 1.329 . . . . 0.0 109.593 168.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 . . . . . 0 CA--C 1.543 0.674 0 O-C-N 122.183 -0.323 . . . . 0.0 111.055 166.306 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -118.42 150.75 39.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.321 1.848 . . . . 0.0 111.094 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -133.92 103.86 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.563 1.945 . . . . 0.0 110.082 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -85.35 145.47 27.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.341 0.656 . . . . 0.0 111.73 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.06 87.99 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.441 2.296 . . . . 0.0 110.057 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.18 154.16 19.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.851 0.861 . . . . 0.0 110.953 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.254 52.2 m-70 70.82 55.62 0.24 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.768 2.027 . . . . 0.0 113.734 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.9 149.05 23.81 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.68 1.592 . . . . 0.0 111.015 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.6 -48.58 10.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 113.024 166.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -145.21 152.09 39.44 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.282 1.833 . . . . 0.0 110.812 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -85.18 159.89 20.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.572 0.749 . . . . 0.0 109.988 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -112.16 -25.28 9.4 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.174 0.99 . . . . 0.0 111.126 164.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.92 168.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.983 1.713 . . . . 0.0 111.423 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -119.73 167.44 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.346 1.458 . . . . 0.0 111.122 166.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.01 130.23 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.544 1.138 . . . . 0.0 108.766 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.06 1.2 76.44 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.989 1.281 . . . . 0.0 115.709 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -81.68 129.79 34.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.457 1.628 . . . . 0.0 112.416 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -68.62 143.94 54.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.784 0.802 . . . . 0.0 110.422 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.3 m -128.71 157.76 41.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.877 1.671 . . . . 0.0 109.036 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.71 143.81 50.99 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.118 1.767 . . . . 0.0 109.427 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.02 125.27 7.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.669 0.747 . . . . 0.0 112.105 174.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.98 -3.77 82.91 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.15 1.357 . . . . 0.0 115.837 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.4 142.26 37.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.469 1.635 . . . . 0.0 112.978 170.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.6 mm -72.88 131.19 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.931 0.872 . . . . 0.0 111.545 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -114.63 -24.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.565 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -168.62 -178.94 3.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.163 1.385 . . . . 0.0 110.566 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -129.28 134.1 47.79 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 99.0 p -62.49 145.94 52.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 112.329 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.556 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 -172.767 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.3 m170 . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.74 116.72 7.96 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 111.881 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -94.67 99.99 12.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.145 0.978 . . . . 0.0 110.168 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 46.5 t80 -89.55 113.08 24.44 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.161 1.384 . . . . 0.0 114.332 171.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -118.27 115.26 24.38 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 111.301 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -95.29 128.47 42.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.303 1.441 . . . . 0.0 110.7 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.3 mtm -131.91 157.83 42.98 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.792 1.637 . . . . 0.0 110.819 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -135.12 133.24 39.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.165 0.986 . . . . 0.0 111.813 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.88 5.81 76.29 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.936 1.255 . . . . 0.0 115.089 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 162.63 -170.47 38.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.342 1.449 . . . . 0.0 112.739 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.47 121.15 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -173.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.32 171.89 17.68 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.974 1.749 . . . . 0.0 113.411 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -51.1 -48.75 61.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.382 1.473 . . . . 0.0 112.916 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.93 -13.29 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.238 1.415 . . . . 0.0 114.662 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -92.05 -16.86 25.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.99 135.12 53.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.036 0.934 . . . . 0.0 113.047 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -103.33 -92.06 0.35 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.317 1.447 . . . . 0.0 112.827 -171.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -168.5 100.97 0.53 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.46 -39.71 3.51 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.169 1.913 . . . . 0.0 113.276 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -54.62 -53.03 64.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.2 -23.5 28.71 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.918 3.079 . . . . 0.0 112.458 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -69.3 -39.46 78.28 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 56.9 mt -71.09 -38.71 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 122.979 0.512 . . . . 0.0 110.95 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.52 -15.58 11.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -110.68 -12.06 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.952 1.301 . . . . 0.0 112.778 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.3 154.1 33.83 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.721 1.208 . . . . 0.0 112.394 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.56 -50.57 13.39 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.445 3.43 . . . . 0.0 114.386 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -107.52 9.41 29.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.45 -139.02 43.38 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 120.51 -1.369 . . . . 0.0 112.651 -171.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.27 -21.79 66.72 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.058 -1.26 . . . . 0.0 112.993 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -64.11 -8.58 12.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.91 1.284 . . . . 0.0 112.895 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.8 t -88.56 -1.86 58.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.809 1.244 . . . . 0.0 112.751 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.47 -15.25 12.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.666 1.586 . . . . 0.0 112.417 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -145.67 164.6 31.27 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.56 -1.337 . . . . 0.0 112.912 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -114.53 86.62 2.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.472 0.631 0 C-N-CA 125.06 1.344 . . . . 0.0 110.424 174.754 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.291 98.3 m-85 -95.99 23.04 6.76 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -172.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.96 -162.91 12.74 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.88 -1.137 . . . . 0.0 113.266 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.18 133.31 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.472 1.909 . . . . 0.0 108.488 175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -109.51 97.0 6.65 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.67 107.87 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.29 123.7 18.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.416 1.007 . . . . 0.0 110.941 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 mt -138.85 146.67 51.03 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.274 0.63 . . . . 0.0 111.733 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.81 137.85 79.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.295 1.997 . . . . 0.0 110.747 163.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.39 135.18 56.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 111.434 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.25 -7.22 81.9 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.273 -1.293 . . . . 0.0 114.944 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.2 m -53.73 126.13 48.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-N 120.069 1.934 . . . . 0.0 113.362 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.17 136.66 38.22 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.486 2.124 . . . . 0.0 112.883 171.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.7 mm -92.39 132.45 36.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.566 1.946 . . . . 0.0 108.186 173.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -103.73 151.01 23.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.768 1.227 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.3 129.25 90.63 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.241 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.27 -33.18 11.68 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.675 2.917 . . . . 0.0 113.396 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.0 p -140.78 156.59 46.13 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.397 1.479 . . . . 0.0 107.872 -169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -65.56 129.58 40.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.685 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -153.19 7.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.268 0.461 . . . . 0.0 112.795 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.35 28.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.285 1.834 . . . . 0.0 109.776 176.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.17 136.87 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.125 -0.985 . . . . 0.0 113.211 171.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.22 -38.84 5.87 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.612 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -150.82 142.55 23.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.707 0.803 . . . . 0.0 111.137 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -139.64 123.81 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.348 1.459 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.5 p90 . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.215 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 mttm . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.024 2.13 . . . . 0.0 112.884 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.97 136.04 51.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.388 1.475 . . . . 0.0 109.386 166.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.29 123.11 41.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 111.881 177.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -120.23 144.58 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.899 1.28 . . . . 0.0 110.784 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.59 141.72 41.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.368 1.867 . . . . 0.0 109.829 169.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 177.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -120.97 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.509 1.524 . . . . 0.0 111.41 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -119.09 123.52 44.65 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 126.078 1.751 . . . . 0.0 108.394 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -96.93 146.5 24.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.531 0.733 . . . . 0.0 112.463 161.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -130.9 104.03 6.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.806 2.442 . . . . 0.0 110.01 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -105.59 155.69 18.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.648 1.179 . . . . 0.0 111.992 -175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 63.8 59.83 1.11 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.629 1.972 . . . . 0.0 112.32 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.32 145.78 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.647 1.579 . . . . 0.0 111.187 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -89.86 -41.86 11.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.011 1.324 . . . . 0.0 108.692 171.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -148.21 150.9 34.56 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.478 1.511 . . . . 0.0 113.273 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -97.29 141.32 30.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 112.281 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -103.07 -21.45 13.91 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.253 1.021 . . . . 0.0 112.172 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.95 168.68 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.28 1.832 . . . . 0.0 111.193 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -113.96 171.32 7.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.365 1.866 . . . . 0.0 110.813 168.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.86 137.05 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.527 -1.358 . . . . 0.0 108.786 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.88 10.53 85.56 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.08 1.324 . . . . 0.0 114.143 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -93.22 129.45 39.25 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.92 138.79 48.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.479 0.711 . . . . 0.0 112.548 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.36 160.21 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.8 140.53 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.577 1.951 . . . . 0.0 109.482 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.17 112.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.285 1.834 . . . . 0.0 112.414 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.15 9.3 54.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.637 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -94.37 145.3 24.85 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.586 1.954 . . . . 0.0 114.239 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.6 mm -70.76 132.89 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.553 1.07 . . . . 0.0 112.566 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.1 -22.67 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.399 1.48 . . . . 0.0 113.426 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.08 -176.04 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.255 1.422 . . . . 0.0 110.865 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -136.67 135.42 38.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.2 t -80.94 143.58 32.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 C-N-CA 125.114 1.34 . . . . 0.0 111.275 179.862 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 110.814 -0.069 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.43 115.34 22.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.628 0.771 . . . . 0.0 110.156 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -90.13 98.79 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.85 0.86 . . . . 0.0 110.067 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.276 38.5 t80 -88.86 110.95 21.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.835 1.254 . . . . 0.0 114.341 171.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -113.3 114.59 26.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.874 0.869 . . . . 0.0 111.687 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -97.02 120.71 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.731 1.612 . . . . 0.0 110.854 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.3 mtm -123.05 152.39 41.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.354 1.861 . . . . 0.0 111.266 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -131.51 133.18 44.83 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 111.772 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.61 52.63 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.66 1.6 . . . . 0.0 116.12 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.78 -175.28 45.84 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.086 1.803 . . . . 0.0 111.89 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.16 111.34 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.37 171.43 29.6 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 126.511 2.005 . . . . 0.0 112.408 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -58.8 -44.68 90.82 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.773 -1.427 . . . . 0.0 113.549 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -74.56 -1.07 19.83 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -93.62 -17.17 23.59 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 165.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.18 144.53 57.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.737 0.815 . . . . 0.0 111.931 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -126.78 -75.43 0.58 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -164.52 109.17 0.86 Allowed Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.33 -27.76 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.241 1.96 . . . . 0.0 114.356 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -54.29 -55.68 34.39 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 121.253 1.842 . . . . 0.0 114.443 -177.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 -21.37 57.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.689 2.926 . . . . 0.0 112.814 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.53 -37.93 59.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.98 -30.26 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.62 0.368 . . . . 0.0 110.79 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.75 -9.62 4.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -112.63 -9.71 13.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.035 2.134 . . . . 0.0 113.666 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.7 mt -69.95 151.57 96.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -170.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.49 -41.86 50.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.817 3.678 . . . . 0.0 114.755 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -119.0 16.64 13.36 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.903 1.281 . . . . 0.0 112.418 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.09 -132.52 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 120.814 -1.179 . . . . 0.0 112.723 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.15 -25.03 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.261 -1.14 . . . . 0.0 112.617 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -70.18 -6.73 36.41 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.074 -1.016 . . . . 0.0 113.004 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.2 m -81.59 -3.91 54.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 0.986 . . . . 0.0 113.17 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.13 -18.01 15.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.17 1.388 . . . . 0.0 111.889 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -144.14 164.04 31.83 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.498 -1.376 . . . . 0.0 114.657 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.46 89.72 3.08 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.395 0.998 . . . . 0.0 113.027 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 124.469 1.108 . . . . 0.0 110.276 173.147 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.303 88.4 m-85 -91.14 26.93 2.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -167.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.93 -167.66 22.7 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.717 -1.239 . . . . 0.0 114.9 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 136.81 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.783 2.033 . . . . 0.0 108.874 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -113.6 115.54 28.08 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -97.84 117.47 32.24 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.06 112.82 2.78 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.624 1.102 . . . . 0.0 111.616 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -139.4 140.4 25.58 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.207 0.603 . . . . 0.0 112.333 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 139.47 57.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.993 2.462 . . . . 0.0 111.446 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.69 129.52 29.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.744 1.218 . . . . 0.0 109.972 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.17 81.29 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.178 -1.345 . . . . 0.0 115.982 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.0 m -54.23 125.18 49.59 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 120.169 1.984 . . . . 0.0 112.364 163.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -71.43 133.22 22.11 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.956 1.771 . . . . 0.0 111.701 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.2 mm -89.21 129.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 108.504 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -102.56 149.17 24.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.936 1.294 . . . . 0.0 109.528 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.73 126.93 93.21 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.566 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.34 -38.47 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.359 2.706 . . . . 0.0 112.291 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.3 p -126.13 161.9 26.58 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.873 2.069 . . . . 0.0 111.693 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -69.58 136.01 50.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -160.91 13.08 Favored Glycine 0 N--CA 1.473 1.12 0 O-C-N 121.777 -0.577 . . . . 0.0 113.768 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.49 145.75 28.06 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.345 1.073 . . . . 0.0 112.412 172.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.36 126.01 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -40.3 9.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.189 1.796 . . . . 0.0 115.657 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -155.51 145.59 21.62 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.154 1.382 . . . . 0.0 110.292 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -137.66 125.44 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.012 1.325 . . . . 0.0 109.083 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.6 p90 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.986 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.16 138.67 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.78 136.43 49.86 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.634 1.574 . . . . 0.0 109.579 166.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 124.52 51.98 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.252 0.621 . . . . 0.0 112.108 167.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.6 mt -118.59 144.05 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.323 1.049 . . . . 0.0 111.879 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.87 138.41 36.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.825 2.05 . . . . 0.0 110.608 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 178.477 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -128.65 159.18 36.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.053 2.141 . . . . 0.0 111.503 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -141.62 103.89 4.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.435 1.894 . . . . 0.0 110.849 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -87.36 143.28 27.32 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.919 0.487 . . . . 0.0 111.571 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -130.06 96.48 4.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.052 1.741 . . . . 0.0 107.558 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.71 155.37 19.26 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 0.0 110.142 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 68.42 64.43 0.34 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.798 2.039 . . . . 0.0 113.699 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.5 mt -104.56 154.27 20.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.867 1.667 . . . . 0.0 111.171 172.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -97.99 -44.08 6.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.206 1.802 . . . . 0.0 106.931 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -162.12 159.09 25.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.389 2.276 . . . . 0.0 110.548 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -97.95 162.94 12.99 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.002 1.721 . . . . 0.0 114.454 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -124.17 -8.78 7.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.874 1.27 . . . . 0.0 112.721 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.2 m -134.06 168.03 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.56 1.944 . . . . 0.0 111.187 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -120.36 166.79 13.05 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.97 2.108 . . . . 0.0 111.783 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.95 132.43 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.37 7.59 72.46 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.45 1.024 . . . . 0.0 115.175 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -86.48 115.06 23.73 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.128 1.464 . . . . 0.0 112.256 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -65.87 135.15 54.43 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.289 0.235 . . . . 0.0 110.592 164.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -127.33 163.86 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 126.522 1.929 . . . . 0.0 110.555 -176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.24 140.07 47.31 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.421 1.488 . . . . 0.0 109.526 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.08 126.81 13.29 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.15 -4.93 74.97 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.124 1.821 . . . . 0.0 114.742 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.8 141.69 36.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.664 1.186 . . . . 0.0 112.145 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.6 mm -70.63 130.1 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.519 -0.738 . . . . 0.0 111.579 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.4 pt -113.86 -21.42 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.725 1.21 . . . . 0.0 113.363 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.76 -176.53 1.77 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 110.729 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -132.71 134.67 45.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.1 t -78.1 145.97 35.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.15 0 C-N-CA 125.672 1.606 . . . . 0.0 111.713 -177.876 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.97 115.2 18.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.692 0.678 . . . . 0.0 110.154 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -91.51 100.05 12.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.826 0.85 . . . . 0.0 110.462 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -92.89 116.52 29.11 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -122.13 112.05 17.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.687 1.195 . . . . 0.0 111.381 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -94.56 129.06 41.53 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.636 1.174 . . . . 0.0 110.536 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.7 mtm -127.24 150.65 49.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.654 1.582 . . . . 0.0 110.856 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -120.05 135.91 54.76 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.027 1.331 . . . . 0.0 110.831 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.02 -15.98 1.69 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.169 1.843 . . . . 0.0 116.525 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.19 -168.78 35.52 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.56 1.553 . . . . 0.0 112.057 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.24 131.26 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.393 1.477 . . . . 0.0 112.747 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.56 166.6 10.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.727 1.632 . . . . 0.0 112.048 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -57.84 -43.74 86.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.426 -1.044 . . . . 0.0 113.487 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.76 -14.24 50.86 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -92.58 -15.88 26.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.59 1.156 . . . . 0.0 114.055 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.41 137.86 58.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.774 1.23 . . . . 0.0 112.836 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -101.5 -90.86 0.33 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.588 1.155 . . . . 0.0 113.805 -173.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -170.15 108.21 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 129.36 3.064 . . . . 0.0 110.591 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.97 -23.06 14.24 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.126 1.884 . . . . 0.0 114.587 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -52.26 -53.83 48.29 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 120.582 1.537 . . . . 0.0 115.085 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.74 -20.03 40.53 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.646 2.898 . . . . 0.0 112.931 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.273 3.8 t80 -70.68 -47.59 59.11 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.5 mt -67.47 -24.29 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.833 -1.167 . . . . 0.0 111.79 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.32 -18.14 64.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -109.28 -7.31 15.27 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.866 -1.146 . . . . 0.0 114.03 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 32.0 mt -69.34 147.72 97.15 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.952 1.301 . . . . 0.0 112.894 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.23 -27.99 34.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.209 2.606 . . . . 0.0 114.164 -166.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.86 2.51 17.07 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.84 -144.06 37.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.84 0.733 . . . . 0.0 112.793 -166.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.97 -24.6 66.23 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.455 -1.027 . . . . 0.0 112.553 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -65.31 -9.89 28.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.481 1.512 . . . . 0.0 111.986 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.6 t -82.52 -3.21 55.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.091 1.356 . . . . 0.0 112.575 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -110.46 -13.11 14.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.517 1.527 . . . . 0.0 112.701 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -146.63 163.52 35.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.705 1.593 . . . . 0.0 115.196 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -115.25 79.06 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 109.998 175.301 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.951 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -61.6 -41.94 98.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.273 1.429 . . . . 0.0 113.703 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -100.1 116.7 32.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -173.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -154.28 -12.79 0.13 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 pm0 -60.3 146.08 45.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.447 1.899 . . . . 0.0 115.085 -165.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.01 137.39 41.48 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.376 9.8 p90 -79.6 42.98 0.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 164.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.84 141.74 58.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.521 1.528 . . . . 0.0 112.242 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -155.87 121.25 4.86 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.034 0.834 . . . . 0.0 111.974 163.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.14 -175.04 14.7 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.567 1.556 . . . . 0.0 114.801 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.3 m -75.05 168.86 19.15 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -76.24 -4.94 44.59 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -171.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.5 125.24 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.339 0.972 . . . . 0.0 110.784 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.282 0.7 OUTLIER -76.46 -51.15 12.33 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 169.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -146.73 139.46 25.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.411 1.884 . . . . 0.0 112.132 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.8 p -98.69 -170.91 2.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.768 2.027 . . . . 0.0 111.015 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -76.45 124.05 26.96 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.683 -1.261 . . . . 0.0 107.935 -170.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.84 173.58 19.71 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 124.241 0.924 . . . . 0.0 115.379 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -62.64 147.95 47.82 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.348 -1.089 . . . . 0.0 113.612 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.294 33.8 m-85 -70.53 -40.15 73.62 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 174.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -151.26 173.82 14.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.095 1.358 . . . . 0.0 111.493 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -59.38 165.86 2.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.838 0.855 . . . . 0.0 111.861 164.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.1 m 67.56 161.31 0.14 Allowed Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.26 1.824 . . . . 0.0 114.045 -167.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.28 5.9 5.72 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.007 2.471 . . . . 0.0 114.744 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -95.14 -35.6 11.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.2 0.909 . . . . 0.0 110.773 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -87.5 94.54 9.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.816 1.647 . . . . 0.0 112.417 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.96 -164.22 9.99 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.459 1.504 . . . . 0.0 115.772 -167.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -85.16 140.24 31.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.789 1.236 . . . . 0.0 113.329 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -82.03 122.23 27.54 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.929 1.692 . . . . 0.0 108.348 158.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -98.56 25.06 6.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.74 -162.65 11.86 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.872 -1.143 . . . . 0.0 114.824 -173.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.53 134.85 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.415 2.286 . . . . 0.0 108.833 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -109.67 91.73 3.76 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.93 106.78 11.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 125.87 26.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.045 0.839 . . . . 0.0 110.337 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.7 mt -137.14 151.4 71.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.66 0.784 . . . . 0.0 112.094 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.55 138.65 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.582 2.188 . . . . 0.0 111.528 165.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.63 128.77 38.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.442 0.697 . . . . 0.0 110.978 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.49 63.98 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.047 1.308 . . . . 0.0 115.285 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.3 m -57.72 126.38 75.83 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-N 119.583 1.692 . . . . 0.0 112.714 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -69.26 133.27 26.06 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.211 1.941 . . . . 0.0 112.412 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -89.58 130.0 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.561 1.944 . . . . 0.0 107.964 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -102.75 152.73 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.665 1.586 . . . . 0.0 109.834 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.49 124.0 90.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.936 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.39 -40.3 19.33 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.083 2.522 . . . . 0.0 112.456 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.3 p -130.23 164.12 25.22 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.543 1.937 . . . . 0.0 110.382 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.27 137.61 50.89 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 166.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.08 -161.93 17.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.576 0.608 . . . . 0.0 113.167 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -145.72 144.5 30.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 112.008 174.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.81 129.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -40.06 8.62 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -157.76 146.49 19.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.144 1.378 . . . . 0.0 111.007 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.7 mt -141.13 120.31 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.85 1.26 . . . . 0.0 109.425 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -155.04 165.55 36.36 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -129.44 119.46 23.83 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.783 0.801 . . . . 0.0 111.211 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -100.9 140.44 35.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.794 2.038 . . . . 0.0 111.269 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -67.04 -17.63 64.99 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.92 -23.31 3.67 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.915 1.286 . . . . 0.0 114.317 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.5 -5.57 57.81 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 126.364 1.935 . . . . 0.0 114.518 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.89 -157.09 48.39 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 117.944 0.872 . . . . 0.0 113.004 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -67.19 144.01 56.23 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.845 -0.797 . . . . 0.0 112.389 174.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.99 123.26 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.35 131.86 48.71 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.341 1.456 . . . . 0.0 110.187 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.13 125.44 53.78 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.114 1.365 . . . . 0.0 111.384 171.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.7 mt -121.39 149.26 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.241 1.416 . . . . 0.0 111.807 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.05 139.84 48.35 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 111.376 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -80.19 162.67 24.56 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.529 1.132 . . . . 0.0 113.363 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -64.54 -23.77 67.38 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -169.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -80.18 -6.32 57.57 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.52 3.0 90.73 Favored Glycine 0 CA--C 1.538 1.512 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 167.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -109.91 -40.07 4.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.198 1.499 . . . . 0.0 111.868 -172.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -77.74 134.69 38.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 170.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -117.87 159.44 23.08 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.651 1.98 . . . . 0.0 111.907 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -143.45 104.4 4.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.951 2.1 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 148.52 24.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.34 0.656 . . . . 0.0 112.503 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -136.17 89.76 2.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.586 2.355 . . . . 0.0 109.92 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.01 160.51 16.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.666 1.186 . . . . 0.0 111.216 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 62.44 57.1 1.96 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.559 1.944 . . . . 0.0 114.032 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.85 145.46 26.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.322 1.049 . . . . 0.0 111.555 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -87.44 -43.72 11.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.108 1.363 . . . . 0.0 108.045 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -147.45 144.77 28.86 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.186 1.794 . . . . 0.0 112.473 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -86.83 149.71 24.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.146 0.978 . . . . 0.0 111.927 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -117.18 -4.43 11.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.243 1.017 . . . . 0.0 112.607 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.25 162.82 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.179 1.392 . . . . 0.0 111.529 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -111.66 161.52 16.16 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.583 1.153 . . . . 0.0 111.29 168.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.39 128.04 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.123 1.369 . . . . 0.0 107.641 170.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.66 16.05 66.8 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.179 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -87.23 123.52 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.067 1.434 . . . . 0.0 112.871 167.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -69.02 137.8 53.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.199 0.523 . . . . 0.0 111.718 160.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.83 164.14 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.011 2.125 . . . . 0.0 110.67 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -133.83 142.32 47.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.882 1.273 . . . . 0.0 108.677 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.38 132.35 10.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.337 1.055 . . . . 0.0 113.392 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.88 -7.54 81.83 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.446 1.974 . . . . 0.0 115.011 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -77.37 140.92 40.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.1 1.45 . . . . 0.0 113.148 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.9 mm -67.78 129.4 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.76 -0.587 . . . . 0.0 110.997 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.0 pt -114.45 -20.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.762 1.225 . . . . 0.0 113.304 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.02 -177.07 2.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.137 1.775 . . . . 0.0 110.415 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -132.3 130.85 41.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.4 t -79.05 146.39 33.32 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.559 0.695 . . . . 0.0 112.645 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -156.57 160.97 30.64 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.758 1.17 . . . . 0.0 111.108 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -76.31 35.57 0.14 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.212 1.005 . . . . 0.0 113.702 -174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.251 7.5 p -66.59 145.89 55.11 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.678 1.191 . . . . 0.0 112.619 171.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.97 -41.43 1.07 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.335 1.445 . . . . 0.0 114.51 -166.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mt -65.5 131.07 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.975 1.31 . . . . 0.0 111.488 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -72.08 -47.88 48.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 112.857 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.254 0.6 OUTLIER -134.21 -32.45 1.06 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 176.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.08 157.96 23.99 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.47 159.83 47.54 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.716 1.151 . . . . 0.0 113.781 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.39 146.7 53.79 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -170.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -145.05 124.11 12.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.916 0.886 . . . . 0.0 112.364 169.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.15 115.32 8.3 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 109.663 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -95.16 99.88 11.78 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.739 0.816 . . . . 0.0 110.24 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 51.8 t80 -89.09 114.44 25.69 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.025 1.33 . . . . 0.0 114.508 172.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -118.21 116.83 27.61 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.708 1.203 . . . . 0.0 111.908 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.3 ttt-85 -100.64 124.74 46.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.909 1.684 . . . . 0.0 111.567 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 32.9 mtm -130.44 157.27 43.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.96 1.304 . . . . 0.0 112.338 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -131.5 135.96 47.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.403 1.481 . . . . 0.0 111.52 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.7 -7.66 57.83 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 126.368 1.937 . . . . 0.0 115.363 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 171.14 -166.65 39.79 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.689 2.566 . . . . 0.0 109.806 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.57 131.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 122.483 1.135 . . . . 0.0 110.555 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.43 168.98 14.89 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 128.466 2.936 . . . . 0.0 109.896 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -56.22 -41.96 76.5 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.849 1.325 . . . . 0.0 112.852 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.69 64.91 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.055 -1.028 . . . . 0.0 112.505 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.0 -15.1 58.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.954 1.301 . . . . 0.0 113.44 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.88 56.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.927 0.891 . . . . 0.0 112.763 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.96 -85.57 0.55 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.635 1.174 . . . . 0.0 113.66 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -166.97 126.89 1.14 Allowed Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 127.386 2.274 . . . . 0.0 106.109 167.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.0 -28.71 8.94 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.277 2.652 . . . . 0.0 114.601 171.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -53.24 -53.51 55.22 Favored Pre-proline 0 N--CA 1.478 0.971 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.53 -19.5 32.39 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.704 2.936 . . . . 0.0 112.584 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -72.36 -44.87 61.96 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 24.2 mt -66.68 -29.43 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.432 0.693 . . . . 0.0 111.056 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.86 -15.8 5.48 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.85 -3.23 9.71 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.437 1.495 . . . . 0.0 114.27 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.61 147.62 98.03 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.088 0.955 . . . . 0.0 112.097 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -51.35 -44.72 41.61 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.747 3.631 . . . . 0.0 114.626 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -111.71 12.96 21.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.898 1.279 . . . . 0.0 113.686 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.04 -135.39 46.07 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 120.821 -1.174 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.12 -25.85 64.2 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.308 -1.113 . . . . 0.0 113.319 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -70.18 -5.77 29.62 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.563 -1.336 . . . . 0.0 113.373 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.9 m -77.98 -4.05 45.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.987 0.812 . . . . 0.0 111.991 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.51 -15.55 12.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.735 1.614 . . . . 0.0 113.825 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -148.95 158.14 43.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 121.635 2.016 . . . . 0.0 115.037 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -110.06 79.42 1.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.47 0.544 0 C-N-CA 124.584 1.154 . . . . 0.0 109.523 174.516 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.944 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.5 t -150.71 -34.69 0.15 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.099 0.949 . . . . 0.0 113.129 166.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -75.0 143.87 43.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.389 1.075 . . . . 0.0 111.37 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -104.32 159.03 16.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.855 1.262 . . . . 0.0 112.964 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -63.88 132.2 50.06 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.568 -0.708 . . . . 0.0 110.64 171.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.42 107.81 2.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.64 0.776 . . . . 0.0 112.056 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.338 18.2 p90 -69.44 132.63 46.64 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 -170.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.283 8.0 t80 -68.61 132.7 47.35 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 116.858 2.169 . . . . 0.0 116.858 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' HE ' ' HB3' ' A' ' 58' ' ' SER . 39.2 ttt180 -79.9 105.52 11.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.407 1.083 . . . . 0.0 111.859 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.83 43.3 0.94 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.709 1.623 . . . . 0.0 114.346 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.414 ' HB3' ' HE ' ' A' ' 56' ' ' ARG . 78.9 p -80.77 163.52 23.43 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.366 1.466 . . . . 0.0 114.408 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -136.78 40.65 2.55 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.182 1.793 . . . . 0.0 113.364 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -70.36 114.78 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.259 -0.9 . . . . 0.0 110.397 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -40.76 75.24 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.956 1.702 . . . . 0.0 115.508 172.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -148.11 135.98 20.98 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.394 1.878 . . . . 0.0 109.52 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.1 p -96.31 169.54 9.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.197 0.998 . . . . 0.0 110.22 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -74.29 138.33 43.49 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.153 -0.967 . . . . 0.0 108.775 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.55 -68.11 0.38 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.351 0.977 . . . . 0.0 112.745 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.59 160.97 35.08 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.681 1.193 . . . . 0.0 113.216 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.33 56.8 m-85 -65.3 42.12 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 160.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 62.72 -70.24 0.06 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 128.195 2.598 . . . . 0.0 114.791 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -73.4 -29.11 62.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 116.431 2.012 . . . . 0.0 116.431 -152.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -158.96 152.15 18.65 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.762 1.225 . . . . 0.0 111.822 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.11 -33.78 3.35 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.824 2.349 . . . . 0.0 113.476 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.5 116.83 7.19 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -164.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.315 3.1 m-20 58.22 16.11 3.75 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.32 23.0 14.47 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 -165.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -63.4 145.2 56.09 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.156 1.978 . . . . 0.0 114.347 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -146.73 136.87 23.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.625 1.97 . . . . 0.0 110.127 -173.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 97.8 m-85 -120.54 25.21 9.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -168.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.81 -178.63 25.83 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.97 -1.081 . . . . 0.0 113.354 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.37 146.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.823 1.649 . . . . 0.0 108.109 163.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.8 142.06 48.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.987 0.812 . . . . 0.0 112.177 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -116.43 122.6 45.27 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.338 1.455 . . . . 0.0 114.538 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.79 114.6 17.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.026 0.93 . . . . 0.0 110.864 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.3 mt -126.66 151.26 73.0 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.77 136.9 47.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.612 2.208 . . . . 0.0 110.373 152.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -54.22 138.65 38.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.802 1.241 . . . . 0.0 110.847 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.18 -1.62 84.4 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.589 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 36.2 m -50.25 124.94 18.7 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 119.938 1.869 . . . . 0.0 111.273 166.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.31 129.32 15.78 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.798 1.665 . . . . 0.0 110.896 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.34 131.46 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 108.738 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -106.13 155.74 19.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.119 1.367 . . . . 0.0 110.224 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.96 75.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 O-C-N 121.521 -0.737 . . . . 0.0 111.707 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.51 -36.79 10.78 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.283 2.655 . . . . 0.0 113.24 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 p -134.62 163.18 30.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.148 1.779 . . . . 0.0 107.05 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.66 139.69 53.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.73 22.74 Favored Glycine 0 N--CA 1.467 0.702 0 O-C-N 121.433 -0.792 . . . . 0.0 113.219 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -148.02 144.87 28.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.372 1.069 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.51 128.22 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.3 -38.81 7.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.203 1.001 . . . . 0.0 112.045 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -148.62 141.35 24.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.49 1.516 . . . . 0.0 111.778 -168.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -139.76 127.29 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.142 1.377 . . . . 0.0 110.381 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -159.49 167.44 28.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -111.6 164.65 12.77 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.635 1.174 . . . . 0.0 109.31 158.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -144.02 170.09 16.59 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.324 -0.86 . . . . 0.0 112.598 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -55.44 -31.79 62.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.043 1.737 . . . . 0.0 115.171 -165.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.52 -14.03 1.49 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.98 -8.81 87.28 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.47 -149.46 36.99 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 119.006 1.403 . . . . 0.0 112.178 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -72.34 150.68 43.28 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.249 -0.56 . . . . 0.0 112.442 164.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.79 137.18 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.885 2.474 . . . . 0.0 113.394 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.68 135.92 53.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.016 1.326 . . . . 0.0 110.237 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 124.6 44.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.11 147.1 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 125.187 1.395 . . . . 0.0 111.796 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.98 138.13 51.2 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.34 2.256 . . . . 0.0 111.764 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -90.52 159.55 16.44 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -65.83 -10.92 42.27 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -76.34 -15.84 59.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.146 0.979 . . . . 0.0 113.627 167.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.78 -2.2 25.91 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.108 1.337 . . . . 0.0 115.976 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -99.35 -45.67 5.77 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.716 1.758 . . . . 0.0 110.475 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 39.6 m-85 -81.57 145.91 30.4 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 118.28 2.696 . . . . 0.0 118.28 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -130.0 150.36 51.31 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.154 1.781 . . . . 0.0 111.847 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -118.61 131.84 56.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.846 1.658 . . . . 0.0 108.763 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -105.43 150.69 25.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.377 1.071 . . . . 0.0 111.856 157.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -135.19 112.56 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.585 1.954 . . . . 0.0 106.35 171.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -106.7 159.9 15.87 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 111.25 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 68.74 55.3 0.47 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.484 1.913 . . . . 0.0 113.282 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.82 158.03 16.27 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 111.382 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -40.42 5.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.638 1.175 . . . . 0.0 112.557 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -144.64 147.9 33.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.034 1.734 . . . . 0.0 111.782 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -94.32 145.99 24.36 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.037 1.335 . . . . 0.0 112.397 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -106.73 -16.44 14.49 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.47 1.108 . . . . 0.0 112.012 170.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.35 167.21 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.149 1.38 . . . . 0.0 111.499 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -124.19 165.4 17.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 111.939 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.5 t -56.22 123.78 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.36 1.064 . . . . 0.0 108.931 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.34 61.01 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.209 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -97.92 135.83 39.09 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.032 1.916 . . . . 0.0 109.419 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -76.49 145.17 39.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.456 1.102 . . . . 0.0 113.254 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.99 161.04 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 127.013 2.125 . . . . 0.0 111.293 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -123.93 144.09 49.99 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.498 2.319 . . . . 0.0 108.552 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -45.44 112.73 0.49 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.014 1.326 . . . . 0.0 112.308 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.39 -3.2 34.76 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.946 1.736 . . . . 0.0 115.51 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.15 144.54 26.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 19.2 mm -70.9 130.82 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.763 0.71 . . . . 0.0 111.924 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.6 pt -115.96 -22.94 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.712 1.205 . . . . 0.0 113.298 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.44 -178.33 2.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.938 1.295 . . . . 0.0 111.278 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -129.73 135.44 48.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.68 146.65 53.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.933 0.893 . . . . 0.0 112.27 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.02 150.65 22.34 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 121.52 0.511 . . . . 0.0 112.751 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -77.73 34.6 0.18 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.491 1.116 . . . . 0.0 112.761 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.7 p -81.52 -15.18 55.69 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -165.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -133.5 32.28 2.74 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.652 1.596 . . . . 0.0 113.752 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 6.0 mt -126.26 136.33 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.961 1.304 . . . . 0.0 111.834 -164.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -61.15 -34.49 75.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.639 1.976 . . . . 0.0 114.544 -173.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.5 p -140.34 -153.53 0.47 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.915 2.486 . . . . 0.0 109.693 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.272 0.8 OUTLIER -77.66 149.95 34.62 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 175.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 158.09 -18.3 0.33 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.226 -1.319 . . . . 0.0 115.878 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 51.58 20.45 1.06 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.065 2.146 . . . . 0.0 116.373 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -70.87 133.44 46.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -164.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 115.77 12.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.482 0.713 . . . . 0.0 110.478 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -92.12 98.78 11.75 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.79 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.288 50.6 t80 -89.07 109.67 20.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.66 117.49 33.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.447 1.099 . . . . 0.0 111.467 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -102.53 126.37 49.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.012 1.325 . . . . 0.0 111.059 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.5 mtm -129.49 149.11 51.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.573 1.549 . . . . 0.0 111.451 -170.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -124.32 131.08 53.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.47 1.508 . . . . 0.0 110.759 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.25 -1.27 35.18 Favored Glycine 0 CA--C 1.545 1.914 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.42 -169.74 41.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.997 1.284 . . . . 0.0 112.521 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.76 115.73 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.28 1.432 . . . . 0.0 112.781 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.52 15.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.395 1.95 . . . . 0.0 111.347 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -57.84 -40.5 80.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.607 1.204 . . . . 0.0 112.832 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.49 -17.61 64.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -88.65 -11.8 44.31 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 151.09 34.08 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -130.57 -89.12 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.517 1.527 . . . . 0.0 113.98 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -160.22 95.89 1.53 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -167.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.4 -34.94 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.15 1.9 . . . . 0.0 114.206 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -54.95 -55.36 39.7 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 121.098 1.772 . . . . 0.0 115.53 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.46 -26.51 40.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.362 2.708 . . . . 0.0 112.099 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.17 -38.3 81.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.44 -40.8 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.887 0.475 . . . . 0.0 110.861 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.45 -5.05 13.09 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -114.12 -4.79 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.018 2.127 . . . . 0.0 113.225 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.84 156.04 48.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.53 1.132 . . . . 0.0 112.327 171.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.65 -49.51 16.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.868 3.045 . . . . 0.0 113.148 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.41 5.21 36.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.454 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.37 -143.76 47.61 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.033 -1.042 . . . . 0.0 112.181 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.44 61.93 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -64.7 -10.08 24.57 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -86.72 5.46 36.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 171.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.1 -18.56 9.35 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.624 1.57 . . . . 0.0 112.709 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -149.1 157.73 43.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.363 -1.461 . . . . 0.0 111.701 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.69 89.02 2.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.241 0.65 0 C-N-CA 124.978 1.311 . . . . 0.0 110.796 173.126 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.944 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.0 p -70.75 -15.02 62.65 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -110.95 -38.33 5.13 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.784 1.634 . . . . 0.0 113.391 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -153.8 166.0 34.26 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.649 1.58 . . . . 0.0 112.3 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -76.73 126.1 30.4 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.254 -0.904 . . . . 0.0 113.316 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -81.7 91.74 6.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.021 0.929 . . . . 0.0 112.433 166.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.331 45.4 m-85 -75.41 171.41 14.29 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 116.99 2.218 . . . . 0.0 116.99 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.317 3.8 p90 -61.56 21.87 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 120.598 3.555 . . . . 0.0 120.598 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -57.75 129.52 42.24 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.644 -1.285 . . . . 0.0 111.944 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.37 -24.1 24.99 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.676 1.131 . . . . 0.0 113.687 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -96.96 123.9 40.79 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.954 1.377 . . . . 0.0 112.786 170.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -83.1 4.74 25.09 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -163.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.1 mt -71.81 123.23 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -167.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 15.3 p -77.24 -42.26 37.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.113 1.365 . . . . 0.0 114.135 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -145.91 135.79 23.49 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.506 1.522 . . . . 0.0 112.718 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 p -104.74 -164.95 1.09 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.981 1.713 . . . . 0.0 108.135 174.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -87.32 140.57 29.4 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 119.88 -1.762 . . . . 0.0 109.721 -160.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.99 -159.33 15.75 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.076 1.798 . . . . 0.0 112.811 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -58.4 153.98 14.63 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 118.419 1.11 . . . . 0.0 112.63 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.35 147.39 29.87 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -76.71 -46.38 25.68 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.719 -0.613 . . . . 0.0 112.382 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -154.24 120.94 5.52 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.647 1.979 . . . . 0.0 109.838 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.2 p -165.03 169.12 7.83 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.87 1.268 . . . . 0.0 110.358 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.23 1.81 8.86 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.083 2.522 . . . . 0.0 114.323 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -84.66 147.32 27.0 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.483 -1.386 . . . . 0.0 114.599 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -89.7 -34.25 16.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 162.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.65 -175.4 40.94 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 122.031 0.795 . . . . 0.0 114.072 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -90.47 166.69 13.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.322 . . . . 0.0 111.677 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -87.27 139.65 30.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.696 1.198 . . . . 0.0 110.0 161.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.49 22.63 11.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.571 1.548 . . . . 0.0 114.675 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.59 -158.05 8.93 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 121.206 -0.934 . . . . 0.0 113.56 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.92 133.31 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.867 2.067 . . . . 0.0 108.796 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.45 96.08 5.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.48 110.44 14.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 114.17 4.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.267 0.94 . . . . 0.0 111.351 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -129.82 147.27 64.76 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.22 0.608 . . . . 0.0 112.057 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.47 135.43 49.58 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.04 1.827 . . . . 0.0 110.346 162.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -60.67 130.3 45.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.769 0.827 . . . . 0.0 111.129 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.58 -7.92 68.56 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.737 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -51.32 126.65 28.75 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-N 120.121 1.961 . . . . 0.0 113.101 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -67.73 136.07 37.73 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.638 2.226 . . . . 0.0 112.151 172.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.67 127.6 44.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.484 1.514 . . . . 0.0 107.888 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -96.91 148.8 22.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.087 1.355 . . . . 0.0 109.643 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.1 125.06 88.5 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.692 -0.671 . . . . 0.0 110.277 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.64 -39.93 14.58 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.314 2.676 . . . . 0.0 111.72 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.2 p -120.34 166.44 13.52 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.736 2.414 . . . . 0.0 110.089 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -67.36 144.92 55.56 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 154.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.95 -157.68 16.18 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.407 1.003 . . . . 0.0 114.345 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.14 143.96 25.38 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.044 1.738 . . . . 0.0 112.09 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.32 127.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -42.7 8.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 -159.19 143.72 15.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.2 1.0 . . . . 0.0 110.85 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.422 HG22 ' CE2' ' A' ' 129' ' ' TYR . 53.1 mt -141.78 122.31 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.486 1.514 . . . . 0.0 109.101 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -154.7 166.2 34.17 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -118.84 142.19 47.95 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.508 1.123 . . . . 0.0 109.757 161.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -101.96 129.75 48.31 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.041 1.736 . . . . 0.0 111.288 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.67 -23.05 66.91 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.19 31.28 6.82 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.683 1.593 . . . . 0.0 111.992 173.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.09 -128.39 1.48 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.98 1.752 . . . . 0.0 109.958 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.73 -157.84 7.99 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.839 1.209 . . . . 0.0 112.029 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -66.98 146.61 54.19 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.4 139.36 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.656 1.982 . . . . 0.0 114.208 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.298 1.439 . . . . 0.0 109.821 171.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 126.5 55.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.391 0.676 . . . . 0.0 112.57 171.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.14 145.18 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.829 1.252 . . . . 0.0 112.218 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.94 132.25 52.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.701 2.4 . . . . 0.0 112.182 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -81.51 157.81 24.7 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.38 -37.74 81.71 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 -170.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -73.22 -9.92 59.21 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.92 17.95 57.02 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 165.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -125.49 -31.66 2.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.365 1.583 . . . . 0.0 112.846 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.264 50.0 m-85 -83.47 141.79 31.41 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -126.48 155.71 41.85 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.646 2.378 . . . . 0.0 111.332 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -137.8 105.3 5.54 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.473 1.909 . . . . 0.0 110.625 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -88.52 146.03 25.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.156 0.582 . . . . 0.0 111.225 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -132.21 109.52 9.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.689 1.596 . . . . 0.0 108.218 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.08 162.49 12.9 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.939 1.296 . . . . 0.0 111.112 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 59.32 61.76 1.97 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.203 2.201 . . . . 0.0 112.798 -174.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.03 140.49 36.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.973 1.309 . . . . 0.0 111.998 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -80.86 -48.75 11.97 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 0.0 108.716 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -152.42 149.21 28.34 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.536 1.935 . . . . 0.0 111.152 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.422 ' CE2' HG22 ' A' ' 100' ' ' ILE . 97.9 m-85 -98.06 143.27 28.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.728 1.211 . . . . 0.0 113.032 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -103.45 -29.36 11.23 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.524 -0.735 . . . . 0.0 111.812 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.6 m -111.03 172.61 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.737 1.615 . . . . 0.0 112.208 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -128.55 162.94 26.08 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.734 1.614 . . . . 0.0 111.681 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -56.04 130.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 122.37 1.081 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.29 5.42 67.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.476 1.512 . . . . 0.0 114.995 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -95.21 136.8 35.11 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.24 1.52 . . . . 0.0 114.061 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.1 mmm-85 -86.49 133.93 33.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.94 159.21 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.423 1.489 . . . . 0.0 110.863 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.19 143.54 51.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.216 1.806 . . . . 0.0 108.462 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.65 128.99 13.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.23 1.012 . . . . 0.0 113.06 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.45 -2.69 78.22 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.33 1.443 . . . . 0.0 114.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -79.31 139.74 37.74 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.754 1.277 . . . . 0.0 113.692 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.6 mm -69.82 126.81 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 118.846 0.748 . . . . 0.0 111.544 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -108.8 -26.06 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.125 1.37 . . . . 0.0 113.133 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.11 -176.81 2.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 110.389 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.47 136.34 41.21 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -82.48 143.87 30.83 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.25 165.73 37.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.601 1.096 . . . . 0.0 113.27 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -77.97 15.6 0.86 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -165.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.9 p -60.62 -17.21 45.54 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -122.84 29.8 5.27 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.745 1.64 . . . . 0.0 113.015 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.3 146.89 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.185 1.794 . . . . 0.0 109.536 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -74.61 101.43 4.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.693 0.797 . . . . 0.0 110.688 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.322 0.2 OUTLIER 64.41 -68.58 0.1 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 176.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.73 126.77 43.24 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -159.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.86 174.55 8.03 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.688 1.137 . . . . 0.0 115.45 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.14 146.33 40.5 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.521 1.128 . . . . 0.0 112.257 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -150.54 135.44 17.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.991 0.916 . . . . 0.0 111.693 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.08 118.08 19.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.857 0.753 . . . . 0.0 110.587 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -94.95 100.91 12.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.51 113.14 25.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.015 1.326 . . . . 0.0 113.953 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -117.7 112.41 20.44 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 110.088 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 ttt-85 -99.93 127.26 46.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.122 0.969 . . . . 0.0 110.603 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.1 mtm -127.37 154.09 45.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.622 1.569 . . . . 0.0 111.731 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -130.07 131.92 45.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.419 1.087 . . . . 0.0 112.246 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.54 6.11 75.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.053 0.835 . . . . 0.0 114.68 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.83 -161.1 31.23 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.116 1.817 . . . . 0.0 111.374 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.48 135.6 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.63 1.172 . . . . 0.0 111.838 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 138.71 171.72 12.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.084 1.802 . . . . 0.0 112.578 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -54.23 -51.29 64.96 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.75 1.22 . . . . 0.0 113.569 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.15 -17.12 63.17 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.712 -1.243 . . . . 0.0 114.279 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -80.23 -18.2 50.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.07 145.87 55.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.667 0.787 . . . . 0.0 111.602 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -122.8 -81.0 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -166.92 97.37 0.68 Allowed Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.27 -26.35 5.13 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.127 1.884 . . . . 0.0 114.51 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -51.91 77.18 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-N 121.622 2.01 . . . . 0.0 113.821 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.48 -25.75 24.95 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.512 2.141 . . . . 0.0 112.379 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.67 -32.7 74.26 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -80.71 -26.37 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.341 0.657 . . . . 0.0 111.717 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -59.46 -10.44 3.29 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -117.39 -5.84 11.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.887 2.075 . . . . 0.0 113.616 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.04 148.76 91.91 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.367 -0.833 . . . . 0.0 111.8 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -36.95 52.87 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.306 2.671 . . . . 0.0 114.066 -166.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -109.64 0.13 18.9 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.265 -0.897 . . . . 0.0 110.864 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 78.3 -143.2 26.96 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.613 1.097 . . . . 0.0 112.083 -164.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.54 -25.97 64.96 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.916 -1.344 . . . . 0.0 114.14 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -63.25 -8.88 9.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.01 1.324 . . . . 0.0 114.485 173.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -83.05 -5.44 59.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.397 1.079 . . . . 0.0 112.952 170.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -104.2 -14.61 15.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.903 1.681 . . . . 0.0 113.184 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -143.51 160.16 41.11 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.834 1.652 . . . . 0.0 114.7 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -108.07 78.16 1.16 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 124.315 1.046 . . . . 0.0 112.354 -176.693 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 m -68.4 124.26 23.04 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.439 1.496 . . . . 0.0 112.035 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -60.11 155.64 16.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.301 1.44 . . . . 0.0 112.977 172.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -152.34 155.99 38.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.935 1.294 . . . . 0.0 111.593 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -141.28 151.05 43.34 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.26 1.824 . . . . 0.0 110.528 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -97.41 126.49 42.69 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.283 9.2 p90 -145.33 156.98 44.12 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.393 77.2 t80 -127.01 154.92 44.01 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -65.53 155.45 35.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.918 2.087 . . . . 0.0 115.405 -160.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.94 -48.93 2.43 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.333 1.444 . . . . 0.0 114.095 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 p -69.46 167.03 17.53 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.758 1.623 . . . . 0.0 113.394 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -110.42 0.76 17.98 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.44 138.37 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.36 1.436 . . . . 0.0 110.085 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 t -128.5 -26.89 2.7 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.843 2.057 . . . . 0.0 115.415 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -130.81 151.37 51.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.468 1.507 . . . . 0.0 110.821 167.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.4 p -138.24 164.94 27.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.862 1.265 . . . . 0.0 110.305 -170.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -76.23 158.54 31.51 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.391 -0.818 . . . . 0.0 108.986 -168.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.47 -155.74 23.58 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.623 1.106 . . . . 0.0 112.462 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 157.54 17.95 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.199 -1.177 . . . . 0.0 111.708 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -55.85 140.21 43.2 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -64.24 -20.94 66.38 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.824 -1.172 . . . . 0.0 114.025 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -104.37 9.49 35.77 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.348 1.859 . . . . 0.0 113.681 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.7 m -147.42 142.23 16.61 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -171.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -95.74 -9.78 1.09 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.29 3.327 . . . . 0.0 114.192 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -71.72 171.98 10.57 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.438 1.895 . . . . 0.0 109.674 -169.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -69.45 118.84 12.84 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.868 -1.145 . . . . 0.0 113.801 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.32 120.91 0.82 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.248 1.404 . . . . 0.0 111.234 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -121.81 146.06 47.45 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -166.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -103.59 113.97 27.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.23 2.212 . . . . 0.0 109.474 172.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.279 69.9 m-85 -90.07 43.76 1.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.56 -175.91 38.44 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.506 -1.371 . . . . 0.0 115.055 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.32 146.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.152 1.781 . . . . 0.0 107.866 165.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 137.44 50.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.518 1.054 . . . . 0.0 113.13 167.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.08 118.96 38.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.005 1.722 . . . . 0.0 113.93 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.82 110.47 4.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.585 0.754 . . . . 0.0 110.199 171.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.7 mt -125.34 150.42 67.35 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 111.466 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.6 138.21 73.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.637 2.225 . . . . 0.0 110.578 161.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -56.76 121.61 10.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.185 1.394 . . . . 0.0 111.291 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.37 1.65 66.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.1 m -52.18 125.46 33.38 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 120.407 2.104 . . . . 0.0 112.436 166.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -68.22 135.66 35.04 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.095 1.863 . . . . 0.0 111.841 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.3 mm -91.51 130.51 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.716 1.606 . . . . 0.0 107.428 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -101.25 150.19 23.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.995 1.318 . . . . 0.0 109.246 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 93.13 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.936 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.03 -30.53 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.317 2.678 . . . . 0.0 113.345 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.7 p -132.43 163.73 28.12 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.724 2.41 . . . . 0.0 112.225 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.54 135.94 42.14 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.71 -159.26 11.54 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.403 1.001 . . . . 0.0 114.057 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -150.9 145.55 25.71 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.681 1.593 . . . . 0.0 111.174 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.59 125.66 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.83 -41.35 7.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.822 1.249 . . . . 0.0 111.075 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -149.32 142.93 25.46 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.724 1.21 . . . . 0.0 111.654 -166.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.9 mt -140.99 134.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.446 1.098 . . . . 0.0 109.386 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -157.52 177.76 11.05 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -120.47 161.8 20.64 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.881 1.272 . . . . 0.0 111.918 164.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -132.29 145.92 51.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.031 1.733 . . . . 0.0 111.491 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -63.97 -30.35 71.44 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -97.95 -38.71 9.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.263 1.425 . . . . 0.0 112.429 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.4 -9.23 55.53 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.317 1.437 . . . . 0.0 115.519 -162.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.54 -149.11 36.37 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 118.341 1.07 . . . . 0.0 112.934 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.4 146.57 45.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -134.53 138.89 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.137 1.775 . . . . 0.0 113.851 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -115.21 134.27 55.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.566 1.946 . . . . 0.0 109.784 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.44 123.62 46.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.755 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.2 mt -119.48 142.67 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 0.0 111.373 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.09 138.93 37.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.534 1.934 . . . . 0.0 110.89 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -76.92 168.0 20.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 112.241 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -65.81 -22.26 66.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -61.45 -21.45 64.16 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.46 2.304 . . . . 0.0 113.992 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.68 10.7 78.81 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.468 1.509 . . . . 0.0 115.088 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -149.55 -25.33 0.28 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.296 38.5 m-85 -80.36 140.39 36.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 173.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -131.8 150.38 52.17 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.387 1.075 . . . . 0.0 112.598 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -125.53 121.4 33.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.693 1.997 . . . . 0.0 108.184 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -97.49 150.41 21.1 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.27 91.77 2.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.829 2.452 . . . . 0.0 108.823 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.47 162.91 13.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.472 0.709 . . . . 0.0 111.838 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 65.26 53.63 1.29 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.352 1.861 . . . . 0.0 111.721 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.7 mt -96.75 140.95 30.58 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.266 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.53 -50.83 12.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.376 1.87 . . . . 0.0 107.802 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -147.78 146.84 29.33 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.884 1.673 . . . . 0.0 111.322 -163.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -91.09 151.03 21.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.059 0.543 . . . . 0.0 111.728 171.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -118.12 -7.11 10.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.437 1.095 . . . . 0.0 112.657 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.81 166.8 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.294 1.838 . . . . 0.0 111.219 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -122.16 165.96 15.31 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.718 1.607 . . . . 0.0 111.135 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.5 t -52.64 125.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.782 1.233 . . . . 0.0 107.993 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.1 13.72 61.65 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.42 126.37 35.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.749 1.774 . . . . 0.0 112.603 168.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -71.2 135.22 47.43 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.981 0.512 . . . . 0.0 111.371 167.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.51 156.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.91 1.684 . . . . 0.0 110.348 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -136.13 140.73 43.89 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.988 1.715 . . . . 0.0 109.336 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.25 131.62 16.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.265 1.031 . . . . 0.0 113.488 -171.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.22 -6.68 83.31 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.861 2.172 . . . . 0.0 115.128 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -79.23 140.75 37.58 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.036 1.418 . . . . 0.0 114.017 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.0 mm -70.42 129.63 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.688 0.795 . . . . 0.0 111.603 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -115.5 -23.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.966 1.307 . . . . 0.0 113.089 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.67 -175.92 1.67 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.879 1.672 . . . . 0.0 110.386 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -136.85 138.18 40.48 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.5 t -79.92 143.24 34.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.048 0.84 . . . . 0.0 113.236 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.28 167.74 30.19 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.953 1.264 . . . . 0.0 112.977 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -82.77 16.83 2.06 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 p -62.48 1.87 0.32 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 118.052 2.612 . . . . 0.0 118.052 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.64 51.12 0.14 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.298 0.952 . . . . 0.0 113.243 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.91 122.68 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.912 0.863 . . . . 0.0 111.161 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -67.95 -21.16 65.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.053 1.341 . . . . 0.0 114.05 -170.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.8 p -66.55 -12.95 60.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.932 1.693 . . . . 0.0 115.357 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.397 0.2 OUTLIER 68.07 12.25 8.7 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -164.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -95.4 166.07 25.3 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.94 1.257 . . . . 0.0 113.197 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.9 131.79 54.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.614 1.166 . . . . 0.0 110.8 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -154.91 132.31 11.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.681 0.792 . . . . 0.0 111.971 169.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.65 117.09 13.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.082 0.953 . . . . 0.0 110.702 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -90.9 106.07 18.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.219 0.918 . . . . 0.0 111.865 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.251 41.5 t80 -95.28 115.04 26.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.409 1.484 . . . . 0.0 114.563 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -113.85 120.43 40.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.822 0.849 . . . . 0.0 111.755 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -92.95 124.0 36.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.078 1.751 . . . . 0.0 111.35 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.3 mtm -126.07 161.32 27.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.984 1.714 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -134.16 141.96 47.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 111.353 169.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.35 -5.26 60.52 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.252 1.406 . . . . 0.0 115.867 167.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.59 -175.12 47.45 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.751 2.596 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.25 121.76 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.637 1.175 . . . . 0.0 112.544 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.93 163.75 10.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.28 1.419 . . . . 0.0 112.356 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -48.23 -46.13 35.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.736 1.214 . . . . 0.0 113.468 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.34 69.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -81.46 -14.24 57.26 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.1 131.83 49.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.614 1.166 . . . . 0.0 112.119 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -103.28 -80.48 0.52 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.778 0.831 . . . . 0.0 112.681 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -166.78 101.34 0.66 Allowed Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.397 1.479 . . . . 0.0 114.046 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.02 -32.29 1.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.866 1.711 . . . . 0.0 114.097 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -57.83 -53.84 61.55 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 120.976 1.717 . . . . 0.0 115.475 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.24 -25.97 49.6 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.241 2.627 . . . . 0.0 112.122 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -61.13 -27.56 68.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 166.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.21 -31.52 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.836 0.854 . . . . 0.0 111.998 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.4 -4.7 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -114.81 -5.75 12.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.807 2.043 . . . . 0.0 113.652 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.9 mt -77.72 148.1 75.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.743 1.217 . . . . 0.0 112.532 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.65 -21.31 22.13 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.811 3.007 . . . . 0.0 115.2 -164.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -119.01 9.44 11.86 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.106 1.363 . . . . 0.0 113.921 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.02 -141.24 34.1 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.252 0.93 . . . . 0.0 112.975 -169.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.63 -25.25 52.8 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.313 -1.11 . . . . 0.0 113.414 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -64.89 -9.11 18.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 113.753 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.3 m -81.74 -7.96 59.65 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.08 0.952 . . . . 0.0 112.76 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.36 -18.69 14.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.624 1.17 . . . . 0.0 113.346 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -144.17 159.42 42.68 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.378 -1.451 . . . . 0.0 113.441 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -104.78 93.11 4.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.241 0.631 0 C-N-CA 123.658 0.783 . . . . 0.0 111.824 177.196 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.179 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.4 p -82.43 -15.37 52.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.56 156.17 35.29 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.042 1.292 . . . . 0.0 113.536 -171.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -153.06 150.85 29.58 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.239 1.416 . . . . 0.0 113.011 -172.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.41 -24.32 57.13 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -165.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -91.41 138.36 31.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.439 1.496 . . . . 0.0 113.682 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -62.11 129.0 38.79 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 168.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -68.13 134.33 50.37 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 117.346 2.35 . . . . 0.0 117.346 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -89.81 -26.55 20.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.43 -123.22 4.15 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.444 1.973 . . . . 0.0 111.729 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.1 m -67.76 149.64 49.68 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -127.47 21.48 6.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -166.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.26 127.94 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 120.198 1.363 . . . . 0.0 110.969 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.1 t -107.9 -27.14 10.38 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.264 1.825 . . . . 0.0 115.724 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -142.53 153.99 44.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.59 1.156 . . . . 0.0 111.242 162.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 p -128.64 176.43 7.8 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.53 1.532 . . . . 0.0 107.613 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -69.99 158.62 35.3 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.52 -135.99 12.5 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.297 -0.877 . . . . 0.0 112.245 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.75 154.13 42.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.97 1.385 . . . . 0.0 112.867 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -61.73 -64.97 0.77 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -160.04 -177.01 6.0 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.714 2.006 . . . . 0.0 111.025 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -63.42 18.68 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 128.219 2.608 . . . . 0.0 116.742 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.7 p -76.31 161.91 73.13 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.954 2.501 . . . . 0.0 115.09 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.1 -28.04 11.28 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.026 2.484 . . . . 0.0 112.192 162.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.276 1.2 p90 -66.43 128.67 37.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 163.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -155.59 96.48 1.77 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -112.49 -1.31 26.19 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.443 1.497 . . . . 0.0 114.455 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm 59.35 159.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.572 2.349 . . . . 0.0 115.926 -171.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -134.0 111.15 10.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.435 1.894 . . . . 0.0 110.099 -162.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.453 68.5 m-85 -93.41 28.07 2.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.43 -168.97 23.09 Favored Glycine 0 CA--C 1.532 1.097 0 O-C-N 121.109 -0.994 . . . . 0.0 114.766 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.27 144.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.977 2.111 . . . . 0.0 108.859 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -123.47 129.88 51.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -102.62 118.77 37.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.106 1.762 . . . . 0.0 113.804 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 157' ' ' HIS . . . -72.76 78.14 1.12 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.356 1.062 . . . . 0.0 112.421 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.6 mt -95.77 150.17 37.02 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.099 0.959 . . . . 0.0 112.484 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.07 151.52 83.6 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.864 2.376 . . . . 0.0 112.214 162.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -54.74 139.68 38.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.325 1.45 . . . . 0.0 111.054 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.77 -9.56 59.21 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.028 -1.429 . . . . 0.0 115.818 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 m -50.62 122.47 16.19 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.707 1.754 . . . . 0.0 113.938 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -67.31 129.3 20.03 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.165 1.243 . . . . 0.0 111.662 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 45.6 mm -87.94 127.68 40.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.267 1.827 . . . . 0.0 107.771 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -99.25 154.38 18.2 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.482 1.513 . . . . 0.0 109.77 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.9 123.95 90.16 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.939 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -35.79 51.61 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.148 2.565 . . . . 0.0 112.716 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -138.58 154.89 48.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.725 1.61 . . . . 0.0 107.137 -169.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.29 134.33 55.65 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.494 0.718 . . . . 0.0 110.926 169.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.01 -157.92 11.58 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.937 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 146.47 25.65 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.438 1.895 . . . . 0.0 111.911 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.03 129.23 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 -44.91 7.09 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -158.62 143.73 16.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.049 1.34 . . . . 0.0 111.104 -166.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -141.1 118.75 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.761 1.224 . . . . 0.0 109.637 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -159.68 174.46 14.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -129.9 156.38 44.49 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.982 1.313 . . . . 0.0 110.172 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -124.97 132.92 53.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.702 1.601 . . . . 0.0 108.785 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -52.16 -31.52 31.67 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -155.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.0 pp -130.72 6.22 4.7 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.87 1.668 . . . . 0.0 113.682 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.62 -20.21 20.18 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 126.167 1.842 . . . . 0.0 115.605 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.06 -173.05 21.23 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.495 1.521 . . . . 0.0 114.547 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -72.08 152.16 42.56 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.09 -0.653 . . . . 0.0 112.543 167.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.81 140.93 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 127.005 2.122 . . . . 0.0 114.451 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.86 132.53 56.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.302 1.841 . . . . 0.0 108.683 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.99 124.49 51.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.586 1.155 . . . . 0.0 110.403 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.76 144.43 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.455 1.102 . . . . 0.0 111.153 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.76 127.09 53.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.362 1.865 . . . . 0.0 110.35 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -64.94 144.59 57.18 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.006 -1.059 . . . . 0.0 111.428 169.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -69.2 -12.84 62.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.08 -20.67 65.57 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 165.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.69 1.83 63.51 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 116.131 1.213 . . . . 0.0 116.131 164.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -124.79 -30.56 3.27 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.09 1.445 . . . . 0.0 113.639 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.312 35.1 m-85 -83.95 136.47 34.06 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -120.13 155.32 33.28 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.316 2.246 . . . . 0.0 110.843 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -140.97 103.17 4.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.245 1.818 . . . . 0.0 109.994 -168.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -85.06 142.72 29.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.685 0.394 . . . . 0.0 111.38 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -130.78 89.94 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.872 2.469 . . . . 0.0 109.979 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mp -93.27 157.06 16.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.342 0.657 . . . . 0.0 111.346 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 71.18 58.56 0.19 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.269 1.827 . . . . 0.0 113.187 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -103.72 148.86 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.024 1.33 . . . . 0.0 111.288 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.42 -52.68 6.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.412 1.885 . . . . 0.0 107.618 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -150.98 157.79 43.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 127.168 2.187 . . . . 0.0 110.921 -165.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -98.77 154.29 18.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.94 0.896 . . . . 0.0 112.076 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -117.18 -14.28 10.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.677 1.191 . . . . 0.0 112.934 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.93 163.17 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.067 1.347 . . . . 0.0 110.397 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -117.88 163.84 15.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.4 t -54.52 135.43 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.57 3.72 83.7 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.561 1.077 . . . . 0.0 115.263 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -79.67 124.57 28.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 119.326 1.563 . . . . 0.0 111.863 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -74.19 140.95 45.46 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.77 160.92 40.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.617 1.567 . . . . 0.0 110.298 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -129.2 145.06 51.41 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.605 1.562 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.0 116.56 2.05 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.558 1.143 . . . . 0.0 112.732 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.68 -1.33 42.19 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 126.203 1.859 . . . . 0.0 115.305 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -86.34 142.58 28.39 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.407 1.883 . . . . 0.0 114.958 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.4 mm -69.01 129.05 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.109 0.868 . . . . 0.0 112.01 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.77 -23.97 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.707 1.603 . . . . 0.0 113.312 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.77 3.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.469 1.108 . . . . 0.0 110.54 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.66 132.08 46.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.6 t -69.06 137.52 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.704 1.601 . . . . 0.0 110.43 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.87 163.36 34.16 Favored Glycine 0 N--CA 1.464 0.502 0 CA-C-O 122.893 1.274 . . . . 0.0 115.027 -169.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -81.3 34.24 0.36 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -163.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.0 p -88.21 113.81 24.2 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.327 1.451 . . . . 0.0 112.248 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.14 17.8 74.23 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 118.891 2.317 . . . . 0.0 118.891 168.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.41 145.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 120.182 1.991 . . . . 0.0 111.468 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -75.13 -43.57 51.86 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.16 132.21 31.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 174.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.413 2.3 p 66.96 -128.59 0.17 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -170.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.8 166.58 38.84 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 121.168 1.803 . . . . 0.0 116.212 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 67.2 -9.68 0.38 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 119.467 3.136 . . . . 0.0 119.467 172.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 82' ' ' ALA . 25.1 m170 -74.61 124.94 27.6 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.106 1.362 . . . . 0.0 113.99 -171.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.48 128.53 36.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.292 1.437 . . . . 0.0 112.089 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -106.23 105.9 16.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.798 0.839 . . . . 0.0 112.109 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.287 33.7 t80 -95.4 111.98 23.77 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.882 1.673 . . . . 0.0 114.941 175.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -116.7 114.0 23.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.621 1.168 . . . . 0.0 111.282 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.94 122.63 43.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.415 1.486 . . . . 0.0 110.808 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.0 mtm -128.64 156.46 43.38 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.618 1.567 . . . . 0.0 111.415 -172.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -127.76 128.29 45.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 110.669 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.3 -15.2 12.7 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 125.886 1.708 . . . . 0.0 116.623 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.53 40.31 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.049 1.309 . . . . 0.0 112.179 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.93 91.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 173.03 173.21 39.28 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.872 1.701 . . . . 0.0 112.86 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -48.58 -48.65 38.77 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.1 -14.62 62.74 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.19 -16.34 38.12 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 143.49 52.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.564 1.146 . . . . 0.0 112.823 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -125.23 -79.94 0.61 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -164.79 110.51 0.84 Allowed Pre-proline 0 N--CA 1.47 0.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -29.99 4.13 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.257 1.971 . . . . 0.0 114.151 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -51.35 -59.98 6.72 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.6 -28.62 69.73 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.689 2.926 . . . . 0.0 111.695 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -66.72 -39.17 87.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.22 -34.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.775 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.51 -16.84 17.12 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.93 1.12 11.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.144 1.778 . . . . 0.0 114.692 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.23 154.39 87.36 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.44 1.096 . . . . 0.0 111.848 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -47.2 -54.69 4.7 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.921 3.748 . . . . 0.0 114.028 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -106.99 10.84 30.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.272 1.029 . . . . 0.0 112.727 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.32 -139.1 30.15 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.711 -1.243 . . . . 0.0 112.332 -169.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.97 -26.4 62.28 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.706 -1.467 . . . . 0.0 112.807 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -69.55 -3.37 14.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.983 1.313 . . . . 0.0 113.067 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.6 m -80.54 -8.04 59.44 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.31 1.044 . . . . 0.0 113.013 166.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.57 -13.47 15.05 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.854 1.662 . . . . 0.0 112.687 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.16 161.47 42.67 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -106.04 90.15 3.29 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.849 1.26 . . . . 0.0 109.806 170.272 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.747 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.1 p -56.46 128.49 36.34 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.12 155.34 21.52 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.882 1.673 . . . . 0.0 111.483 165.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -136.31 159.64 41.12 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.695 1.198 . . . . 0.0 113.358 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.07 158.43 31.11 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.76 1.267 . . . . 0.0 112.883 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -151.94 161.85 41.99 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.625 1.97 . . . . 0.0 113.861 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -88.03 124.82 34.14 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 167.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.261 16.2 t80 -66.68 156.58 34.89 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -47.58 104.93 0.06 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.692 1.597 . . . . 0.0 112.982 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.97 -11.1 0.29 Allowed Glycine 0 CA--C 1.544 1.871 0 N-CA-C 118.045 1.978 . . . . 0.0 118.045 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 m -148.72 153.46 38.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.425 2.112 . . . . 0.0 113.909 -162.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -84.83 16.02 3.58 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 mt -87.49 125.98 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.937 -1.102 . . . . 0.0 113.548 -167.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.1 p -88.1 -36.78 16.72 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -141.0 122.88 15.4 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.173 1.389 . . . . 0.0 111.641 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.0 p -85.43 -176.69 6.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.622 1.169 . . . . 0.0 110.412 164.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -68.66 134.89 50.55 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.34 -120.5 1.01 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.351 0.501 . . . . 0.0 112.092 -171.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 149.56 35.06 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.667 1.587 . . . . 0.0 112.813 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -62.48 160.04 14.43 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.155 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -59.69 156.44 13.79 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.454 -0.779 . . . . 0.0 112.431 166.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.2 m170 63.12 52.76 2.44 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.87 1.668 . . . . 0.0 113.825 -171.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.8 m 68.66 160.9 0.14 Allowed Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 128.525 2.73 . . . . 0.0 117.409 169.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -86.09 1.45 7.87 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.067 3.178 . . . . 0.0 115.257 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -76.14 109.67 10.0 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.31 25.5 m-20 55.12 36.09 26.21 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -166.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.46 20.96 1.87 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.895 1.236 . . . . 0.0 115.782 -165.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -83.87 144.74 29.03 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.006 1.903 . . . . 0.0 112.908 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -115.28 129.04 56.51 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.335 1.854 . . . . 0.0 110.688 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.96 23.0 14.27 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -170.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.0 -166.97 14.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 120.696 -1.252 . . . . 0.0 114.579 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.01 130.36 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.828 2.051 . . . . 0.0 109.291 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -109.64 89.15 2.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.15 108.1 12.4 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.17 126.83 30.43 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.417 1.008 . . . . 0.0 111.776 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.45 159.17 71.64 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.137 0.975 . . . . 0.0 113.325 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.19 145.8 73.91 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.234 2.623 . . . . 0.0 111.22 161.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -65.87 131.71 46.91 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.345 -0.847 . . . . 0.0 111.149 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.27 84.24 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.586 -1.675 . . . . 0.0 115.415 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -47.72 121.93 8.58 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.923 1.862 . . . . 0.0 112.459 171.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -68.2 129.25 18.94 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.424 1.416 . . . . 0.0 111.589 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -86.23 128.1 39.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.73 1.612 . . . . 0.0 108.482 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -100.4 149.81 23.27 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 109.644 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.76 133.37 90.46 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 121.777 -0.577 . . . . 0.0 110.861 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.59 -32.39 6.11 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.193 2.595 . . . . 0.0 112.667 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.3 p -140.22 160.92 38.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.34 2.256 . . . . 0.0 107.847 -170.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -74.64 136.78 41.94 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.772 -1.205 . . . . 0.0 109.326 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.56 -159.11 11.81 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.973 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.09 144.68 25.89 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.913 1.285 . . . . 0.0 113.108 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.65 127.26 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.06 -41.95 5.69 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.614 1.166 . . . . 0.0 111.939 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -147.06 140.43 25.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.697 1.199 . . . . 0.0 110.915 -165.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 mt -144.82 110.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.512 1.525 . . . . 0.0 109.42 -173.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -154.81 -175.23 5.32 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.461 0.704 . . . . 0.0 112.545 -169.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.51 32.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.697 1.199 . . . . 0.0 112.456 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -143.65 153.98 43.06 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.906 2.082 . . . . 0.0 112.023 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -63.55 -31.16 72.24 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.67 -19.02 5.04 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.955 1.302 . . . . 0.0 113.692 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.21 -8.32 75.26 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.809 1.671 . . . . 0.0 114.326 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.2 -152.39 49.82 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 118.02 0.91 . . . . 0.0 113.074 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -73.33 148.07 43.82 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.684 -0.892 . . . . 0.0 112.498 170.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.25 134.79 62.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.528 1.531 . . . . 0.0 115.087 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -111.35 134.97 52.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.135 1.374 . . . . 0.0 109.574 168.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.4 124.34 44.28 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 177.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 55.6 mt -119.85 139.91 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.557 1.143 . . . . 0.0 111.193 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.33 131.27 40.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.852 2.061 . . . . 0.0 110.118 166.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -77.34 155.53 31.9 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -68.48 -12.43 61.21 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.417 1.887 . . . . 0.0 111.564 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -71.04 -13.35 61.95 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 167.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.32 -2.28 57.78 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -114.75 -35.56 4.79 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.581 1.69 . . . . 0.0 112.517 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -88.99 143.31 26.94 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -121.9 152.77 39.27 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.536 1.534 . . . . 0.0 112.54 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.38 138.95 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.586 1.954 . . . . 0.0 109.153 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -114.0 148.65 36.59 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.977 1.311 . . . . 0.0 112.827 161.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -133.7 99.63 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.896 1.679 . . . . 0.0 106.964 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.41 163.67 13.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.695 1.198 . . . . 0.0 110.508 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 66.25 40.15 3.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.154 2.181 . . . . 0.0 114.937 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -83.98 154.22 23.44 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.312 -1.493 . . . . 0.0 112.827 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.36 -46.75 7.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.799 1.239 . . . . 0.0 108.955 171.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -152.82 160.27 43.09 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -104.0 148.64 25.98 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.646 1.578 . . . . 0.0 111.911 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -107.33 -8.61 16.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.662 1.585 . . . . 0.0 112.25 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 175.39 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.772 1.629 . . . . 0.0 111.464 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -130.82 169.21 16.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.438 1.495 . . . . 0.0 111.424 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.29 132.47 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 122.225 1.012 . . . . 0.0 108.983 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.69 9.16 69.08 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.511 1.053 . . . . 0.0 115.128 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -86.27 124.61 32.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.727 1.264 . . . . 0.0 113.33 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -75.87 139.68 41.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.514 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.4 164.6 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.214 1.805 . . . . 0.0 112.676 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.05 140.14 48.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.254 1.822 . . . . 0.0 110.218 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.1 125.68 3.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.875 1.27 . . . . 0.0 113.402 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.94 -10.14 72.33 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.0 1.762 . . . . 0.0 114.995 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -80.74 145.0 31.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.179 1.489 . . . . 0.0 114.667 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.1 mm -70.82 135.06 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.225 0.61 . . . . 0.0 111.817 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 42.1 pt -121.22 -20.52 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.493 1.117 . . . . 0.0 113.321 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.7 -176.03 1.19 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.896 1.678 . . . . 0.0 111.388 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -132.82 134.46 44.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.2 t -71.01 143.65 50.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.179 0.591 . . . . 0.0 112.231 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.88 175.06 21.07 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.554 1.073 . . . . 0.0 113.185 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -87.38 17.34 4.52 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.218 -1.166 . . . . 0.0 112.98 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.269 5.6 p -65.98 137.67 57.29 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.34 -34.06 2.91 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 125.326 1.441 . . . . 0.0 115.094 -174.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.7 144.97 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.3 1.44 . . . . 0.0 112.331 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -75.41 -37.61 60.35 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -170.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.269 1.3 m -127.13 -70.61 0.71 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -169.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.8 p -145.13 146.0 31.62 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.19 134.61 8.37 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.979 1.752 . . . . 0.0 113.736 171.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -97.84 150.38 21.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.856 1.662 . . . . 0.0 111.87 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -156.97 171.12 21.03 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.569 -0.707 . . . . 0.0 111.684 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.42 120.88 41.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.167 1.387 . . . . 0.0 110.887 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -98.45 99.41 10.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.301 1.04 . . . . 0.0 110.583 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.283 36.8 t80 -88.75 116.66 27.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -122.29 116.95 24.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.323 1.049 . . . . 0.0 111.886 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -95.29 131.39 41.42 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.747 1.619 . . . . 0.0 110.93 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.8 mtm -132.43 155.09 49.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.681 1.593 . . . . 0.0 111.498 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -128.76 136.7 50.91 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.304 1.442 . . . . 0.0 111.235 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.39 2.75 43.85 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.75 -175.81 43.78 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.6 2.048 . . . . 0.0 111.0 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.56 123.29 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 122.438 1.114 . . . . 0.0 108.266 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.07 159.58 9.94 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.724 2.583 . . . . 0.0 110.685 -165.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.61 -46.68 83.78 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.774 1.287 . . . . 0.0 113.534 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.72 -15.98 63.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -76.28 -15.07 60.08 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.27 152.31 42.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.51 1.124 . . . . 0.0 113.861 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -119.97 -90.49 0.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.37 1.468 . . . . 0.0 112.409 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -160.91 118.13 1.44 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.371 1.469 . . . . 0.0 108.385 165.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -20.9 29.96 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.096 2.531 . . . . 0.0 115.512 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -50.86 -55.32 28.28 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.98 -28.2 42.09 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.905 3.07 . . . . 0.0 112.873 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.46 -34.51 78.46 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.2 mt -79.14 -32.66 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.107 0.563 . . . . 0.0 111.37 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.81 -5.59 2.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -117.45 -9.05 10.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.964 1.706 . . . . 0.0 113.804 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 58.7 mt -63.98 152.53 87.15 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.198 1.399 . . . . 0.0 113.078 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.97 -32.71 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.539 2.826 . . . . 0.0 114.603 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.64 13.43 19.93 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.108 1.363 . . . . 0.0 113.09 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.06 -135.73 48.67 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.98 0.8 . . . . 0.0 112.197 -167.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.23 -26.92 53.07 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.91 -10.28 56.29 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.7 t -78.66 0.62 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.211 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.7 mt -111.13 -16.23 13.51 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.726 1.61 . . . . 0.0 112.834 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -146.24 153.87 41.08 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.771 1.623 . . . . 0.0 114.558 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -107.75 76.53 1.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.399 1.095 . . . . 0.0 113.317 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 C--O 1.239 0.543 0 C-N-CA 124.464 1.105 . . . . 0.0 109.454 169.065 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.1 m -66.15 155.61 36.43 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.099 1.36 . . . . 0.0 114.302 -175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -94.01 -31.89 14.05 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.375 1.47 . . . . 0.0 112.21 161.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -147.22 161.87 40.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.126 1.77 . . . . 0.0 112.656 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -138.88 -178.45 5.33 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.899 1.679 . . . . 0.0 113.135 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.356 4.4 p30 -68.85 51.9 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 128.001 2.52 . . . . 0.0 117.645 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.274 12.8 m-85 -93.24 135.71 34.19 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 120.015 3.339 . . . . 0.0 120.015 -172.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -111.31 149.46 31.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 128.262 2.625 . . . . 0.0 116.275 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.0 mtm-85 -138.5 60.9 1.6 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.93 -39.73 95.06 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 159.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -84.92 135.46 34.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.186 0.995 . . . . 0.0 109.952 156.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -71.3 -9.57 58.34 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -166.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -79.73 126.11 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 119.569 1.077 . . . . 0.0 111.488 -170.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.251 0.7 OUTLIER -74.95 -42.19 58.16 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 167.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.49 122.22 10.54 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.486 1.514 . . . . 0.0 109.801 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.0 p -82.51 170.82 14.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.177 1.391 . . . . 0.0 112.434 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -67.39 131.18 45.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.19 -90.4 0.18 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.116 0.865 . . . . 0.0 112.439 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -137.21 163.07 31.76 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.988 1.315 . . . . 0.0 113.533 -164.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.85 172.03 8.74 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 164.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -88.42 -0.88 57.67 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.313 1.045 . . . . 0.0 113.047 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -62.59 -29.85 70.9 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.737 1.215 . . . . 0.0 114.163 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.4 p -158.09 162.25 27.3 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.482 1.113 . . . . 0.0 111.038 168.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.85 -8.61 20.4 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.01 2.474 . . . . 0.0 113.449 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -89.62 -63.6 1.26 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -171.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.08 168.83 26.04 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 122.498 1.142 . . . . 0.0 109.547 -168.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.39 110.67 2.36 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 127.558 2.504 . . . . 0.0 110.821 -171.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -122.25 137.59 54.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.027 1.331 . . . . 0.0 113.954 -165.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -122.18 136.99 54.98 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.105 1.762 . . . . 0.0 110.847 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -122.47 27.22 7.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.155 0.982 . . . . 0.0 113.627 -166.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.99 -169.47 17.5 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.888 -1.132 . . . . 0.0 113.588 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.68 132.8 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.995 2.118 . . . . 0.0 108.617 173.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.96 93.76 4.61 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -79.82 111.19 15.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 121.55 17.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.729 0.695 . . . . 0.0 111.307 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.8 mt -135.99 156.78 76.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.373 1.469 . . . . 0.0 110.653 -173.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.29 137.68 67.11 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.56 2.174 . . . . 0.0 110.774 160.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -60.21 133.37 56.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 0.0 111.063 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.29 5.25 89.02 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.24 -1.311 . . . . 0.0 115.07 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.5 m -55.12 125.55 57.75 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.179 1.99 . . . . 0.0 110.506 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -68.02 132.31 26.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.968 1.779 . . . . 0.0 111.851 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.46 126.22 41.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.208 1.803 . . . . 0.0 107.665 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -95.99 153.61 17.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.216 1.007 . . . . 0.0 110.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.32 123.71 89.44 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.727 -0.608 . . . . 0.0 110.672 172.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.19 -40.19 20.58 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.992 2.461 . . . . 0.0 111.475 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.1 p -134.82 165.02 26.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.079 2.552 . . . . 0.0 111.309 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -70.94 136.03 48.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.493 1.117 . . . . 0.0 112.056 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.54 -157.32 13.22 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.521 1.058 . . . . 0.0 114.629 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.68 150.42 31.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.557 1.943 . . . . 0.0 110.19 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 t -66.01 133.26 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -41.74 8.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 176.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -158.88 145.64 17.17 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.069 1.748 . . . . 0.0 109.372 -169.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.6 mt -137.32 129.87 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.901 1.28 . . . . 0.0 108.864 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -157.53 173.38 16.97 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -128.54 152.73 47.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.119 0.967 . . . . 0.0 111.141 170.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -145.16 143.03 30.12 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.281 1.432 . . . . 0.0 112.68 -174.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -66.22 -21.91 66.32 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.06 -37.85 9.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.888 1.275 . . . . 0.0 112.156 171.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -91.54 -9.5 62.91 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.855 1.217 . . . . 0.0 115.917 -168.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.0 -154.98 52.56 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.021 0.91 . . . . 0.0 112.455 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -69.29 144.17 53.64 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.857 -0.79 . . . . 0.0 111.438 165.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.51 137.01 56.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.607 1.563 . . . . 0.0 114.823 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.4 tp -115.95 123.44 48.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.21 125.47 48.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.276 1.03 . . . . 0.0 109.753 171.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.1 mt -121.45 147.46 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.588 1.155 . . . . 0.0 111.606 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.87 136.95 49.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.692 1.997 . . . . 0.0 110.812 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -76.42 154.93 34.4 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.876 0.87 . . . . 0.0 112.773 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -58.21 -28.71 65.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -175.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -85.68 0.36 52.93 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.85 5.13 90.04 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 160.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.23 -31.54 7.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.54 1.67 . . . . 0.0 112.209 -174.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.295 52.4 m-85 -88.03 131.07 34.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 172.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -115.16 151.86 33.64 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.376 1.87 . . . . 0.0 110.746 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.89 102.85 4.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.123 1.769 . . . . 0.0 110.206 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -85.31 139.83 31.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.384 0.274 . . . . 0.0 111.193 170.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -126.25 91.36 3.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.532 2.333 . . . . 0.0 109.436 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.55 158.36 16.49 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.961 1.304 . . . . 0.0 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 63.54 56.34 1.62 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.503 1.921 . . . . 0.0 114.124 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.2 mt -96.49 147.37 23.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 111.332 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -84.42 -48.49 9.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.63 148.11 30.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.062 1.745 . . . . 0.0 112.076 -169.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -93.66 144.62 25.22 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.938 1.295 . . . . 0.0 113.153 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -104.36 -10.97 17.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.605 0.762 . . . . 0.0 112.288 166.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.53 164.31 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.97 1.708 . . . . 0.0 113.191 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.45 164.37 14.98 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.016 2.126 . . . . 0.0 110.515 168.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.73 128.12 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.74 7.9 74.16 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.634 1.111 . . . . 0.0 115.747 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.27 133.32 35.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.044 1.922 . . . . 0.0 107.276 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -70.5 146.24 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.016 0.527 . . . . 0.0 111.8 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.6 m -129.33 154.06 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 110.007 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -133.5 140.59 47.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.954 1.702 . . . . 0.0 108.736 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.26 125.68 11.39 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.264 1.031 . . . . 0.0 112.751 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.63 -1.37 66.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.829 1.68 . . . . 0.0 115.46 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -88.54 142.29 27.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.125 1.37 . . . . 0.0 114.031 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 16.1 mm -67.3 132.12 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.084 0.856 . . . . 0.0 111.774 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 44.2 pt -116.57 -23.17 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.826 1.25 . . . . 0.0 113.211 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -172.54 -175.49 1.35 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.623 1.969 . . . . 0.0 110.665 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.38 139.14 46.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 0.0 107.505 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.11 144.37 50.29 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.64 0.776 . . . . 0.0 112.126 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.93 156.23 26.89 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 123.664 0.649 . . . . 0.0 113.004 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -82.36 31.45 0.4 Allowed 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.05 -1.265 . . . . 0.0 113.685 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.3 p -67.21 134.25 51.33 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.055 0.942 . . . . 0.0 110.93 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 72.67 -20.78 1.0 Allowed Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.314 1.435 . . . . 0.0 116.319 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.5 140.79 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.635 1.717 . . . . 0.0 111.617 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -74.95 -0.8 19.89 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.158 1.783 . . . . 0.0 115.376 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.3 t -153.56 140.46 19.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.017 2.127 . . . . 0.0 110.806 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.334 4.8 p -72.34 21.44 0.06 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.802 2.89 . . . . 0.0 118.802 -164.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.51 -9.19 81.81 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 116.789 1.476 . . . . 0.0 116.789 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 56.89 28.15 14.13 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 163.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -76.46 134.47 39.53 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -169.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.54 117.37 14.13 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.08 0.952 . . . . 0.0 111.138 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -92.68 101.54 13.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.713 0.805 . . . . 0.0 110.784 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.281 52.9 t80 -93.28 115.65 28.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 170.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -117.62 116.08 26.36 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.632 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -92.24 121.85 34.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.72 1.608 . . . . 0.0 110.426 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.6 mtm -125.67 153.18 44.22 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.341 1.456 . . . . 0.0 110.756 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.12 128.92 46.97 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.654 1.181 . . . . 0.0 110.817 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.61 1.71 83.53 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.285 1.421 . . . . 0.0 115.812 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.51 -174.7 43.85 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.031 1.777 . . . . 0.0 111.846 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.8 125.3 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.618 1.167 . . . . 0.0 114.126 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 151.81 171.5 19.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.648 1.594 . . . . 0.0 113.037 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -65.06 -34.93 79.6 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.343 -1.093 . . . . 0.0 112.15 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.35 67.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.462 1.505 . . . . 0.0 113.58 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -92.94 -14.85 27.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.77 144.61 57.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.537 1.135 . . . . 0.0 112.329 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -116.24 -82.9 0.63 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.048 0.939 . . . . 0.0 112.24 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -170.4 129.02 0.81 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 128.125 2.57 . . . . 0.0 106.111 160.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -71.58 -24.48 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.948 2.432 . . . . 0.0 114.539 171.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -54.05 -55.08 40.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -171.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.88 -31.09 48.28 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.688 2.925 . . . . 0.0 112.082 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -65.1 -41.62 94.77 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 29.9 mt -71.58 -35.78 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.391 0.541 . . . . 0.0 111.303 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 44.3 m-20 -63.68 -2.85 1.9 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -126.53 -7.59 6.29 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.096 2.158 . . . . 0.0 115.01 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.76 151.12 55.05 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.14 0.976 . . . . 0.0 112.484 170.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.41 -32.87 49.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.537 2.824 . . . . 0.0 114.947 -168.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.98 10.2 24.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.534 1.133 . . . . 0.0 109.61 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.68 -136.26 44.32 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.548 -1.345 . . . . 0.0 111.915 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.7 -25.28 68.08 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.934 -1.333 . . . . 0.0 113.939 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -68.41 -3.28 10.7 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.9 m -77.3 -6.69 54.12 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 111.94 166.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.06 -12.92 12.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.779 1.632 . . . . 0.0 113.854 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.13 161.52 38.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -114.81 87.01 2.55 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 122.228 1.013 . . . . 0.0 111.904 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.203 1.401 . . . . 0.0 110.915 177.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 CA-C-O 120.781 0.101 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -113.34 154.55 26.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.855 1.262 . . . . 0.0 110.665 165.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.42 162.6 13.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.627 1.571 . . . . 0.0 111.005 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -134.29 133.21 40.5 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.708 1.203 . . . . 0.0 112.832 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -68.02 142.16 55.99 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.017 0.913 . . . . 0.0 112.129 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -117.07 147.84 42.03 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.087 1.755 . . . . 0.0 114.73 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.262 21.9 t80 -56.58 136.71 54.45 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 116.542 2.052 . . . . 0.0 116.542 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.281 1.1 p90 -141.43 147.74 38.43 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 117.743 2.497 . . . . 0.0 117.743 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -130.84 152.22 50.41 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.484 1.914 . . . . 0.0 111.094 166.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.24 -107.85 2.0 Allowed Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -167.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.7 m -64.58 152.1 42.93 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -126.17 34.81 4.78 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.89 138.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 O-C-N 120.05 -1.656 . . . . 0.0 112.671 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 p -107.41 -27.11 10.65 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.294 2.238 . . . . 0.0 116.379 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -146.51 149.92 34.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.979 1.712 . . . . 0.0 110.39 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.1 p -135.94 169.17 18.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.852 1.661 . . . . 0.0 109.484 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -68.27 126.23 28.92 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.38 -142.57 8.56 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.427 0.537 . . . . 0.0 113.739 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -132.9 146.76 52.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.408 1.483 . . . . 0.0 111.067 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -67.0 138.9 57.58 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -72.56 -49.84 29.68 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.375 0.67 . . . . 0.0 109.763 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -144.44 131.34 20.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.841 1.656 . . . . 0.0 110.752 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 p -162.55 164.99 16.04 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.118 0.967 . . . . 0.0 111.971 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.58 -6.76 11.69 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.262 2.641 . . . . 0.0 113.143 167.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -93.33 -174.41 3.51 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.683 1.593 . . . . 0.0 109.984 -167.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.293 8.7 p30 -64.5 -14.13 55.71 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.21 13.96 27.44 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.475 1.512 . . . . 0.0 116.226 167.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -130.74 144.56 51.53 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.259 2.029 . . . . 0.0 113.178 -167.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -147.07 131.47 17.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.579 -0.701 . . . . 0.0 112.832 -170.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.66 21.29 7.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.17 -172.08 13.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.703 1.144 . . . . 0.0 113.903 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.78 136.8 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.342 2.257 . . . . 0.0 108.549 173.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.07 100.88 7.82 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.49 130.61 36.22 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.32 34.22 0.13 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.968 2.107 . . . . 0.0 115.901 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 148.74 90.33 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.727 -1.233 . . . . 0.0 111.835 -168.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.43 146.54 85.59 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.213 1.942 . . . . 0.0 111.982 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.12 129.0 33.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.967 0.907 . . . . 0.0 110.331 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.62 63.06 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.707 1.146 . . . . 0.0 115.523 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -58.87 126.5 80.97 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-N 119.612 1.706 . . . . 0.0 113.15 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -69.66 130.31 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.27 1.98 . . . . 0.0 112.317 172.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 mm -85.13 129.6 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.974 1.71 . . . . 0.0 108.532 170.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -100.78 151.98 21.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.164 . . . . 0.0 110.39 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.75 88.98 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.367 0.667 . . . . 0.0 111.621 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.71 -26.02 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.176 3.251 . . . . 0.0 113.249 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.9 p -133.27 164.33 27.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 127.306 2.242 . . . . 0.0 110.263 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.98 145.39 46.32 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.169 -0.957 . . . . 0.0 108.479 151.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.83 -163.92 24.67 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.144 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -147.28 143.75 28.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.58 1.152 . . . . 0.0 111.917 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.16 128.11 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.33 -43.88 7.83 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.426 1.491 . . . . 0.0 114.947 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -159.21 144.1 15.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.048 0.939 . . . . 0.0 110.992 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -140.75 114.85 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.674 1.19 . . . . 0.0 109.88 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -154.24 -177.27 6.33 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -167.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -139.65 150.54 45.05 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.981 -1.074 . . . . 0.0 111.828 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -123.84 162.18 23.79 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.108 1.763 . . . . 0.0 111.215 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.5 pm0 -66.14 -40.92 90.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 -169.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.2 -11.19 6.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.796 1.238 . . . . 0.0 113.842 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.14 -6.53 88.83 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.826 1.679 . . . . 0.0 114.006 163.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.24 -156.39 53.54 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.95 0.786 . . . . 0.0 113.49 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -69.11 145.86 53.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.048 -0.678 . . . . 0.0 111.958 171.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.13 137.45 55.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 tp -115.95 131.5 56.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.719 2.007 . . . . 0.0 108.582 167.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 125.81 53.54 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.59 1.156 . . . . 0.0 110.316 173.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.17 144.46 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.27 1.028 . . . . 0.0 111.552 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.36 136.27 41.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.654 1.982 . . . . 0.0 110.793 171.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -79.16 159.69 27.3 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.628 0.771 . . . . 0.0 111.619 170.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -74.66 -10.62 59.7 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.318 -1.489 . . . . 0.0 114.367 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -58.65 -24.17 60.64 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.602 1.561 . . . . 0.0 112.454 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.72 2.08 56.33 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.648 1.594 . . . . 0.0 115.226 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -142.65 -28.0 0.59 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -86.28 141.53 29.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.73 159.08 31.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.556 2.742 . . . . 0.0 112.117 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.62 105.26 4.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.184 2.194 . . . . 0.0 110.96 -171.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -85.79 144.33 27.8 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.472 0.709 . . . . 0.0 112.314 171.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.42 87.12 2.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.136 2.574 . . . . 0.0 108.887 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.39 159.55 19.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.044 1.338 . . . . 0.0 110.918 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 62.87 50.41 3.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.754 2.021 . . . . 0.0 114.455 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.9 mt -89.79 158.41 17.51 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.672 -1.267 . . . . 0.0 112.419 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -98.76 -46.61 5.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 0.0 109.13 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -150.14 149.41 30.21 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.207 1.803 . . . . 0.0 111.888 -171.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -103.39 134.52 46.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 112.108 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -87.43 -27.51 22.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.125 0.57 . . . . 0.0 111.791 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -112.93 166.72 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.023 1.729 . . . . 0.0 112.521 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -116.69 162.22 18.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.801 2.04 . . . . 0.0 111.283 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.2 t -55.99 126.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.401 1.081 . . . . 0.0 109.189 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.34 12.14 61.79 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.453 1.501 . . . . 0.0 115.389 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -96.4 133.69 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.764 1.782 . . . . 0.0 107.657 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -72.97 146.75 45.79 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.011 0.924 . . . . 0.0 111.413 167.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.86 167.12 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.343 1.857 . . . . 0.0 111.879 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.85 134.16 44.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.427 1.891 . . . . 0.0 110.055 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.55 121.78 3.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.045 1.338 . . . . 0.0 112.851 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.81 4.69 69.35 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.523 1.535 . . . . 0.0 115.412 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -90.25 148.97 22.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 114.649 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 14.8 mm -70.12 139.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.63 0.729 . . . . 0.0 111.469 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.53 -23.06 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.507 1.123 . . . . 0.0 112.544 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.15 -179.01 2.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.026 1.33 . . . . 0.0 111.368 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.97 138.14 54.76 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 80.0 p -66.43 135.99 55.08 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.651 1.18 . . . . 0.0 112.104 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -126.52 168.56 18.63 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 122.389 0.994 . . . . 0.0 113.318 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -85.56 1.28 49.72 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.095 1.358 . . . . 0.0 112.802 174.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.0 p -57.37 130.1 44.74 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.714 1.605 . . . . 0.0 114.183 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.3 -20.89 1.16 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.151 1.358 . . . . 0.0 116.35 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 mt -87.14 -70.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.889 1.845 . . . . 0.0 111.425 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -154.42 166.02 34.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.103 1.761 . . . . 0.0 108.758 -167.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.346 0.6 OUTLIER -67.22 -25.52 66.14 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 176.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.267 0.7 OUTLIER -132.32 -26.12 1.9 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 174.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -76.18 142.09 27.88 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.677 1.132 . . . . 0.0 114.437 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.65 152.13 38.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.983 1.313 . . . . 0.0 113.811 -166.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -160.21 133.96 7.09 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.477 1.511 . . . . 0.0 112.157 169.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.19 116.11 16.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.487 -1.383 . . . . 0.0 111.082 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -94.62 102.04 13.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.855 0.752 . . . . 0.0 111.774 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.275 43.9 t80 -93.9 116.81 29.3 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.381 1.473 . . . . 0.0 114.77 171.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -124.6 116.61 22.69 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.757 1.223 . . . . 0.0 111.654 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -101.1 127.08 47.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.517 1.127 . . . . 0.0 111.409 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.2 mtm -128.44 157.33 41.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.792 1.637 . . . . 0.0 111.65 -173.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -136.09 137.17 40.79 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.177 1.391 . . . . 0.0 111.243 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.78 -18.61 8.72 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.167 1.365 . . . . 0.0 115.031 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -176.83 -168.74 37.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.152 1.834 . . . . 0.0 111.273 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.59 112.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 156.49 169.36 20.45 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.895 1.712 . . . . 0.0 111.557 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -61.14 -40.64 94.59 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.361 -1.082 . . . . 0.0 113.245 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.47 -26.95 67.17 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.51 -11.86 55.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.55 141.82 51.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.734 1.214 . . . . 0.0 112.651 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -106.03 -80.09 0.56 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -174.51 123.93 0.38 Allowed Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 128.37 2.668 . . . . 0.0 106.147 160.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.42 -29.49 11.09 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.054 2.503 . . . . 0.0 114.715 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -52.84 71.17 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.58 -30.69 70.93 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.926 2.417 . . . . 0.0 111.881 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.17 -45.75 93.32 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 166.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.7 mt -69.53 -32.12 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.767 -1.208 . . . . 0.0 111.719 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.08 0.42 1.95 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.061 1.744 . . . . 0.0 115.07 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -124.74 -8.52 7.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 114.303 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.59 151.31 88.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.927 -1.108 . . . . 0.0 112.82 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.5 -35.2 39.87 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.743 2.962 . . . . 0.0 114.806 -165.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -112.13 16.4 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.923 1.289 . . . . 0.0 112.16 166.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.38 -134.72 48.04 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 121.076 -1.015 . . . . 0.0 112.441 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.34 -22.7 65.16 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.419 -1.048 . . . . 0.0 112.544 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.6 mtt-85 -72.3 -3.36 23.31 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.632 -1.293 . . . . 0.0 112.564 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 75.5 m -84.54 -7.53 59.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.501 1.12 . . . . 0.0 113.054 163.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.94 -19.88 15.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.777 1.631 . . . . 0.0 111.671 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -147.41 160.21 42.82 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -104.9 86.24 2.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.472 0.655 0 C-N-CA 124.604 1.162 . . . . 0.0 109.666 173.5 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 m -97.37 -13.58 21.77 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -76.68 153.07 35.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.265 1.426 . . . . 0.0 111.353 171.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -65.63 119.98 12.12 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 118.137 0.426 . . . . 0.0 111.542 166.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -64.83 148.46 51.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.376 1.07 . . . . 0.0 112.73 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -78.17 143.69 37.01 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.163 1.385 . . . . 0.0 112.073 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -84.57 166.04 17.51 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.288 56.0 m-85 -108.8 -21.73 12.54 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 171.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -141.2 167.17 22.83 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.609 1.964 . . . . 0.0 110.912 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.42 147.01 48.09 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 123.844 0.735 . . . . 0.0 113.351 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.8 t -148.09 151.48 35.72 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -81.35 -11.13 59.4 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.209 2.204 . . . . 0.0 113.679 170.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.1 mt -79.69 116.65 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 120.336 1.425 . . . . 0.0 112.158 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.273 1.3 p -64.64 -52.71 55.96 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.315 1.046 . . . . 0.0 113.663 169.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -143.89 128.15 17.75 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.884 1.674 . . . . 0.0 110.939 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.1 p -83.27 -172.25 4.03 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.403 1.481 . . . . 0.0 108.451 171.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -70.26 122.92 20.45 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.07 -155.09 18.59 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 121.491 -0.755 . . . . 0.0 112.716 -172.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -136.98 148.8 47.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.398 1.099 . . . . 0.0 113.179 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.27 48.8 m-85 -67.88 -36.3 80.0 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 119.3 3.074 . . . . 0.0 119.3 -160.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -133.84 156.59 47.79 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.288 1.435 . . . . 0.0 111.696 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -64.95 4.89 0.38 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.036 1.734 . . . . 0.0 115.664 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.0 p -56.81 166.52 1.32 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 128.301 2.64 . . . . 0.0 112.788 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.11 -15.18 35.69 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.648 2.232 . . . . 0.0 113.921 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -73.59 159.0 33.75 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.993 1.317 . . . . 0.0 114.165 -167.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -84.71 37.3 0.64 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 125.947 1.699 . . . . 0.0 110.725 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.48 59.76 2.43 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 127.436 2.446 . . . . 0.0 114.477 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -79.38 146.37 32.87 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 -167.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -97.54 125.32 42.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.875 1.67 . . . . 0.0 109.491 155.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -112.71 93.96 4.68 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.78 -172.47 26.45 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.198 0.904 . . . . 0.0 113.444 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.23 134.62 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.705 2.002 . . . . 0.0 108.862 173.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -110.53 92.29 3.99 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -78.37 106.18 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.72 120.24 10.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.341 0.973 . . . . 0.0 110.744 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.8 mt -129.83 152.32 79.67 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 124.012 0.925 . . . . 0.0 111.106 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.58 135.52 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.476 -1.009 . . . . 0.0 109.476 160.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.4 tttt -58.67 139.04 56.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.846 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 -6.46 76.29 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.111 -1.383 . . . . 0.0 115.881 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.4 m -51.76 127.53 34.4 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.693 2.247 . . . . 0.0 112.964 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -68.42 131.26 22.79 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.852 1.701 . . . . 0.0 112.084 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.2 132.2 32.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.152 1.781 . . . . 0.0 107.824 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -104.52 155.65 18.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 109.492 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.04 129.59 82.65 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.263 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.13 -31.87 22.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.382 2.721 . . . . 0.0 113.472 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -140.21 159.97 41.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.957 2.103 . . . . 0.0 107.546 -171.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -77.01 138.48 39.62 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.93 -1.106 . . . . 0.0 111.764 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.7 -157.05 10.05 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.075 1.322 . . . . 0.0 113.651 -173.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.91 146.86 25.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.428 1.491 . . . . 0.0 113.005 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.21 129.3 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -43.11 6.92 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -159.41 141.65 13.61 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.694 1.198 . . . . 0.0 110.983 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 55.5 mt -142.6 113.83 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.785 1.234 . . . . 0.0 110.965 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -157.2 -173.36 4.4 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.493 1.117 . . . . 0.0 111.823 -168.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.85 132.71 47.79 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.091 -1.005 . . . . 0.0 111.054 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -76.95 130.25 37.26 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -70.4 -18.36 63.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.47 -3.43 59.0 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.215 1.006 . . . . 0.0 112.806 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -150.03 -154.63 6.5 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-O 122.801 1.223 . . . . 0.0 112.579 -147.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -108.44 -166.81 21.1 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.799 1.666 . . . . 0.0 113.7 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -66.29 148.01 52.48 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.416 -0.461 . . . . 0.0 111.909 170.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.13 137.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.777 1.631 . . . . 0.0 115.051 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.9 tp -117.87 126.68 52.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.042 2.137 . . . . 0.0 108.955 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.01 126.38 52.13 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.819 1.248 . . . . 0.0 110.256 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.97 147.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.998 1.319 . . . . 0.0 111.45 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.04 137.3 47.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.696 1.998 . . . . 0.0 110.144 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -74.43 146.17 43.07 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.223 -0.923 . . . . 0.0 113.443 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -66.6 -20.67 66.06 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.61 -26.06 67.66 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 121.497 -0.752 . . . . 0.0 112.491 168.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.93 18.81 10.16 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 117.994 1.957 . . . . 0.0 117.994 157.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -143.8 -25.09 0.56 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.34 2.07 . . . . 0.0 115.873 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.297 42.1 m-85 -79.26 146.65 32.9 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -123.22 161.21 24.98 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 112.141 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -143.84 104.13 4.13 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.252 2.221 . . . . 0.0 110.955 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -84.81 145.8 27.68 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 167.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -130.72 93.33 3.4 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.604 2.362 . . . . 0.0 109.837 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.39 157.37 15.92 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.663 1.185 . . . . 0.0 110.839 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.266 94.1 m-70 69.76 49.79 0.51 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.072 2.149 . . . . 0.0 114.484 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.84 143.82 25.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.873 0.869 . . . . 0.0 111.485 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.11 -43.32 15.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.402 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -154.48 151.11 28.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.016 2.526 . . . . 0.0 110.847 -169.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -96.96 159.33 14.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.744 0.818 . . . . 0.0 111.238 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -109.67 -28.58 8.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.448 1.099 . . . . 0.0 112.385 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.78 168.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.165 1.786 . . . . 0.0 110.667 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -128.12 172.1 11.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 111.358 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.98 130.8 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.275 1.03 . . . . 0.0 109.224 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.15 3.46 72.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.783 1.182 . . . . 0.0 115.323 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.75 126.14 31.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.015 1.407 . . . . 0.0 111.877 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.24 124.89 28.19 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.803 0.441 . . . . 0.0 111.488 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -106.94 157.03 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.858 1.663 . . . . 0.0 110.46 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.36 140.54 52.11 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.656 1.582 . . . . 0.0 109.307 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -44.02 123.31 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.446 1.098 . . . . 0.0 112.992 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.96 6.95 86.21 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.246 1.403 . . . . 0.0 115.362 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -91.63 145.88 24.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.374 1.469 . . . . 0.0 112.858 170.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.2 mm -70.12 137.93 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.081 0.855 . . . . 0.0 112.114 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -123.58 -24.05 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.19 -173.17 1.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.45 1.023 . . . . 0.0 111.629 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.55 137.05 41.64 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.161 1.385 . . . . 0.0 107.3 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.8 t -75.56 142.62 42.72 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.71 163.9 28.52 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.268 0.937 . . . . 0.0 113.157 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -79.97 30.72 0.26 Allowed 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.092 -1.24 . . . . 0.0 112.526 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.284 6.7 p -66.07 127.39 31.91 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.818 1.247 . . . . 0.0 112.153 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.04 89.38 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 117.658 -1.634 . . . . 0.0 116.822 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mt -123.13 135.96 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.285 2.043 . . . . 0.0 112.395 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -74.48 8.32 2.35 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.613 1.965 . . . . 0.0 114.762 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.0 p -129.55 151.95 49.61 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -171.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.314 0.9 OUTLIER -83.41 152.8 24.84 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.027 1.331 . . . . 0.0 113.721 171.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.7 167.09 42.45 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -152.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.82 168.15 23.75 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.189 1.396 . . . . 0.0 111.82 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -150.99 171.59 17.05 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.309 0.644 . . . . 0.0 111.714 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.81 121.56 42.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 110.485 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -96.11 102.4 14.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.92 0.888 . . . . 0.0 110.524 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.76 112.86 24.8 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.371 1.468 . . . . 0.0 114.65 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.44 118.62 35.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.19 0.596 . . . . 0.0 112.155 174.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -93.84 127.56 39.65 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.639 1.576 . . . . 0.0 111.55 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.1 mtm -132.16 162.43 30.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.475 1.91 . . . . 0.0 111.593 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -132.5 128.91 38.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.39 1.076 . . . . 0.0 112.796 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.87 6.93 74.32 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.254 1.261 . . . . 0.0 116.254 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.63 -179.6 44.04 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 126.439 1.971 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.72 128.9 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.282 1.433 . . . . 0.0 112.336 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.62 156.79 6.97 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.786 1.66 . . . . 0.0 112.056 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -48.2 -42.51 30.15 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.23 62.41 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -92.28 -13.41 30.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.628 1.571 . . . . 0.0 114.537 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.54 148.18 34.26 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.314 1.045 . . . . 0.0 113.508 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -116.99 -96.78 0.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.714 1.606 . . . . 0.0 111.826 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -159.51 118.24 1.65 Allowed Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.603 1.961 . . . . 0.0 113.114 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -85.35 -30.97 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.913 1.742 . . . . 0.0 114.296 175.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -52.37 -55.71 29.25 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 121.169 1.804 . . . . 0.0 114.697 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.01 -26.75 21.34 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.778 2.985 . . . . 0.0 112.225 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -67.26 -37.48 83.54 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.05 -44.95 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.093 0.557 . . . . 0.0 110.572 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -67.52 -0.89 4.2 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -173.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -111.92 -9.57 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.212 1.805 . . . . 0.0 113.52 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.28 159.15 42.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.243 1.417 . . . . 0.0 113.378 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.35 -48.06 24.02 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.73 3.62 . . . . 0.0 114.062 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -114.08 8.85 17.13 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.446 1.099 . . . . 0.0 113.356 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.51 -135.79 27.41 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.562 1.077 . . . . 0.0 111.961 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.18 -28.83 19.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.605 1.162 . . . . 0.0 113.6 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -70.72 -7.84 47.78 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.055 -1.028 . . . . 0.0 113.31 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.4 m -81.49 -3.86 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.802 0.841 . . . . 0.0 112.27 167.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.1 mp -111.11 -14.83 13.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.993 1.717 . . . . 0.0 113.322 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -145.03 161.88 38.31 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.234 -1.541 . . . . 0.0 113.76 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -110.14 82.75 1.64 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.015 0.912 . . . . 0.0 113.134 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 125.316 1.446 . . . . 0.0 111.061 174.22 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 CA-C-O 120.969 0.205 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.2 t -77.28 139.58 39.85 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.969 1.708 . . . . 0.0 114.682 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -80.67 -43.63 20.09 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.191 1.796 . . . . 0.0 112.764 172.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 t-105 -163.04 148.56 11.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.197 1.799 . . . . 0.0 110.724 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.64 -13.56 0.5 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 172.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.72 146.18 55.1 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 118.11 2.633 . . . . 0.0 118.11 -175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -59.6 -36.31 76.03 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -140.89 164.79 29.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.918 2.087 . . . . 0.0 114.677 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -98.23 124.47 42.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.553 1.541 . . . . 0.0 112.187 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.57 -32.3 78.39 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 123.51 0.576 . . . . 0.0 113.084 168.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.4 p -152.44 156.57 39.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.048 1.739 . . . . 0.0 112.856 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 62.3 mtt85 -77.33 16.38 0.62 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.9 mt -77.62 122.74 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 121.072 -1.017 . . . . 0.0 111.371 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 p -75.49 -45.73 36.57 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.466 0.914 . . . . 0.0 113.466 165.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -134.92 119.12 17.66 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.796 1.638 . . . . 0.0 110.503 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 p -81.48 176.63 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.549 1.14 . . . . 0.0 107.94 166.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -67.14 137.93 56.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.94 -173.47 30.45 Favored Glycine 0 N--CA 1.474 1.178 0 O-C-N 121.136 -0.978 . . . . 0.0 112.879 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -67.12 154.64 40.74 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.442 1.621 . . . . 0.0 111.526 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -67.01 138.16 57.02 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 163.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -152.1 154.75 36.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.713 0.805 . . . . 0.0 111.456 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 65.52 -38.79 0.27 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.511 2.325 . . . . 0.0 115.852 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.7 p -83.87 167.31 28.84 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.152 2.181 . . . . 0.0 111.951 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.94 1.99 5.28 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.66 2.907 . . . . 0.0 114.84 173.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.263 90.4 m-85 -68.95 145.9 53.23 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -124.47 147.94 48.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.48 1.912 . . . . 0.0 114.693 -171.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.85 -141.79 20.4 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.785 0.707 . . . . 0.0 111.55 -170.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -129.92 151.76 50.14 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.039 0.919 . . . . 0.0 112.064 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -89.79 125.66 35.39 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.261 1.824 . . . . 0.0 110.46 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.357 83.2 m-85 -108.12 23.43 14.5 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -170.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.28 -164.51 13.44 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.332 0.968 . . . . 0.0 113.266 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.48 133.71 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 126.609 1.963 . . . . 0.0 108.953 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -110.43 96.48 6.22 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -78.64 123.88 27.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.49 56.59 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.703 2.001 . . . . 0.0 113.847 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.6 149.0 63.55 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.288 -0.883 . . . . 0.0 111.112 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.45 146.28 93.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.05 1.833 . . . . 0.0 111.777 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -54.58 135.48 46.26 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 110.678 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.95 68.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.737 1.161 . . . . 0.0 115.63 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 m -52.71 126.14 39.78 Favored Pre-proline 0 N--CA 1.478 0.936 0 CA-C-N 118.75 1.275 . . . . 0.0 112.238 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -69.49 129.28 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.09 1.86 . . . . 0.0 111.998 173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -85.86 130.59 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 108.468 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -103.35 149.94 24.27 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 109.764 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.54 83.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.879 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.4 -46.86 4.96 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.47 2.78 . . . . 0.0 111.574 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -113.98 172.81 6.77 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 128.487 2.715 . . . . 0.0 109.703 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -68.98 149.97 48.22 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.245 -0.91 . . . . 0.0 110.017 155.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 -154.64 12.45 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.475 0.56 . . . . 0.0 114.159 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -151.24 145.84 25.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.574 1.549 . . . . 0.0 111.021 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -66.0 128.12 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.04 -41.34 9.61 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -159.37 145.67 16.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.001 1.72 . . . . 0.0 109.543 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.0 mt -137.99 127.64 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 109.365 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -155.22 164.09 39.29 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -129.52 147.26 51.31 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.84 0.856 . . . . 0.0 110.257 161.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -101.81 128.7 48.05 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.663 1.185 . . . . 0.0 111.311 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -57.25 -19.14 19.68 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.689 1.996 . . . . 0.0 115.537 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 pp -129.35 19.56 5.8 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.404 1.882 . . . . 0.0 113.251 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.37 -132.58 3.45 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.445 1.498 . . . . 0.0 111.294 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -131.65 -164.75 11.21 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.964 1.269 . . . . 0.0 113.224 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -76.31 145.95 39.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.286 0.635 . . . . 0.0 112.064 166.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.14 143.16 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.861 1.665 . . . . 0.0 114.421 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 tt -122.76 136.6 54.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.803 1.641 . . . . 0.0 109.416 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.52 125.83 52.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.311 0.644 . . . . 0.0 111.935 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.02 147.92 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.883 1.273 . . . . 0.0 111.813 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -112.54 141.45 46.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 111.726 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -80.82 179.2 7.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.769 1.228 . . . . 0.0 113.062 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -48.78 -46.22 41.17 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 118.682 2.845 . . . . 0.0 118.682 -171.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -83.42 -19.1 36.59 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.874 1.27 . . . . 0.0 113.671 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.35 27.2 71.97 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.798 1.19 . . . . 0.0 114.649 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -94.18 -36.62 11.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.635 1.717 . . . . 0.0 110.83 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -79.75 130.62 35.49 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 168.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -121.14 142.97 49.36 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.954 1.702 . . . . 0.0 111.31 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -123.93 103.68 8.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.762 2.025 . . . . 0.0 110.426 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -86.68 144.01 27.33 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.566 0.346 . . . . 0.0 111.62 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -128.7 97.67 4.75 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.427 1.891 . . . . 0.0 106.892 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.28 151.59 22.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 109.844 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 71.56 63.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.937 2.095 . . . . 0.0 113.95 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.4 mt -101.67 155.7 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.512 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.45 -43.3 6.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.738 1.215 . . . . 0.0 110.939 167.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -145.14 150.29 36.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.614 1.566 . . . . 0.0 112.38 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -92.54 158.31 16.07 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.57 1.148 . . . . 0.0 112.441 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -122.2 -10.63 8.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.05 0.94 . . . . 0.0 113.205 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.3 160.81 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.56 1.144 . . . . 0.0 112.341 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -120.26 155.33 33.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.29 1.836 . . . . 0.0 112.841 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.1 t -55.11 123.14 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 0.0 109.413 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.08 0.7 61.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.078 1.323 . . . . 0.0 115.528 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -88.28 128.95 35.49 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.966 1.883 . . . . 0.0 113.3 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -74.55 139.97 44.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.064 0.546 . . . . 0.0 111.998 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.31 159.86 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 110.373 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -126.67 148.3 49.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.407 1.483 . . . . 0.0 108.658 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.42 121.74 4.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.363 1.065 . . . . 0.0 111.984 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.23 10.25 58.55 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.732 1.158 . . . . 0.0 114.971 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.33 134.75 34.09 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.966 1.306 . . . . 0.0 112.676 167.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.4 mm -65.57 131.41 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 118.888 0.767 . . . . 0.0 110.372 172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.4 pt -114.98 -21.96 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.479 1.112 . . . . 0.0 113.231 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.44 -179.82 1.96 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 110.904 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -129.63 135.0 48.0 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t -80.27 144.54 32.77 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.71 155.76 26.97 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.312 1.434 . . . . 0.0 112.361 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.251 34.1 p30 -81.7 47.95 1.14 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -172.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 35.5 p -65.38 117.58 8.13 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 164.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.77 25.85 68.64 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 -175.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.14 165.91 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 119.627 1.714 . . . . 0.0 113.44 172.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -51.7 141.59 16.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.972 1.709 . . . . 0.0 113.727 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.287 1.0 OUTLIER -66.2 5.5 0.53 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 171.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.6 p -75.39 -17.39 60.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.014 1.726 . . . . 0.0 114.778 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 157.1 -170.28 34.33 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.334 1.445 . . . . 0.0 111.919 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.25 169.15 17.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.682 1.193 . . . . 0.0 112.918 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -151.13 141.04 21.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.803 0.841 . . . . 0.0 112.656 169.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.85 115.49 19.47 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.159 170.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -93.75 101.29 13.41 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.29 0.636 . . . . 0.0 110.943 172.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.66 117.21 29.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.948 1.299 . . . . 0.0 114.128 171.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -122.6 114.44 20.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.348 1.059 . . . . 0.0 111.888 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -92.51 121.94 34.46 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.208 1.803 . . . . 0.0 110.828 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.1 mtm -127.38 160.86 30.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.238 1.815 . . . . 0.0 111.189 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -140.26 133.96 30.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.11 6.96 81.21 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.722 1.153 . . . . 0.0 115.125 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.29 179.46 38.48 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 127.57 2.51 . . . . 0.0 110.086 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.1 125.07 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.76 168.86 15.45 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.607 1.575 . . . . 0.0 112.875 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -60.3 -36.9 78.95 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.184 -1.186 . . . . 0.0 113.523 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.08 -17.36 63.22 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.795 -1.191 . . . . 0.0 114.05 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.23 -12.55 43.43 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.47 137.11 52.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.567 1.147 . . . . 0.0 112.986 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -103.13 -89.86 0.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -161.91 115.9 1.23 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.575 2.35 . . . . 0.0 113.585 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 -31.76 2.08 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.103 1.869 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -54.37 -53.39 59.93 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.78 -22.56 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.886 3.058 . . . . 0.0 112.052 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -65.52 -42.67 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 167.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 49.0 mt -72.21 -25.62 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.297 -0.877 . . . . 0.0 112.206 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -59.76 -14.2 13.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -118.13 -1.14 11.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.431 1.092 . . . . 0.0 113.641 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.89 148.65 92.23 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.517 0.727 . . . . 0.0 112.632 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.58 -26.45 23.71 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.609 2.873 . . . . 0.0 114.932 -168.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -112.82 -7.86 13.76 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.83 -137.81 13.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.413 1.482 . . . . 0.0 112.535 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -55.09 -30.78 60.39 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.727 1.263 . . . . 0.0 111.694 170.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.0 mtp-105 -63.97 -12.25 36.04 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.476 1.51 . . . . 0.0 113.899 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 71.6 m -79.77 -7.85 58.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.472 1.033 . . . . 0.0 112.565 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.06 -14.0 15.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.106 1.363 . . . . 0.0 112.948 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -149.98 162.3 40.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -111.72 80.57 1.34 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--O 1.24 0.555 0 C-N-CA 124.888 1.275 . . . . 0.0 110.123 173.59 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -62.39 160.83 12.66 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.021 1.328 . . . . 0.0 114.491 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -57.81 139.22 54.56 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.505 0.722 . . . . 0.0 111.367 168.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -76.31 139.77 41.21 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.191 0.519 . . . . 0.0 111.381 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -135.9 129.71 32.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.099 1.36 . . . . 0.0 110.873 167.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -70.95 176.01 4.68 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.325 1.05 . . . . 0.0 113.056 167.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -149.2 162.41 40.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.733 -1.229 . . . . 0.0 111.393 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.275 21.2 t80 -66.46 141.34 57.94 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -137.55 146.53 44.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.208 1.803 . . . . 0.0 110.493 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.66 -12.58 79.86 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.702 1.144 . . . . 0.0 114.179 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.6 p -63.74 161.71 14.67 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.923 1.689 . . . . 0.0 114.062 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.2 mtp85 -103.62 -18.58 14.68 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.05 104.24 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 121.144 1.793 . . . . 0.0 110.999 176.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.26 1.2 t -79.88 -24.23 41.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -153.84 130.62 10.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.797 1.239 . . . . 0.0 109.748 164.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.02 174.54 8.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -174.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -67.13 134.54 51.99 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.129 -0.982 . . . . 0.0 110.918 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.65 -137.05 9.57 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.273 0.94 . . . . 0.0 113.052 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -76.7 155.11 33.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.265 0.626 . . . . 0.0 111.888 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.1 157.9 45.4 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -173.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -59.32 154.24 17.04 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -42.29 132.07 3.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.743 2.017 . . . . 0.0 112.901 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 p -171.53 163.68 4.8 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.316 1.846 . . . . 0.0 110.348 -165.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.91 -25.65 32.43 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.431 2.087 . . . . 0.0 113.489 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -75.59 151.73 37.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.83 1.252 . . . . 0.0 109.903 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -97.55 167.97 10.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.959 1.703 . . . . 0.0 115.312 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.3 -125.96 7.2 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.09 1.196 . . . . 0.0 116.09 162.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HE2' ' CZ ' ' A' ' 77' ' ' TYR . 1.7 ptmt -126.88 165.91 18.47 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 126.332 1.853 . . . . 0.0 112.107 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -118.41 93.61 4.18 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.211 1.404 . . . . 0.0 110.89 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' CZ ' ' HE2' ' A' ' 75' ' ' LYS 0.526 12.1 m-30 -90.74 39.44 0.98 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -173.423 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.91 -179.55 26.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.82 1.2 . . . . 0.0 112.897 170.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.58 127.48 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.687 1.595 . . . . 0.0 109.501 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -99.26 90.0 4.41 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -74.1 107.24 6.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.97 123.95 20.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.056 0.844 . . . . 0.0 110.294 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 mt -138.35 151.98 70.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.61 0.764 . . . . 0.0 111.228 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.2 136.5 44.26 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.36 2.04 . . . . 0.0 110.033 162.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.02 134.61 52.58 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.207 1.003 . . . . 0.0 109.949 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.32 -8.35 79.32 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.237 -1.313 . . . . 0.0 115.824 -175.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.6 m -53.77 123.81 40.23 Favored Pre-proline 0 N--CA 1.481 1.114 0 CA-C-N 120.219 2.009 . . . . 0.0 112.331 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.03 130.85 19.71 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.726 1.617 . . . . 0.0 111.161 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -85.74 131.2 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.463 1.505 . . . . 0.0 108.216 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -101.32 149.8 23.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.31 1.044 . . . . 0.0 109.84 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.19 130.85 87.45 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.76 -0.588 . . . . 0.0 110.835 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.62 -27.42 15.33 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.923 3.082 . . . . 0.0 112.724 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 p -129.94 161.67 30.36 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.039 2.535 . . . . 0.0 112.905 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -63.92 138.83 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 157.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.52 -155.95 11.37 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -151.99 148.78 28.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.187 1.395 . . . . 0.0 111.584 171.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.66 129.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -41.92 7.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.003 1.721 . . . . 0.0 115.244 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -157.9 143.25 16.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.467 1.107 . . . . 0.0 111.464 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.4 mt -136.42 125.73 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.381 1.072 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -158.82 176.99 11.65 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -127.61 157.48 40.11 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.899 1.28 . . . . 0.0 112.588 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -144.68 144.14 31.08 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.779 1.232 . . . . 0.0 113.681 -165.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -58.44 -30.08 66.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.393 1.477 . . . . 0.0 114.344 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 mt -112.63 -31.39 6.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.765 1.226 . . . . 0.0 112.857 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -86.83 -8.29 76.55 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.751 1.167 . . . . 0.0 115.034 -169.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.12 -150.58 47.61 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 117.696 0.748 . . . . 0.0 112.2 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -71.39 143.73 50.06 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.887 -0.772 . . . . 0.0 111.649 165.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.42 138.39 53.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.689 1.595 . . . . 0.0 114.743 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -119.46 127.09 52.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.959 2.104 . . . . 0.0 108.605 171.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 126.76 52.22 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.365 1.066 . . . . 0.0 110.464 171.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.8 mt -123.12 147.78 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.952 1.301 . . . . 0.0 111.927 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.22 141.96 42.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.201 2.2 . . . . 0.0 111.737 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.06 160.89 27.95 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -50.44 -38.47 43.57 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 166.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -86.09 -8.34 57.96 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.469 1.508 . . . . 0.0 114.412 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.66 66.98 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 117.604 1.802 . . . . 0.0 117.604 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -90.91 -43.9 9.71 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.758 2.279 . . . . 0.0 110.85 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 42.4 m-85 -82.95 145.22 29.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -125.81 152.51 45.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.541 1.936 . . . . 0.0 111.431 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.74 104.03 6.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.846 2.059 . . . . 0.0 109.986 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.95 139.99 29.95 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.527 0.331 . . . . 0.0 111.63 170.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -125.57 92.93 3.71 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.621 2.368 . . . . 0.0 108.759 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.23 163.29 14.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.889 1.276 . . . . 0.0 110.914 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 64.71 38.08 7.15 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.489 1.916 . . . . 0.0 114.966 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.54 154.25 27.62 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.496 -1.378 . . . . 0.0 112.848 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.53 -49.43 6.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.73 1.612 . . . . 0.0 109.272 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -152.18 149.33 28.63 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.641 1.976 . . . . 0.0 111.387 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -94.47 141.35 28.69 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.503 1.121 . . . . 0.0 111.913 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -95.43 -15.51 22.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.058 0.943 . . . . 0.0 111.878 167.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.94 165.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.27 1.828 . . . . 0.0 113.154 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -120.79 164.34 16.76 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.744 2.018 . . . . 0.0 111.2 172.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.07 129.72 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.32 4.58 68.28 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.531 1.062 . . . . 0.0 115.713 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.62 130.27 35.22 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.623 1.712 . . . . 0.0 112.912 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -65.0 143.87 57.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.407 0.622 . . . . 0.0 110.795 163.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 161.62 21.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.514 1.526 . . . . 0.0 110.535 167.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -133.86 143.29 48.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.576 1.55 . . . . 0.0 109.88 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.14 117.61 2.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.966 0.889 . . . . 0.0 111.904 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.83 74.88 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.547 1.546 . . . . 0.0 115.205 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -85.36 145.14 27.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.519 1.66 . . . . 0.0 114.487 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.9 mm -70.82 136.46 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.854 0.835 . . . . 0.0 111.969 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 49.1 pt -122.79 -23.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.69 1.196 . . . . 0.0 112.903 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.32 -176.57 1.91 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.527 1.531 . . . . 0.0 110.853 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -129.44 136.63 50.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.8 t -66.08 137.07 56.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -125.53 -169.88 12.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.575 1.56 . . . . 0.0 111.885 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.259 41.2 p30 -111.03 16.94 20.9 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 168.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.8 p -57.85 131.56 50.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.224 1.009 . . . . 0.0 111.958 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.6 -16.65 3.0 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.26 1.409 . . . . 0.0 115.835 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 4.6 mt -78.61 146.85 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.769 1.785 . . . . 0.0 110.652 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -111.09 -46.64 3.29 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.637 1.175 . . . . 0.0 111.749 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.8 157.57 30.02 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.303 0.7 OUTLIER -63.17 142.83 58.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -172.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.81 149.26 9.31 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.885 1.707 . . . . 0.0 114.731 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.22 156.58 20.92 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.973 1.309 . . . . 0.0 112.814 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -149.56 165.6 31.76 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.814 0.846 . . . . 0.0 112.834 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.46 123.13 47.38 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.588 1.555 . . . . 0.0 109.812 165.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -98.38 103.62 15.58 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.472 0.709 . . . . 0.0 110.867 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.272 36.0 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 172.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -116.26 115.28 25.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.436 1.094 . . . . 0.0 111.851 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -95.31 125.25 39.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.804 1.642 . . . . 0.0 111.149 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.9 mtm -131.0 153.0 49.69 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.494 1.518 . . . . 0.0 111.372 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.24 130.51 52.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.227 1.411 . . . . 0.0 111.898 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.99 36.15 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.39 -179.73 48.0 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.549 2.023 . . . . 0.0 111.9 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 125.9 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.579 1.552 . . . . 0.0 112.891 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.98 164.85 10.08 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.888 . . . . 0.0 112.325 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -56.79 -36.95 70.47 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.038 -1.272 . . . . 0.0 113.155 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.45 -12.37 56.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -97.59 -8.82 28.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.29 142.12 55.65 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.212 1.405 . . . . 0.0 113.087 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.13 -79.7 0.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.354 1.062 . . . . 0.0 112.335 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -170.07 123.57 0.64 Allowed Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.843 2.057 . . . . 0.0 113.054 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.25 -35.4 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.535 2.156 . . . . 0.0 114.102 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -54.41 -54.69 45.53 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.11 -18.9 39.83 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.879 3.053 . . . . 0.0 113.14 -175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.06 -44.18 66.27 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.76 -31.25 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.707 0.803 . . . . 0.0 111.634 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.82 -3.77 3.69 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -123.53 -1.99 8.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.685 1.594 . . . . 0.0 114.374 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.7 mt -69.25 151.22 97.07 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.292 1.037 . . . . 0.0 112.292 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.08 -36.17 71.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.174 2.583 . . . . 0.0 115.063 -165.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -111.51 9.59 21.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.896 0.878 . . . . 0.0 113.366 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 71.51 -134.06 22.16 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.026 -1.046 . . . . 0.0 112.241 -171.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.69 -26.0 65.23 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.341 -1.094 . . . . 0.0 112.94 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -70.91 -3.9 21.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.407 1.483 . . . . 0.0 114.171 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 68.9 m -82.13 -6.08 58.92 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.14 0.976 . . . . 0.0 113.122 165.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.85 -13.25 14.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.307 1.443 . . . . 0.0 113.114 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.92 163.1 36.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.448 1.476 . . . . 0.0 113.896 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -111.35 89.67 3.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 124.531 1.132 . . . . 0.0 110.682 170.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.2 p -136.15 -27.91 1.07 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -88.98 -174.61 4.54 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.199 1.799 . . . . 0.0 111.679 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -64.09 132.11 49.54 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.404 0.681 . . . . 0.0 110.989 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -139.85 160.99 38.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.21 1.404 . . . . 0.0 112.533 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.89 161.87 17.49 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 173.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -142.49 167.62 21.67 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -65.03 152.2 44.05 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.67 157.77 40.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.443 1.497 . . . . 0.0 112.683 173.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.17 -121.0 5.75 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.848 0.737 . . . . 0.0 113.552 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t -60.82 139.35 57.97 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.606 1.162 . . . . 0.0 112.763 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -69.58 -15.95 63.32 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -64.04 132.04 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 119.909 1.232 . . . . 0.0 110.438 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.37 0.1 OUTLIER -94.9 -35.14 12.14 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 164.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -146.47 150.4 35.53 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.567 1.547 . . . . 0.0 112.417 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 p -140.25 -179.38 5.96 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.911 1.684 . . . . 0.0 109.709 -166.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -74.15 133.2 42.77 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 120.307 -1.496 . . . . 0.0 110.06 -164.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.36 179.49 16.09 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.12 1.343 . . . . 0.0 114.874 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -53.64 143.88 19.11 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -66.73 -179.53 0.89 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 168.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -57.4 159.18 4.97 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.252 1.021 . . . . 0.0 112.126 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -83.05 36.29 0.5 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -154.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -57.77 156.11 19.58 Favored Pre-proline 0 N--CA 1.472 0.668 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.16 -25.28 79.53 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.138 2.559 . . . . 0.0 112.323 169.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.26 3.0 p90 -76.64 122.18 24.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 159.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.71 149.91 37.97 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.28 144.78 7.96 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.295 1.426 . . . . 0.0 113.382 173.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -122.29 137.4 54.86 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.776 1.23 . . . . 0.0 111.82 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -94.25 125.53 38.95 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.477 1.111 . . . . 0.0 110.027 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.285 97.1 m-85 -107.14 15.33 25.28 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -170.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.96 -164.77 12.26 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.12 -0.987 . . . . 0.0 115.027 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.21 137.09 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 127.477 2.311 . . . . 0.0 109.384 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.9 97.17 5.49 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -77.67 108.49 10.91 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.03 117.95 5.71 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.313 1.045 . . . . 0.0 111.051 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -133.93 148.76 69.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.147 0.979 . . . . 0.0 111.089 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.36 139.46 65.44 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.234 1.956 . . . . 0.0 110.635 163.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -51.92 136.73 28.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 110.184 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.86 -4.73 78.67 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.537 -1.702 . . . . 0.0 116.19 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 m -53.1 123.5 34.15 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 120.431 2.116 . . . . 0.0 112.343 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.46 127.95 16.47 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.654 1.569 . . . . 0.0 110.907 174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 mm -84.38 129.01 38.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.876 1.27 . . . . 0.0 107.797 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -99.03 152.41 19.85 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.656 1.183 . . . . 0.0 109.983 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.01 124.72 90.25 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 118.39 -0.815 . . . . 0.0 110.085 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.26 -36.42 21.17 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.582 2.855 . . . . 0.0 112.835 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.573 2.349 . . . . 0.0 108.989 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.97 147.73 49.8 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.058 -1.026 . . . . 0.0 108.988 155.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.15 -159.4 19.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.916 0.77 . . . . 0.0 113.607 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -148.35 144.46 27.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.874 1.27 . . . . 0.0 112.397 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.21 125.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.91 -44.87 8.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.942 1.697 . . . . 0.0 115.101 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -157.06 147.48 21.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.012 1.325 . . . . 0.0 111.105 -168.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.406 HG23 ' CE1' ' A' ' 129' ' ' TYR . 47.0 mt -140.79 118.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.716 1.206 . . . . 0.0 109.513 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -160.2 -168.47 2.2 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.26 146.33 42.41 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.232 1.413 . . . . 0.0 113.428 173.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -101.33 145.03 29.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.267 1.827 . . . . 0.0 111.729 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -66.2 -18.32 65.28 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -161.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 pp -138.85 -14.45 1.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.042 1.337 . . . . 0.0 113.495 167.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.16 -18.57 79.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.375 0.988 . . . . 0.0 115.172 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.5 -159.22 29.37 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 119.462 1.631 . . . . 0.0 113.739 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -70.61 148.38 48.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.8 t -131.92 137.18 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 126.188 1.795 . . . . 0.0 114.61 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.66 137.52 51.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.75 1.62 . . . . 0.0 109.618 165.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.53 125.28 51.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.676 0.79 . . . . 0.0 112.266 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.69 153.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.295 1.438 . . . . 0.0 111.906 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.63 55.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.857 2.063 . . . . 0.0 111.636 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -86.59 161.34 18.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.587 1.155 . . . . 0.0 113.016 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.405 34.8 p-10 -69.64 -8.48 47.96 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 119.854 3.279 . . . . 0.0 119.854 -165.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -77.86 -12.61 59.99 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.791 1.632 . . . . 0.0 112.936 163.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.97 18.99 71.33 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.283 1.421 . . . . 0.0 114.954 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -113.73 -25.83 8.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.108 1.454 . . . . 0.0 112.581 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.273 55.5 m-85 -102.07 128.37 48.56 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 171.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -104.23 157.08 17.38 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.465 1.906 . . . . 0.0 111.139 170.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -138.36 105.13 5.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.098 2.159 . . . . 0.0 110.501 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -85.81 147.74 26.16 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.19 109.78 8.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.947 1.699 . . . . 0.0 107.875 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.8 157.02 17.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.809 1.643 . . . . 0.0 110.562 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 67.1 59.11 0.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.113 1.765 . . . . 0.0 113.253 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 mt -104.82 151.23 24.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.691 1.597 . . . . 0.0 111.058 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.75 -42.67 6.4 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.487 . . . . 0.0 111.298 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -146.58 147.08 30.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.652 1.581 . . . . 0.0 112.265 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.406 ' CE1' HG23 ' A' ' 100' ' ' ILE . 90.1 m-85 -94.04 141.69 28.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 112.647 176.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -106.89 -5.77 18.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.808 1.243 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.29 166.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.341 1.456 . . . . 0.0 110.225 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -122.19 165.17 16.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.05 1.34 . . . . 0.0 110.265 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.69 131.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.978 0.911 . . . . 0.0 108.771 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.87 8.14 73.34 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.929 1.252 . . . . 0.0 115.278 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -84.19 119.22 24.75 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.01 1.405 . . . . 0.0 112.862 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -65.83 142.02 58.08 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.231 163.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.99 159.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.307 1.843 . . . . 0.0 109.195 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.66 142.7 50.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.449 1.9 . . . . 0.0 108.848 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.58 123.01 4.56 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.948 0.899 . . . . 0.0 113.326 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.39 3.73 64.74 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.582 1.087 . . . . 0.0 114.804 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.88 133.61 38.09 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.666 1.186 . . . . 0.0 112.487 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.7 mm -67.73 129.31 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.721 0.691 . . . . 0.0 109.992 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.1 pt -112.87 -22.09 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.201 1.001 . . . . 0.0 113.266 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.93 -179.18 2.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.429 1.491 . . . . 0.0 110.322 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.18 132.17 45.91 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.0 t -77.24 146.53 36.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.08 159.69 28.66 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.98 1.276 . . . . 0.0 111.448 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -77.73 37.89 0.24 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 118.905 1.352 . . . . 0.0 113.635 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.253 6.7 p -64.67 125.16 23.86 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.742 -1.224 . . . . 0.0 111.006 164.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.72 10.93 84.83 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 -170.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.73 165.52 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 119.78 1.79 . . . . 0.0 113.582 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -81.35 162.26 23.48 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.186 1.395 . . . . 0.0 114.283 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.254 0.3 OUTLIER -62.59 -1.59 0.86 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 173.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -64.45 -30.18 71.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.462 1.505 . . . . 0.0 110.018 167.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 160.93 155.19 7.71 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 119.488 1.04 . . . . 0.0 115.268 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -87.73 152.79 21.86 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.903 1.681 . . . . 0.0 111.852 169.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -151.99 128.44 10.67 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 168.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.15 114.07 7.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.173 0.989 . . . . 0.0 110.744 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -91.9 99.04 11.97 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.597 0.759 . . . . 0.0 111.343 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 43.3 t80 -90.97 120.07 31.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.153 1.381 . . . . 0.0 114.679 172.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -130.0 108.36 10.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.987 1.315 . . . . 0.0 111.01 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -96.45 135.78 37.85 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.144 1.378 . . . . 0.0 111.386 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 41.0 mtm -136.11 143.22 44.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.332 1.453 . . . . 0.0 112.065 -166.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -111.62 132.62 54.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.948 1.299 . . . . 0.0 112.988 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.66 1.0 64.95 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.575 1.56 . . . . 0.0 115.17 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 161.64 -169.99 37.25 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 127.856 2.646 . . . . 0.0 109.438 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.87 138.26 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 122.269 1.033 . . . . 0.0 111.006 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.59 161.69 10.67 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 128.757 3.075 . . . . 0.0 109.595 -171.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -57.51 -42.29 82.51 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.704 -1.468 . . . . 0.0 113.44 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.16 -20.63 66.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -78.33 -16.0 58.16 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.8 147.46 45.47 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.36 1.064 . . . . 0.0 112.353 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.36 -61.35 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.409 1.084 . . . . 0.0 113.825 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.4 t0 178.42 123.07 0.2 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 130.557 3.543 . . . . 0.0 108.309 160.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.6 -21.63 21.91 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.78 2.986 . . . . 0.0 116.099 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -51.9 -56.22 23.47 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 120.658 1.572 . . . . 0.0 114.699 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.87 -24.89 60.58 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.618 2.879 . . . . 0.0 112.937 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.275 3.5 t80 -64.26 -45.11 89.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 169.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.5 mt -66.63 -28.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.854 -1.154 . . . . 0.0 111.357 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.22 -4.4 10.39 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -118.09 -10.15 10.39 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.1 mt -66.31 149.66 97.71 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.371 1.068 . . . . 0.0 112.423 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.75 -41.68 10.36 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.789 2.326 . . . . 0.0 113.597 -166.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.67 9.91 34.99 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.11 -133.98 45.93 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 120.866 -1.146 . . . . 0.0 112.441 -172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -54.21 -30.87 51.53 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.907 -0.76 . . . . 0.0 112.772 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -71.43 -5.47 33.04 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.09 1.356 . . . . 0.0 112.456 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.7 m -83.67 -6.91 59.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.968 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.9 -14.81 15.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.992 1.317 . . . . 0.0 113.0 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -146.41 159.12 43.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.535 1.516 . . . . 0.0 115.018 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -104.13 96.42 6.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 122.363 1.078 . . . . 0.0 112.777 -179.444 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.139 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.4 t -161.38 151.09 16.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.501 1.52 . . . . 0.0 113.199 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -53.5 -38.2 63.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.619 1.168 . . . . 0.0 113.368 171.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -153.33 123.59 7.05 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.698 1.199 . . . . 0.0 110.34 165.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mp0 -71.75 -31.76 67.01 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.998 155.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -152.87 125.88 8.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.392 1.477 . . . . 0.0 114.763 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.267 1.9 p90 -67.1 156.36 36.32 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.321 39.3 t80 -133.33 140.82 47.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.47 148.44 34.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.485 1.514 . . . . 0.0 112.087 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.85 2.86 22.18 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.267 1.889 . . . . 0.0 114.692 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.3 t -164.52 154.03 13.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.609 1.564 . . . . 0.0 111.544 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -87.37 14.28 8.29 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.6 mt -71.12 138.62 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 120.062 1.301 . . . . 0.0 113.112 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.8 t -107.0 -28.19 10.19 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.181 1.792 . . . . 0.0 114.781 166.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -146.73 123.92 11.51 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.64 1.576 . . . . 0.0 111.178 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -82.3 177.63 8.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.703 1.201 . . . . 0.0 113.889 166.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -68.26 121.32 15.98 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.14 -139.18 5.62 Favored Glycine 0 N--CA 1.469 0.853 0 O-C-N 121.185 -0.947 . . . . 0.0 112.714 -170.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 157.87 40.52 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 117.857 0.829 . . . . 0.0 113.216 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.257 41.7 m-85 -69.15 -42.28 76.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -148.71 161.09 42.46 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -63.14 -11.66 21.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 127.015 2.126 . . . . 0.0 115.377 170.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.1 m -68.91 155.99 92.28 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.138 1.775 . . . . 0.0 114.538 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.13 -27.21 49.41 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.928 2.419 . . . . 0.0 113.652 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -66.94 138.82 57.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.461 1.504 . . . . 0.0 108.142 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -72.45 130.22 40.17 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.783 1.233 . . . . 0.0 111.96 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.16 80.49 0.08 OUTLIER Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.456 1.503 . . . . 0.0 113.037 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.73 163.57 16.44 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.653 1.581 . . . . 0.0 114.15 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -128.76 128.84 44.79 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.572 2.349 . . . . 0.0 109.36 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.358 93.7 m-85 -106.08 18.96 21.28 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -169.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.72 -172.25 19.03 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.032 -1.042 . . . . 0.0 113.788 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.63 132.92 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.44 1.896 . . . . 0.0 109.039 172.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -111.01 102.01 10.52 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -85.23 115.82 23.22 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 76.1 4.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.862 1.665 . . . . 0.0 112.267 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.49 152.8 41.23 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.37 142.72 91.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.523 2.149 . . . . 0.0 111.001 158.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -59.98 136.3 57.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.935 1.294 . . . . 0.0 110.28 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.68 1.78 90.3 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -57.14 124.67 67.26 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.597 1.698 . . . . 0.0 111.654 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.28 125.31 11.22 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.037 1.158 . . . . 0.0 110.031 176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.8 mm -80.76 129.38 37.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.356 1.462 . . . . 0.0 107.577 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -101.35 152.8 20.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.689 1.196 . . . . 0.0 109.954 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.62 131.54 87.89 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.766 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.75 -34.56 18.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.328 2.685 . . . . 0.0 112.833 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.0 p -129.59 163.4 26.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.547 1.939 . . . . 0.0 108.587 -173.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.93 141.84 58.09 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 121.256 -0.903 . . . . 0.0 108.988 158.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.12 -159.98 21.51 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.068 0.842 . . . . 0.0 113.418 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -151.05 140.91 21.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.228 1.514 . . . . 0.0 111.267 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 t -55.1 137.87 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.108 0.963 . . . . 0.0 113.419 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.97 -44.14 5.58 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -159.27 148.49 18.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.681 1.593 . . . . 0.0 109.776 -167.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.2 mt -139.8 128.0 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.447 1.099 . . . . 0.0 108.391 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -160.23 173.33 15.89 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -127.98 158.39 38.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.066 -1.021 . . . . 0.0 111.506 168.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -132.24 128.61 38.25 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.356 1.862 . . . . 0.0 108.732 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -68.46 -20.03 64.59 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.461 -1.4 . . . . 0.0 113.567 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.45 -19.57 23.74 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.449 1.5 . . . . 0.0 113.412 169.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.29 -16.76 5.98 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.688 1.137 . . . . 0.0 115.808 -162.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.23 44.85 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 118.418 1.109 . . . . 0.0 113.236 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.89 147.9 42.79 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.897 -0.767 . . . . 0.0 112.344 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 t -134.82 137.79 50.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 126.268 1.827 . . . . 0.0 114.616 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.1 tp -117.39 133.04 56.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.138 1.775 . . . . 0.0 108.819 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.27 125.65 53.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.778 1.231 . . . . 0.0 110.279 172.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.78 141.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.552 1.141 . . . . 0.0 110.809 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.52 137.82 36.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.021 1.329 . . . . 0.0 109.593 168.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -68.95 164.54 22.01 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.183 -0.323 . . . . 0.0 111.055 166.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -61.21 -31.89 71.66 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -75.76 -13.31 60.3 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.99 7.65 76.59 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 117.631 1.812 . . . . 0.0 117.631 168.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -98.16 -40.56 8.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.342 1.571 . . . . 0.0 110.979 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -74.59 131.52 41.02 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -118.42 150.75 39.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.321 1.848 . . . . 0.0 111.094 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -133.92 103.86 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.563 1.945 . . . . 0.0 110.082 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -85.35 145.47 27.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.341 0.656 . . . . 0.0 111.73 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.06 87.99 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.441 2.296 . . . . 0.0 110.057 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.18 154.16 19.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.851 0.861 . . . . 0.0 110.953 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.254 52.2 m-70 70.82 55.62 0.24 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.768 2.027 . . . . 0.0 113.734 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.9 149.05 23.81 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.68 1.592 . . . . 0.0 111.015 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.6 -48.58 10.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 113.024 166.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -145.21 152.09 39.44 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.282 1.833 . . . . 0.0 110.812 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -85.18 159.89 20.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.572 0.749 . . . . 0.0 109.988 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -112.16 -25.28 9.4 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.174 0.99 . . . . 0.0 111.126 164.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.92 168.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.983 1.713 . . . . 0.0 111.423 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -119.73 167.44 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.346 1.458 . . . . 0.0 111.122 166.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.01 130.23 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.544 1.138 . . . . 0.0 108.766 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.06 1.2 76.44 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.989 1.281 . . . . 0.0 115.709 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -81.68 129.79 34.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.457 1.628 . . . . 0.0 112.416 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -68.62 143.94 54.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.784 0.802 . . . . 0.0 110.422 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.3 m -128.71 157.76 41.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.877 1.671 . . . . 0.0 109.036 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.71 143.81 50.99 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.118 1.767 . . . . 0.0 109.427 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.02 125.27 7.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.669 0.747 . . . . 0.0 112.105 174.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.98 -3.77 82.91 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.15 1.357 . . . . 0.0 115.837 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.4 142.26 37.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.469 1.635 . . . . 0.0 112.978 170.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 17.6 mm -72.88 131.19 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.931 0.872 . . . . 0.0 111.545 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -114.63 -24.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.565 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -168.62 -178.94 3.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.163 1.385 . . . . 0.0 110.566 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -129.28 134.1 47.79 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 99.0 p -62.49 145.94 52.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 112.329 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -156.56 160.17 30.05 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -85.82 34.82 0.61 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.426 1.09 . . . . 0.0 113.267 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.7 p -84.32 134.16 34.52 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.815 1.246 . . . . 0.0 111.987 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 76.78 -38.87 1.51 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.789 1.662 . . . . 0.0 114.961 -174.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.3 mt -69.93 166.49 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 126.116 1.767 . . . . 0.0 110.22 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -57.14 152.7 13.02 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.355 -1.466 . . . . 0.0 111.162 159.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.1 t -54.51 -22.22 12.31 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -175.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.3 p -81.48 -12.81 58.74 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -120.65 146.76 17.67 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 124.638 1.113 . . . . 0.0 113.121 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.439 ' H ' ' CD2' ' A' ' 157' ' ' HIS . . . -149.18 34.65 0.73 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -165.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.439 ' CD2' ' H ' ' A' ' 156' ' ' ALA . 12.3 m170 -100.6 124.05 45.65 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.208 -0.932 . . . . 0.0 111.708 -153.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.74 116.72 7.96 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 111.881 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -94.67 99.99 12.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.145 0.978 . . . . 0.0 110.168 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 46.5 t80 -89.55 113.08 24.44 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.161 1.384 . . . . 0.0 114.332 171.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -118.27 115.26 24.38 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 111.301 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -95.29 128.47 42.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.303 1.441 . . . . 0.0 110.7 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.3 mtm -131.91 157.83 42.98 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.792 1.637 . . . . 0.0 110.819 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -135.12 133.24 39.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.165 0.986 . . . . 0.0 111.813 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.88 5.81 76.29 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.936 1.255 . . . . 0.0 115.089 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 162.63 -170.47 38.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.342 1.449 . . . . 0.0 112.739 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.47 121.15 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -173.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.32 171.89 17.68 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.974 1.749 . . . . 0.0 113.411 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -51.1 -48.75 61.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.382 1.473 . . . . 0.0 112.916 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.93 -13.29 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.238 1.415 . . . . 0.0 114.662 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -92.05 -16.86 25.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.99 135.12 53.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.036 0.934 . . . . 0.0 113.047 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -103.33 -92.06 0.35 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.317 1.447 . . . . 0.0 112.827 -171.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -168.5 100.97 0.53 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.46 -39.71 3.51 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.169 1.913 . . . . 0.0 113.276 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -54.62 -53.03 64.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.2 -23.5 28.71 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.918 3.079 . . . . 0.0 112.458 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -69.3 -39.46 78.28 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 56.9 mt -71.09 -38.71 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 122.979 0.512 . . . . 0.0 110.95 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.52 -15.58 11.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -110.68 -12.06 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.952 1.301 . . . . 0.0 112.778 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.3 154.1 33.83 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.721 1.208 . . . . 0.0 112.394 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.56 -50.57 13.39 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.445 3.43 . . . . 0.0 114.386 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -107.52 9.41 29.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.45 -139.02 43.38 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 120.51 -1.369 . . . . 0.0 112.651 -171.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.27 -21.79 66.72 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.058 -1.26 . . . . 0.0 112.993 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -64.11 -8.58 12.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.91 1.284 . . . . 0.0 112.895 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.8 t -88.56 -1.86 58.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.809 1.244 . . . . 0.0 112.751 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.47 -15.25 12.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.666 1.586 . . . . 0.0 112.417 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -145.67 164.6 31.27 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.56 -1.337 . . . . 0.0 112.912 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -114.53 86.62 2.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.472 0.631 0 C-N-CA 125.06 1.344 . . . . 0.0 110.424 174.754 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.041 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.3 m -61.59 153.88 26.5 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HE2' ' CE2' ' A' ' 54' ' ' PHE . 50.5 pttt -143.11 -179.84 6.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.093 2.157 . . . . 0.0 110.567 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -130.05 -15.16 3.82 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.883 1.273 . . . . 0.0 114.062 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.74 153.89 27.1 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.965 1.306 . . . . 0.0 112.384 162.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -76.4 148.54 37.27 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.45 ' CE2' ' HE2' ' A' ' 50' ' ' LYS 0.343 47.4 m-85 -72.56 51.44 0.26 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 173.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -47.01 141.42 4.18 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -150.07 140.23 22.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.392 1.477 . . . . 0.0 108.999 163.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.48 -42.85 47.08 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 118.497 0.59 . . . . 0.0 112.89 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -74.36 158.32 34.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.631 1.205 . . . . 0.0 112.969 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.5 mtt-85 -76.51 4.33 9.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.7 mt -74.01 131.13 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 119.552 1.069 . . . . 0.0 111.986 -172.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 p -93.66 -35.17 12.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.367 1.867 . . . . 0.0 115.145 167.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -143.7 116.19 8.59 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.609 1.964 . . . . 0.0 109.139 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 p -74.23 171.07 14.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 122.859 1.314 . . . . 0.0 108.365 163.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -67.72 132.82 48.19 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.62 -134.49 4.39 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.563 -0.711 . . . . 0.0 112.765 -174.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -127.47 153.03 46.8 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.493 1.117 . . . . 0.0 112.371 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -72.72 133.99 44.82 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -77.15 -17.05 58.87 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -58.91 -29.02 66.74 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -167.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 p -158.87 170.42 8.96 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.311 1.444 . . . . 0.0 108.918 168.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.87 -21.18 28.68 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 121.682 1.588 . . . . 0.0 113.08 168.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -84.9 -31.92 23.43 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.149 1.38 . . . . 0.0 109.521 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -60.21 135.6 57.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.646 1.578 . . . . 0.0 114.314 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.0 -139.24 6.94 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 116.72 1.448 . . . . 0.0 116.72 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -99.72 155.69 17.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -164.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -114.38 116.9 29.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.386 1.875 . . . . 0.0 110.024 172.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.291 98.3 m-85 -95.99 23.04 6.76 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -172.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.96 -162.91 12.74 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.88 -1.137 . . . . 0.0 113.266 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.18 133.31 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.472 1.909 . . . . 0.0 108.488 175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -109.51 97.0 6.65 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.67 107.87 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.29 123.7 18.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.416 1.007 . . . . 0.0 110.941 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 mt -138.85 146.67 51.03 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.274 0.63 . . . . 0.0 111.733 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.81 137.85 79.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.295 1.997 . . . . 0.0 110.747 163.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.39 135.18 56.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 111.434 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.25 -7.22 81.9 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.273 -1.293 . . . . 0.0 114.944 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.2 m -53.73 126.13 48.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-N 120.069 1.934 . . . . 0.0 113.362 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.17 136.66 38.22 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.486 2.124 . . . . 0.0 112.883 171.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.7 mm -92.39 132.45 36.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.566 1.946 . . . . 0.0 108.186 173.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -103.73 151.01 23.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.768 1.227 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.3 129.25 90.63 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.241 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.27 -33.18 11.68 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.675 2.917 . . . . 0.0 113.396 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.0 p -140.78 156.59 46.13 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.397 1.479 . . . . 0.0 107.872 -169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -65.56 129.58 40.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.685 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -153.19 7.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.268 0.461 . . . . 0.0 112.795 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.35 28.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.285 1.834 . . . . 0.0 109.776 176.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.17 136.87 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.125 -0.985 . . . . 0.0 113.211 171.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.22 -38.84 5.87 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.612 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -150.82 142.55 23.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.707 0.803 . . . . 0.0 111.137 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -139.64 123.81 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.348 1.459 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -160.86 169.29 22.98 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -102.01 144.11 31.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.132 1.373 . . . . 0.0 111.546 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -106.78 139.74 40.73 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.146 1.778 . . . . 0.0 109.642 170.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -68.16 -27.36 66.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.4 mt -89.34 -48.62 7.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.708 1.203 . . . . 0.0 110.873 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -88.5 -5.42 75.3 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.202 1.382 . . . . 0.0 116.271 -161.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.73 -148.99 40.9 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.091 1.446 . . . . 0.0 111.539 -174.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -66.28 144.32 56.66 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.024 2.13 . . . . 0.0 112.884 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.97 136.04 51.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.388 1.475 . . . . 0.0 109.386 166.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.29 123.11 41.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 111.881 177.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -120.23 144.58 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.899 1.28 . . . . 0.0 110.784 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.59 141.72 41.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.368 1.867 . . . . 0.0 109.829 169.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -74.06 29.03 0.08 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.301 65.0 m-20 59.95 -31.11 0.05 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.579 2.352 . . . . 0.0 117.204 -166.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -62.63 -37.03 84.73 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.895 -1.128 . . . . 0.0 112.811 167.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.83 7.8 66.73 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.026 -0.875 . . . . 0.0 114.88 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -80.85 -46.84 14.68 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.548 1.674 . . . . 0.0 107.547 165.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -86.57 126.52 34.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -120.97 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.509 1.524 . . . . 0.0 111.41 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -119.09 123.52 44.65 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 126.078 1.751 . . . . 0.0 108.394 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -96.93 146.5 24.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.531 0.733 . . . . 0.0 112.463 161.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -130.9 104.03 6.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.806 2.442 . . . . 0.0 110.01 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -105.59 155.69 18.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.648 1.179 . . . . 0.0 111.992 -175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 63.8 59.83 1.11 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.629 1.972 . . . . 0.0 112.32 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.32 145.78 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.647 1.579 . . . . 0.0 111.187 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -89.86 -41.86 11.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.011 1.324 . . . . 0.0 108.692 171.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -148.21 150.9 34.56 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.478 1.511 . . . . 0.0 113.273 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -97.29 141.32 30.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 112.281 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -103.07 -21.45 13.91 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.253 1.021 . . . . 0.0 112.172 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.95 168.68 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.28 1.832 . . . . 0.0 111.193 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -113.96 171.32 7.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.365 1.866 . . . . 0.0 110.813 168.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.86 137.05 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.527 -1.358 . . . . 0.0 108.786 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.88 10.53 85.56 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.08 1.324 . . . . 0.0 114.143 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -93.22 129.45 39.25 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.92 138.79 48.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.479 0.711 . . . . 0.0 112.548 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.36 160.21 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.8 140.53 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.577 1.951 . . . . 0.0 109.482 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.17 112.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.285 1.834 . . . . 0.0 112.414 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.15 9.3 54.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.637 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -94.37 145.3 24.85 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.586 1.954 . . . . 0.0 114.239 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 20.6 mm -70.76 132.89 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.553 1.07 . . . . 0.0 112.566 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.1 -22.67 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.399 1.48 . . . . 0.0 113.426 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.08 -176.04 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.255 1.422 . . . . 0.0 110.865 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -136.67 135.42 38.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.2 t -80.94 143.58 32.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -151.65 153.44 24.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.114 1.34 . . . . 0.0 111.275 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -72.82 20.42 0.08 Allowed 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.5 p -54.44 -32.96 58.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.119 2.167 . . . . 0.0 114.028 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.18 25.81 6.92 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.097 1.332 . . . . 0.0 115.251 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 59.3 mt -118.22 146.88 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 118.723 1.262 . . . . 0.0 109.874 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -81.71 16.96 1.59 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.12 -179.62 6.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.968 2.907 . . . . 0.0 112.047 174.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -8.37 55.99 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.12 94.67 1.91 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.235 1.398 . . . . 0.0 113.194 -171.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.09 146.03 49.49 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.026 0.93 . . . . 0.0 113.479 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -147.47 145.97 29.36 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.246 1.018 . . . . 0.0 110.814 167.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.43 115.34 22.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.628 0.771 . . . . 0.0 110.156 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -90.13 98.79 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.85 0.86 . . . . 0.0 110.067 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.276 38.5 t80 -88.86 110.95 21.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.835 1.254 . . . . 0.0 114.341 171.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -113.3 114.59 26.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.874 0.869 . . . . 0.0 111.687 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -97.02 120.71 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.731 1.612 . . . . 0.0 110.854 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.3 mtm -123.05 152.39 41.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.354 1.861 . . . . 0.0 111.266 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -131.51 133.18 44.83 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 111.772 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.61 52.63 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.66 1.6 . . . . 0.0 116.12 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.78 -175.28 45.84 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.086 1.803 . . . . 0.0 111.89 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.16 111.34 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.37 171.43 29.6 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 126.511 2.005 . . . . 0.0 112.408 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -58.8 -44.68 90.82 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.773 -1.427 . . . . 0.0 113.549 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -74.56 -1.07 19.83 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -93.62 -17.17 23.59 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 165.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.18 144.53 57.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.737 0.815 . . . . 0.0 111.931 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -126.78 -75.43 0.58 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -164.52 109.17 0.86 Allowed Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.33 -27.76 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.241 1.96 . . . . 0.0 114.356 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -54.29 -55.68 34.39 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 121.253 1.842 . . . . 0.0 114.443 -177.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 -21.37 57.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.689 2.926 . . . . 0.0 112.814 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.53 -37.93 59.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.98 -30.26 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.62 0.368 . . . . 0.0 110.79 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.75 -9.62 4.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -112.63 -9.71 13.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.035 2.134 . . . . 0.0 113.666 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.7 mt -69.95 151.57 96.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -170.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.49 -41.86 50.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.817 3.678 . . . . 0.0 114.755 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -119.0 16.64 13.36 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.903 1.281 . . . . 0.0 112.418 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.09 -132.52 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 120.814 -1.179 . . . . 0.0 112.723 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.15 -25.03 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.261 -1.14 . . . . 0.0 112.617 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -70.18 -6.73 36.41 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.074 -1.016 . . . . 0.0 113.004 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.2 m -81.59 -3.91 54.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 0.986 . . . . 0.0 113.17 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.13 -18.01 15.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.17 1.388 . . . . 0.0 111.889 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -144.14 164.04 31.83 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.498 -1.376 . . . . 0.0 114.657 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.46 89.72 3.08 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.395 0.998 . . . . 0.0 113.027 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 124.469 1.108 . . . . 0.0 110.276 173.147 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.007 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -74.0 -37.6 64.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.644 0.777 . . . . 0.0 111.875 -172.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -65.67 170.09 5.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.188 1.395 . . . . 0.0 112.635 174.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.5 m95 63.02 15.62 8.59 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -64.49 -41.12 96.64 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.013 0.824 . . . . 0.0 112.858 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -86.61 123.63 32.01 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.604 1.162 . . . . 0.0 112.837 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.255 6.3 m-85 -63.59 145.21 56.12 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.345 29.2 t80 -70.9 138.83 50.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -150.52 -27.19 0.23 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.113 2.165 . . . . 0.0 114.019 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.93 -69.42 0.06 OUTLIER Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.588 1.566 . . . . 0.0 113.451 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.9 p -68.87 154.44 42.01 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -115.72 15.05 16.49 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 mp -68.66 132.66 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 120.577 1.535 . . . . 0.0 112.416 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -93.82 -44.84 7.92 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.281 1.832 . . . . 0.0 115.396 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -139.78 134.41 31.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.465 1.506 . . . . 0.0 111.875 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.7 p -97.25 178.38 5.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.689 1.996 . . . . 0.0 113.186 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -81.37 134.94 35.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.243 1.017 . . . . 0.0 111.161 -167.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.18 -156.49 16.88 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.594 1.569 . . . . 0.0 115.068 168.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -60.87 159.59 11.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.085 1.354 . . . . 0.0 113.5 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.73 156.5 47.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 173.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 68.84 37.22 2.4 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.411 1.884 . . . . 0.0 115.983 172.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 58.57 34.37 23.82 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 162.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.8 m -139.86 167.12 19.51 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.547 1.539 . . . . 0.0 114.086 -163.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -90.46 -8.78 3.7 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.365 2.71 . . . . 0.0 115.236 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -74.82 163.4 27.71 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.874 -1.141 . . . . 0.0 111.296 -166.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.19 -15.54 3.96 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 118.927 2.936 . . . . 0.0 118.927 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -53.94 117.04 6.81 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.751 1.167 . . . . 0.0 113.967 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -145.01 140.62 28.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.894 1.678 . . . . 0.0 112.819 -176.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -101.82 111.8 24.19 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.747 1.619 . . . . 0.0 110.286 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.303 88.4 m-85 -91.14 26.93 2.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -167.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.93 -167.66 22.7 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.717 -1.239 . . . . 0.0 114.9 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 136.81 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.783 2.033 . . . . 0.0 108.874 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -113.6 115.54 28.08 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -97.84 117.47 32.24 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.06 112.82 2.78 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.624 1.102 . . . . 0.0 111.616 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -139.4 140.4 25.58 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.207 0.603 . . . . 0.0 112.333 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 139.47 57.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.993 2.462 . . . . 0.0 111.446 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.69 129.52 29.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.744 1.218 . . . . 0.0 109.972 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.17 81.29 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.178 -1.345 . . . . 0.0 115.982 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.0 m -54.23 125.18 49.59 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 120.169 1.984 . . . . 0.0 112.364 163.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -71.43 133.22 22.11 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.956 1.771 . . . . 0.0 111.701 174.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.2 mm -89.21 129.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 108.504 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -102.56 149.17 24.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.936 1.294 . . . . 0.0 109.528 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.73 126.93 93.21 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.566 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.34 -38.47 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.359 2.706 . . . . 0.0 112.291 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.3 p -126.13 161.9 26.58 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.873 2.069 . . . . 0.0 111.693 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -69.58 136.01 50.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -160.91 13.08 Favored Glycine 0 N--CA 1.473 1.12 0 O-C-N 121.777 -0.577 . . . . 0.0 113.768 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.49 145.75 28.06 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.345 1.073 . . . . 0.0 112.412 172.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.36 126.01 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -40.3 9.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.189 1.796 . . . . 0.0 115.657 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -155.51 145.59 21.62 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.154 1.382 . . . . 0.0 110.292 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -137.66 125.44 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.012 1.325 . . . . 0.0 109.083 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -158.36 -176.21 5.77 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -145.04 142.71 29.98 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.68 1.192 . . . . 0.0 111.062 171.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -126.01 169.07 13.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.102 1.361 . . . . 0.0 113.137 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -66.03 -24.56 66.77 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -165.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.64 -12.8 0.88 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.622 1.169 . . . . 0.0 113.878 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.83 -7.63 75.72 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.388 0.994 . . . . 0.0 114.478 169.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.73 -151.74 50.82 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 118.097 0.948 . . . . 0.0 112.847 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.26 146.6 45.29 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.189 0.596 . . . . 0.0 112.12 167.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.16 138.67 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.78 136.43 49.86 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.634 1.574 . . . . 0.0 109.579 166.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 124.52 51.98 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.252 0.621 . . . . 0.0 112.108 167.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.6 mt -118.59 144.05 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.323 1.049 . . . . 0.0 111.879 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.87 138.41 36.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.825 2.05 . . . . 0.0 110.608 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -81.07 144.61 31.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -58.85 -12.08 4.01 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 161.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -67.83 -15.03 63.43 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 120.594 -1.316 . . . . 0.0 114.44 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.84 -0.81 84.81 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.931 1.253 . . . . 0.0 115.977 166.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -151.48 2.53 0.4 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -110.64 150.57 28.82 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -128.65 159.18 36.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.053 2.141 . . . . 0.0 111.503 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -141.62 103.89 4.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.435 1.894 . . . . 0.0 110.849 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -87.36 143.28 27.32 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.919 0.487 . . . . 0.0 111.571 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -130.06 96.48 4.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.052 1.741 . . . . 0.0 107.558 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.71 155.37 19.26 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 0.0 110.142 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 68.42 64.43 0.34 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.798 2.039 . . . . 0.0 113.699 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.5 mt -104.56 154.27 20.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.867 1.667 . . . . 0.0 111.171 172.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -97.99 -44.08 6.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.206 1.802 . . . . 0.0 106.931 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -162.12 159.09 25.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.389 2.276 . . . . 0.0 110.548 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -97.95 162.94 12.99 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.002 1.721 . . . . 0.0 114.454 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -124.17 -8.78 7.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.874 1.27 . . . . 0.0 112.721 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.2 m -134.06 168.03 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.56 1.944 . . . . 0.0 111.187 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -120.36 166.79 13.05 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.97 2.108 . . . . 0.0 111.783 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.95 132.43 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.37 7.59 72.46 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.45 1.024 . . . . 0.0 115.175 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -86.48 115.06 23.73 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.128 1.464 . . . . 0.0 112.256 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -65.87 135.15 54.43 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.289 0.235 . . . . 0.0 110.592 164.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -127.33 163.86 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 126.522 1.929 . . . . 0.0 110.555 -176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.24 140.07 47.31 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.421 1.488 . . . . 0.0 109.526 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.08 126.81 13.29 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.15 -4.93 74.97 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.124 1.821 . . . . 0.0 114.742 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.8 141.69 36.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.664 1.186 . . . . 0.0 112.145 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 18.6 mm -70.63 130.1 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.519 -0.738 . . . . 0.0 111.579 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.4 pt -113.86 -21.42 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.725 1.21 . . . . 0.0 113.363 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.76 -176.53 1.77 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 110.729 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -132.71 134.67 45.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.1 t -78.1 145.97 35.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -156.28 153.55 24.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.672 1.606 . . . . 0.0 111.713 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -77.77 26.68 0.18 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.0 p -58.87 140.21 55.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.532 1.133 . . . . 0.0 110.477 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 78.63 -38.64 1.91 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.183 1.373 . . . . 0.0 115.208 -170.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.0 mt -73.81 144.76 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.16 1.384 . . . . 0.0 112.337 -174.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -74.85 -148.19 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.597 1.959 . . . . 0.0 110.794 167.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.65 4.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 119.263 3.06 . . . . 0.0 119.263 -173.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -19.26 59.86 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 -169.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 73.39 163.63 8.35 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.238 0.923 . . . . 0.0 113.459 -168.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.43 150.01 42.0 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.348 -1.09 . . . . 0.0 113.901 -171.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.63 145.8 26.95 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.641 1.176 . . . . 0.0 110.011 162.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.97 115.2 18.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.692 0.678 . . . . 0.0 110.154 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -91.51 100.05 12.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.826 0.85 . . . . 0.0 110.462 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -92.89 116.52 29.11 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -122.13 112.05 17.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.687 1.195 . . . . 0.0 111.381 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -94.56 129.06 41.53 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.636 1.174 . . . . 0.0 110.536 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.7 mtm -127.24 150.65 49.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.654 1.582 . . . . 0.0 110.856 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -120.05 135.91 54.76 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.027 1.331 . . . . 0.0 110.831 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.02 -15.98 1.69 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.169 1.843 . . . . 0.0 116.525 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.19 -168.78 35.52 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.56 1.553 . . . . 0.0 112.057 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.24 131.26 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.393 1.477 . . . . 0.0 112.747 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.56 166.6 10.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.727 1.632 . . . . 0.0 112.048 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -57.84 -43.74 86.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.426 -1.044 . . . . 0.0 113.487 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.76 -14.24 50.86 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -92.58 -15.88 26.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.59 1.156 . . . . 0.0 114.055 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.41 137.86 58.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.774 1.23 . . . . 0.0 112.836 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -101.5 -90.86 0.33 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.588 1.155 . . . . 0.0 113.805 -173.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -170.15 108.21 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 129.36 3.064 . . . . 0.0 110.591 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.97 -23.06 14.24 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.126 1.884 . . . . 0.0 114.587 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -52.26 -53.83 48.29 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 120.582 1.537 . . . . 0.0 115.085 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.74 -20.03 40.53 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.646 2.898 . . . . 0.0 112.931 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.273 3.8 t80 -70.68 -47.59 59.11 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.5 mt -67.47 -24.29 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.833 -1.167 . . . . 0.0 111.79 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.32 -18.14 64.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -109.28 -7.31 15.27 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.866 -1.146 . . . . 0.0 114.03 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 32.0 mt -69.34 147.72 97.15 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.952 1.301 . . . . 0.0 112.894 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.23 -27.99 34.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.209 2.606 . . . . 0.0 114.164 -166.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.86 2.51 17.07 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.84 -144.06 37.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.84 0.733 . . . . 0.0 112.793 -166.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.97 -24.6 66.23 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.455 -1.027 . . . . 0.0 112.553 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -65.31 -9.89 28.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.481 1.512 . . . . 0.0 111.986 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.6 t -82.52 -3.21 55.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.091 1.356 . . . . 0.0 112.575 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -110.46 -13.11 14.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.517 1.527 . . . . 0.0 112.701 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -146.63 163.52 35.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.705 1.593 . . . . 0.0 115.196 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -115.25 79.06 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 109.998 175.301 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -98.56 25.06 6.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.74 -162.65 11.86 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.872 -1.143 . . . . 0.0 114.824 -173.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.53 134.85 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.415 2.286 . . . . 0.0 108.833 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -109.67 91.73 3.76 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.93 106.78 11.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 125.87 26.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.045 0.839 . . . . 0.0 110.337 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.7 mt -137.14 151.4 71.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.66 0.784 . . . . 0.0 112.094 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.55 138.65 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.582 2.188 . . . . 0.0 111.528 165.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.63 128.77 38.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.442 0.697 . . . . 0.0 110.978 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.49 63.98 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.047 1.308 . . . . 0.0 115.285 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.3 m -57.72 126.38 75.83 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-N 119.583 1.692 . . . . 0.0 112.714 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.532 ' HB2' HD12 ' A' ' 142' ' ' ILE . 17.6 Cg_endo -69.26 133.27 26.06 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.211 1.941 . . . . 0.0 112.412 172.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -89.58 130.0 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.561 1.944 . . . . 0.0 107.964 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -102.75 152.73 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.665 1.586 . . . . 0.0 109.834 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.49 124.0 90.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.936 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.39 -40.3 19.33 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.083 2.522 . . . . 0.0 112.456 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.3 p -130.23 164.12 25.22 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.543 1.937 . . . . 0.0 110.382 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.27 137.61 50.89 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 166.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.08 -161.93 17.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.576 0.608 . . . . 0.0 113.167 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -145.72 144.5 30.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 112.008 174.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.81 129.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -40.06 8.62 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -157.76 146.49 19.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.144 1.378 . . . . 0.0 111.007 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 129' ' ' TYR . 59.7 mt -141.13 120.31 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.85 1.26 . . . . 0.0 109.425 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 p90 . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.236 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 mttm . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.99 123.26 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.35 131.86 48.71 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.341 1.456 . . . . 0.0 110.187 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.13 125.44 53.78 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.114 1.365 . . . . 0.0 111.384 171.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.7 mt -121.39 149.26 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.241 1.416 . . . . 0.0 111.807 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.05 139.84 48.35 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 111.376 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 124.529 1.132 . . . . 0.0 113.363 176.134 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -117.87 159.44 23.08 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.651 1.98 . . . . 0.0 111.907 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -143.45 104.4 4.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.951 2.1 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 148.52 24.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.34 0.656 . . . . 0.0 112.503 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -136.17 89.76 2.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.586 2.355 . . . . 0.0 109.92 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.01 160.51 16.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.666 1.186 . . . . 0.0 111.216 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 62.44 57.1 1.96 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.559 1.944 . . . . 0.0 114.032 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.85 145.46 26.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.322 1.049 . . . . 0.0 111.555 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -87.44 -43.72 11.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.108 1.363 . . . . 0.0 108.045 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -147.45 144.77 28.86 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.186 1.794 . . . . 0.0 112.473 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 100' ' ' ILE . 84.0 m-85 -86.83 149.71 24.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.146 0.978 . . . . 0.0 111.927 171.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -117.18 -4.43 11.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.243 1.017 . . . . 0.0 112.607 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.25 162.82 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.179 1.392 . . . . 0.0 111.529 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -111.66 161.52 16.16 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.583 1.153 . . . . 0.0 111.29 168.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.39 128.04 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.123 1.369 . . . . 0.0 107.641 170.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.66 16.05 66.8 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.179 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -87.23 123.52 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.067 1.434 . . . . 0.0 112.871 167.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -69.02 137.8 53.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.199 0.523 . . . . 0.0 111.718 160.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.83 164.14 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.011 2.125 . . . . 0.0 110.67 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -133.83 142.32 47.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.882 1.273 . . . . 0.0 108.677 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.38 132.35 10.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.337 1.055 . . . . 0.0 113.392 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.88 -7.54 81.83 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.446 1.974 . . . . 0.0 115.011 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -77.37 140.92 40.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.1 1.45 . . . . 0.0 113.148 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.9 mm -67.78 129.4 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.76 -0.587 . . . . 0.0 110.997 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.0 pt -114.45 -20.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.762 1.225 . . . . 0.0 113.304 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.02 -177.07 2.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.137 1.775 . . . . 0.0 110.415 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -132.3 130.85 41.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.4 t -79.05 146.39 33.32 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.559 0.695 . . . . 0.0 112.645 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 C-N-CA 124.758 1.17 . . . . 0.0 111.108 -179.893 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.7 p80 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.15 115.32 8.3 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 109.663 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -95.16 99.88 11.78 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.739 0.816 . . . . 0.0 110.24 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 51.8 t80 -89.09 114.44 25.69 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.025 1.33 . . . . 0.0 114.508 172.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -118.21 116.83 27.61 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.708 1.203 . . . . 0.0 111.908 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.3 ttt-85 -100.64 124.74 46.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.909 1.684 . . . . 0.0 111.567 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 32.9 mtm -130.44 157.27 43.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.96 1.304 . . . . 0.0 112.338 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -131.5 135.96 47.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.403 1.481 . . . . 0.0 111.52 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.7 -7.66 57.83 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 126.368 1.937 . . . . 0.0 115.363 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 171.14 -166.65 39.79 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.689 2.566 . . . . 0.0 109.806 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.57 131.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 122.483 1.135 . . . . 0.0 110.555 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.43 168.98 14.89 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 128.466 2.936 . . . . 0.0 109.896 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -56.22 -41.96 76.5 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.849 1.325 . . . . 0.0 112.852 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.69 64.91 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.055 -1.028 . . . . 0.0 112.505 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.0 -15.1 58.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.954 1.301 . . . . 0.0 113.44 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.88 56.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.927 0.891 . . . . 0.0 112.763 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.96 -85.57 0.55 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.635 1.174 . . . . 0.0 113.66 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -166.97 126.89 1.14 Allowed Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 127.386 2.274 . . . . 0.0 106.109 167.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.0 -28.71 8.94 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.277 2.652 . . . . 0.0 114.601 171.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -53.24 -53.51 55.22 Favored Pre-proline 0 N--CA 1.478 0.971 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.53 -19.5 32.39 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.704 2.936 . . . . 0.0 112.584 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -72.36 -44.87 61.96 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 24.2 mt -66.68 -29.43 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.432 0.693 . . . . 0.0 111.056 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.86 -15.8 5.48 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.85 -3.23 9.71 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.437 1.495 . . . . 0.0 114.27 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.61 147.62 98.03 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.088 0.955 . . . . 0.0 112.097 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -51.35 -44.72 41.61 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.747 3.631 . . . . 0.0 114.626 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -111.71 12.96 21.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.898 1.279 . . . . 0.0 113.686 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.04 -135.39 46.07 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 120.821 -1.174 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.12 -25.85 64.2 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.308 -1.113 . . . . 0.0 113.319 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -70.18 -5.77 29.62 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.563 -1.336 . . . . 0.0 113.373 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.9 m -77.98 -4.05 45.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.987 0.812 . . . . 0.0 111.991 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.51 -15.55 12.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.735 1.614 . . . . 0.0 113.825 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -148.95 158.14 43.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 121.635 2.016 . . . . 0.0 115.037 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -110.06 79.42 1.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.47 0.544 0 C-N-CA 124.584 1.154 . . . . 0.0 109.523 174.516 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 97.8 m-85 -120.54 25.21 9.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -168.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.81 -178.63 25.83 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.97 -1.081 . . . . 0.0 113.354 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.37 146.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.823 1.649 . . . . 0.0 108.109 163.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.8 142.06 48.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.987 0.812 . . . . 0.0 112.177 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -116.43 122.6 45.27 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.338 1.455 . . . . 0.0 114.538 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.79 114.6 17.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.026 0.93 . . . . 0.0 110.864 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.3 mt -126.66 151.26 73.0 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.77 136.9 47.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.612 2.208 . . . . 0.0 110.373 152.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -54.22 138.65 38.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.802 1.241 . . . . 0.0 110.847 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.18 -1.62 84.4 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.589 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 36.2 m -50.25 124.94 18.7 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 119.938 1.869 . . . . 0.0 111.273 166.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HB2' HD12 ' A' ' 142' ' ' ILE . 37.5 Cg_endo -71.31 129.32 15.78 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.798 1.665 . . . . 0.0 110.896 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.34 131.46 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 108.738 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -106.13 155.74 19.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.119 1.367 . . . . 0.0 110.224 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.96 75.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 O-C-N 121.521 -0.737 . . . . 0.0 111.707 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.51 -36.79 10.78 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.283 2.655 . . . . 0.0 113.24 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 p -134.62 163.18 30.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.148 1.779 . . . . 0.0 107.05 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.66 139.69 53.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.73 22.74 Favored Glycine 0 N--CA 1.467 0.702 0 O-C-N 121.433 -0.792 . . . . 0.0 113.219 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -148.02 144.87 28.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.372 1.069 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.51 128.22 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.3 -38.81 7.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.203 1.001 . . . . 0.0 112.045 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -148.62 141.35 24.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.49 1.516 . . . . 0.0 111.778 -168.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -139.76 127.29 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.142 1.377 . . . . 0.0 110.381 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 p90 . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -178.833 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.79 137.18 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.885 2.474 . . . . 0.0 113.394 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.68 135.92 53.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.016 1.326 . . . . 0.0 110.237 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 124.6 44.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.11 147.1 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 125.187 1.395 . . . . 0.0 111.796 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.98 138.13 51.2 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.34 2.256 . . . . 0.0 111.764 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.735 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 39.6 m-85 . . . . . 0 C--O 1.235 0.305 0 N-CA-C 118.28 2.696 . . . . 0.0 118.28 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -130.0 150.36 51.31 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.154 1.781 . . . . 0.0 111.847 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -118.61 131.84 56.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.846 1.658 . . . . 0.0 108.763 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -105.43 150.69 25.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.377 1.071 . . . . 0.0 111.856 157.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -135.19 112.56 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.585 1.954 . . . . 0.0 106.35 171.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -106.7 159.9 15.87 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 111.25 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 68.74 55.3 0.47 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.484 1.913 . . . . 0.0 113.282 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.82 158.03 16.27 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 111.382 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -40.42 5.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.638 1.175 . . . . 0.0 112.557 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -144.64 147.9 33.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.034 1.734 . . . . 0.0 111.782 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -94.32 145.99 24.36 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.037 1.335 . . . . 0.0 112.397 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -106.73 -16.44 14.49 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.47 1.108 . . . . 0.0 112.012 170.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.35 167.21 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.149 1.38 . . . . 0.0 111.499 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -124.19 165.4 17.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 111.939 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.5 t -56.22 123.78 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.36 1.064 . . . . 0.0 108.931 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.34 61.01 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.209 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -97.92 135.83 39.09 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.032 1.916 . . . . 0.0 109.419 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -76.49 145.17 39.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.456 1.102 . . . . 0.0 113.254 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.99 161.04 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 127.013 2.125 . . . . 0.0 111.293 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -123.93 144.09 49.99 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.498 2.319 . . . . 0.0 108.552 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -45.44 112.73 0.49 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.014 1.326 . . . . 0.0 112.308 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.39 -3.2 34.76 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.946 1.736 . . . . 0.0 115.51 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.15 144.54 26.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 88' ' ' PRO . 19.2 mm -70.9 130.82 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.763 0.71 . . . . 0.0 111.924 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.6 pt -115.96 -22.94 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.712 1.205 . . . . 0.0 113.298 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.44 -178.33 2.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.938 1.295 . . . . 0.0 111.278 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -129.73 135.44 48.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.68 146.65 53.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.933 0.893 . . . . 0.0 112.27 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 CA-C-O 121.52 0.511 . . . . 0.0 112.751 176.03 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 115.77 12.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.482 0.713 . . . . 0.0 110.478 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -92.12 98.78 11.75 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.79 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.288 50.6 t80 -89.07 109.67 20.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.66 117.49 33.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.447 1.099 . . . . 0.0 111.467 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -102.53 126.37 49.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.012 1.325 . . . . 0.0 111.059 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.5 mtm -129.49 149.11 51.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.573 1.549 . . . . 0.0 111.451 -170.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -124.32 131.08 53.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.47 1.508 . . . . 0.0 110.759 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.25 -1.27 35.18 Favored Glycine 0 CA--C 1.545 1.914 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.42 -169.74 41.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.997 1.284 . . . . 0.0 112.521 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.76 115.73 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.28 1.432 . . . . 0.0 112.781 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.52 15.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.395 1.95 . . . . 0.0 111.347 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -57.84 -40.5 80.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.607 1.204 . . . . 0.0 112.832 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.49 -17.61 64.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -88.65 -11.8 44.31 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 151.09 34.08 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -130.57 -89.12 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.517 1.527 . . . . 0.0 113.98 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -160.22 95.89 1.53 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -167.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.4 -34.94 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.15 1.9 . . . . 0.0 114.206 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -54.95 -55.36 39.7 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 121.098 1.772 . . . . 0.0 115.53 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.46 -26.51 40.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.362 2.708 . . . . 0.0 112.099 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.17 -38.3 81.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.44 -40.8 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.887 0.475 . . . . 0.0 110.861 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.45 -5.05 13.09 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -114.12 -4.79 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.018 2.127 . . . . 0.0 113.225 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.84 156.04 48.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.53 1.132 . . . . 0.0 112.327 171.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.65 -49.51 16.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.868 3.045 . . . . 0.0 113.148 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.41 5.21 36.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.454 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.37 -143.76 47.61 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.033 -1.042 . . . . 0.0 112.181 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.44 61.93 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -64.7 -10.08 24.57 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -86.72 5.46 36.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 171.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.1 -18.56 9.35 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.624 1.57 . . . . 0.0 112.709 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -149.1 157.73 43.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.363 -1.461 . . . . 0.0 111.701 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.69 89.02 2.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.241 0.65 0 C-N-CA 124.978 1.311 . . . . 0.0 110.796 173.126 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.49 22.63 11.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.571 1.548 . . . . 0.0 114.675 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.59 -158.05 8.93 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 121.206 -0.934 . . . . 0.0 113.56 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.593 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -125.92 133.31 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.867 2.067 . . . . 0.0 108.796 178.472 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.45 96.08 5.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.48 110.44 14.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 114.17 4.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.267 0.94 . . . . 0.0 111.351 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -129.82 147.27 64.76 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.22 0.608 . . . . 0.0 112.057 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.47 135.43 49.58 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.04 1.827 . . . . 0.0 110.346 162.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -60.67 130.3 45.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.769 0.827 . . . . 0.0 111.129 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.58 -7.92 68.56 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.737 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -51.32 126.65 28.75 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-N 120.121 1.961 . . . . 0.0 113.101 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.606 ' HB2' HD12 ' A' ' 142' ' ' ILE . 6.4 Cg_endo -67.73 136.07 37.73 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.638 2.226 . . . . 0.0 112.151 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.67 127.6 44.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.484 1.514 . . . . 0.0 107.888 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -96.91 148.8 22.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.087 1.355 . . . . 0.0 109.643 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.1 125.06 88.5 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.692 -0.671 . . . . 0.0 110.277 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.64 -39.93 14.58 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.314 2.676 . . . . 0.0 111.72 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.2 p -120.34 166.44 13.52 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.736 2.414 . . . . 0.0 110.089 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -67.36 144.92 55.56 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 154.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.95 -157.68 16.18 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.407 1.003 . . . . 0.0 114.345 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.14 143.96 25.38 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.044 1.738 . . . . 0.0 112.09 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.32 127.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -42.7 8.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 -159.19 143.72 15.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.2 1.0 . . . . 0.0 110.85 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.429 HG23 ' CE2' ' A' ' 129' ' ' TYR . 53.1 mt -141.78 122.31 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.486 1.514 . . . . 0.0 109.101 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -177.316 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 mttm . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.4 139.36 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.656 1.982 . . . . 0.0 114.208 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.298 1.439 . . . . 0.0 109.821 171.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 126.5 55.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.391 0.676 . . . . 0.0 112.57 171.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.14 145.18 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.829 1.252 . . . . 0.0 112.218 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.94 132.25 52.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.701 2.4 . . . . 0.0 112.182 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.422 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.264 50.0 m-85 . . . . . 0 C--O 1.238 0.468 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -126.48 155.71 41.85 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.646 2.378 . . . . 0.0 111.332 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -137.8 105.3 5.54 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.473 1.909 . . . . 0.0 110.625 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -88.52 146.03 25.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.156 0.582 . . . . 0.0 111.225 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -132.21 109.52 9.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.689 1.596 . . . . 0.0 108.218 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.08 162.49 12.9 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.939 1.296 . . . . 0.0 111.112 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 59.32 61.76 1.97 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.203 2.201 . . . . 0.0 112.798 -174.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.03 140.49 36.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.973 1.309 . . . . 0.0 111.998 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -80.86 -48.75 11.97 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 0.0 108.716 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -152.42 149.21 28.34 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.536 1.935 . . . . 0.0 111.152 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.429 ' CE2' HG23 ' A' ' 100' ' ' ILE . 97.9 m-85 -98.06 143.27 28.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.728 1.211 . . . . 0.0 113.032 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -103.45 -29.36 11.23 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.524 -0.735 . . . . 0.0 111.812 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.6 m -111.03 172.61 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.737 1.615 . . . . 0.0 112.208 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -128.55 162.94 26.08 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.734 1.614 . . . . 0.0 111.681 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -56.04 130.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 122.37 1.081 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.29 5.42 67.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.476 1.512 . . . . 0.0 114.995 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -95.21 136.8 35.11 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.24 1.52 . . . . 0.0 114.061 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.1 mmm-85 -86.49 133.93 33.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.94 159.21 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.423 1.489 . . . . 0.0 110.863 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.19 143.54 51.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.216 1.806 . . . . 0.0 108.462 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.65 128.99 13.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.23 1.012 . . . . 0.0 113.06 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.45 -2.69 78.22 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.33 1.443 . . . . 0.0 114.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -79.31 139.74 37.74 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.754 1.277 . . . . 0.0 113.692 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.6 mm -69.82 126.81 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 118.846 0.748 . . . . 0.0 111.544 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -108.8 -26.06 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.125 1.37 . . . . 0.0 113.133 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.11 -176.81 2.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 110.389 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.47 136.34 41.21 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -82.48 143.87 30.83 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 C-N-CA 124.601 1.096 . . . . 0.0 113.27 -176.111 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.0 p80 . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.08 118.08 19.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.857 0.753 . . . . 0.0 110.587 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -94.95 100.91 12.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.51 113.14 25.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.015 1.326 . . . . 0.0 113.953 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -117.7 112.41 20.44 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 110.088 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 ttt-85 -99.93 127.26 46.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.122 0.969 . . . . 0.0 110.603 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.1 mtm -127.37 154.09 45.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.622 1.569 . . . . 0.0 111.731 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -130.07 131.92 45.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.419 1.087 . . . . 0.0 112.246 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.54 6.11 75.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.053 0.835 . . . . 0.0 114.68 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.83 -161.1 31.23 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.116 1.817 . . . . 0.0 111.374 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.48 135.6 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.63 1.172 . . . . 0.0 111.838 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 138.71 171.72 12.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.084 1.802 . . . . 0.0 112.578 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -54.23 -51.29 64.96 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.75 1.22 . . . . 0.0 113.569 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.15 -17.12 63.17 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.712 -1.243 . . . . 0.0 114.279 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -80.23 -18.2 50.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.07 145.87 55.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.667 0.787 . . . . 0.0 111.602 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -122.8 -81.0 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -166.92 97.37 0.68 Allowed Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.27 -26.35 5.13 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.127 1.884 . . . . 0.0 114.51 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.593 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -56.3 -51.91 77.18 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-N 121.622 2.01 . . . . 0.0 113.821 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.48 -25.75 24.95 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.512 2.141 . . . . 0.0 112.379 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.67 -32.7 74.26 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -80.71 -26.37 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.341 0.657 . . . . 0.0 111.717 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -59.46 -10.44 3.29 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -117.39 -5.84 11.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.887 2.075 . . . . 0.0 113.616 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.04 148.76 91.91 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.367 -0.833 . . . . 0.0 111.8 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -36.95 52.87 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.306 2.671 . . . . 0.0 114.066 -166.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -109.64 0.13 18.9 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.265 -0.897 . . . . 0.0 110.864 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 78.3 -143.2 26.96 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.613 1.097 . . . . 0.0 112.083 -164.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.54 -25.97 64.96 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.916 -1.344 . . . . 0.0 114.14 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -63.25 -8.88 9.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.01 1.324 . . . . 0.0 114.485 173.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -83.05 -5.44 59.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.397 1.079 . . . . 0.0 112.952 170.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -104.2 -14.61 15.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.903 1.681 . . . . 0.0 113.184 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -143.51 160.16 41.11 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.834 1.652 . . . . 0.0 114.7 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -108.07 78.16 1.16 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 124.315 1.046 . . . . 0.0 112.354 -176.693 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.279 69.9 m-85 -90.07 43.76 1.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.56 -175.91 38.44 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.506 -1.371 . . . . 0.0 115.055 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.32 146.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.152 1.781 . . . . 0.0 107.866 165.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 137.44 50.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.518 1.054 . . . . 0.0 113.13 167.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.08 118.96 38.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.005 1.722 . . . . 0.0 113.93 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.82 110.47 4.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.585 0.754 . . . . 0.0 110.199 171.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.7 mt -125.34 150.42 67.35 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 111.466 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.6 138.21 73.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.637 2.225 . . . . 0.0 110.578 161.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -56.76 121.61 10.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.185 1.394 . . . . 0.0 111.291 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.37 1.65 66.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.1 m -52.18 125.46 33.38 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 120.407 2.104 . . . . 0.0 112.436 166.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.601 ' HB2' HD12 ' A' ' 142' ' ' ILE . 9.0 Cg_endo -68.22 135.66 35.04 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.095 1.863 . . . . 0.0 111.841 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.3 mm -91.51 130.51 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.716 1.606 . . . . 0.0 107.428 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -101.25 150.19 23.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.995 1.318 . . . . 0.0 109.246 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 93.13 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.936 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.03 -30.53 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.317 2.678 . . . . 0.0 113.345 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.7 p -132.43 163.73 28.12 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.724 2.41 . . . . 0.0 112.225 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.54 135.94 42.14 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.71 -159.26 11.54 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.403 1.001 . . . . 0.0 114.057 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -150.9 145.55 25.71 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.681 1.593 . . . . 0.0 111.174 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.59 125.66 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.83 -41.35 7.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.822 1.249 . . . . 0.0 111.075 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -149.32 142.93 25.46 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.724 1.21 . . . . 0.0 111.654 -166.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.9 mt -140.99 134.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.446 1.098 . . . . 0.0 109.386 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.5 p90 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.969 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -134.53 138.89 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.137 1.775 . . . . 0.0 113.851 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -115.21 134.27 55.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.566 1.946 . . . . 0.0 109.784 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.44 123.62 46.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.755 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.2 mt -119.48 142.67 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 0.0 111.373 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.09 138.93 37.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.534 1.934 . . . . 0.0 110.89 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 112.241 169.779 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.296 38.5 m-85 . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -131.8 150.38 52.17 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.387 1.075 . . . . 0.0 112.598 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -125.53 121.4 33.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.693 1.997 . . . . 0.0 108.184 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -97.49 150.41 21.1 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.27 91.77 2.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.829 2.452 . . . . 0.0 108.823 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.47 162.91 13.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.472 0.709 . . . . 0.0 111.838 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 65.26 53.63 1.29 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.352 1.861 . . . . 0.0 111.721 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.7 mt -96.75 140.95 30.58 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.266 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.53 -50.83 12.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.376 1.87 . . . . 0.0 107.802 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -147.78 146.84 29.33 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.884 1.673 . . . . 0.0 111.322 -163.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -91.09 151.03 21.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.059 0.543 . . . . 0.0 111.728 171.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -118.12 -7.11 10.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.437 1.095 . . . . 0.0 112.657 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.81 166.8 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.294 1.838 . . . . 0.0 111.219 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -122.16 165.96 15.31 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.718 1.607 . . . . 0.0 111.135 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.5 t -52.64 125.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.782 1.233 . . . . 0.0 107.993 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.1 13.72 61.65 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.42 126.37 35.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.749 1.774 . . . . 0.0 112.603 168.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -71.2 135.22 47.43 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.981 0.512 . . . . 0.0 111.371 167.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.51 156.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.91 1.684 . . . . 0.0 110.348 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -136.13 140.73 43.89 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.988 1.715 . . . . 0.0 109.336 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.25 131.62 16.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.265 1.031 . . . . 0.0 113.488 -171.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.22 -6.68 83.31 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.861 2.172 . . . . 0.0 115.128 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -79.23 140.75 37.58 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.036 1.418 . . . . 0.0 114.017 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.0 mm -70.42 129.63 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.688 0.795 . . . . 0.0 111.603 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -115.5 -23.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.966 1.307 . . . . 0.0 113.089 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.67 -175.92 1.67 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.879 1.672 . . . . 0.0 110.386 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -136.85 138.18 40.48 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.5 t -79.92 143.24 34.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.048 0.84 . . . . 0.0 113.236 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 C-N-CA 124.953 1.264 . . . . 0.0 112.977 -176.213 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.65 117.09 13.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.082 0.953 . . . . 0.0 110.702 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -90.9 106.07 18.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.219 0.918 . . . . 0.0 111.865 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.251 41.5 t80 -95.28 115.04 26.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.409 1.484 . . . . 0.0 114.563 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -113.85 120.43 40.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.822 0.849 . . . . 0.0 111.755 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -92.95 124.0 36.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.078 1.751 . . . . 0.0 111.35 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.3 mtm -126.07 161.32 27.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.984 1.714 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -134.16 141.96 47.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 111.353 169.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.35 -5.26 60.52 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.252 1.406 . . . . 0.0 115.867 167.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.59 -175.12 47.45 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.751 2.596 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.25 121.76 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.637 1.175 . . . . 0.0 112.544 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.93 163.75 10.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.28 1.419 . . . . 0.0 112.356 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -48.23 -46.13 35.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.736 1.214 . . . . 0.0 113.468 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.34 69.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -81.46 -14.24 57.26 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.1 131.83 49.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.614 1.166 . . . . 0.0 112.119 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -103.28 -80.48 0.52 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.778 0.831 . . . . 0.0 112.681 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -166.78 101.34 0.66 Allowed Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.397 1.479 . . . . 0.0 114.046 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.02 -32.29 1.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.866 1.711 . . . . 0.0 114.097 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -57.83 -53.84 61.55 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 120.976 1.717 . . . . 0.0 115.475 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.24 -25.97 49.6 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.241 2.627 . . . . 0.0 112.122 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -61.13 -27.56 68.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 166.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.21 -31.52 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.836 0.854 . . . . 0.0 111.998 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.4 -4.7 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -114.81 -5.75 12.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.807 2.043 . . . . 0.0 113.652 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.9 mt -77.72 148.1 75.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.743 1.217 . . . . 0.0 112.532 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.65 -21.31 22.13 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.811 3.007 . . . . 0.0 115.2 -164.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -119.01 9.44 11.86 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.106 1.363 . . . . 0.0 113.921 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.02 -141.24 34.1 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.252 0.93 . . . . 0.0 112.975 -169.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.63 -25.25 52.8 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.313 -1.11 . . . . 0.0 113.414 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -64.89 -9.11 18.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 113.753 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.3 m -81.74 -7.96 59.65 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.08 0.952 . . . . 0.0 112.76 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.36 -18.69 14.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.624 1.17 . . . . 0.0 113.346 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -144.17 159.42 42.68 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.378 -1.451 . . . . 0.0 113.441 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -104.78 93.11 4.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.241 0.631 0 C-N-CA 123.658 0.783 . . . . 0.0 111.824 177.196 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 121.454 0.645 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.453 68.5 m-85 -93.41 28.07 2.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.43 -168.97 23.09 Favored Glycine 0 CA--C 1.532 1.097 0 O-C-N 121.109 -0.994 . . . . 0.0 114.766 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.27 144.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.977 2.111 . . . . 0.0 108.859 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -123.47 129.88 51.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -102.62 118.77 37.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.106 1.762 . . . . 0.0 113.804 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.76 78.14 1.12 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.356 1.062 . . . . 0.0 112.421 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.6 mt -95.77 150.17 37.02 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.099 0.959 . . . . 0.0 112.484 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.07 151.52 83.6 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.864 2.376 . . . . 0.0 112.214 162.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -54.74 139.68 38.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.325 1.45 . . . . 0.0 111.054 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.77 -9.56 59.21 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.028 -1.429 . . . . 0.0 115.818 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 m -50.62 122.47 16.19 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.707 1.754 . . . . 0.0 113.938 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.568 ' HB2' HD12 ' A' ' 142' ' ' ILE . 14.7 Cg_endo -67.31 129.3 20.03 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.165 1.243 . . . . 0.0 111.662 172.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.426 HD11 ' HB2' ' A' ' 146' ' ' SER . 45.6 mm -87.94 127.68 40.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.267 1.827 . . . . 0.0 107.771 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -99.25 154.38 18.2 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.482 1.513 . . . . 0.0 109.77 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.9 123.95 90.16 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.939 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -35.79 51.61 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.148 2.565 . . . . 0.0 112.716 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -138.58 154.89 48.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.725 1.61 . . . . 0.0 107.137 -169.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.29 134.33 55.65 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.494 0.718 . . . . 0.0 110.926 169.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.01 -157.92 11.58 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.937 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 146.47 25.65 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.438 1.895 . . . . 0.0 111.911 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.03 129.23 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 -44.91 7.09 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -158.62 143.73 16.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.049 1.34 . . . . 0.0 111.104 -166.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -141.1 118.75 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.761 1.224 . . . . 0.0 109.637 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.0 p90 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.577 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.8 mttp . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.81 140.93 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 127.005 2.122 . . . . 0.0 114.451 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.86 132.53 56.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.302 1.841 . . . . 0.0 108.683 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.99 124.49 51.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.586 1.155 . . . . 0.0 110.403 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.76 144.43 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.455 1.102 . . . . 0.0 111.153 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.76 127.09 53.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.362 1.865 . . . . 0.0 110.35 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 . . . . . 0 N--CA 1.473 0.689 0 O-C-N 121.006 -1.059 . . . . 0.0 111.428 169.328 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.312 35.1 m-85 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -120.13 155.32 33.28 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.316 2.246 . . . . 0.0 110.843 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -140.97 103.17 4.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.245 1.818 . . . . 0.0 109.994 -168.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -85.06 142.72 29.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.685 0.394 . . . . 0.0 111.38 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -130.78 89.94 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.872 2.469 . . . . 0.0 109.979 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mp -93.27 157.06 16.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.342 0.657 . . . . 0.0 111.346 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 71.18 58.56 0.19 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.269 1.827 . . . . 0.0 113.187 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -103.72 148.86 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.024 1.33 . . . . 0.0 111.288 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.42 -52.68 6.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.412 1.885 . . . . 0.0 107.618 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -150.98 157.79 43.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 127.168 2.187 . . . . 0.0 110.921 -165.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -98.77 154.29 18.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.94 0.896 . . . . 0.0 112.076 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -117.18 -14.28 10.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.677 1.191 . . . . 0.0 112.934 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.93 163.17 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.067 1.347 . . . . 0.0 110.397 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -117.88 163.84 15.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.4 t -54.52 135.43 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.57 3.72 83.7 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.561 1.077 . . . . 0.0 115.263 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -79.67 124.57 28.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 119.326 1.563 . . . . 0.0 111.863 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -74.19 140.95 45.46 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.77 160.92 40.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.617 1.567 . . . . 0.0 110.298 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -129.2 145.06 51.41 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.605 1.562 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.0 116.56 2.05 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.558 1.143 . . . . 0.0 112.732 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.68 -1.33 42.19 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 126.203 1.859 . . . . 0.0 115.305 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -86.34 142.58 28.39 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.407 1.883 . . . . 0.0 114.958 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 88' ' ' PRO . 13.4 mm -69.01 129.05 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.109 0.868 . . . . 0.0 112.01 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.77 -23.97 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.707 1.603 . . . . 0.0 113.312 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.77 3.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.469 1.108 . . . . 0.0 110.54 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.66 132.08 46.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 89' ' ' ILE . 1.6 t -69.06 137.52 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.704 1.601 . . . . 0.0 110.43 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.502 0 CA-C-O 122.893 1.274 . . . . 0.0 115.027 -169.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.48 128.53 36.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.292 1.437 . . . . 0.0 112.089 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -106.23 105.9 16.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.798 0.839 . . . . 0.0 112.109 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.287 33.7 t80 -95.4 111.98 23.77 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.882 1.673 . . . . 0.0 114.941 175.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -116.7 114.0 23.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.621 1.168 . . . . 0.0 111.282 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.94 122.63 43.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.415 1.486 . . . . 0.0 110.808 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.0 mtm -128.64 156.46 43.38 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.618 1.567 . . . . 0.0 111.415 -172.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -127.76 128.29 45.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 110.669 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.3 -15.2 12.7 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 125.886 1.708 . . . . 0.0 116.623 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.53 40.31 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.049 1.309 . . . . 0.0 112.179 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.93 91.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 173.03 173.21 39.28 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.872 1.701 . . . . 0.0 112.86 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -48.58 -48.65 38.77 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.1 -14.62 62.74 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.19 -16.34 38.12 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 143.49 52.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.564 1.146 . . . . 0.0 112.823 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -125.23 -79.94 0.61 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -164.79 110.51 0.84 Allowed Pre-proline 0 N--CA 1.47 0.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -29.99 4.13 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.257 1.971 . . . . 0.0 114.151 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -51.35 -59.98 6.72 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.6 -28.62 69.73 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.689 2.926 . . . . 0.0 111.695 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -66.72 -39.17 87.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.22 -34.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.775 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.51 -16.84 17.12 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.93 1.12 11.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.144 1.778 . . . . 0.0 114.692 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.23 154.39 87.36 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.44 1.096 . . . . 0.0 111.848 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -47.2 -54.69 4.7 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.921 3.748 . . . . 0.0 114.028 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -106.99 10.84 30.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.272 1.029 . . . . 0.0 112.727 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.32 -139.1 30.15 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.711 -1.243 . . . . 0.0 112.332 -169.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.97 -26.4 62.28 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.706 -1.467 . . . . 0.0 112.807 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -69.55 -3.37 14.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.983 1.313 . . . . 0.0 113.067 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.6 m -80.54 -8.04 59.44 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.31 1.044 . . . . 0.0 113.013 166.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.57 -13.47 15.05 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.854 1.662 . . . . 0.0 112.687 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.16 161.47 42.67 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -106.04 90.15 3.29 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.849 1.26 . . . . 0.0 109.806 170.272 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.96 23.0 14.27 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -170.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.0 -166.97 14.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 120.696 -1.252 . . . . 0.0 114.579 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.01 130.36 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.828 2.051 . . . . 0.0 109.291 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -109.64 89.15 2.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.15 108.1 12.4 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.17 126.83 30.43 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.417 1.008 . . . . 0.0 111.776 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.45 159.17 71.64 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.137 0.975 . . . . 0.0 113.325 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.19 145.8 73.91 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.234 2.623 . . . . 0.0 111.22 161.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -65.87 131.71 46.91 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.345 -0.847 . . . . 0.0 111.149 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.27 84.24 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.586 -1.675 . . . . 0.0 115.415 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -47.72 121.93 8.58 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.923 1.862 . . . . 0.0 112.459 171.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.594 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.6 Cg_endo -68.2 129.25 18.94 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.424 1.416 . . . . 0.0 111.589 175.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -86.23 128.1 39.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.73 1.612 . . . . 0.0 108.482 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -100.4 149.81 23.27 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 109.644 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.76 133.37 90.46 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 121.777 -0.577 . . . . 0.0 110.861 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.59 -32.39 6.11 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.193 2.595 . . . . 0.0 112.667 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.3 p -140.22 160.92 38.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.34 2.256 . . . . 0.0 107.847 -170.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -74.64 136.78 41.94 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.772 -1.205 . . . . 0.0 109.326 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.56 -159.11 11.81 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.973 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.09 144.68 25.89 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.913 1.285 . . . . 0.0 113.108 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.65 127.26 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.06 -41.95 5.69 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.614 1.166 . . . . 0.0 111.939 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -147.06 140.43 25.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.697 1.199 . . . . 0.0 110.915 -165.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 mt -144.82 110.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.512 1.525 . . . . 0.0 109.42 -173.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 p90 . . . . . 0 N--CA 1.48 1.074 0 C-N-CA 123.461 0.704 . . . . 0.0 112.545 -169.617 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.25 134.79 62.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.528 1.531 . . . . 0.0 115.087 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -111.35 134.97 52.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.135 1.374 . . . . 0.0 109.574 168.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.4 124.34 44.28 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 55.6 mt -119.85 139.91 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.557 1.143 . . . . 0.0 111.193 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.33 131.27 40.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.852 2.061 . . . . 0.0 110.118 166.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.611 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 . . . . . 0 C--O 1.236 0.394 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -121.9 152.77 39.27 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.536 1.534 . . . . 0.0 112.54 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.38 138.95 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.586 1.954 . . . . 0.0 109.153 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -114.0 148.65 36.59 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.977 1.311 . . . . 0.0 112.827 161.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -133.7 99.63 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.896 1.679 . . . . 0.0 106.964 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.41 163.67 13.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.695 1.198 . . . . 0.0 110.508 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 66.25 40.15 3.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.154 2.181 . . . . 0.0 114.937 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -83.98 154.22 23.44 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.312 -1.493 . . . . 0.0 112.827 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.36 -46.75 7.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.799 1.239 . . . . 0.0 108.955 171.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -152.82 160.27 43.09 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -104.0 148.64 25.98 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.646 1.578 . . . . 0.0 111.911 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -107.33 -8.61 16.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.662 1.585 . . . . 0.0 112.25 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 175.39 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.772 1.629 . . . . 0.0 111.464 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -130.82 169.21 16.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.438 1.495 . . . . 0.0 111.424 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.29 132.47 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 122.225 1.012 . . . . 0.0 108.983 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.69 9.16 69.08 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.511 1.053 . . . . 0.0 115.128 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -86.27 124.61 32.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.727 1.264 . . . . 0.0 113.33 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -75.87 139.68 41.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.514 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.4 164.6 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.214 1.805 . . . . 0.0 112.676 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.05 140.14 48.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.254 1.822 . . . . 0.0 110.218 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.1 125.68 3.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.875 1.27 . . . . 0.0 113.402 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.94 -10.14 72.33 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.0 1.762 . . . . 0.0 114.995 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -80.74 145.0 31.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.179 1.489 . . . . 0.0 114.667 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.1 mm -70.82 135.06 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.225 0.61 . . . . 0.0 111.817 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 42.1 pt -121.22 -20.52 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.493 1.117 . . . . 0.0 113.321 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.7 -176.03 1.19 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.896 1.678 . . . . 0.0 111.388 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -132.82 134.46 44.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.2 t -71.01 143.65 50.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.179 0.591 . . . . 0.0 112.231 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.15 0 C-N-CA 124.554 1.073 . . . . 0.0 113.185 -178.016 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 120.727 0.298 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.42 120.88 41.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.167 1.387 . . . . 0.0 110.887 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -98.45 99.41 10.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.301 1.04 . . . . 0.0 110.583 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.283 36.8 t80 -88.75 116.66 27.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -122.29 116.95 24.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.323 1.049 . . . . 0.0 111.886 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -95.29 131.39 41.42 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.747 1.619 . . . . 0.0 110.93 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.8 mtm -132.43 155.09 49.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.681 1.593 . . . . 0.0 111.498 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -128.76 136.7 50.91 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.304 1.442 . . . . 0.0 111.235 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.39 2.75 43.85 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.75 -175.81 43.78 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.6 2.048 . . . . 0.0 111.0 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.56 123.29 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 122.438 1.114 . . . . 0.0 108.266 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.07 159.58 9.94 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.724 2.583 . . . . 0.0 110.685 -165.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.61 -46.68 83.78 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.774 1.287 . . . . 0.0 113.534 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.72 -15.98 63.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -76.28 -15.07 60.08 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.27 152.31 42.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.51 1.124 . . . . 0.0 113.861 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -119.97 -90.49 0.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.37 1.468 . . . . 0.0 112.409 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -160.91 118.13 1.44 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.371 1.469 . . . . 0.0 108.385 165.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -20.9 29.96 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.096 2.531 . . . . 0.0 115.512 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -50.86 -55.32 28.28 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.98 -28.2 42.09 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.905 3.07 . . . . 0.0 112.873 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.46 -34.51 78.46 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.2 mt -79.14 -32.66 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.107 0.563 . . . . 0.0 111.37 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.81 -5.59 2.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -117.45 -9.05 10.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.964 1.706 . . . . 0.0 113.804 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 58.7 mt -63.98 152.53 87.15 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.198 1.399 . . . . 0.0 113.078 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.97 -32.71 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.539 2.826 . . . . 0.0 114.603 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.64 13.43 19.93 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.108 1.363 . . . . 0.0 113.09 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.06 -135.73 48.67 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.98 0.8 . . . . 0.0 112.197 -167.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.23 -26.92 53.07 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.91 -10.28 56.29 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.7 t -78.66 0.62 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.211 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.7 mt -111.13 -16.23 13.51 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.726 1.61 . . . . 0.0 112.834 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -146.24 153.87 41.08 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.771 1.623 . . . . 0.0 114.558 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -107.75 76.53 1.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.399 1.095 . . . . 0.0 113.317 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 C--O 1.239 0.543 0 C-N-CA 124.464 1.105 . . . . 0.0 109.454 169.065 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -122.47 27.22 7.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.155 0.982 . . . . 0.0 113.627 -166.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.99 -169.47 17.5 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.888 -1.132 . . . . 0.0 113.588 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.585 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -113.68 132.8 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.995 2.118 . . . . 0.0 108.617 173.509 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.96 93.76 4.61 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -79.82 111.19 15.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 121.55 17.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.729 0.695 . . . . 0.0 111.307 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.8 mt -135.99 156.78 76.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.373 1.469 . . . . 0.0 110.653 -173.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.29 137.68 67.11 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.56 2.174 . . . . 0.0 110.774 160.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -60.21 133.37 56.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 0.0 111.063 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.29 5.25 89.02 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.24 -1.311 . . . . 0.0 115.07 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.5 m -55.12 125.55 57.75 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.179 1.99 . . . . 0.0 110.506 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.579 ' HB2' HD12 ' A' ' 142' ' ' ILE . 10.9 Cg_endo -68.02 132.31 26.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.968 1.779 . . . . 0.0 111.851 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.46 126.22 41.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.208 1.803 . . . . 0.0 107.665 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -95.99 153.61 17.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.216 1.007 . . . . 0.0 110.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.32 123.71 89.44 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.727 -0.608 . . . . 0.0 110.672 172.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.19 -40.19 20.58 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.992 2.461 . . . . 0.0 111.475 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.1 p -134.82 165.02 26.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.079 2.552 . . . . 0.0 111.309 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -70.94 136.03 48.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.493 1.117 . . . . 0.0 112.056 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.54 -157.32 13.22 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.521 1.058 . . . . 0.0 114.629 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.68 150.42 31.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.557 1.943 . . . . 0.0 110.19 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 t -66.01 133.26 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -41.74 8.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -158.88 145.64 17.17 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.069 1.748 . . . . 0.0 109.372 -169.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.6 mt -137.32 129.87 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.901 1.28 . . . . 0.0 108.864 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.6 p90 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.928 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.51 137.01 56.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.607 1.563 . . . . 0.0 114.823 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.4 tp -115.95 123.44 48.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.21 125.47 48.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.276 1.03 . . . . 0.0 109.753 171.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.1 mt -121.45 147.46 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.588 1.155 . . . . 0.0 111.606 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.87 136.95 49.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.692 1.997 . . . . 0.0 110.812 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 123.876 0.87 . . . . 0.0 112.773 171.336 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.295 52.4 m-85 . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -115.16 151.86 33.64 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.376 1.87 . . . . 0.0 110.746 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.89 102.85 4.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.123 1.769 . . . . 0.0 110.206 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -85.31 139.83 31.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.384 0.274 . . . . 0.0 111.193 170.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -126.25 91.36 3.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.532 2.333 . . . . 0.0 109.436 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.55 158.36 16.49 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.961 1.304 . . . . 0.0 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 63.54 56.34 1.62 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.503 1.921 . . . . 0.0 114.124 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.2 mt -96.49 147.37 23.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 111.332 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -84.42 -48.49 9.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.63 148.11 30.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.062 1.745 . . . . 0.0 112.076 -169.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -93.66 144.62 25.22 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.938 1.295 . . . . 0.0 113.153 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -104.36 -10.97 17.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.605 0.762 . . . . 0.0 112.288 166.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.53 164.31 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.97 1.708 . . . . 0.0 113.191 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.45 164.37 14.98 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.016 2.126 . . . . 0.0 110.515 168.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.73 128.12 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.74 7.9 74.16 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.634 1.111 . . . . 0.0 115.747 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.27 133.32 35.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.044 1.922 . . . . 0.0 107.276 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -70.5 146.24 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.016 0.527 . . . . 0.0 111.8 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.6 m -129.33 154.06 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 110.007 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -133.5 140.59 47.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.954 1.702 . . . . 0.0 108.736 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.26 125.68 11.39 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.264 1.031 . . . . 0.0 112.751 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.63 -1.37 66.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.829 1.68 . . . . 0.0 115.46 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -88.54 142.29 27.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.125 1.37 . . . . 0.0 114.031 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.1 mm -67.3 132.12 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.084 0.856 . . . . 0.0 111.774 177.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 44.2 pt -116.57 -23.17 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.826 1.25 . . . . 0.0 113.211 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -172.54 -175.49 1.35 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.623 1.969 . . . . 0.0 110.665 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.38 139.14 46.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 0.0 107.505 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.11 144.37 50.29 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.64 0.776 . . . . 0.0 112.126 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 C-N-CA 123.664 0.649 . . . . 0.0 113.004 -175.858 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.54 117.37 14.13 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.08 0.952 . . . . 0.0 111.138 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -92.68 101.54 13.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.713 0.805 . . . . 0.0 110.784 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.281 52.9 t80 -93.28 115.65 28.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 170.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -117.62 116.08 26.36 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.632 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -92.24 121.85 34.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.72 1.608 . . . . 0.0 110.426 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.6 mtm -125.67 153.18 44.22 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.341 1.456 . . . . 0.0 110.756 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.12 128.92 46.97 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.654 1.181 . . . . 0.0 110.817 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.61 1.71 83.53 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.285 1.421 . . . . 0.0 115.812 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.51 -174.7 43.85 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.031 1.777 . . . . 0.0 111.846 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.8 125.3 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.618 1.167 . . . . 0.0 114.126 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 151.81 171.5 19.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.648 1.594 . . . . 0.0 113.037 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -65.06 -34.93 79.6 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.343 -1.093 . . . . 0.0 112.15 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.35 67.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.462 1.505 . . . . 0.0 113.58 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -92.94 -14.85 27.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.77 144.61 57.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.537 1.135 . . . . 0.0 112.329 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -116.24 -82.9 0.63 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.048 0.939 . . . . 0.0 112.24 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -170.4 129.02 0.81 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 128.125 2.57 . . . . 0.0 106.111 160.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.469 ' HG2' HD12 ' A' ' 79' ' ' ILE . 69.7 Cg_endo -71.58 -24.48 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.948 2.432 . . . . 0.0 114.539 171.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.585 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -54.05 -55.08 40.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -171.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.88 -31.09 48.28 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.688 2.925 . . . . 0.0 112.082 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -65.1 -41.62 94.77 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.45 HD12 HD13 ' A' ' 79' ' ' ILE . 29.9 mt -71.58 -35.78 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.391 0.541 . . . . 0.0 111.303 174.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 44.3 m-20 -63.68 -2.85 1.9 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -126.53 -7.59 6.29 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.096 2.158 . . . . 0.0 115.01 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.76 151.12 55.05 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.14 0.976 . . . . 0.0 112.484 170.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.41 -32.87 49.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.537 2.824 . . . . 0.0 114.947 -168.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.98 10.2 24.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.534 1.133 . . . . 0.0 109.61 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.68 -136.26 44.32 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.548 -1.345 . . . . 0.0 111.915 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.7 -25.28 68.08 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.934 -1.333 . . . . 0.0 113.939 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -68.41 -3.28 10.7 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.9 m -77.3 -6.69 54.12 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 111.94 166.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.06 -12.92 12.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.779 1.632 . . . . 0.0 113.854 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.13 161.52 38.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -114.81 87.01 2.55 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 122.228 1.013 . . . . 0.0 111.904 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.203 1.401 . . . . 0.0 110.915 177.942 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.66 21.29 7.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.17 -172.08 13.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.703 1.144 . . . . 0.0 113.903 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.78 136.8 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.342 2.257 . . . . 0.0 108.549 173.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.07 100.88 7.82 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.49 130.61 36.22 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.32 34.22 0.13 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.968 2.107 . . . . 0.0 115.901 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 148.74 90.33 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.727 -1.233 . . . . 0.0 111.835 -168.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.43 146.54 85.59 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.213 1.942 . . . . 0.0 111.982 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.12 129.0 33.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.967 0.907 . . . . 0.0 110.331 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.62 63.06 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.707 1.146 . . . . 0.0 115.523 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -58.87 126.5 80.97 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-N 119.612 1.706 . . . . 0.0 113.15 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.572 ' HB2' HD12 ' A' ' 142' ' ' ILE . 14.2 Cg_endo -69.66 130.31 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.27 1.98 . . . . 0.0 112.317 172.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 146' ' ' SER . 27.4 mm -85.13 129.6 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.974 1.71 . . . . 0.0 108.532 170.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -100.78 151.98 21.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.164 . . . . 0.0 110.39 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.75 88.98 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.367 0.667 . . . . 0.0 111.621 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.71 -26.02 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.176 3.251 . . . . 0.0 113.249 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.9 p -133.27 164.33 27.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 127.306 2.242 . . . . 0.0 110.263 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.98 145.39 46.32 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.169 -0.957 . . . . 0.0 108.479 151.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.83 -163.92 24.67 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.144 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -147.28 143.75 28.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.58 1.152 . . . . 0.0 111.917 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.16 128.11 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.33 -43.88 7.83 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.426 1.491 . . . . 0.0 114.947 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -159.21 144.1 15.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.048 0.939 . . . . 0.0 110.992 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -140.75 114.85 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.674 1.19 . . . . 0.0 109.88 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 p90 . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -167.339 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.7 mttm . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.13 137.45 55.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 tp -115.95 131.5 56.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.719 2.007 . . . . 0.0 108.582 167.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 125.81 53.54 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.59 1.156 . . . . 0.0 110.316 173.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.17 144.46 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.27 1.028 . . . . 0.0 111.552 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.36 136.27 41.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.654 1.982 . . . . 0.0 110.793 171.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 123.628 0.771 . . . . 0.0 111.619 170.422 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.73 159.08 31.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.556 2.742 . . . . 0.0 112.117 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.62 105.26 4.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.184 2.194 . . . . 0.0 110.96 -171.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -85.79 144.33 27.8 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.472 0.709 . . . . 0.0 112.314 171.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.42 87.12 2.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.136 2.574 . . . . 0.0 108.887 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.39 159.55 19.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.044 1.338 . . . . 0.0 110.918 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 62.87 50.41 3.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.754 2.021 . . . . 0.0 114.455 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.9 mt -89.79 158.41 17.51 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.672 -1.267 . . . . 0.0 112.419 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -98.76 -46.61 5.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 0.0 109.13 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -150.14 149.41 30.21 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.207 1.803 . . . . 0.0 111.888 -171.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -103.39 134.52 46.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 112.108 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -87.43 -27.51 22.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.125 0.57 . . . . 0.0 111.791 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -112.93 166.72 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.023 1.729 . . . . 0.0 112.521 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -116.69 162.22 18.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.801 2.04 . . . . 0.0 111.283 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.2 t -55.99 126.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.401 1.081 . . . . 0.0 109.189 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.34 12.14 61.79 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.453 1.501 . . . . 0.0 115.389 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -96.4 133.69 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.764 1.782 . . . . 0.0 107.657 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -72.97 146.75 45.79 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.011 0.924 . . . . 0.0 111.413 167.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.86 167.12 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.343 1.857 . . . . 0.0 111.879 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.85 134.16 44.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.427 1.891 . . . . 0.0 110.055 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.55 121.78 3.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.045 1.338 . . . . 0.0 112.851 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.81 4.69 69.35 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.523 1.535 . . . . 0.0 115.412 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -90.25 148.97 22.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 114.649 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 88' ' ' PRO . 14.8 mm -70.12 139.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.63 0.729 . . . . 0.0 111.469 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.53 -23.06 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.507 1.123 . . . . 0.0 112.544 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.15 -179.01 2.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.026 1.33 . . . . 0.0 111.368 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.97 138.14 54.76 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.502 ' HB3' HD11 ' A' ' 89' ' ' ILE . 80.0 p -66.43 135.99 55.08 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.651 1.18 . . . . 0.0 112.104 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.038 0 CA-C-O 122.389 0.994 . . . . 0.0 113.318 -176.452 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.19 116.11 16.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.487 -1.383 . . . . 0.0 111.082 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -94.62 102.04 13.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.855 0.752 . . . . 0.0 111.774 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.275 43.9 t80 -93.9 116.81 29.3 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.381 1.473 . . . . 0.0 114.77 171.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -124.6 116.61 22.69 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.757 1.223 . . . . 0.0 111.654 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -101.1 127.08 47.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.517 1.127 . . . . 0.0 111.409 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.2 mtm -128.44 157.33 41.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.792 1.637 . . . . 0.0 111.65 -173.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -136.09 137.17 40.79 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.177 1.391 . . . . 0.0 111.243 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.78 -18.61 8.72 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.167 1.365 . . . . 0.0 115.031 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -176.83 -168.74 37.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.152 1.834 . . . . 0.0 111.273 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.59 112.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 156.49 169.36 20.45 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.895 1.712 . . . . 0.0 111.557 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -61.14 -40.64 94.59 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.361 -1.082 . . . . 0.0 113.245 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.47 -26.95 67.17 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.51 -11.86 55.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.55 141.82 51.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.734 1.214 . . . . 0.0 112.651 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -106.03 -80.09 0.56 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -174.51 123.93 0.38 Allowed Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 128.37 2.668 . . . . 0.0 106.147 160.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.42 -29.49 11.09 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.054 2.503 . . . . 0.0 114.715 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -59.63 -52.84 71.17 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.58 -30.69 70.93 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.926 2.417 . . . . 0.0 111.881 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.17 -45.75 93.32 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 166.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.7 mt -69.53 -32.12 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.767 -1.208 . . . . 0.0 111.719 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.08 0.42 1.95 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.061 1.744 . . . . 0.0 115.07 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -124.74 -8.52 7.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 114.303 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.59 151.31 88.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.927 -1.108 . . . . 0.0 112.82 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.5 -35.2 39.87 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.743 2.962 . . . . 0.0 114.806 -165.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -112.13 16.4 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.923 1.289 . . . . 0.0 112.16 166.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.38 -134.72 48.04 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 121.076 -1.015 . . . . 0.0 112.441 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.34 -22.7 65.16 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.419 -1.048 . . . . 0.0 112.544 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.6 mtt-85 -72.3 -3.36 23.31 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.632 -1.293 . . . . 0.0 112.564 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 75.5 m -84.54 -7.53 59.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.501 1.12 . . . . 0.0 113.054 163.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.94 -19.88 15.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.777 1.631 . . . . 0.0 111.671 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -147.41 160.21 42.82 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -104.9 86.24 2.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.472 0.655 0 C-N-CA 124.604 1.162 . . . . 0.0 109.666 173.5 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -112.71 93.96 4.68 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.78 -172.47 26.45 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.198 0.904 . . . . 0.0 113.444 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.557 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -120.23 134.62 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.705 2.002 . . . . 0.0 108.862 173.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -110.53 92.29 3.99 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -78.37 106.18 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.72 120.24 10.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.341 0.973 . . . . 0.0 110.744 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.8 mt -129.83 152.32 79.67 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 124.012 0.925 . . . . 0.0 111.106 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.58 135.52 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.476 -1.009 . . . . 0.0 109.476 160.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.4 tttt -58.67 139.04 56.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.846 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 -6.46 76.29 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.111 -1.383 . . . . 0.0 115.881 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.4 m -51.76 127.53 34.4 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.693 2.247 . . . . 0.0 112.964 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HB2' HD12 ' A' ' 142' ' ' ILE . 11.7 Cg_endo -68.42 131.26 22.79 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.852 1.701 . . . . 0.0 112.084 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.2 132.2 32.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.152 1.781 . . . . 0.0 107.824 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -104.52 155.65 18.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 109.492 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.04 129.59 82.65 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.263 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.13 -31.87 22.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.382 2.721 . . . . 0.0 113.472 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -140.21 159.97 41.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.957 2.103 . . . . 0.0 107.546 -171.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -77.01 138.48 39.62 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.93 -1.106 . . . . 0.0 111.764 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.7 -157.05 10.05 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.075 1.322 . . . . 0.0 113.651 -173.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.91 146.86 25.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.428 1.491 . . . . 0.0 113.005 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.21 129.3 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -43.11 6.92 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -159.41 141.65 13.61 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.694 1.198 . . . . 0.0 110.983 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 55.5 mt -142.6 113.83 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.785 1.234 . . . . 0.0 110.965 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.8 p90 . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 124.493 1.117 . . . . 0.0 111.823 -168.993 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.2 mttm . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.13 137.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.777 1.631 . . . . 0.0 115.051 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.9 tp -117.87 126.68 52.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.042 2.137 . . . . 0.0 108.955 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.01 126.38 52.13 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.819 1.248 . . . . 0.0 110.256 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.97 147.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.998 1.319 . . . . 0.0 111.45 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.04 137.3 47.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.696 1.998 . . . . 0.0 110.144 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 . . . . . 0 N--CA 1.472 0.665 0 O-C-N 121.223 -0.923 . . . . 0.0 113.443 175.335 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.297 42.1 m-85 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -123.22 161.21 24.98 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 112.141 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -143.84 104.13 4.13 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.252 2.221 . . . . 0.0 110.955 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -84.81 145.8 27.68 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 167.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -130.72 93.33 3.4 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.604 2.362 . . . . 0.0 109.837 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.39 157.37 15.92 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.663 1.185 . . . . 0.0 110.839 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.266 43.9 m80 69.76 49.79 0.51 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.072 2.149 . . . . 0.0 114.484 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.84 143.82 25.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.873 0.869 . . . . 0.0 111.485 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.11 -43.32 15.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.402 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -154.48 151.11 28.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.016 2.526 . . . . 0.0 110.847 -169.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -96.96 159.33 14.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.744 0.818 . . . . 0.0 111.238 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -109.67 -28.58 8.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.448 1.099 . . . . 0.0 112.385 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.78 168.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.165 1.786 . . . . 0.0 110.667 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -128.12 172.1 11.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 111.358 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.98 130.8 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.275 1.03 . . . . 0.0 109.224 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.15 3.46 72.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.783 1.182 . . . . 0.0 115.323 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.75 126.14 31.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.015 1.407 . . . . 0.0 111.877 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.24 124.89 28.19 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.803 0.441 . . . . 0.0 111.488 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -106.94 157.03 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.858 1.663 . . . . 0.0 110.46 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.36 140.54 52.11 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.656 1.582 . . . . 0.0 109.307 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -44.02 123.31 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.446 1.098 . . . . 0.0 112.992 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.96 6.95 86.21 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.246 1.403 . . . . 0.0 115.362 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -91.63 145.88 24.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.374 1.469 . . . . 0.0 112.858 170.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 88' ' ' PRO . 20.2 mm -70.12 137.93 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.081 0.855 . . . . 0.0 112.114 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -123.58 -24.05 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.19 -173.17 1.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.45 1.023 . . . . 0.0 111.629 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.55 137.05 41.64 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.161 1.385 . . . . 0.0 107.3 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.8 t -75.56 142.62 42.72 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 C-N-CA 124.268 0.937 . . . . 0.0 113.157 177.755 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.2 p80 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 121.105 0.479 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.81 121.56 42.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 110.485 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -96.11 102.4 14.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.92 0.888 . . . . 0.0 110.524 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.76 112.86 24.8 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.371 1.468 . . . . 0.0 114.65 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.44 118.62 35.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.19 0.596 . . . . 0.0 112.155 174.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -93.84 127.56 39.65 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.639 1.576 . . . . 0.0 111.55 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.1 mtm -132.16 162.43 30.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.475 1.91 . . . . 0.0 111.593 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -132.5 128.91 38.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.39 1.076 . . . . 0.0 112.796 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.87 6.93 74.32 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.254 1.261 . . . . 0.0 116.254 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.63 -179.6 44.04 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 126.439 1.971 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.72 128.9 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.282 1.433 . . . . 0.0 112.336 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.62 156.79 6.97 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.786 1.66 . . . . 0.0 112.056 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -48.2 -42.51 30.15 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.23 62.41 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -92.28 -13.41 30.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.628 1.571 . . . . 0.0 114.537 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.54 148.18 34.26 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.314 1.045 . . . . 0.0 113.508 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -116.99 -96.78 0.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.714 1.606 . . . . 0.0 111.826 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -159.51 118.24 1.65 Allowed Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.603 1.961 . . . . 0.0 113.114 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.439 ' HG2' HD12 ' A' ' 79' ' ' ILE . 89.2 Cg_endo -85.35 -30.97 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.913 1.742 . . . . 0.0 114.296 175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.557 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -52.37 -55.71 29.25 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 121.169 1.804 . . . . 0.0 114.697 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.01 -26.75 21.34 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.778 2.985 . . . . 0.0 112.225 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -67.26 -37.48 83.54 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.05 -44.95 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.093 0.557 . . . . 0.0 110.572 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -67.52 -0.89 4.2 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -173.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -111.92 -9.57 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.212 1.805 . . . . 0.0 113.52 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.28 159.15 42.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.243 1.417 . . . . 0.0 113.378 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.35 -48.06 24.02 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.73 3.62 . . . . 0.0 114.062 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -114.08 8.85 17.13 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.446 1.099 . . . . 0.0 113.356 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.51 -135.79 27.41 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.562 1.077 . . . . 0.0 111.961 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.18 -28.83 19.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.605 1.162 . . . . 0.0 113.6 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -70.72 -7.84 47.78 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.055 -1.028 . . . . 0.0 113.31 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.4 m -81.49 -3.86 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.802 0.841 . . . . 0.0 112.27 167.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.1 mp -111.11 -14.83 13.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.993 1.717 . . . . 0.0 113.322 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -145.03 161.88 38.31 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.234 -1.541 . . . . 0.0 113.76 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -110.14 82.75 1.64 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.015 0.912 . . . . 0.0 113.134 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 125.316 1.446 . . . . 0.0 111.061 174.22 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 . . . . . 0 CA--C 1.538 0.49 0 CA-C-O 120.592 0.234 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.357 83.2 m-85 -108.12 23.43 14.5 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -170.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.28 -164.51 13.44 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.332 0.968 . . . . 0.0 113.266 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.48 133.71 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 126.609 1.963 . . . . 0.0 108.953 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -110.43 96.48 6.22 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -78.64 123.88 27.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.49 56.59 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.703 2.001 . . . . 0.0 113.847 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.6 149.0 63.55 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.288 -0.883 . . . . 0.0 111.112 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.45 146.28 93.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.05 1.833 . . . . 0.0 111.777 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -54.58 135.48 46.26 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 110.678 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.95 68.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.737 1.161 . . . . 0.0 115.63 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 m -52.71 126.14 39.78 Favored Pre-proline 0 N--CA 1.478 0.936 0 CA-C-N 118.75 1.275 . . . . 0.0 112.238 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.495 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.6 Cg_endo -69.49 129.28 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.09 1.86 . . . . 0.0 111.998 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -85.86 130.59 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 108.468 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -103.35 149.94 24.27 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 109.764 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.54 83.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.879 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.4 -46.86 4.96 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.47 2.78 . . . . 0.0 111.574 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -113.98 172.81 6.77 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 128.487 2.715 . . . . 0.0 109.703 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -68.98 149.97 48.22 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.245 -0.91 . . . . 0.0 110.017 155.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 -154.64 12.45 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.475 0.56 . . . . 0.0 114.159 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -151.24 145.84 25.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.574 1.549 . . . . 0.0 111.021 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -66.0 128.12 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.04 -41.34 9.61 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -159.37 145.67 16.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.001 1.72 . . . . 0.0 109.543 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.0 mt -137.99 127.64 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 109.365 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.517 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.4 mttp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.14 143.16 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.861 1.665 . . . . 0.0 114.421 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 tt -122.76 136.6 54.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.803 1.641 . . . . 0.0 109.416 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.52 125.83 52.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.311 0.644 . . . . 0.0 111.935 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.02 147.92 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.883 1.273 . . . . 0.0 111.813 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -112.54 141.45 46.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 111.726 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 124.769 1.228 . . . . 0.0 113.062 173.187 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 C--O 1.235 0.328 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -121.14 142.97 49.36 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.954 1.702 . . . . 0.0 111.31 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -123.93 103.68 8.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.762 2.025 . . . . 0.0 110.426 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -86.68 144.01 27.33 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.566 0.346 . . . . 0.0 111.62 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -128.7 97.67 4.75 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.427 1.891 . . . . 0.0 106.892 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.28 151.59 22.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 109.844 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 71.56 63.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.937 2.095 . . . . 0.0 113.95 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.4 mt -101.67 155.7 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.512 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.45 -43.3 6.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.738 1.215 . . . . 0.0 110.939 167.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -145.14 150.29 36.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.614 1.566 . . . . 0.0 112.38 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -92.54 158.31 16.07 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.57 1.148 . . . . 0.0 112.441 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -122.2 -10.63 8.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.05 0.94 . . . . 0.0 113.205 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.3 160.81 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.56 1.144 . . . . 0.0 112.341 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -120.26 155.33 33.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.29 1.836 . . . . 0.0 112.841 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.1 t -55.11 123.14 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 0.0 109.413 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.08 0.7 61.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.078 1.323 . . . . 0.0 115.528 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -88.28 128.95 35.49 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.966 1.883 . . . . 0.0 113.3 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -74.55 139.97 44.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.064 0.546 . . . . 0.0 111.998 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.31 159.86 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 110.373 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -126.67 148.3 49.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.407 1.483 . . . . 0.0 108.658 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.42 121.74 4.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.363 1.065 . . . . 0.0 111.984 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.23 10.25 58.55 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.732 1.158 . . . . 0.0 114.971 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.33 134.75 34.09 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.966 1.306 . . . . 0.0 112.676 167.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 88' ' ' PRO . 15.4 mm -65.57 131.41 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 118.888 0.767 . . . . 0.0 110.372 172.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.4 pt -114.98 -21.96 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.479 1.112 . . . . 0.0 113.231 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.44 -179.82 1.96 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 110.904 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -129.63 135.0 48.0 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t -80.27 144.54 32.77 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.217 0 C-N-CA 125.312 1.434 . . . . 0.0 112.361 -179.076 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.0 p80 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.85 115.49 19.47 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.159 170.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -93.75 101.29 13.41 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.29 0.636 . . . . 0.0 110.943 172.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.66 117.21 29.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.948 1.299 . . . . 0.0 114.128 171.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -122.6 114.44 20.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.348 1.059 . . . . 0.0 111.888 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -92.51 121.94 34.46 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.208 1.803 . . . . 0.0 110.828 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.1 mtm -127.38 160.86 30.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.238 1.815 . . . . 0.0 111.189 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -140.26 133.96 30.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.11 6.96 81.21 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.722 1.153 . . . . 0.0 115.125 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.29 179.46 38.48 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 127.57 2.51 . . . . 0.0 110.086 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.1 125.07 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.76 168.86 15.45 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.607 1.575 . . . . 0.0 112.875 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -60.3 -36.9 78.95 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.184 -1.186 . . . . 0.0 113.523 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.08 -17.36 63.22 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.795 -1.191 . . . . 0.0 114.05 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.23 -12.55 43.43 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.47 137.11 52.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.567 1.147 . . . . 0.0 112.986 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -103.13 -89.86 0.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -161.91 115.9 1.23 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.575 2.35 . . . . 0.0 113.585 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 -31.76 2.08 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.103 1.869 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -54.37 -53.39 59.93 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.78 -22.56 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.886 3.058 . . . . 0.0 112.052 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -65.52 -42.67 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 167.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 49.0 mt -72.21 -25.62 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.297 -0.877 . . . . 0.0 112.206 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -59.76 -14.2 13.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -118.13 -1.14 11.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.431 1.092 . . . . 0.0 113.641 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.89 148.65 92.23 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.517 0.727 . . . . 0.0 112.632 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.58 -26.45 23.71 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.609 2.873 . . . . 0.0 114.932 -168.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -112.82 -7.86 13.76 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.83 -137.81 13.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.413 1.482 . . . . 0.0 112.535 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -55.09 -30.78 60.39 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.727 1.263 . . . . 0.0 111.694 170.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.0 mtp-105 -63.97 -12.25 36.04 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.476 1.51 . . . . 0.0 113.899 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 71.6 m -79.77 -7.85 58.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.472 1.033 . . . . 0.0 112.565 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.06 -14.0 15.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.106 1.363 . . . . 0.0 112.948 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -149.98 162.3 40.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -111.72 80.57 1.34 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--O 1.24 0.555 0 C-N-CA 124.888 1.275 . . . . 0.0 110.123 173.59 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 121.739 0.781 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.526 12.1 m-30 -90.74 39.44 0.98 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -173.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.91 -179.55 26.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.82 1.2 . . . . 0.0 112.897 170.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.58 127.48 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.687 1.595 . . . . 0.0 109.501 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -99.26 90.0 4.41 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -74.1 107.24 6.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.97 123.95 20.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.056 0.844 . . . . 0.0 110.294 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 mt -138.35 151.98 70.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.61 0.764 . . . . 0.0 111.228 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.2 136.5 44.26 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.36 2.04 . . . . 0.0 110.033 162.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.02 134.61 52.58 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.207 1.003 . . . . 0.0 109.949 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.32 -8.35 79.32 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.237 -1.313 . . . . 0.0 115.824 -175.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.6 m -53.77 123.81 40.23 Favored Pre-proline 0 N--CA 1.481 1.114 0 CA-C-N 120.219 2.009 . . . . 0.0 112.331 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.556 ' HB2' HD12 ' A' ' 142' ' ' ILE . 32.2 Cg_endo -70.03 130.85 19.71 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.726 1.617 . . . . 0.0 111.161 175.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -85.74 131.2 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.463 1.505 . . . . 0.0 108.216 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -101.32 149.8 23.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.31 1.044 . . . . 0.0 109.84 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.19 130.85 87.45 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.76 -0.588 . . . . 0.0 110.835 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.62 -27.42 15.33 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.923 3.082 . . . . 0.0 112.724 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 p -129.94 161.67 30.36 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.039 2.535 . . . . 0.0 112.905 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -63.92 138.83 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 157.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.52 -155.95 11.37 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -151.99 148.78 28.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.187 1.395 . . . . 0.0 111.584 171.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.66 129.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -41.92 7.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.003 1.721 . . . . 0.0 115.244 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -157.9 143.25 16.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.467 1.107 . . . . 0.0 111.464 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.4 mt -136.42 125.73 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.381 1.072 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.8 p90 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.967 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 mttm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 111.649 0.241 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.42 138.39 53.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.689 1.595 . . . . 0.0 114.743 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -119.46 127.09 52.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.959 2.104 . . . . 0.0 108.605 171.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 126.76 52.22 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.365 1.066 . . . . 0.0 110.464 171.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.8 mt -123.12 147.78 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.952 1.301 . . . . 0.0 111.927 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.22 141.96 42.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.201 2.2 . . . . 0.0 111.737 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 173.982 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 42.4 m-85 . . . . . 0 C--O 1.237 0.447 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -125.81 152.51 45.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.541 1.936 . . . . 0.0 111.431 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.74 104.03 6.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.846 2.059 . . . . 0.0 109.986 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.95 139.99 29.95 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.527 0.331 . . . . 0.0 111.63 170.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -125.57 92.93 3.71 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.621 2.368 . . . . 0.0 108.759 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.23 163.29 14.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.889 1.276 . . . . 0.0 110.914 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 64.71 38.08 7.15 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.489 1.916 . . . . 0.0 114.966 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.54 154.25 27.62 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.496 -1.378 . . . . 0.0 112.848 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.53 -49.43 6.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.73 1.612 . . . . 0.0 109.272 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -152.18 149.33 28.63 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.641 1.976 . . . . 0.0 111.387 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -94.47 141.35 28.69 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.503 1.121 . . . . 0.0 111.913 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -95.43 -15.51 22.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.058 0.943 . . . . 0.0 111.878 167.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.94 165.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.27 1.828 . . . . 0.0 113.154 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -120.79 164.34 16.76 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.744 2.018 . . . . 0.0 111.2 172.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.07 129.72 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.32 4.58 68.28 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.531 1.062 . . . . 0.0 115.713 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.62 130.27 35.22 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.623 1.712 . . . . 0.0 112.912 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -65.0 143.87 57.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.407 0.622 . . . . 0.0 110.795 163.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 161.62 21.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.514 1.526 . . . . 0.0 110.535 167.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -133.86 143.29 48.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.576 1.55 . . . . 0.0 109.88 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.14 117.61 2.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.966 0.889 . . . . 0.0 111.904 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.83 74.88 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.547 1.546 . . . . 0.0 115.205 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -85.36 145.14 27.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.519 1.66 . . . . 0.0 114.487 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 88' ' ' PRO . 15.9 mm -70.82 136.46 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.854 0.835 . . . . 0.0 111.969 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 49.1 pt -122.79 -23.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.69 1.196 . . . . 0.0 112.903 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.32 -176.57 1.91 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.527 1.531 . . . . 0.0 110.853 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -129.44 136.63 50.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.8 t -66.08 137.07 56.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.981 0 C-N-CA 125.575 1.56 . . . . 0.0 111.885 179.169 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.46 123.13 47.38 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.588 1.555 . . . . 0.0 109.812 165.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -98.38 103.62 15.58 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.472 0.709 . . . . 0.0 110.867 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.272 36.0 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 172.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -116.26 115.28 25.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.436 1.094 . . . . 0.0 111.851 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -95.31 125.25 39.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.804 1.642 . . . . 0.0 111.149 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.9 mtm -131.0 153.0 49.69 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.494 1.518 . . . . 0.0 111.372 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.24 130.51 52.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.227 1.411 . . . . 0.0 111.898 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.99 36.15 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.39 -179.73 48.0 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.549 2.023 . . . . 0.0 111.9 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 125.9 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.579 1.552 . . . . 0.0 112.891 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.98 164.85 10.08 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.888 . . . . 0.0 112.325 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -56.79 -36.95 70.47 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.038 -1.272 . . . . 0.0 113.155 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.45 -12.37 56.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -97.59 -8.82 28.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 173.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.29 142.12 55.65 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.212 1.405 . . . . 0.0 113.087 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.13 -79.7 0.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.354 1.062 . . . . 0.0 112.335 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -170.07 123.57 0.64 Allowed Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.843 2.057 . . . . 0.0 113.054 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.25 -35.4 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.535 2.156 . . . . 0.0 114.102 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -54.41 -54.69 45.53 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.11 -18.9 39.83 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.879 3.053 . . . . 0.0 113.14 -175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.06 -44.18 66.27 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.76 -31.25 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.707 0.803 . . . . 0.0 111.634 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.82 -3.77 3.69 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -123.53 -1.99 8.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.685 1.594 . . . . 0.0 114.374 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.7 mt -69.25 151.22 97.07 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.292 1.037 . . . . 0.0 112.292 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.08 -36.17 71.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.174 2.583 . . . . 0.0 115.063 -165.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -111.51 9.59 21.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.896 0.878 . . . . 0.0 113.366 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 71.51 -134.06 22.16 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.026 -1.046 . . . . 0.0 112.241 -171.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.69 -26.0 65.23 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.341 -1.094 . . . . 0.0 112.94 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -70.91 -3.9 21.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.407 1.483 . . . . 0.0 114.171 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 68.9 m -82.13 -6.08 58.92 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.14 0.976 . . . . 0.0 113.122 165.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.85 -13.25 14.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.307 1.443 . . . . 0.0 113.114 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.92 163.1 36.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.448 1.476 . . . . 0.0 113.896 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -111.35 89.67 3.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 124.531 1.132 . . . . 0.0 110.682 170.987 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.285 97.1 m-85 -107.14 15.33 25.28 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -170.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.96 -164.77 12.26 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.12 -0.987 . . . . 0.0 115.027 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.21 137.09 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 127.477 2.311 . . . . 0.0 109.384 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.9 97.17 5.49 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -77.67 108.49 10.91 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.03 117.95 5.71 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.313 1.045 . . . . 0.0 111.051 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -133.93 148.76 69.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.147 0.979 . . . . 0.0 111.089 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.36 139.46 65.44 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.234 1.956 . . . . 0.0 110.635 163.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -51.92 136.73 28.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 110.184 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.86 -4.73 78.67 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.537 -1.702 . . . . 0.0 116.19 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 m -53.1 123.5 34.15 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 120.431 2.116 . . . . 0.0 112.343 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.54 ' HB2' HD12 ' A' ' 142' ' ' ILE . 10.7 Cg_endo -68.46 127.95 16.47 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.654 1.569 . . . . 0.0 110.907 174.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 mm -84.38 129.01 38.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.876 1.27 . . . . 0.0 107.797 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -99.03 152.41 19.85 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.656 1.183 . . . . 0.0 109.983 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.01 124.72 90.25 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 118.39 -0.815 . . . . 0.0 110.085 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.26 -36.42 21.17 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.582 2.855 . . . . 0.0 112.835 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.573 2.349 . . . . 0.0 108.989 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.97 147.73 49.8 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.058 -1.026 . . . . 0.0 108.988 155.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.15 -159.4 19.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.916 0.77 . . . . 0.0 113.607 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -148.35 144.46 27.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.874 1.27 . . . . 0.0 112.397 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.21 125.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.91 -44.87 8.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.942 1.697 . . . . 0.0 115.101 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -157.06 147.48 21.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.012 1.325 . . . . 0.0 111.105 -168.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.411 HG23 ' CE1' ' A' ' 129' ' ' TYR . 47.0 mt -140.79 118.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.716 1.206 . . . . 0.0 109.513 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 p90 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.724 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.489 HG13 HD22 ' A' ' 124' ' ' LEU . 8.8 t -131.92 137.18 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 126.188 1.795 . . . . 0.0 114.61 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.66 137.52 51.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.75 1.62 . . . . 0.0 109.618 165.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.53 125.28 51.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.676 0.79 . . . . 0.0 112.266 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.69 153.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.295 1.438 . . . . 0.0 111.906 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.63 55.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.857 2.063 . . . . 0.0 111.636 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 124.587 1.155 . . . . 0.0 113.016 177.619 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.273 55.5 m-85 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -104.23 157.08 17.38 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.465 1.906 . . . . 0.0 111.139 170.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -138.36 105.13 5.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.098 2.159 . . . . 0.0 110.501 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -85.81 147.74 26.16 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.19 109.78 8.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.947 1.699 . . . . 0.0 107.875 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 HG13 ' A' ' 109' ' ' VAL . 1.9 mm? -103.8 157.02 17.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.809 1.643 . . . . 0.0 110.562 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 67.1 59.11 0.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.113 1.765 . . . . 0.0 113.253 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 mt -104.82 151.23 24.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.691 1.597 . . . . 0.0 111.058 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.75 -42.67 6.4 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.487 . . . . 0.0 111.298 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -146.58 147.08 30.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.652 1.581 . . . . 0.0 112.265 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.411 ' CE1' HG23 ' A' ' 100' ' ' ILE . 90.1 m-85 -94.04 141.69 28.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 112.647 176.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -106.89 -5.77 18.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.808 1.243 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.29 166.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.341 1.456 . . . . 0.0 110.225 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -122.19 165.17 16.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.05 1.34 . . . . 0.0 110.265 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.69 131.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.978 0.911 . . . . 0.0 108.771 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.87 8.14 73.34 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.929 1.252 . . . . 0.0 115.278 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -84.19 119.22 24.75 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.01 1.405 . . . . 0.0 112.862 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -65.83 142.02 58.08 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.231 163.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.99 159.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.307 1.843 . . . . 0.0 109.195 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.66 142.7 50.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.449 1.9 . . . . 0.0 108.848 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.58 123.01 4.56 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.948 0.899 . . . . 0.0 113.326 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.39 3.73 64.74 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.582 1.087 . . . . 0.0 114.804 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.88 133.61 38.09 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.666 1.186 . . . . 0.0 112.487 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 88' ' ' PRO . 13.7 mm -67.73 129.31 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.721 0.691 . . . . 0.0 109.992 172.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.1 pt -112.87 -22.09 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.201 1.001 . . . . 0.0 113.266 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.93 -179.18 2.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.429 1.491 . . . . 0.0 110.322 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.18 132.17 45.91 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.0 t -77.24 146.53 36.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.094 0 C-N-CA 124.98 1.276 . . . . 0.0 111.448 -179.757 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.15 114.07 7.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.173 0.989 . . . . 0.0 110.744 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -91.9 99.04 11.97 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.597 0.759 . . . . 0.0 111.343 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 43.3 t80 -90.97 120.07 31.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.153 1.381 . . . . 0.0 114.679 172.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -130.0 108.36 10.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.987 1.315 . . . . 0.0 111.01 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -96.45 135.78 37.85 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.144 1.378 . . . . 0.0 111.386 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 41.0 mtm -136.11 143.22 44.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.332 1.453 . . . . 0.0 112.065 -166.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -111.62 132.62 54.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.948 1.299 . . . . 0.0 112.988 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.66 1.0 64.95 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.575 1.56 . . . . 0.0 115.17 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 161.64 -169.99 37.25 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 127.856 2.646 . . . . 0.0 109.438 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.87 138.26 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 122.269 1.033 . . . . 0.0 111.006 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.59 161.69 10.67 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 128.757 3.075 . . . . 0.0 109.595 -171.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -57.51 -42.29 82.51 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.704 -1.468 . . . . 0.0 113.44 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.16 -20.63 66.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -78.33 -16.0 58.16 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.8 147.46 45.47 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.36 1.064 . . . . 0.0 112.353 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.36 -61.35 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.409 1.084 . . . . 0.0 113.825 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.4 t0 178.42 123.07 0.2 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 130.557 3.543 . . . . 0.0 108.309 160.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.6 -21.63 21.91 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.78 2.986 . . . . 0.0 116.099 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -51.9 -56.22 23.47 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 120.658 1.572 . . . . 0.0 114.699 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.87 -24.89 60.58 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.618 2.879 . . . . 0.0 112.937 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.275 3.5 t80 -64.26 -45.11 89.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 169.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.5 mt -66.63 -28.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.854 -1.154 . . . . 0.0 111.357 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.22 -4.4 10.39 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -118.09 -10.15 10.39 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.1 mt -66.31 149.66 97.71 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.371 1.068 . . . . 0.0 112.423 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.75 -41.68 10.36 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.789 2.326 . . . . 0.0 113.597 -166.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.67 9.91 34.99 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.11 -133.98 45.93 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 120.866 -1.146 . . . . 0.0 112.441 -172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -54.21 -30.87 51.53 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.907 -0.76 . . . . 0.0 112.772 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -71.43 -5.47 33.04 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.09 1.356 . . . . 0.0 112.456 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.7 m -83.67 -6.91 59.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.968 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.9 -14.81 15.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.992 1.317 . . . . 0.0 113.0 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -146.41 159.12 43.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.535 1.516 . . . . 0.0 115.018 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -104.13 96.42 6.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 122.363 1.078 . . . . 0.0 112.777 -179.444 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.358 93.7 m-85 -106.08 18.96 21.28 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -169.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.72 -172.25 19.03 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.032 -1.042 . . . . 0.0 113.788 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.63 132.92 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.44 1.896 . . . . 0.0 109.039 172.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -111.01 102.01 10.52 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -85.23 115.82 23.22 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 76.1 4.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.862 1.665 . . . . 0.0 112.267 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.49 152.8 41.23 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.37 142.72 91.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.523 2.149 . . . . 0.0 111.001 158.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -59.98 136.3 57.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.935 1.294 . . . . 0.0 110.28 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.68 1.78 90.3 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -57.14 124.67 67.26 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.597 1.698 . . . . 0.0 111.654 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HB2' HD12 ' A' ' 142' ' ' ILE . 89.0 Cg_endo -71.28 125.31 11.22 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.037 1.158 . . . . 0.0 110.031 176.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 146' ' ' SER . 30.8 mm -80.76 129.38 37.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.356 1.462 . . . . 0.0 107.577 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -101.35 152.8 20.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.689 1.196 . . . . 0.0 109.954 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.62 131.54 87.89 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.766 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.75 -34.56 18.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.328 2.685 . . . . 0.0 112.833 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.0 p -129.59 163.4 26.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.547 1.939 . . . . 0.0 108.587 -173.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.93 141.84 58.09 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 121.256 -0.903 . . . . 0.0 108.988 158.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.12 -159.98 21.51 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.068 0.842 . . . . 0.0 113.418 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -151.05 140.91 21.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.228 1.514 . . . . 0.0 111.267 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 t -55.1 137.87 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.108 0.963 . . . . 0.0 113.419 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.97 -44.14 5.58 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -159.27 148.49 18.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.681 1.593 . . . . 0.0 109.776 -167.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.402 HG23 ' CE2' ' A' ' 129' ' ' TYR . 59.2 mt -139.8 128.0 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.447 1.099 . . . . 0.0 108.391 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.299 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 t -134.82 137.79 50.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 126.268 1.827 . . . . 0.0 114.616 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.1 tp -117.39 133.04 56.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.138 1.775 . . . . 0.0 108.819 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.27 125.65 53.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.778 1.231 . . . . 0.0 110.279 172.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.78 141.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.552 1.141 . . . . 0.0 110.809 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.52 137.82 36.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.021 1.329 . . . . 0.0 109.593 168.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 . . . . . 0 CA--C 1.543 0.674 0 O-C-N 122.183 -0.323 . . . . 0.0 111.055 166.306 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -118.42 150.75 39.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.321 1.848 . . . . 0.0 111.094 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -133.92 103.86 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.563 1.945 . . . . 0.0 110.082 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -85.35 145.47 27.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.341 0.656 . . . . 0.0 111.73 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.06 87.99 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.441 2.296 . . . . 0.0 110.057 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.18 154.16 19.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.851 0.861 . . . . 0.0 110.953 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.254 52.2 m-70 70.82 55.62 0.24 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.768 2.027 . . . . 0.0 113.734 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.9 149.05 23.81 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.68 1.592 . . . . 0.0 111.015 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.6 -48.58 10.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 113.024 166.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -145.21 152.09 39.44 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.282 1.833 . . . . 0.0 110.812 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.402 ' CE2' HG23 ' A' ' 100' ' ' ILE . 75.6 m-85 -85.18 159.89 20.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.572 0.749 . . . . 0.0 109.988 169.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -112.16 -25.28 9.4 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.174 0.99 . . . . 0.0 111.126 164.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.92 168.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.983 1.713 . . . . 0.0 111.423 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -119.73 167.44 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.346 1.458 . . . . 0.0 111.122 166.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.01 130.23 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.544 1.138 . . . . 0.0 108.766 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.06 1.2 76.44 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.989 1.281 . . . . 0.0 115.709 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -81.68 129.79 34.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.457 1.628 . . . . 0.0 112.416 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -68.62 143.94 54.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.784 0.802 . . . . 0.0 110.422 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.3 m -128.71 157.76 41.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.877 1.671 . . . . 0.0 109.036 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.71 143.81 50.99 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.118 1.767 . . . . 0.0 109.427 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.02 125.27 7.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.669 0.747 . . . . 0.0 112.105 174.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.98 -3.77 82.91 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.15 1.357 . . . . 0.0 115.837 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.4 142.26 37.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.469 1.635 . . . . 0.0 112.978 170.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.6 mm -72.88 131.19 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.931 0.872 . . . . 0.0 111.545 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -114.63 -24.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.565 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -168.62 -178.94 3.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.163 1.385 . . . . 0.0 110.566 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -129.28 134.1 47.79 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 89' ' ' ILE . 99.0 p -62.49 145.94 52.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 112.329 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.556 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 -172.767 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.3 m170 . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.74 116.72 7.96 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 111.881 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -94.67 99.99 12.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.145 0.978 . . . . 0.0 110.168 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 46.5 t80 -89.55 113.08 24.44 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.161 1.384 . . . . 0.0 114.332 171.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -118.27 115.26 24.38 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 111.301 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -95.29 128.47 42.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.303 1.441 . . . . 0.0 110.7 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.3 mtm -131.91 157.83 42.98 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.792 1.637 . . . . 0.0 110.819 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -135.12 133.24 39.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.165 0.986 . . . . 0.0 111.813 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.88 5.81 76.29 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.936 1.255 . . . . 0.0 115.089 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 162.63 -170.47 38.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.342 1.449 . . . . 0.0 112.739 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.47 121.15 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -173.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.32 171.89 17.68 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.974 1.749 . . . . 0.0 113.411 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -51.1 -48.75 61.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.382 1.473 . . . . 0.0 112.916 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.93 -13.29 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.238 1.415 . . . . 0.0 114.662 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -92.05 -16.86 25.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.99 135.12 53.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.036 0.934 . . . . 0.0 113.047 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -103.33 -92.06 0.35 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.317 1.447 . . . . 0.0 112.827 -171.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -168.5 100.97 0.53 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.46 -39.71 3.51 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.169 1.913 . . . . 0.0 113.276 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -54.62 -53.03 64.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.2 -23.5 28.71 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.918 3.079 . . . . 0.0 112.458 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -69.3 -39.46 78.28 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 56.9 mt -71.09 -38.71 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 122.979 0.512 . . . . 0.0 110.95 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.52 -15.58 11.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -110.68 -12.06 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.952 1.301 . . . . 0.0 112.778 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.3 154.1 33.83 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.721 1.208 . . . . 0.0 112.394 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.56 -50.57 13.39 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.445 3.43 . . . . 0.0 114.386 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -107.52 9.41 29.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.45 -139.02 43.38 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 120.51 -1.369 . . . . 0.0 112.651 -171.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.27 -21.79 66.72 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.058 -1.26 . . . . 0.0 112.993 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -64.11 -8.58 12.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.91 1.284 . . . . 0.0 112.895 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.8 t -88.56 -1.86 58.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.809 1.244 . . . . 0.0 112.751 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.47 -15.25 12.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.666 1.586 . . . . 0.0 112.417 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -145.67 164.6 31.27 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.56 -1.337 . . . . 0.0 112.912 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -114.53 86.62 2.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.472 0.631 0 C-N-CA 125.06 1.344 . . . . 0.0 110.424 174.754 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.291 98.3 m-85 -95.99 23.04 6.76 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -172.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.96 -162.91 12.74 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.88 -1.137 . . . . 0.0 113.266 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.49 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -119.18 133.31 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.472 1.909 . . . . 0.0 108.488 175.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -109.51 97.0 6.65 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.67 107.87 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.29 123.7 18.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.416 1.007 . . . . 0.0 110.941 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 mt -138.85 146.67 51.03 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.274 0.63 . . . . 0.0 111.733 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.81 137.85 79.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.295 1.997 . . . . 0.0 110.747 163.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.39 135.18 56.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 111.434 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.25 -7.22 81.9 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.273 -1.293 . . . . 0.0 114.944 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.2 m -53.73 126.13 48.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-N 120.069 1.934 . . . . 0.0 113.362 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.578 ' HB2' HD12 ' A' ' 142' ' ' ILE . 9.5 Cg_endo -68.17 136.66 38.22 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.486 2.124 . . . . 0.0 112.883 171.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.7 mm -92.39 132.45 36.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.566 1.946 . . . . 0.0 108.186 173.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -103.73 151.01 23.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.768 1.227 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.3 129.25 90.63 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.241 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.27 -33.18 11.68 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.675 2.917 . . . . 0.0 113.396 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.0 p -140.78 156.59 46.13 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.397 1.479 . . . . 0.0 107.872 -169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -65.56 129.58 40.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.685 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -153.19 7.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.268 0.461 . . . . 0.0 112.795 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.35 28.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.285 1.834 . . . . 0.0 109.776 176.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.17 136.87 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.125 -0.985 . . . . 0.0 113.211 171.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.22 -38.84 5.87 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.612 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -150.82 142.55 23.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.707 0.803 . . . . 0.0 111.137 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -139.64 123.81 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.348 1.459 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.5 p90 . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.215 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 mttm . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.49 HG13 HD22 ' A' ' 124' ' ' LEU . 21.2 t -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.024 2.13 . . . . 0.0 112.884 173.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.97 136.04 51.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.388 1.475 . . . . 0.0 109.386 166.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.29 123.11 41.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 111.881 177.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -120.23 144.58 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.899 1.28 . . . . 0.0 110.784 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.59 141.72 41.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.368 1.867 . . . . 0.0 109.829 169.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 177.952 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -120.97 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.509 1.524 . . . . 0.0 111.41 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -119.09 123.52 44.65 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 126.078 1.751 . . . . 0.0 108.394 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -96.93 146.5 24.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.531 0.733 . . . . 0.0 112.463 161.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -130.9 104.03 6.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.806 2.442 . . . . 0.0 110.01 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.49 HD22 HG13 ' A' ' 109' ' ' VAL . 1.5 mm? -105.59 155.69 18.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.648 1.179 . . . . 0.0 111.992 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 63.8 59.83 1.11 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.629 1.972 . . . . 0.0 112.32 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.32 145.78 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.647 1.579 . . . . 0.0 111.187 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -89.86 -41.86 11.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.011 1.324 . . . . 0.0 108.692 171.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -148.21 150.9 34.56 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.478 1.511 . . . . 0.0 113.273 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -97.29 141.32 30.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 112.281 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -103.07 -21.45 13.91 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.253 1.021 . . . . 0.0 112.172 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.95 168.68 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.28 1.832 . . . . 0.0 111.193 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -113.96 171.32 7.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.365 1.866 . . . . 0.0 110.813 168.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.86 137.05 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.527 -1.358 . . . . 0.0 108.786 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.88 10.53 85.56 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.08 1.324 . . . . 0.0 114.143 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -93.22 129.45 39.25 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.92 138.79 48.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.479 0.711 . . . . 0.0 112.548 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.36 160.21 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.8 140.53 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.577 1.951 . . . . 0.0 109.482 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.17 112.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.285 1.834 . . . . 0.0 112.414 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.15 9.3 54.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.637 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -94.37 145.3 24.85 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.586 1.954 . . . . 0.0 114.239 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 88' ' ' PRO . 20.6 mm -70.76 132.89 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.553 1.07 . . . . 0.0 112.566 176.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.1 -22.67 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.399 1.48 . . . . 0.0 113.426 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.08 -176.04 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.255 1.422 . . . . 0.0 110.865 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -136.67 135.42 38.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.2 t -80.94 143.58 32.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 C-N-CA 125.114 1.34 . . . . 0.0 111.275 179.862 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 110.814 -0.069 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.43 115.34 22.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.628 0.771 . . . . 0.0 110.156 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -90.13 98.79 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.85 0.86 . . . . 0.0 110.067 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.276 38.5 t80 -88.86 110.95 21.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.835 1.254 . . . . 0.0 114.341 171.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -113.3 114.59 26.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.874 0.869 . . . . 0.0 111.687 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -97.02 120.71 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.731 1.612 . . . . 0.0 110.854 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.3 mtm -123.05 152.39 41.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.354 1.861 . . . . 0.0 111.266 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -131.51 133.18 44.83 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 111.772 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.61 52.63 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.66 1.6 . . . . 0.0 116.12 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.78 -175.28 45.84 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.086 1.803 . . . . 0.0 111.89 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.16 111.34 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.37 171.43 29.6 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 126.511 2.005 . . . . 0.0 112.408 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -58.8 -44.68 90.82 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.773 -1.427 . . . . 0.0 113.549 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -74.56 -1.07 19.83 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -93.62 -17.17 23.59 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 165.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.18 144.53 57.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.737 0.815 . . . . 0.0 111.931 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -126.78 -75.43 0.58 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -164.52 109.17 0.86 Allowed Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.33 -27.76 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.241 1.96 . . . . 0.0 114.356 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.49 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -54.29 -55.68 34.39 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 121.253 1.842 . . . . 0.0 114.443 -177.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 -21.37 57.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.689 2.926 . . . . 0.0 112.814 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.53 -37.93 59.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.98 -30.26 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.62 0.368 . . . . 0.0 110.79 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.75 -9.62 4.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -112.63 -9.71 13.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.035 2.134 . . . . 0.0 113.666 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.7 mt -69.95 151.57 96.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -170.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.49 -41.86 50.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.817 3.678 . . . . 0.0 114.755 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -119.0 16.64 13.36 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.903 1.281 . . . . 0.0 112.418 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.09 -132.52 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 120.814 -1.179 . . . . 0.0 112.723 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.15 -25.03 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.261 -1.14 . . . . 0.0 112.617 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -70.18 -6.73 36.41 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.074 -1.016 . . . . 0.0 113.004 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.2 m -81.59 -3.91 54.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 0.986 . . . . 0.0 113.17 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.13 -18.01 15.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.17 1.388 . . . . 0.0 111.889 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -144.14 164.04 31.83 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.498 -1.376 . . . . 0.0 114.657 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.46 89.72 3.08 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.395 0.998 . . . . 0.0 113.027 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 124.469 1.108 . . . . 0.0 110.276 173.147 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.303 88.4 m-85 -91.14 26.93 2.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -167.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.93 -167.66 22.7 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.717 -1.239 . . . . 0.0 114.9 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 136.81 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.783 2.033 . . . . 0.0 108.874 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -113.6 115.54 28.08 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -97.84 117.47 32.24 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.06 112.82 2.78 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.624 1.102 . . . . 0.0 111.616 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -139.4 140.4 25.58 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.207 0.603 . . . . 0.0 112.333 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 139.47 57.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.993 2.462 . . . . 0.0 111.446 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.69 129.52 29.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.744 1.218 . . . . 0.0 109.972 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.17 81.29 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.178 -1.345 . . . . 0.0 115.982 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.0 m -54.23 125.18 49.59 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 120.169 1.984 . . . . 0.0 112.364 163.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.567 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.1 Cg_endo -71.43 133.22 22.11 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.956 1.771 . . . . 0.0 111.701 174.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.2 mm -89.21 129.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 108.504 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -102.56 149.17 24.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.936 1.294 . . . . 0.0 109.528 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.73 126.93 93.21 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.566 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.34 -38.47 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.359 2.706 . . . . 0.0 112.291 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.3 p -126.13 161.9 26.58 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.873 2.069 . . . . 0.0 111.693 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -69.58 136.01 50.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -160.91 13.08 Favored Glycine 0 N--CA 1.473 1.12 0 O-C-N 121.777 -0.577 . . . . 0.0 113.768 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.49 145.75 28.06 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.345 1.073 . . . . 0.0 112.412 172.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.36 126.01 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -40.3 9.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.189 1.796 . . . . 0.0 115.657 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -155.51 145.59 21.62 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.154 1.382 . . . . 0.0 110.292 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -137.66 125.44 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.012 1.325 . . . . 0.0 109.083 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.6 p90 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.986 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.16 138.67 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.78 136.43 49.86 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.634 1.574 . . . . 0.0 109.579 166.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 124.52 51.98 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.252 0.621 . . . . 0.0 112.108 167.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.6 mt -118.59 144.05 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.323 1.049 . . . . 0.0 111.879 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.87 138.41 36.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.825 2.05 . . . . 0.0 110.608 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 178.477 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -128.65 159.18 36.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.053 2.141 . . . . 0.0 111.503 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -141.62 103.89 4.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.435 1.894 . . . . 0.0 110.849 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -87.36 143.28 27.32 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.919 0.487 . . . . 0.0 111.571 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -130.06 96.48 4.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.052 1.741 . . . . 0.0 107.558 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.71 155.37 19.26 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 0.0 110.142 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 68.42 64.43 0.34 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.798 2.039 . . . . 0.0 113.699 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.5 mt -104.56 154.27 20.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.867 1.667 . . . . 0.0 111.171 172.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -97.99 -44.08 6.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.206 1.802 . . . . 0.0 106.931 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -162.12 159.09 25.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.389 2.276 . . . . 0.0 110.548 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -97.95 162.94 12.99 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.002 1.721 . . . . 0.0 114.454 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -124.17 -8.78 7.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.874 1.27 . . . . 0.0 112.721 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.2 m -134.06 168.03 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.56 1.944 . . . . 0.0 111.187 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -120.36 166.79 13.05 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.97 2.108 . . . . 0.0 111.783 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.95 132.43 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.37 7.59 72.46 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.45 1.024 . . . . 0.0 115.175 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -86.48 115.06 23.73 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.128 1.464 . . . . 0.0 112.256 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -65.87 135.15 54.43 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.289 0.235 . . . . 0.0 110.592 164.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -127.33 163.86 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 126.522 1.929 . . . . 0.0 110.555 -176.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.24 140.07 47.31 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.421 1.488 . . . . 0.0 109.526 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.08 126.81 13.29 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.15 -4.93 74.97 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.124 1.821 . . . . 0.0 114.742 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.8 141.69 36.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.664 1.186 . . . . 0.0 112.145 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 88' ' ' PRO . 18.6 mm -70.63 130.1 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.519 -0.738 . . . . 0.0 111.579 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.4 pt -113.86 -21.42 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.725 1.21 . . . . 0.0 113.363 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.76 -176.53 1.77 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 110.729 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -132.71 134.67 45.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.1 t -78.1 145.97 35.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.15 0 C-N-CA 125.672 1.606 . . . . 0.0 111.713 -177.876 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.97 115.2 18.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.692 0.678 . . . . 0.0 110.154 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -91.51 100.05 12.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.826 0.85 . . . . 0.0 110.462 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -92.89 116.52 29.11 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -122.13 112.05 17.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.687 1.195 . . . . 0.0 111.381 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -94.56 129.06 41.53 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.636 1.174 . . . . 0.0 110.536 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.7 mtm -127.24 150.65 49.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.654 1.582 . . . . 0.0 110.856 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -120.05 135.91 54.76 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.027 1.331 . . . . 0.0 110.831 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.02 -15.98 1.69 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.169 1.843 . . . . 0.0 116.525 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.19 -168.78 35.52 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.56 1.553 . . . . 0.0 112.057 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.24 131.26 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.393 1.477 . . . . 0.0 112.747 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.56 166.6 10.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.727 1.632 . . . . 0.0 112.048 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -57.84 -43.74 86.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.426 -1.044 . . . . 0.0 113.487 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.76 -14.24 50.86 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -92.58 -15.88 26.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.59 1.156 . . . . 0.0 114.055 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.41 137.86 58.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.774 1.23 . . . . 0.0 112.836 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -101.5 -90.86 0.33 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.588 1.155 . . . . 0.0 113.805 -173.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -170.15 108.21 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 129.36 3.064 . . . . 0.0 110.591 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.97 -23.06 14.24 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.126 1.884 . . . . 0.0 114.587 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -52.26 -53.83 48.29 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 120.582 1.537 . . . . 0.0 115.085 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.74 -20.03 40.53 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.646 2.898 . . . . 0.0 112.931 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.273 3.8 t80 -70.68 -47.59 59.11 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.5 mt -67.47 -24.29 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.833 -1.167 . . . . 0.0 111.79 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.32 -18.14 64.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -109.28 -7.31 15.27 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.866 -1.146 . . . . 0.0 114.03 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 32.0 mt -69.34 147.72 97.15 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.952 1.301 . . . . 0.0 112.894 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.23 -27.99 34.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.209 2.606 . . . . 0.0 114.164 -166.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.86 2.51 17.07 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.84 -144.06 37.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.84 0.733 . . . . 0.0 112.793 -166.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.97 -24.6 66.23 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.455 -1.027 . . . . 0.0 112.553 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -65.31 -9.89 28.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.481 1.512 . . . . 0.0 111.986 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.6 t -82.52 -3.21 55.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.091 1.356 . . . . 0.0 112.575 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -110.46 -13.11 14.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.517 1.527 . . . . 0.0 112.701 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -146.63 163.52 35.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.705 1.593 . . . . 0.0 115.196 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -115.25 79.06 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 109.998 175.301 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.951 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -61.6 -41.94 98.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.273 1.429 . . . . 0.0 113.703 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -100.1 116.7 32.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -173.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -154.28 -12.79 0.13 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 pm0 -60.3 146.08 45.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.447 1.899 . . . . 0.0 115.085 -165.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.01 137.39 41.48 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.376 9.8 p90 -79.6 42.98 0.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 164.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.84 141.74 58.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.521 1.528 . . . . 0.0 112.242 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -155.87 121.25 4.86 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.034 0.834 . . . . 0.0 111.974 163.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.14 -175.04 14.7 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.567 1.556 . . . . 0.0 114.801 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.3 m -75.05 168.86 19.15 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -76.24 -4.94 44.59 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -171.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.5 125.24 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.339 0.972 . . . . 0.0 110.784 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.282 0.7 OUTLIER -76.46 -51.15 12.33 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 169.337 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -146.73 139.46 25.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.411 1.884 . . . . 0.0 112.132 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.8 p -98.69 -170.91 2.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.768 2.027 . . . . 0.0 111.015 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -76.45 124.05 26.96 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.683 -1.261 . . . . 0.0 107.935 -170.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.84 173.58 19.71 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 124.241 0.924 . . . . 0.0 115.379 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -62.64 147.95 47.82 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.348 -1.089 . . . . 0.0 113.612 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.294 33.8 m-85 -70.53 -40.15 73.62 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 174.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -151.26 173.82 14.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.095 1.358 . . . . 0.0 111.493 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -59.38 165.86 2.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.838 0.855 . . . . 0.0 111.861 164.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.1 m 67.56 161.31 0.14 Allowed Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.26 1.824 . . . . 0.0 114.045 -167.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.28 5.9 5.72 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.007 2.471 . . . . 0.0 114.744 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -95.14 -35.6 11.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.2 0.909 . . . . 0.0 110.773 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -87.5 94.54 9.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.816 1.647 . . . . 0.0 112.417 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.96 -164.22 9.99 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.459 1.504 . . . . 0.0 115.772 -167.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -85.16 140.24 31.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.789 1.236 . . . . 0.0 113.329 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -82.03 122.23 27.54 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.929 1.692 . . . . 0.0 108.348 158.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -98.56 25.06 6.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.74 -162.65 11.86 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.872 -1.143 . . . . 0.0 114.824 -173.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.53 134.85 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.415 2.286 . . . . 0.0 108.833 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -109.67 91.73 3.76 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.93 106.78 11.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 125.87 26.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.045 0.839 . . . . 0.0 110.337 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.7 mt -137.14 151.4 71.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.66 0.784 . . . . 0.0 112.094 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.55 138.65 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.582 2.188 . . . . 0.0 111.528 165.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.63 128.77 38.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.442 0.697 . . . . 0.0 110.978 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.49 63.98 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.047 1.308 . . . . 0.0 115.285 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.3 m -57.72 126.38 75.83 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-N 119.583 1.692 . . . . 0.0 112.714 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.532 ' HB2' HD12 ' A' ' 142' ' ' ILE . 17.6 Cg_endo -69.26 133.27 26.06 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.211 1.941 . . . . 0.0 112.412 172.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -89.58 130.0 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.561 1.944 . . . . 0.0 107.964 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -102.75 152.73 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.665 1.586 . . . . 0.0 109.834 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.49 124.0 90.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.936 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.39 -40.3 19.33 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.083 2.522 . . . . 0.0 112.456 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.3 p -130.23 164.12 25.22 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.543 1.937 . . . . 0.0 110.382 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.27 137.61 50.89 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 166.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.08 -161.93 17.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.576 0.608 . . . . 0.0 113.167 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -145.72 144.5 30.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 112.008 174.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.81 129.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -40.06 8.62 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -157.76 146.49 19.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.144 1.378 . . . . 0.0 111.007 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 129' ' ' TYR . 59.7 mt -141.13 120.31 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.85 1.26 . . . . 0.0 109.425 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -155.04 165.55 36.36 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -129.44 119.46 23.83 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.783 0.801 . . . . 0.0 111.211 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -100.9 140.44 35.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.794 2.038 . . . . 0.0 111.269 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -67.04 -17.63 64.99 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.92 -23.31 3.67 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.915 1.286 . . . . 0.0 114.317 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.5 -5.57 57.81 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 126.364 1.935 . . . . 0.0 114.518 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.89 -157.09 48.39 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 117.944 0.872 . . . . 0.0 113.004 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -67.19 144.01 56.23 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.845 -0.797 . . . . 0.0 112.389 174.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.99 123.26 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.35 131.86 48.71 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.341 1.456 . . . . 0.0 110.187 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.13 125.44 53.78 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.114 1.365 . . . . 0.0 111.384 171.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.7 mt -121.39 149.26 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.241 1.416 . . . . 0.0 111.807 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.05 139.84 48.35 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 111.376 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -80.19 162.67 24.56 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.529 1.132 . . . . 0.0 113.363 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -64.54 -23.77 67.38 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -169.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -80.18 -6.32 57.57 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.52 3.0 90.73 Favored Glycine 0 CA--C 1.538 1.512 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 167.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -109.91 -40.07 4.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.198 1.499 . . . . 0.0 111.868 -172.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -77.74 134.69 38.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 170.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -117.87 159.44 23.08 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.651 1.98 . . . . 0.0 111.907 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -143.45 104.4 4.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.951 2.1 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 148.52 24.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.34 0.656 . . . . 0.0 112.503 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -136.17 89.76 2.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.586 2.355 . . . . 0.0 109.92 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.01 160.51 16.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.666 1.186 . . . . 0.0 111.216 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 62.44 57.1 1.96 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.559 1.944 . . . . 0.0 114.032 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.85 145.46 26.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.322 1.049 . . . . 0.0 111.555 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -87.44 -43.72 11.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.108 1.363 . . . . 0.0 108.045 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -147.45 144.77 28.86 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.186 1.794 . . . . 0.0 112.473 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 100' ' ' ILE . 84.0 m-85 -86.83 149.71 24.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.146 0.978 . . . . 0.0 111.927 171.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -117.18 -4.43 11.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.243 1.017 . . . . 0.0 112.607 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.25 162.82 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.179 1.392 . . . . 0.0 111.529 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -111.66 161.52 16.16 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.583 1.153 . . . . 0.0 111.29 168.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.39 128.04 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.123 1.369 . . . . 0.0 107.641 170.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.66 16.05 66.8 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.179 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -87.23 123.52 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.067 1.434 . . . . 0.0 112.871 167.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -69.02 137.8 53.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.199 0.523 . . . . 0.0 111.718 160.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.83 164.14 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.011 2.125 . . . . 0.0 110.67 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -133.83 142.32 47.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.882 1.273 . . . . 0.0 108.677 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.38 132.35 10.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.337 1.055 . . . . 0.0 113.392 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.88 -7.54 81.83 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.446 1.974 . . . . 0.0 115.011 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -77.37 140.92 40.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.1 1.45 . . . . 0.0 113.148 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.9 mm -67.78 129.4 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.76 -0.587 . . . . 0.0 110.997 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.0 pt -114.45 -20.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.762 1.225 . . . . 0.0 113.304 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.02 -177.07 2.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.137 1.775 . . . . 0.0 110.415 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -132.3 130.85 41.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.4 t -79.05 146.39 33.32 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.559 0.695 . . . . 0.0 112.645 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -156.57 160.97 30.64 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.758 1.17 . . . . 0.0 111.108 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -76.31 35.57 0.14 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.212 1.005 . . . . 0.0 113.702 -174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.251 7.5 p -66.59 145.89 55.11 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.678 1.191 . . . . 0.0 112.619 171.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.97 -41.43 1.07 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.335 1.445 . . . . 0.0 114.51 -166.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mt -65.5 131.07 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.975 1.31 . . . . 0.0 111.488 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -72.08 -47.88 48.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 112.857 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.254 0.6 OUTLIER -134.21 -32.45 1.06 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 176.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.08 157.96 23.99 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.47 159.83 47.54 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.716 1.151 . . . . 0.0 113.781 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.39 146.7 53.79 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -170.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -145.05 124.11 12.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.916 0.886 . . . . 0.0 112.364 169.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.15 115.32 8.3 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 109.663 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -95.16 99.88 11.78 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.739 0.816 . . . . 0.0 110.24 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 51.8 t80 -89.09 114.44 25.69 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.025 1.33 . . . . 0.0 114.508 172.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -118.21 116.83 27.61 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.708 1.203 . . . . 0.0 111.908 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.3 ttt-85 -100.64 124.74 46.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.909 1.684 . . . . 0.0 111.567 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 32.9 mtm -130.44 157.27 43.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.96 1.304 . . . . 0.0 112.338 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -131.5 135.96 47.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.403 1.481 . . . . 0.0 111.52 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.7 -7.66 57.83 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 126.368 1.937 . . . . 0.0 115.363 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 171.14 -166.65 39.79 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.689 2.566 . . . . 0.0 109.806 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.57 131.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 122.483 1.135 . . . . 0.0 110.555 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.43 168.98 14.89 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 128.466 2.936 . . . . 0.0 109.896 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -56.22 -41.96 76.5 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.849 1.325 . . . . 0.0 112.852 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.69 64.91 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.055 -1.028 . . . . 0.0 112.505 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.0 -15.1 58.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.954 1.301 . . . . 0.0 113.44 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.88 56.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.927 0.891 . . . . 0.0 112.763 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.96 -85.57 0.55 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.635 1.174 . . . . 0.0 113.66 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -166.97 126.89 1.14 Allowed Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 127.386 2.274 . . . . 0.0 106.109 167.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.0 -28.71 8.94 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.277 2.652 . . . . 0.0 114.601 171.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -53.24 -53.51 55.22 Favored Pre-proline 0 N--CA 1.478 0.971 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.53 -19.5 32.39 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.704 2.936 . . . . 0.0 112.584 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -72.36 -44.87 61.96 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 24.2 mt -66.68 -29.43 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.432 0.693 . . . . 0.0 111.056 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.86 -15.8 5.48 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.85 -3.23 9.71 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.437 1.495 . . . . 0.0 114.27 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.61 147.62 98.03 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.088 0.955 . . . . 0.0 112.097 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -51.35 -44.72 41.61 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.747 3.631 . . . . 0.0 114.626 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -111.71 12.96 21.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.898 1.279 . . . . 0.0 113.686 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.04 -135.39 46.07 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 120.821 -1.174 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.12 -25.85 64.2 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.308 -1.113 . . . . 0.0 113.319 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -70.18 -5.77 29.62 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.563 -1.336 . . . . 0.0 113.373 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.9 m -77.98 -4.05 45.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.987 0.812 . . . . 0.0 111.991 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.51 -15.55 12.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.735 1.614 . . . . 0.0 113.825 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -148.95 158.14 43.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 121.635 2.016 . . . . 0.0 115.037 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -110.06 79.42 1.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.47 0.544 0 C-N-CA 124.584 1.154 . . . . 0.0 109.523 174.516 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.944 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.5 t -150.71 -34.69 0.15 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.099 0.949 . . . . 0.0 113.129 166.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -75.0 143.87 43.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.389 1.075 . . . . 0.0 111.37 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -104.32 159.03 16.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.855 1.262 . . . . 0.0 112.964 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -63.88 132.2 50.06 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.568 -0.708 . . . . 0.0 110.64 171.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.42 107.81 2.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.64 0.776 . . . . 0.0 112.056 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.338 18.2 p90 -69.44 132.63 46.64 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 -170.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.283 8.0 t80 -68.61 132.7 47.35 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 116.858 2.169 . . . . 0.0 116.858 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' HE ' ' HB3' ' A' ' 58' ' ' SER . 39.2 ttt180 -79.9 105.52 11.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.407 1.083 . . . . 0.0 111.859 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.83 43.3 0.94 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.709 1.623 . . . . 0.0 114.346 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.466 ' HB3' ' HE ' ' A' ' 56' ' ' ARG . 78.9 p -80.77 163.52 23.43 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.366 1.466 . . . . 0.0 114.408 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -136.78 40.65 2.55 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.182 1.793 . . . . 0.0 113.364 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -70.36 114.78 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.259 -0.9 . . . . 0.0 110.397 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -40.76 75.24 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.956 1.702 . . . . 0.0 115.508 172.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -148.11 135.98 20.98 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.394 1.878 . . . . 0.0 109.52 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.1 p -96.31 169.54 9.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.197 0.998 . . . . 0.0 110.22 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -74.29 138.33 43.49 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.153 -0.967 . . . . 0.0 108.775 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.55 -68.11 0.38 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.351 0.977 . . . . 0.0 112.745 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.59 160.97 35.08 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.681 1.193 . . . . 0.0 113.216 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.33 56.8 m-85 -65.3 42.12 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 160.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 62.72 -70.24 0.06 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 128.195 2.598 . . . . 0.0 114.791 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -73.4 -29.11 62.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 116.431 2.012 . . . . 0.0 116.431 -152.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -158.96 152.15 18.65 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.762 1.225 . . . . 0.0 111.822 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.11 -33.78 3.35 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.824 2.349 . . . . 0.0 113.476 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.5 116.83 7.19 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -164.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.315 3.1 m-20 58.22 16.11 3.75 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.32 23.0 14.47 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 -165.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -63.4 145.2 56.09 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.156 1.978 . . . . 0.0 114.347 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -146.73 136.87 23.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.625 1.97 . . . . 0.0 110.127 -173.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 97.8 m-85 -120.54 25.21 9.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -168.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.81 -178.63 25.83 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.97 -1.081 . . . . 0.0 113.354 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.37 146.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.823 1.649 . . . . 0.0 108.109 163.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.8 142.06 48.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.987 0.812 . . . . 0.0 112.177 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -116.43 122.6 45.27 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.338 1.455 . . . . 0.0 114.538 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.79 114.6 17.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.026 0.93 . . . . 0.0 110.864 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.3 mt -126.66 151.26 73.0 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.77 136.9 47.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.612 2.208 . . . . 0.0 110.373 152.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -54.22 138.65 38.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.802 1.241 . . . . 0.0 110.847 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.18 -1.62 84.4 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.589 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 36.2 m -50.25 124.94 18.7 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 119.938 1.869 . . . . 0.0 111.273 166.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HB2' HD12 ' A' ' 142' ' ' ILE . 37.5 Cg_endo -71.31 129.32 15.78 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.798 1.665 . . . . 0.0 110.896 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.34 131.46 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 108.738 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -106.13 155.74 19.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.119 1.367 . . . . 0.0 110.224 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.96 75.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 O-C-N 121.521 -0.737 . . . . 0.0 111.707 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.51 -36.79 10.78 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.283 2.655 . . . . 0.0 113.24 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 p -134.62 163.18 30.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.148 1.779 . . . . 0.0 107.05 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.66 139.69 53.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.73 22.74 Favored Glycine 0 N--CA 1.467 0.702 0 O-C-N 121.433 -0.792 . . . . 0.0 113.219 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -148.02 144.87 28.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.372 1.069 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.51 128.22 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.3 -38.81 7.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.203 1.001 . . . . 0.0 112.045 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -148.62 141.35 24.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.49 1.516 . . . . 0.0 111.778 -168.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -139.76 127.29 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.142 1.377 . . . . 0.0 110.381 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -159.49 167.44 28.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -111.6 164.65 12.77 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.635 1.174 . . . . 0.0 109.31 158.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -144.02 170.09 16.59 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.324 -0.86 . . . . 0.0 112.598 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -55.44 -31.79 62.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.043 1.737 . . . . 0.0 115.171 -165.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.52 -14.03 1.49 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.98 -8.81 87.28 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.47 -149.46 36.99 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 119.006 1.403 . . . . 0.0 112.178 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -72.34 150.68 43.28 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.249 -0.56 . . . . 0.0 112.442 164.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.79 137.18 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.885 2.474 . . . . 0.0 113.394 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.68 135.92 53.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.016 1.326 . . . . 0.0 110.237 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 124.6 44.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.11 147.1 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 125.187 1.395 . . . . 0.0 111.796 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.98 138.13 51.2 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.34 2.256 . . . . 0.0 111.764 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -90.52 159.55 16.44 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -65.83 -10.92 42.27 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -76.34 -15.84 59.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.146 0.979 . . . . 0.0 113.627 167.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.78 -2.2 25.91 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.108 1.337 . . . . 0.0 115.976 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -99.35 -45.67 5.77 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.716 1.758 . . . . 0.0 110.475 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 39.6 m-85 -81.57 145.91 30.4 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 118.28 2.696 . . . . 0.0 118.28 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -130.0 150.36 51.31 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.154 1.781 . . . . 0.0 111.847 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -118.61 131.84 56.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.846 1.658 . . . . 0.0 108.763 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -105.43 150.69 25.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.377 1.071 . . . . 0.0 111.856 157.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -135.19 112.56 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.585 1.954 . . . . 0.0 106.35 171.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -106.7 159.9 15.87 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 111.25 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 68.74 55.3 0.47 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.484 1.913 . . . . 0.0 113.282 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.82 158.03 16.27 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 111.382 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -40.42 5.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.638 1.175 . . . . 0.0 112.557 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -144.64 147.9 33.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.034 1.734 . . . . 0.0 111.782 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -94.32 145.99 24.36 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.037 1.335 . . . . 0.0 112.397 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -106.73 -16.44 14.49 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.47 1.108 . . . . 0.0 112.012 170.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.35 167.21 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.149 1.38 . . . . 0.0 111.499 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -124.19 165.4 17.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 111.939 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.5 t -56.22 123.78 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.36 1.064 . . . . 0.0 108.931 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.34 61.01 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.209 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -97.92 135.83 39.09 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.032 1.916 . . . . 0.0 109.419 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -76.49 145.17 39.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.456 1.102 . . . . 0.0 113.254 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.99 161.04 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 127.013 2.125 . . . . 0.0 111.293 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -123.93 144.09 49.99 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.498 2.319 . . . . 0.0 108.552 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -45.44 112.73 0.49 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.014 1.326 . . . . 0.0 112.308 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.39 -3.2 34.76 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.946 1.736 . . . . 0.0 115.51 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.15 144.54 26.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 88' ' ' PRO . 19.2 mm -70.9 130.82 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.763 0.71 . . . . 0.0 111.924 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.6 pt -115.96 -22.94 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.712 1.205 . . . . 0.0 113.298 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.44 -178.33 2.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.938 1.295 . . . . 0.0 111.278 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -129.73 135.44 48.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.68 146.65 53.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.933 0.893 . . . . 0.0 112.27 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.02 150.65 22.34 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 121.52 0.511 . . . . 0.0 112.751 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -77.73 34.6 0.18 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.491 1.116 . . . . 0.0 112.761 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.7 p -81.52 -15.18 55.69 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -165.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -133.5 32.28 2.74 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.652 1.596 . . . . 0.0 113.752 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 6.0 mt -126.26 136.33 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.961 1.304 . . . . 0.0 111.834 -164.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -61.15 -34.49 75.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.639 1.976 . . . . 0.0 114.544 -173.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.5 p -140.34 -153.53 0.47 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.915 2.486 . . . . 0.0 109.693 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.272 0.8 OUTLIER -77.66 149.95 34.62 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 175.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 158.09 -18.3 0.33 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.226 -1.319 . . . . 0.0 115.878 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 51.58 20.45 1.06 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.065 2.146 . . . . 0.0 116.373 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -70.87 133.44 46.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -164.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 115.77 12.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.482 0.713 . . . . 0.0 110.478 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -92.12 98.78 11.75 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.79 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.288 50.6 t80 -89.07 109.67 20.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.66 117.49 33.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.447 1.099 . . . . 0.0 111.467 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -102.53 126.37 49.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.012 1.325 . . . . 0.0 111.059 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.5 mtm -129.49 149.11 51.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.573 1.549 . . . . 0.0 111.451 -170.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -124.32 131.08 53.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.47 1.508 . . . . 0.0 110.759 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.25 -1.27 35.18 Favored Glycine 0 CA--C 1.545 1.914 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.42 -169.74 41.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.997 1.284 . . . . 0.0 112.521 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.76 115.73 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.28 1.432 . . . . 0.0 112.781 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.52 15.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.395 1.95 . . . . 0.0 111.347 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -57.84 -40.5 80.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.607 1.204 . . . . 0.0 112.832 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.49 -17.61 64.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -88.65 -11.8 44.31 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 151.09 34.08 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -130.57 -89.12 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.517 1.527 . . . . 0.0 113.98 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -160.22 95.89 1.53 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -167.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.4 -34.94 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.15 1.9 . . . . 0.0 114.206 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -54.95 -55.36 39.7 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 121.098 1.772 . . . . 0.0 115.53 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.46 -26.51 40.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.362 2.708 . . . . 0.0 112.099 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.17 -38.3 81.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.44 -40.8 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.887 0.475 . . . . 0.0 110.861 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.45 -5.05 13.09 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -114.12 -4.79 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.018 2.127 . . . . 0.0 113.225 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.84 156.04 48.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.53 1.132 . . . . 0.0 112.327 171.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.65 -49.51 16.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.868 3.045 . . . . 0.0 113.148 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.41 5.21 36.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.454 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.37 -143.76 47.61 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.033 -1.042 . . . . 0.0 112.181 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.44 61.93 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -64.7 -10.08 24.57 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -86.72 5.46 36.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 171.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.1 -18.56 9.35 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.624 1.57 . . . . 0.0 112.709 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -149.1 157.73 43.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.363 -1.461 . . . . 0.0 111.701 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.69 89.02 2.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.241 0.65 0 C-N-CA 124.978 1.311 . . . . 0.0 110.796 173.126 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.944 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.0 p -70.75 -15.02 62.65 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -110.95 -38.33 5.13 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.784 1.634 . . . . 0.0 113.391 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -153.8 166.0 34.26 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.649 1.58 . . . . 0.0 112.3 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -76.73 126.1 30.4 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.254 -0.904 . . . . 0.0 113.316 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -81.7 91.74 6.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.021 0.929 . . . . 0.0 112.433 166.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.331 45.4 m-85 -75.41 171.41 14.29 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 116.99 2.218 . . . . 0.0 116.99 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.317 3.8 p90 -61.56 21.87 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 120.598 3.555 . . . . 0.0 120.598 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -57.75 129.52 42.24 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.644 -1.285 . . . . 0.0 111.944 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.37 -24.1 24.99 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.676 1.131 . . . . 0.0 113.687 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -96.96 123.9 40.79 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.954 1.377 . . . . 0.0 112.786 170.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -83.1 4.74 25.09 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -163.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.1 mt -71.81 123.23 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -167.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 15.3 p -77.24 -42.26 37.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.113 1.365 . . . . 0.0 114.135 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -145.91 135.79 23.49 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.506 1.522 . . . . 0.0 112.718 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 p -104.74 -164.95 1.09 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.981 1.713 . . . . 0.0 108.135 174.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -87.32 140.57 29.4 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 119.88 -1.762 . . . . 0.0 109.721 -160.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.99 -159.33 15.75 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.076 1.798 . . . . 0.0 112.811 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -58.4 153.98 14.63 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 118.419 1.11 . . . . 0.0 112.63 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.35 147.39 29.87 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -76.71 -46.38 25.68 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.719 -0.613 . . . . 0.0 112.382 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -154.24 120.94 5.52 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.647 1.979 . . . . 0.0 109.838 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.2 p -165.03 169.12 7.83 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.87 1.268 . . . . 0.0 110.358 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.23 1.81 8.86 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.083 2.522 . . . . 0.0 114.323 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -84.66 147.32 27.0 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.483 -1.386 . . . . 0.0 114.599 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -89.7 -34.25 16.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 162.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.65 -175.4 40.94 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 122.031 0.795 . . . . 0.0 114.072 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -90.47 166.69 13.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.322 . . . . 0.0 111.677 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -87.27 139.65 30.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.696 1.198 . . . . 0.0 110.0 161.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.49 22.63 11.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.571 1.548 . . . . 0.0 114.675 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.59 -158.05 8.93 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 121.206 -0.934 . . . . 0.0 113.56 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.593 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -125.92 133.31 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.867 2.067 . . . . 0.0 108.796 178.472 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.45 96.08 5.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.48 110.44 14.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 114.17 4.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.267 0.94 . . . . 0.0 111.351 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -129.82 147.27 64.76 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.22 0.608 . . . . 0.0 112.057 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.47 135.43 49.58 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.04 1.827 . . . . 0.0 110.346 162.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -60.67 130.3 45.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.769 0.827 . . . . 0.0 111.129 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.58 -7.92 68.56 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.737 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -51.32 126.65 28.75 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-N 120.121 1.961 . . . . 0.0 113.101 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.606 ' HB2' HD12 ' A' ' 142' ' ' ILE . 6.4 Cg_endo -67.73 136.07 37.73 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.638 2.226 . . . . 0.0 112.151 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.67 127.6 44.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.484 1.514 . . . . 0.0 107.888 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -96.91 148.8 22.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.087 1.355 . . . . 0.0 109.643 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.1 125.06 88.5 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.692 -0.671 . . . . 0.0 110.277 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.64 -39.93 14.58 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.314 2.676 . . . . 0.0 111.72 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.2 p -120.34 166.44 13.52 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.736 2.414 . . . . 0.0 110.089 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -67.36 144.92 55.56 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 154.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.95 -157.68 16.18 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.407 1.003 . . . . 0.0 114.345 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.14 143.96 25.38 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.044 1.738 . . . . 0.0 112.09 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.32 127.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -42.7 8.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 -159.19 143.72 15.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.2 1.0 . . . . 0.0 110.85 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.429 HG23 ' CE2' ' A' ' 129' ' ' TYR . 53.1 mt -141.78 122.31 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.486 1.514 . . . . 0.0 109.101 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -154.7 166.2 34.17 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -118.84 142.19 47.95 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.508 1.123 . . . . 0.0 109.757 161.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -101.96 129.75 48.31 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.041 1.736 . . . . 0.0 111.288 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.67 -23.05 66.91 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.19 31.28 6.82 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.683 1.593 . . . . 0.0 111.992 173.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.09 -128.39 1.48 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.98 1.752 . . . . 0.0 109.958 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.73 -157.84 7.99 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.839 1.209 . . . . 0.0 112.029 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -66.98 146.61 54.19 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.4 139.36 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.656 1.982 . . . . 0.0 114.208 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.298 1.439 . . . . 0.0 109.821 171.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 126.5 55.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.391 0.676 . . . . 0.0 112.57 171.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.14 145.18 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.829 1.252 . . . . 0.0 112.218 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.94 132.25 52.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.701 2.4 . . . . 0.0 112.182 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -81.51 157.81 24.7 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.38 -37.74 81.71 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 -170.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -73.22 -9.92 59.21 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.92 17.95 57.02 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 165.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -125.49 -31.66 2.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.365 1.583 . . . . 0.0 112.846 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.264 50.0 m-85 -83.47 141.79 31.41 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -126.48 155.71 41.85 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.646 2.378 . . . . 0.0 111.332 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -137.8 105.3 5.54 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.473 1.909 . . . . 0.0 110.625 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -88.52 146.03 25.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.156 0.582 . . . . 0.0 111.225 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -132.21 109.52 9.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.689 1.596 . . . . 0.0 108.218 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.08 162.49 12.9 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.939 1.296 . . . . 0.0 111.112 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 59.32 61.76 1.97 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.203 2.201 . . . . 0.0 112.798 -174.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.03 140.49 36.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.973 1.309 . . . . 0.0 111.998 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -80.86 -48.75 11.97 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 0.0 108.716 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -152.42 149.21 28.34 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.536 1.935 . . . . 0.0 111.152 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.429 ' CE2' HG23 ' A' ' 100' ' ' ILE . 97.9 m-85 -98.06 143.27 28.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.728 1.211 . . . . 0.0 113.032 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -103.45 -29.36 11.23 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.524 -0.735 . . . . 0.0 111.812 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.6 m -111.03 172.61 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.737 1.615 . . . . 0.0 112.208 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -128.55 162.94 26.08 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.734 1.614 . . . . 0.0 111.681 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -56.04 130.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 122.37 1.081 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.29 5.42 67.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.476 1.512 . . . . 0.0 114.995 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -95.21 136.8 35.11 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.24 1.52 . . . . 0.0 114.061 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.1 mmm-85 -86.49 133.93 33.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.94 159.21 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.423 1.489 . . . . 0.0 110.863 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.19 143.54 51.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.216 1.806 . . . . 0.0 108.462 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.65 128.99 13.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.23 1.012 . . . . 0.0 113.06 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.45 -2.69 78.22 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.33 1.443 . . . . 0.0 114.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -79.31 139.74 37.74 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.754 1.277 . . . . 0.0 113.692 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.6 mm -69.82 126.81 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 118.846 0.748 . . . . 0.0 111.544 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -108.8 -26.06 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.125 1.37 . . . . 0.0 113.133 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.11 -176.81 2.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 110.389 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.47 136.34 41.21 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -82.48 143.87 30.83 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.25 165.73 37.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.601 1.096 . . . . 0.0 113.27 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -77.97 15.6 0.86 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -165.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.9 p -60.62 -17.21 45.54 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -122.84 29.8 5.27 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.745 1.64 . . . . 0.0 113.015 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.3 146.89 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.185 1.794 . . . . 0.0 109.536 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -74.61 101.43 4.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.693 0.797 . . . . 0.0 110.688 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.322 0.2 OUTLIER 64.41 -68.58 0.1 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 176.155 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.73 126.77 43.24 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -159.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.86 174.55 8.03 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.688 1.137 . . . . 0.0 115.45 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.14 146.33 40.5 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.521 1.128 . . . . 0.0 112.257 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -150.54 135.44 17.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.991 0.916 . . . . 0.0 111.693 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.08 118.08 19.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.857 0.753 . . . . 0.0 110.587 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -94.95 100.91 12.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.51 113.14 25.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.015 1.326 . . . . 0.0 113.953 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -117.7 112.41 20.44 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 110.088 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 ttt-85 -99.93 127.26 46.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.122 0.969 . . . . 0.0 110.603 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.1 mtm -127.37 154.09 45.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.622 1.569 . . . . 0.0 111.731 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -130.07 131.92 45.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.419 1.087 . . . . 0.0 112.246 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.54 6.11 75.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.053 0.835 . . . . 0.0 114.68 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.83 -161.1 31.23 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.116 1.817 . . . . 0.0 111.374 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.48 135.6 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.63 1.172 . . . . 0.0 111.838 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 138.71 171.72 12.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.084 1.802 . . . . 0.0 112.578 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -54.23 -51.29 64.96 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.75 1.22 . . . . 0.0 113.569 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.15 -17.12 63.17 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.712 -1.243 . . . . 0.0 114.279 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -80.23 -18.2 50.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.07 145.87 55.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.667 0.787 . . . . 0.0 111.602 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -122.8 -81.0 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -166.92 97.37 0.68 Allowed Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.27 -26.35 5.13 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.127 1.884 . . . . 0.0 114.51 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.593 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -56.3 -51.91 77.18 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-N 121.622 2.01 . . . . 0.0 113.821 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.48 -25.75 24.95 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.512 2.141 . . . . 0.0 112.379 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.67 -32.7 74.26 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -80.71 -26.37 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.341 0.657 . . . . 0.0 111.717 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -59.46 -10.44 3.29 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -117.39 -5.84 11.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.887 2.075 . . . . 0.0 113.616 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.04 148.76 91.91 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.367 -0.833 . . . . 0.0 111.8 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -36.95 52.87 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.306 2.671 . . . . 0.0 114.066 -166.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -109.64 0.13 18.9 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.265 -0.897 . . . . 0.0 110.864 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 78.3 -143.2 26.96 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.613 1.097 . . . . 0.0 112.083 -164.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.54 -25.97 64.96 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.916 -1.344 . . . . 0.0 114.14 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -63.25 -8.88 9.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.01 1.324 . . . . 0.0 114.485 173.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -83.05 -5.44 59.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.397 1.079 . . . . 0.0 112.952 170.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -104.2 -14.61 15.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.903 1.681 . . . . 0.0 113.184 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -143.51 160.16 41.11 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.834 1.652 . . . . 0.0 114.7 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -108.07 78.16 1.16 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 124.315 1.046 . . . . 0.0 112.354 -176.693 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 m -68.4 124.26 23.04 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.439 1.496 . . . . 0.0 112.035 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -60.11 155.64 16.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.301 1.44 . . . . 0.0 112.977 172.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -152.34 155.99 38.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.935 1.294 . . . . 0.0 111.593 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -141.28 151.05 43.34 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.26 1.824 . . . . 0.0 110.528 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -97.41 126.49 42.69 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.283 9.2 p90 -145.33 156.98 44.12 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.393 77.2 t80 -127.01 154.92 44.01 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -65.53 155.45 35.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.918 2.087 . . . . 0.0 115.405 -160.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.94 -48.93 2.43 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.333 1.444 . . . . 0.0 114.095 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 p -69.46 167.03 17.53 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.758 1.623 . . . . 0.0 113.394 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -110.42 0.76 17.98 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.2 mp -65.44 138.37 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.36 1.436 . . . . 0.0 110.085 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 t -128.5 -26.89 2.7 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.843 2.057 . . . . 0.0 115.415 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -130.81 151.37 51.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.468 1.507 . . . . 0.0 110.821 167.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.4 p -138.24 164.94 27.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.862 1.265 . . . . 0.0 110.305 -170.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -76.23 158.54 31.51 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.391 -0.818 . . . . 0.0 108.986 -168.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.47 -155.74 23.58 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.623 1.106 . . . . 0.0 112.462 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 157.54 17.95 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.199 -1.177 . . . . 0.0 111.708 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -55.85 140.21 43.2 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -64.24 -20.94 66.38 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.824 -1.172 . . . . 0.0 114.025 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -104.37 9.49 35.77 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.348 1.859 . . . . 0.0 113.681 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.7 m -147.42 142.23 16.61 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -171.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -95.74 -9.78 1.09 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.29 3.327 . . . . 0.0 114.192 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -71.72 171.98 10.57 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.438 1.895 . . . . 0.0 109.674 -169.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -69.45 118.84 12.84 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.868 -1.145 . . . . 0.0 113.801 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.32 120.91 0.82 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.248 1.404 . . . . 0.0 111.234 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -121.81 146.06 47.45 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -166.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -103.59 113.97 27.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.23 2.212 . . . . 0.0 109.474 172.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.279 69.9 m-85 -90.07 43.76 1.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.56 -175.91 38.44 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.506 -1.371 . . . . 0.0 115.055 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.32 146.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.152 1.781 . . . . 0.0 107.866 165.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 137.44 50.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.518 1.054 . . . . 0.0 113.13 167.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.08 118.96 38.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.005 1.722 . . . . 0.0 113.93 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.82 110.47 4.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.585 0.754 . . . . 0.0 110.199 171.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.7 mt -125.34 150.42 67.35 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 111.466 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.6 138.21 73.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.637 2.225 . . . . 0.0 110.578 161.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -56.76 121.61 10.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.185 1.394 . . . . 0.0 111.291 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.37 1.65 66.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.1 m -52.18 125.46 33.38 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 120.407 2.104 . . . . 0.0 112.436 166.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.601 ' HB2' HD12 ' A' ' 142' ' ' ILE . 9.0 Cg_endo -68.22 135.66 35.04 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.095 1.863 . . . . 0.0 111.841 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.3 mm -91.51 130.51 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.716 1.606 . . . . 0.0 107.428 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -101.25 150.19 23.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.995 1.318 . . . . 0.0 109.246 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 93.13 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.936 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.03 -30.53 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.317 2.678 . . . . 0.0 113.345 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.7 p -132.43 163.73 28.12 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.724 2.41 . . . . 0.0 112.225 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.54 135.94 42.14 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.71 -159.26 11.54 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.403 1.001 . . . . 0.0 114.057 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -150.9 145.55 25.71 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.681 1.593 . . . . 0.0 111.174 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.59 125.66 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.83 -41.35 7.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.822 1.249 . . . . 0.0 111.075 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -149.32 142.93 25.46 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.724 1.21 . . . . 0.0 111.654 -166.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.9 mt -140.99 134.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.446 1.098 . . . . 0.0 109.386 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -157.52 177.76 11.05 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -120.47 161.8 20.64 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.881 1.272 . . . . 0.0 111.918 164.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -132.29 145.92 51.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.031 1.733 . . . . 0.0 111.491 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -63.97 -30.35 71.44 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -97.95 -38.71 9.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.263 1.425 . . . . 0.0 112.429 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.4 -9.23 55.53 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.317 1.437 . . . . 0.0 115.519 -162.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.54 -149.11 36.37 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 118.341 1.07 . . . . 0.0 112.934 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.4 146.57 45.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -134.53 138.89 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.137 1.775 . . . . 0.0 113.851 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -115.21 134.27 55.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.566 1.946 . . . . 0.0 109.784 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.44 123.62 46.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.755 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.2 mt -119.48 142.67 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 0.0 111.373 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.09 138.93 37.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.534 1.934 . . . . 0.0 110.89 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -76.92 168.0 20.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 112.241 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -65.81 -22.26 66.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -61.45 -21.45 64.16 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.46 2.304 . . . . 0.0 113.992 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.68 10.7 78.81 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.468 1.509 . . . . 0.0 115.088 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -149.55 -25.33 0.28 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.296 38.5 m-85 -80.36 140.39 36.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 173.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -131.8 150.38 52.17 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.387 1.075 . . . . 0.0 112.598 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -125.53 121.4 33.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.693 1.997 . . . . 0.0 108.184 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -97.49 150.41 21.1 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.27 91.77 2.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.829 2.452 . . . . 0.0 108.823 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.47 162.91 13.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.472 0.709 . . . . 0.0 111.838 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 65.26 53.63 1.29 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.352 1.861 . . . . 0.0 111.721 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.7 mt -96.75 140.95 30.58 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.266 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.53 -50.83 12.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.376 1.87 . . . . 0.0 107.802 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -147.78 146.84 29.33 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.884 1.673 . . . . 0.0 111.322 -163.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -91.09 151.03 21.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.059 0.543 . . . . 0.0 111.728 171.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -118.12 -7.11 10.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.437 1.095 . . . . 0.0 112.657 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.81 166.8 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.294 1.838 . . . . 0.0 111.219 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -122.16 165.96 15.31 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.718 1.607 . . . . 0.0 111.135 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.5 t -52.64 125.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.782 1.233 . . . . 0.0 107.993 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.1 13.72 61.65 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.42 126.37 35.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.749 1.774 . . . . 0.0 112.603 168.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -71.2 135.22 47.43 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.981 0.512 . . . . 0.0 111.371 167.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.51 156.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.91 1.684 . . . . 0.0 110.348 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -136.13 140.73 43.89 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.988 1.715 . . . . 0.0 109.336 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.25 131.62 16.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.265 1.031 . . . . 0.0 113.488 -171.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.22 -6.68 83.31 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.861 2.172 . . . . 0.0 115.128 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -79.23 140.75 37.58 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.036 1.418 . . . . 0.0 114.017 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.0 mm -70.42 129.63 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.688 0.795 . . . . 0.0 111.603 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -115.5 -23.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.966 1.307 . . . . 0.0 113.089 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.67 -175.92 1.67 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.879 1.672 . . . . 0.0 110.386 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -136.85 138.18 40.48 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.5 t -79.92 143.24 34.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.048 0.84 . . . . 0.0 113.236 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.28 167.74 30.19 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.953 1.264 . . . . 0.0 112.977 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -82.77 16.83 2.06 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 p -62.48 1.87 0.32 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 118.052 2.612 . . . . 0.0 118.052 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.64 51.12 0.14 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.298 0.952 . . . . 0.0 113.243 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.91 122.68 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.912 0.863 . . . . 0.0 111.161 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -67.95 -21.16 65.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.053 1.341 . . . . 0.0 114.05 -170.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.8 p -66.55 -12.95 60.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.932 1.693 . . . . 0.0 115.357 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.397 0.2 OUTLIER 68.07 12.25 8.7 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -164.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -95.4 166.07 25.3 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.94 1.257 . . . . 0.0 113.197 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.9 131.79 54.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.614 1.166 . . . . 0.0 110.8 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -154.91 132.31 11.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.681 0.792 . . . . 0.0 111.971 169.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.65 117.09 13.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.082 0.953 . . . . 0.0 110.702 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -90.9 106.07 18.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.219 0.918 . . . . 0.0 111.865 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.251 41.5 t80 -95.28 115.04 26.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.409 1.484 . . . . 0.0 114.563 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -113.85 120.43 40.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.822 0.849 . . . . 0.0 111.755 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -92.95 124.0 36.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.078 1.751 . . . . 0.0 111.35 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.3 mtm -126.07 161.32 27.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.984 1.714 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -134.16 141.96 47.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 111.353 169.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.35 -5.26 60.52 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.252 1.406 . . . . 0.0 115.867 167.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.59 -175.12 47.45 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.751 2.596 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.25 121.76 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.637 1.175 . . . . 0.0 112.544 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.93 163.75 10.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.28 1.419 . . . . 0.0 112.356 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -48.23 -46.13 35.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.736 1.214 . . . . 0.0 113.468 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.34 69.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -81.46 -14.24 57.26 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.1 131.83 49.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.614 1.166 . . . . 0.0 112.119 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -103.28 -80.48 0.52 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.778 0.831 . . . . 0.0 112.681 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -166.78 101.34 0.66 Allowed Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.397 1.479 . . . . 0.0 114.046 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.02 -32.29 1.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.866 1.711 . . . . 0.0 114.097 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -57.83 -53.84 61.55 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 120.976 1.717 . . . . 0.0 115.475 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.24 -25.97 49.6 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.241 2.627 . . . . 0.0 112.122 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -61.13 -27.56 68.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 166.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.21 -31.52 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.836 0.854 . . . . 0.0 111.998 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.4 -4.7 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -114.81 -5.75 12.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.807 2.043 . . . . 0.0 113.652 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.9 mt -77.72 148.1 75.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.743 1.217 . . . . 0.0 112.532 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.65 -21.31 22.13 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.811 3.007 . . . . 0.0 115.2 -164.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -119.01 9.44 11.86 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.106 1.363 . . . . 0.0 113.921 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.02 -141.24 34.1 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.252 0.93 . . . . 0.0 112.975 -169.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.63 -25.25 52.8 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.313 -1.11 . . . . 0.0 113.414 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -64.89 -9.11 18.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 113.753 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.3 m -81.74 -7.96 59.65 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.08 0.952 . . . . 0.0 112.76 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.36 -18.69 14.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.624 1.17 . . . . 0.0 113.346 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -144.17 159.42 42.68 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.378 -1.451 . . . . 0.0 113.441 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -104.78 93.11 4.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.241 0.631 0 C-N-CA 123.658 0.783 . . . . 0.0 111.824 177.196 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.179 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.4 p -82.43 -15.37 52.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.56 156.17 35.29 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.042 1.292 . . . . 0.0 113.536 -171.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -153.06 150.85 29.58 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.239 1.416 . . . . 0.0 113.011 -172.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.41 -24.32 57.13 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -165.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -91.41 138.36 31.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.439 1.496 . . . . 0.0 113.682 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -62.11 129.0 38.79 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 168.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -68.13 134.33 50.37 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 117.346 2.35 . . . . 0.0 117.346 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -89.81 -26.55 20.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.43 -123.22 4.15 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.444 1.973 . . . . 0.0 111.729 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.1 m -67.76 149.64 49.68 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -127.47 21.48 6.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -166.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.26 127.94 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 120.198 1.363 . . . . 0.0 110.969 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.1 t -107.9 -27.14 10.38 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.264 1.825 . . . . 0.0 115.724 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -142.53 153.99 44.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.59 1.156 . . . . 0.0 111.242 162.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 p -128.64 176.43 7.8 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.53 1.532 . . . . 0.0 107.613 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -69.99 158.62 35.3 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.52 -135.99 12.5 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.297 -0.877 . . . . 0.0 112.245 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.75 154.13 42.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.97 1.385 . . . . 0.0 112.867 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -61.73 -64.97 0.77 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -160.04 -177.01 6.0 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.714 2.006 . . . . 0.0 111.025 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -63.42 18.68 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 128.219 2.608 . . . . 0.0 116.742 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.7 p -76.31 161.91 73.13 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.954 2.501 . . . . 0.0 115.09 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.1 -28.04 11.28 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.026 2.484 . . . . 0.0 112.192 162.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.276 1.2 p90 -66.43 128.67 37.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 163.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -155.59 96.48 1.77 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -112.49 -1.31 26.19 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.443 1.497 . . . . 0.0 114.455 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm 59.35 159.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.572 2.349 . . . . 0.0 115.926 -171.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -134.0 111.15 10.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.435 1.894 . . . . 0.0 110.099 -162.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.453 68.5 m-85 -93.41 28.07 2.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.43 -168.97 23.09 Favored Glycine 0 CA--C 1.532 1.097 0 O-C-N 121.109 -0.994 . . . . 0.0 114.766 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.27 144.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.977 2.111 . . . . 0.0 108.859 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -123.47 129.88 51.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -102.62 118.77 37.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.106 1.762 . . . . 0.0 113.804 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.76 78.14 1.12 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.356 1.062 . . . . 0.0 112.421 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.6 mt -95.77 150.17 37.02 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.099 0.959 . . . . 0.0 112.484 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.07 151.52 83.6 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.864 2.376 . . . . 0.0 112.214 162.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -54.74 139.68 38.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.325 1.45 . . . . 0.0 111.054 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.77 -9.56 59.21 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.028 -1.429 . . . . 0.0 115.818 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 m -50.62 122.47 16.19 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.707 1.754 . . . . 0.0 113.938 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.568 ' HB2' HD12 ' A' ' 142' ' ' ILE . 14.7 Cg_endo -67.31 129.3 20.03 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.165 1.243 . . . . 0.0 111.662 172.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.426 HD11 ' HB2' ' A' ' 146' ' ' SER . 45.6 mm -87.94 127.68 40.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.267 1.827 . . . . 0.0 107.771 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -99.25 154.38 18.2 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.482 1.513 . . . . 0.0 109.77 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.9 123.95 90.16 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.939 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -35.79 51.61 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.148 2.565 . . . . 0.0 112.716 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -138.58 154.89 48.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.725 1.61 . . . . 0.0 107.137 -169.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.29 134.33 55.65 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.494 0.718 . . . . 0.0 110.926 169.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.01 -157.92 11.58 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.937 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 146.47 25.65 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.438 1.895 . . . . 0.0 111.911 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.03 129.23 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 -44.91 7.09 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -158.62 143.73 16.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.049 1.34 . . . . 0.0 111.104 -166.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -141.1 118.75 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.761 1.224 . . . . 0.0 109.637 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -159.68 174.46 14.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -129.9 156.38 44.49 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.982 1.313 . . . . 0.0 110.172 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -124.97 132.92 53.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.702 1.601 . . . . 0.0 108.785 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -52.16 -31.52 31.67 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -155.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.0 pp -130.72 6.22 4.7 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.87 1.668 . . . . 0.0 113.682 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.62 -20.21 20.18 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 126.167 1.842 . . . . 0.0 115.605 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.06 -173.05 21.23 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.495 1.521 . . . . 0.0 114.547 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -72.08 152.16 42.56 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.09 -0.653 . . . . 0.0 112.543 167.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.81 140.93 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 127.005 2.122 . . . . 0.0 114.451 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.86 132.53 56.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.302 1.841 . . . . 0.0 108.683 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.99 124.49 51.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.586 1.155 . . . . 0.0 110.403 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.76 144.43 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.455 1.102 . . . . 0.0 111.153 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.76 127.09 53.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.362 1.865 . . . . 0.0 110.35 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -64.94 144.59 57.18 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.006 -1.059 . . . . 0.0 111.428 169.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -69.2 -12.84 62.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.08 -20.67 65.57 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 165.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.69 1.83 63.51 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 116.131 1.213 . . . . 0.0 116.131 164.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -124.79 -30.56 3.27 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.09 1.445 . . . . 0.0 113.639 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.312 35.1 m-85 -83.95 136.47 34.06 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -120.13 155.32 33.28 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.316 2.246 . . . . 0.0 110.843 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -140.97 103.17 4.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.245 1.818 . . . . 0.0 109.994 -168.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -85.06 142.72 29.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.685 0.394 . . . . 0.0 111.38 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -130.78 89.94 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.872 2.469 . . . . 0.0 109.979 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mp -93.27 157.06 16.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.342 0.657 . . . . 0.0 111.346 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 71.18 58.56 0.19 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.269 1.827 . . . . 0.0 113.187 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -103.72 148.86 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.024 1.33 . . . . 0.0 111.288 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.42 -52.68 6.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.412 1.885 . . . . 0.0 107.618 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -150.98 157.79 43.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 127.168 2.187 . . . . 0.0 110.921 -165.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -98.77 154.29 18.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.94 0.896 . . . . 0.0 112.076 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -117.18 -14.28 10.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.677 1.191 . . . . 0.0 112.934 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.93 163.17 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.067 1.347 . . . . 0.0 110.397 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -117.88 163.84 15.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.4 t -54.52 135.43 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.57 3.72 83.7 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.561 1.077 . . . . 0.0 115.263 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -79.67 124.57 28.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 119.326 1.563 . . . . 0.0 111.863 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -74.19 140.95 45.46 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.77 160.92 40.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.617 1.567 . . . . 0.0 110.298 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -129.2 145.06 51.41 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.605 1.562 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.0 116.56 2.05 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.558 1.143 . . . . 0.0 112.732 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.68 -1.33 42.19 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 126.203 1.859 . . . . 0.0 115.305 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -86.34 142.58 28.39 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.407 1.883 . . . . 0.0 114.958 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 88' ' ' PRO . 13.4 mm -69.01 129.05 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.109 0.868 . . . . 0.0 112.01 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.77 -23.97 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.707 1.603 . . . . 0.0 113.312 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.77 3.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.469 1.108 . . . . 0.0 110.54 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.66 132.08 46.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 89' ' ' ILE . 1.6 t -69.06 137.52 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.704 1.601 . . . . 0.0 110.43 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.87 163.36 34.16 Favored Glycine 0 N--CA 1.464 0.502 0 CA-C-O 122.893 1.274 . . . . 0.0 115.027 -169.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -81.3 34.24 0.36 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -163.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.0 p -88.21 113.81 24.2 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.327 1.451 . . . . 0.0 112.248 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.14 17.8 74.23 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 118.891 2.317 . . . . 0.0 118.891 168.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.41 145.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 120.182 1.991 . . . . 0.0 111.468 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -75.13 -43.57 51.86 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.16 132.21 31.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 174.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.413 2.3 p 66.96 -128.59 0.17 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -170.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.8 166.58 38.84 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 121.168 1.803 . . . . 0.0 116.212 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 67.2 -9.68 0.38 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 119.467 3.136 . . . . 0.0 119.467 172.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -74.61 124.94 27.6 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.106 1.362 . . . . 0.0 113.99 -171.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.48 128.53 36.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.292 1.437 . . . . 0.0 112.089 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -106.23 105.9 16.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.798 0.839 . . . . 0.0 112.109 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.287 33.7 t80 -95.4 111.98 23.77 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.882 1.673 . . . . 0.0 114.941 175.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -116.7 114.0 23.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.621 1.168 . . . . 0.0 111.282 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.94 122.63 43.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.415 1.486 . . . . 0.0 110.808 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.0 mtm -128.64 156.46 43.38 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.618 1.567 . . . . 0.0 111.415 -172.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -127.76 128.29 45.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 110.669 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.3 -15.2 12.7 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 125.886 1.708 . . . . 0.0 116.623 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.53 40.31 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.049 1.309 . . . . 0.0 112.179 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.93 91.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 173.03 173.21 39.28 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.872 1.701 . . . . 0.0 112.86 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -48.58 -48.65 38.77 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.1 -14.62 62.74 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.19 -16.34 38.12 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 143.49 52.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.564 1.146 . . . . 0.0 112.823 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -125.23 -79.94 0.61 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -164.79 110.51 0.84 Allowed Pre-proline 0 N--CA 1.47 0.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -29.99 4.13 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.257 1.971 . . . . 0.0 114.151 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -51.35 -59.98 6.72 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.6 -28.62 69.73 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.689 2.926 . . . . 0.0 111.695 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -66.72 -39.17 87.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.22 -34.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.775 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.51 -16.84 17.12 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.93 1.12 11.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.144 1.778 . . . . 0.0 114.692 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.23 154.39 87.36 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.44 1.096 . . . . 0.0 111.848 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -47.2 -54.69 4.7 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.921 3.748 . . . . 0.0 114.028 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -106.99 10.84 30.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.272 1.029 . . . . 0.0 112.727 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.32 -139.1 30.15 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.711 -1.243 . . . . 0.0 112.332 -169.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.97 -26.4 62.28 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.706 -1.467 . . . . 0.0 112.807 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -69.55 -3.37 14.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.983 1.313 . . . . 0.0 113.067 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.6 m -80.54 -8.04 59.44 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.31 1.044 . . . . 0.0 113.013 166.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.57 -13.47 15.05 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.854 1.662 . . . . 0.0 112.687 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.16 161.47 42.67 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -106.04 90.15 3.29 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.849 1.26 . . . . 0.0 109.806 170.272 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.747 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.1 p -56.46 128.49 36.34 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.12 155.34 21.52 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.882 1.673 . . . . 0.0 111.483 165.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -136.31 159.64 41.12 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.695 1.198 . . . . 0.0 113.358 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.07 158.43 31.11 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.76 1.267 . . . . 0.0 112.883 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -151.94 161.85 41.99 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.625 1.97 . . . . 0.0 113.861 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -88.03 124.82 34.14 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 167.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.261 16.2 t80 -66.68 156.58 34.89 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -47.58 104.93 0.06 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.692 1.597 . . . . 0.0 112.982 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.97 -11.1 0.29 Allowed Glycine 0 CA--C 1.544 1.871 0 N-CA-C 118.045 1.978 . . . . 0.0 118.045 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 m -148.72 153.46 38.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.425 2.112 . . . . 0.0 113.909 -162.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -84.83 16.02 3.58 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 mt -87.49 125.98 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.937 -1.102 . . . . 0.0 113.548 -167.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.1 p -88.1 -36.78 16.72 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -141.0 122.88 15.4 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.173 1.389 . . . . 0.0 111.641 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.0 p -85.43 -176.69 6.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.622 1.169 . . . . 0.0 110.412 164.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -68.66 134.89 50.55 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.34 -120.5 1.01 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.351 0.501 . . . . 0.0 112.092 -171.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 149.56 35.06 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.667 1.587 . . . . 0.0 112.813 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -62.48 160.04 14.43 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.155 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -59.69 156.44 13.79 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.454 -0.779 . . . . 0.0 112.431 166.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.2 m170 63.12 52.76 2.44 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.87 1.668 . . . . 0.0 113.825 -171.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.8 m 68.66 160.9 0.14 Allowed Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 128.525 2.73 . . . . 0.0 117.409 169.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -86.09 1.45 7.87 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.067 3.178 . . . . 0.0 115.257 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -76.14 109.67 10.0 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.31 25.5 m-20 55.12 36.09 26.21 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -166.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.46 20.96 1.87 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.895 1.236 . . . . 0.0 115.782 -165.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -83.87 144.74 29.03 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.006 1.903 . . . . 0.0 112.908 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -115.28 129.04 56.51 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.335 1.854 . . . . 0.0 110.688 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.96 23.0 14.27 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -170.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.0 -166.97 14.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 120.696 -1.252 . . . . 0.0 114.579 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.01 130.36 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.828 2.051 . . . . 0.0 109.291 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -109.64 89.15 2.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.15 108.1 12.4 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.17 126.83 30.43 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.417 1.008 . . . . 0.0 111.776 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.45 159.17 71.64 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.137 0.975 . . . . 0.0 113.325 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.19 145.8 73.91 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.234 2.623 . . . . 0.0 111.22 161.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -65.87 131.71 46.91 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.345 -0.847 . . . . 0.0 111.149 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.27 84.24 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.586 -1.675 . . . . 0.0 115.415 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -47.72 121.93 8.58 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.923 1.862 . . . . 0.0 112.459 171.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.594 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.6 Cg_endo -68.2 129.25 18.94 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.424 1.416 . . . . 0.0 111.589 175.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -86.23 128.1 39.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.73 1.612 . . . . 0.0 108.482 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -100.4 149.81 23.27 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 109.644 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.76 133.37 90.46 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 121.777 -0.577 . . . . 0.0 110.861 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.59 -32.39 6.11 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.193 2.595 . . . . 0.0 112.667 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.3 p -140.22 160.92 38.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.34 2.256 . . . . 0.0 107.847 -170.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -74.64 136.78 41.94 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.772 -1.205 . . . . 0.0 109.326 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.56 -159.11 11.81 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.973 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.09 144.68 25.89 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.913 1.285 . . . . 0.0 113.108 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.65 127.26 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.06 -41.95 5.69 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.614 1.166 . . . . 0.0 111.939 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -147.06 140.43 25.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.697 1.199 . . . . 0.0 110.915 -165.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 mt -144.82 110.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.512 1.525 . . . . 0.0 109.42 -173.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -154.81 -175.23 5.32 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.461 0.704 . . . . 0.0 112.545 -169.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.51 32.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.697 1.199 . . . . 0.0 112.456 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -143.65 153.98 43.06 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.906 2.082 . . . . 0.0 112.023 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -63.55 -31.16 72.24 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.67 -19.02 5.04 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.955 1.302 . . . . 0.0 113.692 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.21 -8.32 75.26 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.809 1.671 . . . . 0.0 114.326 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.2 -152.39 49.82 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 118.02 0.91 . . . . 0.0 113.074 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -73.33 148.07 43.82 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.684 -0.892 . . . . 0.0 112.498 170.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.25 134.79 62.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.528 1.531 . . . . 0.0 115.087 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -111.35 134.97 52.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.135 1.374 . . . . 0.0 109.574 168.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.4 124.34 44.28 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 55.6 mt -119.85 139.91 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.557 1.143 . . . . 0.0 111.193 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.33 131.27 40.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.852 2.061 . . . . 0.0 110.118 166.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -77.34 155.53 31.9 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -68.48 -12.43 61.21 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.417 1.887 . . . . 0.0 111.564 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -71.04 -13.35 61.95 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 167.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.32 -2.28 57.78 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -114.75 -35.56 4.79 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.581 1.69 . . . . 0.0 112.517 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -88.99 143.31 26.94 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -121.9 152.77 39.27 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.536 1.534 . . . . 0.0 112.54 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.38 138.95 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.586 1.954 . . . . 0.0 109.153 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -114.0 148.65 36.59 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.977 1.311 . . . . 0.0 112.827 161.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -133.7 99.63 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.896 1.679 . . . . 0.0 106.964 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.41 163.67 13.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.695 1.198 . . . . 0.0 110.508 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 66.25 40.15 3.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.154 2.181 . . . . 0.0 114.937 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -83.98 154.22 23.44 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.312 -1.493 . . . . 0.0 112.827 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.36 -46.75 7.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.799 1.239 . . . . 0.0 108.955 171.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -152.82 160.27 43.09 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -104.0 148.64 25.98 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.646 1.578 . . . . 0.0 111.911 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -107.33 -8.61 16.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.662 1.585 . . . . 0.0 112.25 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 175.39 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.772 1.629 . . . . 0.0 111.464 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -130.82 169.21 16.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.438 1.495 . . . . 0.0 111.424 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.29 132.47 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 122.225 1.012 . . . . 0.0 108.983 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.69 9.16 69.08 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.511 1.053 . . . . 0.0 115.128 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -86.27 124.61 32.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.727 1.264 . . . . 0.0 113.33 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -75.87 139.68 41.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.514 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.4 164.6 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.214 1.805 . . . . 0.0 112.676 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.05 140.14 48.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.254 1.822 . . . . 0.0 110.218 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.1 125.68 3.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.875 1.27 . . . . 0.0 113.402 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.94 -10.14 72.33 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.0 1.762 . . . . 0.0 114.995 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -80.74 145.0 31.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.179 1.489 . . . . 0.0 114.667 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.1 mm -70.82 135.06 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.225 0.61 . . . . 0.0 111.817 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 42.1 pt -121.22 -20.52 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.493 1.117 . . . . 0.0 113.321 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.7 -176.03 1.19 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.896 1.678 . . . . 0.0 111.388 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -132.82 134.46 44.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.2 t -71.01 143.65 50.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.179 0.591 . . . . 0.0 112.231 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.88 175.06 21.07 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.554 1.073 . . . . 0.0 113.185 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -87.38 17.34 4.52 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.218 -1.166 . . . . 0.0 112.98 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.269 5.6 p -65.98 137.67 57.29 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.34 -34.06 2.91 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 125.326 1.441 . . . . 0.0 115.094 -174.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.7 144.97 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.3 1.44 . . . . 0.0 112.331 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -75.41 -37.61 60.35 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -170.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.269 1.3 m -127.13 -70.61 0.71 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -169.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.8 p -145.13 146.0 31.62 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.19 134.61 8.37 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.979 1.752 . . . . 0.0 113.736 171.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -97.84 150.38 21.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.856 1.662 . . . . 0.0 111.87 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -156.97 171.12 21.03 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.569 -0.707 . . . . 0.0 111.684 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.42 120.88 41.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.167 1.387 . . . . 0.0 110.887 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -98.45 99.41 10.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.301 1.04 . . . . 0.0 110.583 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.283 36.8 t80 -88.75 116.66 27.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -122.29 116.95 24.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.323 1.049 . . . . 0.0 111.886 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -95.29 131.39 41.42 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.747 1.619 . . . . 0.0 110.93 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.8 mtm -132.43 155.09 49.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.681 1.593 . . . . 0.0 111.498 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -128.76 136.7 50.91 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.304 1.442 . . . . 0.0 111.235 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.39 2.75 43.85 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.75 -175.81 43.78 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.6 2.048 . . . . 0.0 111.0 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.56 123.29 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 122.438 1.114 . . . . 0.0 108.266 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.07 159.58 9.94 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.724 2.583 . . . . 0.0 110.685 -165.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.61 -46.68 83.78 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.774 1.287 . . . . 0.0 113.534 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.72 -15.98 63.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -76.28 -15.07 60.08 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.27 152.31 42.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.51 1.124 . . . . 0.0 113.861 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -119.97 -90.49 0.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.37 1.468 . . . . 0.0 112.409 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -160.91 118.13 1.44 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.371 1.469 . . . . 0.0 108.385 165.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -20.9 29.96 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.096 2.531 . . . . 0.0 115.512 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -50.86 -55.32 28.28 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.98 -28.2 42.09 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.905 3.07 . . . . 0.0 112.873 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.46 -34.51 78.46 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.2 mt -79.14 -32.66 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.107 0.563 . . . . 0.0 111.37 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.81 -5.59 2.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -117.45 -9.05 10.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.964 1.706 . . . . 0.0 113.804 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 58.7 mt -63.98 152.53 87.15 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.198 1.399 . . . . 0.0 113.078 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.97 -32.71 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.539 2.826 . . . . 0.0 114.603 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.64 13.43 19.93 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.108 1.363 . . . . 0.0 113.09 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.06 -135.73 48.67 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.98 0.8 . . . . 0.0 112.197 -167.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.23 -26.92 53.07 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.91 -10.28 56.29 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.7 t -78.66 0.62 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.211 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.7 mt -111.13 -16.23 13.51 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.726 1.61 . . . . 0.0 112.834 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -146.24 153.87 41.08 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.771 1.623 . . . . 0.0 114.558 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -107.75 76.53 1.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.399 1.095 . . . . 0.0 113.317 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 C--O 1.239 0.543 0 C-N-CA 124.464 1.105 . . . . 0.0 109.454 169.065 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.1 m -66.15 155.61 36.43 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.099 1.36 . . . . 0.0 114.302 -175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -94.01 -31.89 14.05 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.375 1.47 . . . . 0.0 112.21 161.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -147.22 161.87 40.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.126 1.77 . . . . 0.0 112.656 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -138.88 -178.45 5.33 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.899 1.679 . . . . 0.0 113.135 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.356 4.4 p30 -68.85 51.9 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 128.001 2.52 . . . . 0.0 117.645 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.274 12.8 m-85 -93.24 135.71 34.19 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 120.015 3.339 . . . . 0.0 120.015 -172.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -111.31 149.46 31.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 128.262 2.625 . . . . 0.0 116.275 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.0 mtm-85 -138.5 60.9 1.6 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.93 -39.73 95.06 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 159.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -84.92 135.46 34.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.186 0.995 . . . . 0.0 109.952 156.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -71.3 -9.57 58.34 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -166.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -79.73 126.11 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 119.569 1.077 . . . . 0.0 111.488 -170.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.251 0.7 OUTLIER -74.95 -42.19 58.16 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 167.09 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.49 122.22 10.54 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.486 1.514 . . . . 0.0 109.801 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.0 p -82.51 170.82 14.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.177 1.391 . . . . 0.0 112.434 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -67.39 131.18 45.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.19 -90.4 0.18 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.116 0.865 . . . . 0.0 112.439 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -137.21 163.07 31.76 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.988 1.315 . . . . 0.0 113.533 -164.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.85 172.03 8.74 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 164.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -88.42 -0.88 57.67 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.313 1.045 . . . . 0.0 113.047 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -62.59 -29.85 70.9 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.737 1.215 . . . . 0.0 114.163 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.4 p -158.09 162.25 27.3 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.482 1.113 . . . . 0.0 111.038 168.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.85 -8.61 20.4 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.01 2.474 . . . . 0.0 113.449 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -89.62 -63.6 1.26 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -171.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.08 168.83 26.04 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 122.498 1.142 . . . . 0.0 109.547 -168.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.39 110.67 2.36 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 127.558 2.504 . . . . 0.0 110.821 -171.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -122.25 137.59 54.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.027 1.331 . . . . 0.0 113.954 -165.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -122.18 136.99 54.98 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.105 1.762 . . . . 0.0 110.847 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -122.47 27.22 7.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.155 0.982 . . . . 0.0 113.627 -166.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.99 -169.47 17.5 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.888 -1.132 . . . . 0.0 113.588 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.585 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -113.68 132.8 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.995 2.118 . . . . 0.0 108.617 173.509 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.96 93.76 4.61 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -79.82 111.19 15.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 121.55 17.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.729 0.695 . . . . 0.0 111.307 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.8 mt -135.99 156.78 76.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.373 1.469 . . . . 0.0 110.653 -173.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.29 137.68 67.11 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.56 2.174 . . . . 0.0 110.774 160.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -60.21 133.37 56.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 0.0 111.063 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.29 5.25 89.02 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.24 -1.311 . . . . 0.0 115.07 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.5 m -55.12 125.55 57.75 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.179 1.99 . . . . 0.0 110.506 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.579 ' HB2' HD12 ' A' ' 142' ' ' ILE . 10.9 Cg_endo -68.02 132.31 26.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.968 1.779 . . . . 0.0 111.851 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.46 126.22 41.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.208 1.803 . . . . 0.0 107.665 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -95.99 153.61 17.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.216 1.007 . . . . 0.0 110.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.32 123.71 89.44 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.727 -0.608 . . . . 0.0 110.672 172.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.19 -40.19 20.58 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.992 2.461 . . . . 0.0 111.475 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.1 p -134.82 165.02 26.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.079 2.552 . . . . 0.0 111.309 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -70.94 136.03 48.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.493 1.117 . . . . 0.0 112.056 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.54 -157.32 13.22 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.521 1.058 . . . . 0.0 114.629 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.68 150.42 31.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.557 1.943 . . . . 0.0 110.19 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 t -66.01 133.26 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -41.74 8.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -158.88 145.64 17.17 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.069 1.748 . . . . 0.0 109.372 -169.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.6 mt -137.32 129.87 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.901 1.28 . . . . 0.0 108.864 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -157.53 173.38 16.97 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -128.54 152.73 47.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.119 0.967 . . . . 0.0 111.141 170.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -145.16 143.03 30.12 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.281 1.432 . . . . 0.0 112.68 -174.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -66.22 -21.91 66.32 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.06 -37.85 9.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.888 1.275 . . . . 0.0 112.156 171.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -91.54 -9.5 62.91 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.855 1.217 . . . . 0.0 115.917 -168.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.0 -154.98 52.56 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.021 0.91 . . . . 0.0 112.455 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -69.29 144.17 53.64 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.857 -0.79 . . . . 0.0 111.438 165.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.51 137.01 56.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.607 1.563 . . . . 0.0 114.823 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.4 tp -115.95 123.44 48.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.21 125.47 48.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.276 1.03 . . . . 0.0 109.753 171.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.1 mt -121.45 147.46 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.588 1.155 . . . . 0.0 111.606 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.87 136.95 49.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.692 1.997 . . . . 0.0 110.812 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -76.42 154.93 34.4 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.876 0.87 . . . . 0.0 112.773 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -58.21 -28.71 65.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -175.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -85.68 0.36 52.93 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.85 5.13 90.04 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 160.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.23 -31.54 7.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.54 1.67 . . . . 0.0 112.209 -174.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.295 52.4 m-85 -88.03 131.07 34.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 172.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -115.16 151.86 33.64 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.376 1.87 . . . . 0.0 110.746 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.89 102.85 4.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.123 1.769 . . . . 0.0 110.206 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -85.31 139.83 31.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.384 0.274 . . . . 0.0 111.193 170.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -126.25 91.36 3.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.532 2.333 . . . . 0.0 109.436 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.55 158.36 16.49 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.961 1.304 . . . . 0.0 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 63.54 56.34 1.62 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.503 1.921 . . . . 0.0 114.124 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.2 mt -96.49 147.37 23.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 111.332 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -84.42 -48.49 9.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.63 148.11 30.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.062 1.745 . . . . 0.0 112.076 -169.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -93.66 144.62 25.22 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.938 1.295 . . . . 0.0 113.153 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -104.36 -10.97 17.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.605 0.762 . . . . 0.0 112.288 166.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.53 164.31 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.97 1.708 . . . . 0.0 113.191 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.45 164.37 14.98 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.016 2.126 . . . . 0.0 110.515 168.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.73 128.12 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.74 7.9 74.16 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.634 1.111 . . . . 0.0 115.747 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.27 133.32 35.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.044 1.922 . . . . 0.0 107.276 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -70.5 146.24 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.016 0.527 . . . . 0.0 111.8 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.6 m -129.33 154.06 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 110.007 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -133.5 140.59 47.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.954 1.702 . . . . 0.0 108.736 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.26 125.68 11.39 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.264 1.031 . . . . 0.0 112.751 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.63 -1.37 66.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.829 1.68 . . . . 0.0 115.46 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -88.54 142.29 27.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.125 1.37 . . . . 0.0 114.031 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.1 mm -67.3 132.12 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.084 0.856 . . . . 0.0 111.774 177.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 44.2 pt -116.57 -23.17 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.826 1.25 . . . . 0.0 113.211 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -172.54 -175.49 1.35 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.623 1.969 . . . . 0.0 110.665 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.38 139.14 46.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 0.0 107.505 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.11 144.37 50.29 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.64 0.776 . . . . 0.0 112.126 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.93 156.23 26.89 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 123.664 0.649 . . . . 0.0 113.004 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -82.36 31.45 0.4 Allowed 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.05 -1.265 . . . . 0.0 113.685 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.3 p -67.21 134.25 51.33 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.055 0.942 . . . . 0.0 110.93 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 72.67 -20.78 1.0 Allowed Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.314 1.435 . . . . 0.0 116.319 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.5 140.79 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.635 1.717 . . . . 0.0 111.617 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -74.95 -0.8 19.89 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.158 1.783 . . . . 0.0 115.376 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.3 t -153.56 140.46 19.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.017 2.127 . . . . 0.0 110.806 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.334 4.8 p -72.34 21.44 0.06 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.802 2.89 . . . . 0.0 118.802 -164.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.51 -9.19 81.81 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 116.789 1.476 . . . . 0.0 116.789 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 56.89 28.15 14.13 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 163.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -76.46 134.47 39.53 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -169.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.54 117.37 14.13 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.08 0.952 . . . . 0.0 111.138 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -92.68 101.54 13.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.713 0.805 . . . . 0.0 110.784 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.281 52.9 t80 -93.28 115.65 28.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 170.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -117.62 116.08 26.36 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.632 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -92.24 121.85 34.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.72 1.608 . . . . 0.0 110.426 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.6 mtm -125.67 153.18 44.22 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.341 1.456 . . . . 0.0 110.756 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.12 128.92 46.97 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.654 1.181 . . . . 0.0 110.817 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.61 1.71 83.53 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.285 1.421 . . . . 0.0 115.812 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.51 -174.7 43.85 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.031 1.777 . . . . 0.0 111.846 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.8 125.3 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.618 1.167 . . . . 0.0 114.126 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 151.81 171.5 19.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.648 1.594 . . . . 0.0 113.037 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -65.06 -34.93 79.6 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.343 -1.093 . . . . 0.0 112.15 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.35 67.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.462 1.505 . . . . 0.0 113.58 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -92.94 -14.85 27.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.77 144.61 57.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.537 1.135 . . . . 0.0 112.329 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -116.24 -82.9 0.63 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.048 0.939 . . . . 0.0 112.24 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -170.4 129.02 0.81 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 128.125 2.57 . . . . 0.0 106.111 160.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.469 ' HG2' HD12 ' A' ' 79' ' ' ILE . 69.7 Cg_endo -71.58 -24.48 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.948 2.432 . . . . 0.0 114.539 171.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.585 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -54.05 -55.08 40.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -171.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.88 -31.09 48.28 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.688 2.925 . . . . 0.0 112.082 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -65.1 -41.62 94.77 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.45 HD12 HD13 ' A' ' 79' ' ' ILE . 29.9 mt -71.58 -35.78 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.391 0.541 . . . . 0.0 111.303 174.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 44.3 m-20 -63.68 -2.85 1.9 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -126.53 -7.59 6.29 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.096 2.158 . . . . 0.0 115.01 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.76 151.12 55.05 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.14 0.976 . . . . 0.0 112.484 170.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.41 -32.87 49.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.537 2.824 . . . . 0.0 114.947 -168.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.98 10.2 24.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.534 1.133 . . . . 0.0 109.61 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.68 -136.26 44.32 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.548 -1.345 . . . . 0.0 111.915 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.7 -25.28 68.08 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.934 -1.333 . . . . 0.0 113.939 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -68.41 -3.28 10.7 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.9 m -77.3 -6.69 54.12 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 111.94 166.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.06 -12.92 12.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.779 1.632 . . . . 0.0 113.854 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.13 161.52 38.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -114.81 87.01 2.55 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 122.228 1.013 . . . . 0.0 111.904 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.203 1.401 . . . . 0.0 110.915 177.942 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 CA-C-O 120.781 0.101 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -113.34 154.55 26.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.855 1.262 . . . . 0.0 110.665 165.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.42 162.6 13.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.627 1.571 . . . . 0.0 111.005 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -134.29 133.21 40.5 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.708 1.203 . . . . 0.0 112.832 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -68.02 142.16 55.99 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.017 0.913 . . . . 0.0 112.129 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -117.07 147.84 42.03 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.087 1.755 . . . . 0.0 114.73 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.262 21.9 t80 -56.58 136.71 54.45 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 116.542 2.052 . . . . 0.0 116.542 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.281 1.1 p90 -141.43 147.74 38.43 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 117.743 2.497 . . . . 0.0 117.743 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -130.84 152.22 50.41 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.484 1.914 . . . . 0.0 111.094 166.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.24 -107.85 2.0 Allowed Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -167.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.7 m -64.58 152.1 42.93 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -126.17 34.81 4.78 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.89 138.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 O-C-N 120.05 -1.656 . . . . 0.0 112.671 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 p -107.41 -27.11 10.65 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.294 2.238 . . . . 0.0 116.379 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -146.51 149.92 34.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.979 1.712 . . . . 0.0 110.39 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.1 p -135.94 169.17 18.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.852 1.661 . . . . 0.0 109.484 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -68.27 126.23 28.92 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.38 -142.57 8.56 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.427 0.537 . . . . 0.0 113.739 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -132.9 146.76 52.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.408 1.483 . . . . 0.0 111.067 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -67.0 138.9 57.58 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -72.56 -49.84 29.68 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.375 0.67 . . . . 0.0 109.763 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -144.44 131.34 20.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.841 1.656 . . . . 0.0 110.752 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 p -162.55 164.99 16.04 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.118 0.967 . . . . 0.0 111.971 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.58 -6.76 11.69 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.262 2.641 . . . . 0.0 113.143 167.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -93.33 -174.41 3.51 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.683 1.593 . . . . 0.0 109.984 -167.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.293 8.7 p30 -64.5 -14.13 55.71 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.21 13.96 27.44 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.475 1.512 . . . . 0.0 116.226 167.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -130.74 144.56 51.53 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.259 2.029 . . . . 0.0 113.178 -167.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -147.07 131.47 17.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.579 -0.701 . . . . 0.0 112.832 -170.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.66 21.29 7.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.17 -172.08 13.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.703 1.144 . . . . 0.0 113.903 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.78 136.8 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.342 2.257 . . . . 0.0 108.549 173.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.07 100.88 7.82 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.49 130.61 36.22 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.32 34.22 0.13 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.968 2.107 . . . . 0.0 115.901 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 148.74 90.33 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.727 -1.233 . . . . 0.0 111.835 -168.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.43 146.54 85.59 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.213 1.942 . . . . 0.0 111.982 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.12 129.0 33.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.967 0.907 . . . . 0.0 110.331 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.62 63.06 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.707 1.146 . . . . 0.0 115.523 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -58.87 126.5 80.97 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-N 119.612 1.706 . . . . 0.0 113.15 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.572 ' HB2' HD12 ' A' ' 142' ' ' ILE . 14.2 Cg_endo -69.66 130.31 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.27 1.98 . . . . 0.0 112.317 172.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 146' ' ' SER . 27.4 mm -85.13 129.6 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.974 1.71 . . . . 0.0 108.532 170.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -100.78 151.98 21.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.164 . . . . 0.0 110.39 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.75 88.98 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.367 0.667 . . . . 0.0 111.621 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.71 -26.02 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.176 3.251 . . . . 0.0 113.249 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.9 p -133.27 164.33 27.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 127.306 2.242 . . . . 0.0 110.263 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.98 145.39 46.32 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.169 -0.957 . . . . 0.0 108.479 151.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.83 -163.92 24.67 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.144 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -147.28 143.75 28.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.58 1.152 . . . . 0.0 111.917 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.16 128.11 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.33 -43.88 7.83 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.426 1.491 . . . . 0.0 114.947 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -159.21 144.1 15.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.048 0.939 . . . . 0.0 110.992 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -140.75 114.85 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.674 1.19 . . . . 0.0 109.88 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -154.24 -177.27 6.33 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -167.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -139.65 150.54 45.05 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.981 -1.074 . . . . 0.0 111.828 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -123.84 162.18 23.79 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.108 1.763 . . . . 0.0 111.215 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.5 pm0 -66.14 -40.92 90.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 -169.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.2 -11.19 6.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.796 1.238 . . . . 0.0 113.842 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.14 -6.53 88.83 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.826 1.679 . . . . 0.0 114.006 163.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.24 -156.39 53.54 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.95 0.786 . . . . 0.0 113.49 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -69.11 145.86 53.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.048 -0.678 . . . . 0.0 111.958 171.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.13 137.45 55.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 tp -115.95 131.5 56.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.719 2.007 . . . . 0.0 108.582 167.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 125.81 53.54 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.59 1.156 . . . . 0.0 110.316 173.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.17 144.46 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.27 1.028 . . . . 0.0 111.552 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.36 136.27 41.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.654 1.982 . . . . 0.0 110.793 171.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -79.16 159.69 27.3 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.628 0.771 . . . . 0.0 111.619 170.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -74.66 -10.62 59.7 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.318 -1.489 . . . . 0.0 114.367 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -58.65 -24.17 60.64 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.602 1.561 . . . . 0.0 112.454 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.72 2.08 56.33 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.648 1.594 . . . . 0.0 115.226 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -142.65 -28.0 0.59 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -86.28 141.53 29.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.73 159.08 31.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.556 2.742 . . . . 0.0 112.117 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.62 105.26 4.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.184 2.194 . . . . 0.0 110.96 -171.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -85.79 144.33 27.8 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.472 0.709 . . . . 0.0 112.314 171.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.42 87.12 2.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.136 2.574 . . . . 0.0 108.887 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.39 159.55 19.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.044 1.338 . . . . 0.0 110.918 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 62.87 50.41 3.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.754 2.021 . . . . 0.0 114.455 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.9 mt -89.79 158.41 17.51 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.672 -1.267 . . . . 0.0 112.419 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -98.76 -46.61 5.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 0.0 109.13 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -150.14 149.41 30.21 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.207 1.803 . . . . 0.0 111.888 -171.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -103.39 134.52 46.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 112.108 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -87.43 -27.51 22.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.125 0.57 . . . . 0.0 111.791 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -112.93 166.72 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.023 1.729 . . . . 0.0 112.521 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -116.69 162.22 18.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.801 2.04 . . . . 0.0 111.283 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.2 t -55.99 126.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.401 1.081 . . . . 0.0 109.189 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.34 12.14 61.79 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.453 1.501 . . . . 0.0 115.389 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -96.4 133.69 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.764 1.782 . . . . 0.0 107.657 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -72.97 146.75 45.79 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.011 0.924 . . . . 0.0 111.413 167.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.86 167.12 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.343 1.857 . . . . 0.0 111.879 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.85 134.16 44.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.427 1.891 . . . . 0.0 110.055 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.55 121.78 3.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.045 1.338 . . . . 0.0 112.851 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.81 4.69 69.35 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.523 1.535 . . . . 0.0 115.412 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -90.25 148.97 22.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 114.649 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 88' ' ' PRO . 14.8 mm -70.12 139.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.63 0.729 . . . . 0.0 111.469 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.53 -23.06 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.507 1.123 . . . . 0.0 112.544 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.15 -179.01 2.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.026 1.33 . . . . 0.0 111.368 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.97 138.14 54.76 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.502 ' HB3' HD11 ' A' ' 89' ' ' ILE . 80.0 p -66.43 135.99 55.08 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.651 1.18 . . . . 0.0 112.104 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -126.52 168.56 18.63 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 122.389 0.994 . . . . 0.0 113.318 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -85.56 1.28 49.72 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.095 1.358 . . . . 0.0 112.802 174.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.0 p -57.37 130.1 44.74 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.714 1.605 . . . . 0.0 114.183 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.3 -20.89 1.16 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.151 1.358 . . . . 0.0 116.35 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 mt -87.14 -70.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.889 1.845 . . . . 0.0 111.425 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -154.42 166.02 34.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.103 1.761 . . . . 0.0 108.758 -167.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.346 0.6 OUTLIER -67.22 -25.52 66.14 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 176.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.267 0.7 OUTLIER -132.32 -26.12 1.9 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 174.187 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -76.18 142.09 27.88 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.677 1.132 . . . . 0.0 114.437 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.65 152.13 38.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.983 1.313 . . . . 0.0 113.811 -166.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -160.21 133.96 7.09 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.477 1.511 . . . . 0.0 112.157 169.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.19 116.11 16.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.487 -1.383 . . . . 0.0 111.082 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -94.62 102.04 13.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.855 0.752 . . . . 0.0 111.774 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.275 43.9 t80 -93.9 116.81 29.3 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.381 1.473 . . . . 0.0 114.77 171.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -124.6 116.61 22.69 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.757 1.223 . . . . 0.0 111.654 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -101.1 127.08 47.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.517 1.127 . . . . 0.0 111.409 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.2 mtm -128.44 157.33 41.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.792 1.637 . . . . 0.0 111.65 -173.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -136.09 137.17 40.79 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.177 1.391 . . . . 0.0 111.243 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.78 -18.61 8.72 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.167 1.365 . . . . 0.0 115.031 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -176.83 -168.74 37.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.152 1.834 . . . . 0.0 111.273 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.59 112.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 156.49 169.36 20.45 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.895 1.712 . . . . 0.0 111.557 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -61.14 -40.64 94.59 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.361 -1.082 . . . . 0.0 113.245 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.47 -26.95 67.17 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.51 -11.86 55.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.55 141.82 51.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.734 1.214 . . . . 0.0 112.651 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -106.03 -80.09 0.56 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -174.51 123.93 0.38 Allowed Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 128.37 2.668 . . . . 0.0 106.147 160.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.42 -29.49 11.09 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.054 2.503 . . . . 0.0 114.715 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -59.63 -52.84 71.17 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.58 -30.69 70.93 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.926 2.417 . . . . 0.0 111.881 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.17 -45.75 93.32 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 166.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.7 mt -69.53 -32.12 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.767 -1.208 . . . . 0.0 111.719 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.08 0.42 1.95 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.061 1.744 . . . . 0.0 115.07 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -124.74 -8.52 7.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 114.303 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.59 151.31 88.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.927 -1.108 . . . . 0.0 112.82 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.5 -35.2 39.87 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.743 2.962 . . . . 0.0 114.806 -165.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -112.13 16.4 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.923 1.289 . . . . 0.0 112.16 166.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.38 -134.72 48.04 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 121.076 -1.015 . . . . 0.0 112.441 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.34 -22.7 65.16 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.419 -1.048 . . . . 0.0 112.544 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.6 mtt-85 -72.3 -3.36 23.31 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.632 -1.293 . . . . 0.0 112.564 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 75.5 m -84.54 -7.53 59.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.501 1.12 . . . . 0.0 113.054 163.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.94 -19.88 15.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.777 1.631 . . . . 0.0 111.671 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -147.41 160.21 42.82 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -104.9 86.24 2.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.472 0.655 0 C-N-CA 124.604 1.162 . . . . 0.0 109.666 173.5 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 m -97.37 -13.58 21.77 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -76.68 153.07 35.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.265 1.426 . . . . 0.0 111.353 171.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -65.63 119.98 12.12 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 118.137 0.426 . . . . 0.0 111.542 166.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -64.83 148.46 51.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.376 1.07 . . . . 0.0 112.73 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -78.17 143.69 37.01 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.163 1.385 . . . . 0.0 112.073 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -84.57 166.04 17.51 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.288 56.0 m-85 -108.8 -21.73 12.54 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 171.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -141.2 167.17 22.83 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.609 1.964 . . . . 0.0 110.912 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.42 147.01 48.09 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 123.844 0.735 . . . . 0.0 113.351 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.8 t -148.09 151.48 35.72 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -81.35 -11.13 59.4 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.209 2.204 . . . . 0.0 113.679 170.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.1 mt -79.69 116.65 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 120.336 1.425 . . . . 0.0 112.158 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.273 1.3 p -64.64 -52.71 55.96 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.315 1.046 . . . . 0.0 113.663 169.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -143.89 128.15 17.75 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.884 1.674 . . . . 0.0 110.939 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.1 p -83.27 -172.25 4.03 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.403 1.481 . . . . 0.0 108.451 171.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -70.26 122.92 20.45 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.07 -155.09 18.59 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 121.491 -0.755 . . . . 0.0 112.716 -172.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -136.98 148.8 47.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.398 1.099 . . . . 0.0 113.179 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.27 48.8 m-85 -67.88 -36.3 80.0 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 119.3 3.074 . . . . 0.0 119.3 -160.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -133.84 156.59 47.79 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.288 1.435 . . . . 0.0 111.696 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -64.95 4.89 0.38 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.036 1.734 . . . . 0.0 115.664 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.0 p -56.81 166.52 1.32 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 128.301 2.64 . . . . 0.0 112.788 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.11 -15.18 35.69 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.648 2.232 . . . . 0.0 113.921 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -73.59 159.0 33.75 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.993 1.317 . . . . 0.0 114.165 -167.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -84.71 37.3 0.64 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 125.947 1.699 . . . . 0.0 110.725 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.48 59.76 2.43 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 127.436 2.446 . . . . 0.0 114.477 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -79.38 146.37 32.87 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 -167.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -97.54 125.32 42.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.875 1.67 . . . . 0.0 109.491 155.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -112.71 93.96 4.68 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.78 -172.47 26.45 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.198 0.904 . . . . 0.0 113.444 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.557 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -120.23 134.62 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.705 2.002 . . . . 0.0 108.862 173.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -110.53 92.29 3.99 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -78.37 106.18 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.72 120.24 10.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.341 0.973 . . . . 0.0 110.744 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.8 mt -129.83 152.32 79.67 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 124.012 0.925 . . . . 0.0 111.106 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.58 135.52 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.476 -1.009 . . . . 0.0 109.476 160.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.4 tttt -58.67 139.04 56.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.846 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 -6.46 76.29 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.111 -1.383 . . . . 0.0 115.881 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.4 m -51.76 127.53 34.4 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.693 2.247 . . . . 0.0 112.964 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HB2' HD12 ' A' ' 142' ' ' ILE . 11.7 Cg_endo -68.42 131.26 22.79 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.852 1.701 . . . . 0.0 112.084 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.2 132.2 32.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.152 1.781 . . . . 0.0 107.824 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -104.52 155.65 18.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 109.492 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.04 129.59 82.65 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.263 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.13 -31.87 22.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.382 2.721 . . . . 0.0 113.472 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -140.21 159.97 41.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.957 2.103 . . . . 0.0 107.546 -171.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -77.01 138.48 39.62 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.93 -1.106 . . . . 0.0 111.764 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.7 -157.05 10.05 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.075 1.322 . . . . 0.0 113.651 -173.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.91 146.86 25.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.428 1.491 . . . . 0.0 113.005 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.21 129.3 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -43.11 6.92 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -159.41 141.65 13.61 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.694 1.198 . . . . 0.0 110.983 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 55.5 mt -142.6 113.83 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.785 1.234 . . . . 0.0 110.965 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -157.2 -173.36 4.4 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.493 1.117 . . . . 0.0 111.823 -168.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.85 132.71 47.79 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.091 -1.005 . . . . 0.0 111.054 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -76.95 130.25 37.26 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -70.4 -18.36 63.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.47 -3.43 59.0 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.215 1.006 . . . . 0.0 112.806 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -150.03 -154.63 6.5 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-O 122.801 1.223 . . . . 0.0 112.579 -147.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -108.44 -166.81 21.1 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.799 1.666 . . . . 0.0 113.7 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -66.29 148.01 52.48 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.416 -0.461 . . . . 0.0 111.909 170.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.13 137.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.777 1.631 . . . . 0.0 115.051 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.9 tp -117.87 126.68 52.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.042 2.137 . . . . 0.0 108.955 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.01 126.38 52.13 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.819 1.248 . . . . 0.0 110.256 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.97 147.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.998 1.319 . . . . 0.0 111.45 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.04 137.3 47.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.696 1.998 . . . . 0.0 110.144 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -74.43 146.17 43.07 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.223 -0.923 . . . . 0.0 113.443 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -66.6 -20.67 66.06 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.61 -26.06 67.66 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 121.497 -0.752 . . . . 0.0 112.491 168.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.93 18.81 10.16 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 117.994 1.957 . . . . 0.0 117.994 157.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -143.8 -25.09 0.56 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.34 2.07 . . . . 0.0 115.873 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.297 42.1 m-85 -79.26 146.65 32.9 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -123.22 161.21 24.98 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 112.141 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -143.84 104.13 4.13 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.252 2.221 . . . . 0.0 110.955 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -84.81 145.8 27.68 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 167.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -130.72 93.33 3.4 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.604 2.362 . . . . 0.0 109.837 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.39 157.37 15.92 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.663 1.185 . . . . 0.0 110.839 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.266 94.1 m-70 69.76 49.79 0.51 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.072 2.149 . . . . 0.0 114.484 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.84 143.82 25.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.873 0.869 . . . . 0.0 111.485 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.11 -43.32 15.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.402 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -154.48 151.11 28.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.016 2.526 . . . . 0.0 110.847 -169.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -96.96 159.33 14.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.744 0.818 . . . . 0.0 111.238 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -109.67 -28.58 8.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.448 1.099 . . . . 0.0 112.385 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.78 168.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.165 1.786 . . . . 0.0 110.667 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -128.12 172.1 11.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 111.358 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.98 130.8 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.275 1.03 . . . . 0.0 109.224 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.15 3.46 72.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.783 1.182 . . . . 0.0 115.323 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.75 126.14 31.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.015 1.407 . . . . 0.0 111.877 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.24 124.89 28.19 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.803 0.441 . . . . 0.0 111.488 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -106.94 157.03 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.858 1.663 . . . . 0.0 110.46 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.36 140.54 52.11 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.656 1.582 . . . . 0.0 109.307 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -44.02 123.31 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.446 1.098 . . . . 0.0 112.992 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.96 6.95 86.21 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.246 1.403 . . . . 0.0 115.362 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -91.63 145.88 24.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.374 1.469 . . . . 0.0 112.858 170.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 88' ' ' PRO . 20.2 mm -70.12 137.93 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.081 0.855 . . . . 0.0 112.114 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -123.58 -24.05 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.19 -173.17 1.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.45 1.023 . . . . 0.0 111.629 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.55 137.05 41.64 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.161 1.385 . . . . 0.0 107.3 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.8 t -75.56 142.62 42.72 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.71 163.9 28.52 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.268 0.937 . . . . 0.0 113.157 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -79.97 30.72 0.26 Allowed 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.092 -1.24 . . . . 0.0 112.526 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.284 6.7 p -66.07 127.39 31.91 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.818 1.247 . . . . 0.0 112.153 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.04 89.38 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 117.658 -1.634 . . . . 0.0 116.822 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mt -123.13 135.96 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.285 2.043 . . . . 0.0 112.395 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -74.48 8.32 2.35 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.613 1.965 . . . . 0.0 114.762 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.0 p -129.55 151.95 49.61 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -171.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.314 0.9 OUTLIER -83.41 152.8 24.84 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.027 1.331 . . . . 0.0 113.721 171.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.7 167.09 42.45 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -152.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.82 168.15 23.75 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.189 1.396 . . . . 0.0 111.82 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -150.99 171.59 17.05 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.309 0.644 . . . . 0.0 111.714 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.81 121.56 42.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 110.485 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -96.11 102.4 14.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.92 0.888 . . . . 0.0 110.524 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.76 112.86 24.8 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.371 1.468 . . . . 0.0 114.65 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.44 118.62 35.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.19 0.596 . . . . 0.0 112.155 174.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -93.84 127.56 39.65 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.639 1.576 . . . . 0.0 111.55 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.1 mtm -132.16 162.43 30.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.475 1.91 . . . . 0.0 111.593 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -132.5 128.91 38.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.39 1.076 . . . . 0.0 112.796 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.87 6.93 74.32 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.254 1.261 . . . . 0.0 116.254 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.63 -179.6 44.04 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 126.439 1.971 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.72 128.9 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.282 1.433 . . . . 0.0 112.336 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.62 156.79 6.97 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.786 1.66 . . . . 0.0 112.056 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -48.2 -42.51 30.15 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.23 62.41 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -92.28 -13.41 30.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.628 1.571 . . . . 0.0 114.537 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.54 148.18 34.26 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.314 1.045 . . . . 0.0 113.508 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -116.99 -96.78 0.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.714 1.606 . . . . 0.0 111.826 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -159.51 118.24 1.65 Allowed Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.603 1.961 . . . . 0.0 113.114 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.439 ' HG2' HD12 ' A' ' 79' ' ' ILE . 89.2 Cg_endo -85.35 -30.97 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.913 1.742 . . . . 0.0 114.296 175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.557 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -52.37 -55.71 29.25 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 121.169 1.804 . . . . 0.0 114.697 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.01 -26.75 21.34 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.778 2.985 . . . . 0.0 112.225 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -67.26 -37.48 83.54 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.05 -44.95 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.093 0.557 . . . . 0.0 110.572 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -67.52 -0.89 4.2 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -173.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -111.92 -9.57 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.212 1.805 . . . . 0.0 113.52 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.28 159.15 42.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.243 1.417 . . . . 0.0 113.378 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.35 -48.06 24.02 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.73 3.62 . . . . 0.0 114.062 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -114.08 8.85 17.13 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.446 1.099 . . . . 0.0 113.356 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.51 -135.79 27.41 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.562 1.077 . . . . 0.0 111.961 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.18 -28.83 19.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.605 1.162 . . . . 0.0 113.6 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -70.72 -7.84 47.78 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.055 -1.028 . . . . 0.0 113.31 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.4 m -81.49 -3.86 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.802 0.841 . . . . 0.0 112.27 167.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.1 mp -111.11 -14.83 13.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.993 1.717 . . . . 0.0 113.322 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -145.03 161.88 38.31 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.234 -1.541 . . . . 0.0 113.76 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -110.14 82.75 1.64 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.015 0.912 . . . . 0.0 113.134 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 125.316 1.446 . . . . 0.0 111.061 174.22 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 CA-C-O 120.969 0.205 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.2 t -77.28 139.58 39.85 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.969 1.708 . . . . 0.0 114.682 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -80.67 -43.63 20.09 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.191 1.796 . . . . 0.0 112.764 172.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 t-105 -163.04 148.56 11.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.197 1.799 . . . . 0.0 110.724 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.64 -13.56 0.5 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 172.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.72 146.18 55.1 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 118.11 2.633 . . . . 0.0 118.11 -175.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -59.6 -36.31 76.03 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -140.89 164.79 29.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.918 2.087 . . . . 0.0 114.677 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -98.23 124.47 42.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.553 1.541 . . . . 0.0 112.187 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.57 -32.3 78.39 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 123.51 0.576 . . . . 0.0 113.084 168.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.4 p -152.44 156.57 39.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.048 1.739 . . . . 0.0 112.856 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 62.3 mtt85 -77.33 16.38 0.62 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.9 mt -77.62 122.74 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 121.072 -1.017 . . . . 0.0 111.371 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 p -75.49 -45.73 36.57 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.466 0.914 . . . . 0.0 113.466 165.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -134.92 119.12 17.66 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.796 1.638 . . . . 0.0 110.503 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 p -81.48 176.63 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.549 1.14 . . . . 0.0 107.94 166.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -67.14 137.93 56.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.94 -173.47 30.45 Favored Glycine 0 N--CA 1.474 1.178 0 O-C-N 121.136 -0.978 . . . . 0.0 112.879 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -67.12 154.64 40.74 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.442 1.621 . . . . 0.0 111.526 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -67.01 138.16 57.02 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 163.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -152.1 154.75 36.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.713 0.805 . . . . 0.0 111.456 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 65.52 -38.79 0.27 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.511 2.325 . . . . 0.0 115.852 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.7 p -83.87 167.31 28.84 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.152 2.181 . . . . 0.0 111.951 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.94 1.99 5.28 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.66 2.907 . . . . 0.0 114.84 173.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.263 90.4 m-85 -68.95 145.9 53.23 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -124.47 147.94 48.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.48 1.912 . . . . 0.0 114.693 -171.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.85 -141.79 20.4 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.785 0.707 . . . . 0.0 111.55 -170.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -129.92 151.76 50.14 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.039 0.919 . . . . 0.0 112.064 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -89.79 125.66 35.39 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.261 1.824 . . . . 0.0 110.46 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.357 83.2 m-85 -108.12 23.43 14.5 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -170.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.28 -164.51 13.44 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.332 0.968 . . . . 0.0 113.266 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.48 133.71 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 126.609 1.963 . . . . 0.0 108.953 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -110.43 96.48 6.22 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -78.64 123.88 27.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.49 56.59 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.703 2.001 . . . . 0.0 113.847 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.6 149.0 63.55 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.288 -0.883 . . . . 0.0 111.112 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.45 146.28 93.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.05 1.833 . . . . 0.0 111.777 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -54.58 135.48 46.26 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 110.678 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.95 68.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.737 1.161 . . . . 0.0 115.63 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 m -52.71 126.14 39.78 Favored Pre-proline 0 N--CA 1.478 0.936 0 CA-C-N 118.75 1.275 . . . . 0.0 112.238 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.495 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.6 Cg_endo -69.49 129.28 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.09 1.86 . . . . 0.0 111.998 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -85.86 130.59 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 108.468 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -103.35 149.94 24.27 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 109.764 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.54 83.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.879 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.4 -46.86 4.96 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.47 2.78 . . . . 0.0 111.574 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -113.98 172.81 6.77 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 128.487 2.715 . . . . 0.0 109.703 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -68.98 149.97 48.22 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.245 -0.91 . . . . 0.0 110.017 155.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 -154.64 12.45 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.475 0.56 . . . . 0.0 114.159 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -151.24 145.84 25.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.574 1.549 . . . . 0.0 111.021 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -66.0 128.12 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.04 -41.34 9.61 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -159.37 145.67 16.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.001 1.72 . . . . 0.0 109.543 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.0 mt -137.99 127.64 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 109.365 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -155.22 164.09 39.29 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -129.52 147.26 51.31 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.84 0.856 . . . . 0.0 110.257 161.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -101.81 128.7 48.05 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.663 1.185 . . . . 0.0 111.311 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -57.25 -19.14 19.68 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.689 1.996 . . . . 0.0 115.537 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 pp -129.35 19.56 5.8 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.404 1.882 . . . . 0.0 113.251 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.37 -132.58 3.45 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.445 1.498 . . . . 0.0 111.294 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -131.65 -164.75 11.21 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.964 1.269 . . . . 0.0 113.224 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -76.31 145.95 39.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.286 0.635 . . . . 0.0 112.064 166.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.14 143.16 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.861 1.665 . . . . 0.0 114.421 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 tt -122.76 136.6 54.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.803 1.641 . . . . 0.0 109.416 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.52 125.83 52.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.311 0.644 . . . . 0.0 111.935 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.02 147.92 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.883 1.273 . . . . 0.0 111.813 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -112.54 141.45 46.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 111.726 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -80.82 179.2 7.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.769 1.228 . . . . 0.0 113.062 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -48.78 -46.22 41.17 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 118.682 2.845 . . . . 0.0 118.682 -171.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -83.42 -19.1 36.59 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.874 1.27 . . . . 0.0 113.671 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.35 27.2 71.97 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.798 1.19 . . . . 0.0 114.649 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -94.18 -36.62 11.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.635 1.717 . . . . 0.0 110.83 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -79.75 130.62 35.49 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 168.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -121.14 142.97 49.36 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.954 1.702 . . . . 0.0 111.31 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -123.93 103.68 8.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.762 2.025 . . . . 0.0 110.426 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -86.68 144.01 27.33 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.566 0.346 . . . . 0.0 111.62 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -128.7 97.67 4.75 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.427 1.891 . . . . 0.0 106.892 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.28 151.59 22.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 109.844 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 71.56 63.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.937 2.095 . . . . 0.0 113.95 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.4 mt -101.67 155.7 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.512 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.45 -43.3 6.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.738 1.215 . . . . 0.0 110.939 167.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -145.14 150.29 36.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.614 1.566 . . . . 0.0 112.38 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -92.54 158.31 16.07 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.57 1.148 . . . . 0.0 112.441 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -122.2 -10.63 8.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.05 0.94 . . . . 0.0 113.205 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.3 160.81 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.56 1.144 . . . . 0.0 112.341 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -120.26 155.33 33.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.29 1.836 . . . . 0.0 112.841 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.1 t -55.11 123.14 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 0.0 109.413 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.08 0.7 61.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.078 1.323 . . . . 0.0 115.528 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -88.28 128.95 35.49 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.966 1.883 . . . . 0.0 113.3 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -74.55 139.97 44.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.064 0.546 . . . . 0.0 111.998 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.31 159.86 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 110.373 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -126.67 148.3 49.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.407 1.483 . . . . 0.0 108.658 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.42 121.74 4.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.363 1.065 . . . . 0.0 111.984 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.23 10.25 58.55 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.732 1.158 . . . . 0.0 114.971 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.33 134.75 34.09 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.966 1.306 . . . . 0.0 112.676 167.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 88' ' ' PRO . 15.4 mm -65.57 131.41 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 118.888 0.767 . . . . 0.0 110.372 172.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.4 pt -114.98 -21.96 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.479 1.112 . . . . 0.0 113.231 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.44 -179.82 1.96 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 110.904 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -129.63 135.0 48.0 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t -80.27 144.54 32.77 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.71 155.76 26.97 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.312 1.434 . . . . 0.0 112.361 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.251 34.1 p30 -81.7 47.95 1.14 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -172.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 35.5 p -65.38 117.58 8.13 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 164.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.77 25.85 68.64 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 -175.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.14 165.91 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 119.627 1.714 . . . . 0.0 113.44 172.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -51.7 141.59 16.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.972 1.709 . . . . 0.0 113.727 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.287 1.0 OUTLIER -66.2 5.5 0.53 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 171.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.6 p -75.39 -17.39 60.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.014 1.726 . . . . 0.0 114.778 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 157.1 -170.28 34.33 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.334 1.445 . . . . 0.0 111.919 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.25 169.15 17.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.682 1.193 . . . . 0.0 112.918 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -151.13 141.04 21.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.803 0.841 . . . . 0.0 112.656 169.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.85 115.49 19.47 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.159 170.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -93.75 101.29 13.41 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.29 0.636 . . . . 0.0 110.943 172.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.66 117.21 29.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.948 1.299 . . . . 0.0 114.128 171.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -122.6 114.44 20.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.348 1.059 . . . . 0.0 111.888 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -92.51 121.94 34.46 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.208 1.803 . . . . 0.0 110.828 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.1 mtm -127.38 160.86 30.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.238 1.815 . . . . 0.0 111.189 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -140.26 133.96 30.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.11 6.96 81.21 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.722 1.153 . . . . 0.0 115.125 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.29 179.46 38.48 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 127.57 2.51 . . . . 0.0 110.086 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.1 125.07 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.76 168.86 15.45 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.607 1.575 . . . . 0.0 112.875 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -60.3 -36.9 78.95 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.184 -1.186 . . . . 0.0 113.523 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.08 -17.36 63.22 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.795 -1.191 . . . . 0.0 114.05 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.23 -12.55 43.43 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.47 137.11 52.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.567 1.147 . . . . 0.0 112.986 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -103.13 -89.86 0.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -161.91 115.9 1.23 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.575 2.35 . . . . 0.0 113.585 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 -31.76 2.08 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.103 1.869 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -54.37 -53.39 59.93 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.78 -22.56 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.886 3.058 . . . . 0.0 112.052 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -65.52 -42.67 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 167.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 49.0 mt -72.21 -25.62 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.297 -0.877 . . . . 0.0 112.206 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -59.76 -14.2 13.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -118.13 -1.14 11.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.431 1.092 . . . . 0.0 113.641 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.89 148.65 92.23 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.517 0.727 . . . . 0.0 112.632 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.58 -26.45 23.71 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.609 2.873 . . . . 0.0 114.932 -168.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -112.82 -7.86 13.76 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.83 -137.81 13.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.413 1.482 . . . . 0.0 112.535 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -55.09 -30.78 60.39 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.727 1.263 . . . . 0.0 111.694 170.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.0 mtp-105 -63.97 -12.25 36.04 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.476 1.51 . . . . 0.0 113.899 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 71.6 m -79.77 -7.85 58.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.472 1.033 . . . . 0.0 112.565 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.06 -14.0 15.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.106 1.363 . . . . 0.0 112.948 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -149.98 162.3 40.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -111.72 80.57 1.34 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--O 1.24 0.555 0 C-N-CA 124.888 1.275 . . . . 0.0 110.123 173.59 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -62.39 160.83 12.66 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.021 1.328 . . . . 0.0 114.491 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -57.81 139.22 54.56 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.505 0.722 . . . . 0.0 111.367 168.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -76.31 139.77 41.21 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.191 0.519 . . . . 0.0 111.381 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -135.9 129.71 32.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.099 1.36 . . . . 0.0 110.873 167.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -70.95 176.01 4.68 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.325 1.05 . . . . 0.0 113.056 167.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -149.2 162.41 40.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.733 -1.229 . . . . 0.0 111.393 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.275 21.2 t80 -66.46 141.34 57.94 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -137.55 146.53 44.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.208 1.803 . . . . 0.0 110.493 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.66 -12.58 79.86 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.702 1.144 . . . . 0.0 114.179 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.6 p -63.74 161.71 14.67 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.923 1.689 . . . . 0.0 114.062 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.2 mtp85 -103.62 -18.58 14.68 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.462 HG21 HG23 ' A' ' 63' ' ' THR . 59.5 mt -67.05 104.24 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 121.144 1.793 . . . . 0.0 110.999 176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.26 1.2 t -79.88 -24.23 41.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -153.84 130.62 10.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.797 1.239 . . . . 0.0 109.748 164.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.462 HG23 HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -88.02 174.54 8.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -174.021 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -67.13 134.54 51.99 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.129 -0.982 . . . . 0.0 110.918 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.65 -137.05 9.57 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.273 0.94 . . . . 0.0 113.052 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -76.7 155.11 33.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.265 0.626 . . . . 0.0 111.888 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.1 157.9 45.4 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -173.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -59.32 154.24 17.04 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -42.29 132.07 3.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.743 2.017 . . . . 0.0 112.901 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 p -171.53 163.68 4.8 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.316 1.846 . . . . 0.0 110.348 -165.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.91 -25.65 32.43 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.431 2.087 . . . . 0.0 113.489 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -75.59 151.73 37.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.83 1.252 . . . . 0.0 109.903 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -97.55 167.97 10.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.959 1.703 . . . . 0.0 115.312 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.3 -125.96 7.2 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.09 1.196 . . . . 0.0 116.09 162.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.458 ' HE2' ' CZ ' ' A' ' 77' ' ' TYR . 1.7 ptmt -126.88 165.91 18.47 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 126.332 1.853 . . . . 0.0 112.107 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -118.41 93.61 4.18 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.211 1.404 . . . . 0.0 110.89 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CZ ' ' HE2' ' A' ' 75' ' ' LYS 0.526 12.1 m-30 -90.74 39.44 0.98 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -173.423 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.91 -179.55 26.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.82 1.2 . . . . 0.0 112.897 170.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.58 127.48 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.687 1.595 . . . . 0.0 109.501 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -99.26 90.0 4.41 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -74.1 107.24 6.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.97 123.95 20.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.056 0.844 . . . . 0.0 110.294 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 mt -138.35 151.98 70.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.61 0.764 . . . . 0.0 111.228 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.2 136.5 44.26 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.36 2.04 . . . . 0.0 110.033 162.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.02 134.61 52.58 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.207 1.003 . . . . 0.0 109.949 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.32 -8.35 79.32 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.237 -1.313 . . . . 0.0 115.824 -175.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.6 m -53.77 123.81 40.23 Favored Pre-proline 0 N--CA 1.481 1.114 0 CA-C-N 120.219 2.009 . . . . 0.0 112.331 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.556 ' HB2' HD12 ' A' ' 142' ' ' ILE . 32.2 Cg_endo -70.03 130.85 19.71 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.726 1.617 . . . . 0.0 111.161 175.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -85.74 131.2 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.463 1.505 . . . . 0.0 108.216 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -101.32 149.8 23.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.31 1.044 . . . . 0.0 109.84 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.19 130.85 87.45 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.76 -0.588 . . . . 0.0 110.835 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.62 -27.42 15.33 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.923 3.082 . . . . 0.0 112.724 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 p -129.94 161.67 30.36 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.039 2.535 . . . . 0.0 112.905 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -63.92 138.83 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 157.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.52 -155.95 11.37 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -151.99 148.78 28.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.187 1.395 . . . . 0.0 111.584 171.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.66 129.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -41.92 7.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.003 1.721 . . . . 0.0 115.244 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -157.9 143.25 16.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.467 1.107 . . . . 0.0 111.464 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.4 mt -136.42 125.73 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.381 1.072 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -158.82 176.99 11.65 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -127.61 157.48 40.11 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.899 1.28 . . . . 0.0 112.588 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -144.68 144.14 31.08 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.779 1.232 . . . . 0.0 113.681 -165.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -58.44 -30.08 66.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.393 1.477 . . . . 0.0 114.344 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 mt -112.63 -31.39 6.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.765 1.226 . . . . 0.0 112.857 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -86.83 -8.29 76.55 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.751 1.167 . . . . 0.0 115.034 -169.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.12 -150.58 47.61 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 117.696 0.748 . . . . 0.0 112.2 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -71.39 143.73 50.06 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.887 -0.772 . . . . 0.0 111.649 165.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.42 138.39 53.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.689 1.595 . . . . 0.0 114.743 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -119.46 127.09 52.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.959 2.104 . . . . 0.0 108.605 171.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 126.76 52.22 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.365 1.066 . . . . 0.0 110.464 171.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.8 mt -123.12 147.78 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.952 1.301 . . . . 0.0 111.927 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.22 141.96 42.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.201 2.2 . . . . 0.0 111.737 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.06 160.89 27.95 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -50.44 -38.47 43.57 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 166.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -86.09 -8.34 57.96 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.469 1.508 . . . . 0.0 114.412 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.66 66.98 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 117.604 1.802 . . . . 0.0 117.604 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -90.91 -43.9 9.71 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.758 2.279 . . . . 0.0 110.85 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 42.4 m-85 -82.95 145.22 29.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -125.81 152.51 45.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.541 1.936 . . . . 0.0 111.431 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.74 104.03 6.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.846 2.059 . . . . 0.0 109.986 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.95 139.99 29.95 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.527 0.331 . . . . 0.0 111.63 170.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -125.57 92.93 3.71 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.621 2.368 . . . . 0.0 108.759 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.23 163.29 14.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.889 1.276 . . . . 0.0 110.914 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 64.71 38.08 7.15 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.489 1.916 . . . . 0.0 114.966 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.54 154.25 27.62 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.496 -1.378 . . . . 0.0 112.848 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.53 -49.43 6.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.73 1.612 . . . . 0.0 109.272 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -152.18 149.33 28.63 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.641 1.976 . . . . 0.0 111.387 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -94.47 141.35 28.69 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.503 1.121 . . . . 0.0 111.913 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -95.43 -15.51 22.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.058 0.943 . . . . 0.0 111.878 167.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.94 165.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.27 1.828 . . . . 0.0 113.154 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -120.79 164.34 16.76 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.744 2.018 . . . . 0.0 111.2 172.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.07 129.72 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.32 4.58 68.28 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.531 1.062 . . . . 0.0 115.713 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.62 130.27 35.22 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.623 1.712 . . . . 0.0 112.912 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -65.0 143.87 57.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.407 0.622 . . . . 0.0 110.795 163.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 161.62 21.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.514 1.526 . . . . 0.0 110.535 167.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -133.86 143.29 48.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.576 1.55 . . . . 0.0 109.88 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.14 117.61 2.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.966 0.889 . . . . 0.0 111.904 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.83 74.88 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.547 1.546 . . . . 0.0 115.205 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -85.36 145.14 27.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.519 1.66 . . . . 0.0 114.487 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 88' ' ' PRO . 15.9 mm -70.82 136.46 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.854 0.835 . . . . 0.0 111.969 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 49.1 pt -122.79 -23.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.69 1.196 . . . . 0.0 112.903 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.32 -176.57 1.91 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.527 1.531 . . . . 0.0 110.853 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -129.44 136.63 50.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.8 t -66.08 137.07 56.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -125.53 -169.88 12.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.575 1.56 . . . . 0.0 111.885 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.259 41.2 p30 -111.03 16.94 20.9 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 168.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.8 p -57.85 131.56 50.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.224 1.009 . . . . 0.0 111.958 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.6 -16.65 3.0 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.26 1.409 . . . . 0.0 115.835 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 4.6 mt -78.61 146.85 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.769 1.785 . . . . 0.0 110.652 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -111.09 -46.64 3.29 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.637 1.175 . . . . 0.0 111.749 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.8 157.57 30.02 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.303 0.7 OUTLIER -63.17 142.83 58.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -172.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.81 149.26 9.31 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.885 1.707 . . . . 0.0 114.731 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.22 156.58 20.92 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.973 1.309 . . . . 0.0 112.814 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -149.56 165.6 31.76 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.814 0.846 . . . . 0.0 112.834 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.46 123.13 47.38 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.588 1.555 . . . . 0.0 109.812 165.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -98.38 103.62 15.58 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.472 0.709 . . . . 0.0 110.867 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.272 36.0 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 172.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -116.26 115.28 25.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.436 1.094 . . . . 0.0 111.851 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -95.31 125.25 39.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.804 1.642 . . . . 0.0 111.149 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.9 mtm -131.0 153.0 49.69 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.494 1.518 . . . . 0.0 111.372 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.24 130.51 52.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.227 1.411 . . . . 0.0 111.898 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.99 36.15 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.39 -179.73 48.0 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.549 2.023 . . . . 0.0 111.9 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 125.9 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.579 1.552 . . . . 0.0 112.891 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.98 164.85 10.08 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.888 . . . . 0.0 112.325 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -56.79 -36.95 70.47 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.038 -1.272 . . . . 0.0 113.155 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.45 -12.37 56.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -97.59 -8.82 28.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 173.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.29 142.12 55.65 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.212 1.405 . . . . 0.0 113.087 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.13 -79.7 0.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.354 1.062 . . . . 0.0 112.335 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -170.07 123.57 0.64 Allowed Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.843 2.057 . . . . 0.0 113.054 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.25 -35.4 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.535 2.156 . . . . 0.0 114.102 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -54.41 -54.69 45.53 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.11 -18.9 39.83 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.879 3.053 . . . . 0.0 113.14 -175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.06 -44.18 66.27 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.76 -31.25 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.707 0.803 . . . . 0.0 111.634 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.82 -3.77 3.69 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -123.53 -1.99 8.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.685 1.594 . . . . 0.0 114.374 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.7 mt -69.25 151.22 97.07 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.292 1.037 . . . . 0.0 112.292 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.08 -36.17 71.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.174 2.583 . . . . 0.0 115.063 -165.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -111.51 9.59 21.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.896 0.878 . . . . 0.0 113.366 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 71.51 -134.06 22.16 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.026 -1.046 . . . . 0.0 112.241 -171.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.69 -26.0 65.23 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.341 -1.094 . . . . 0.0 112.94 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -70.91 -3.9 21.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.407 1.483 . . . . 0.0 114.171 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 68.9 m -82.13 -6.08 58.92 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.14 0.976 . . . . 0.0 113.122 165.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.85 -13.25 14.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.307 1.443 . . . . 0.0 113.114 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.92 163.1 36.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.448 1.476 . . . . 0.0 113.896 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -111.35 89.67 3.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 124.531 1.132 . . . . 0.0 110.682 170.987 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.2 p -136.15 -27.91 1.07 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -88.98 -174.61 4.54 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.199 1.799 . . . . 0.0 111.679 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -64.09 132.11 49.54 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.404 0.681 . . . . 0.0 110.989 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -139.85 160.99 38.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.21 1.404 . . . . 0.0 112.533 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.89 161.87 17.49 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 173.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -142.49 167.62 21.67 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -65.03 152.2 44.05 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.67 157.77 40.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.443 1.497 . . . . 0.0 112.683 173.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.17 -121.0 5.75 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.848 0.737 . . . . 0.0 113.552 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t -60.82 139.35 57.97 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.606 1.162 . . . . 0.0 112.763 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -69.58 -15.95 63.32 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.405 HG21 ' CG2' ' A' ' 63' ' ' THR . 76.3 mt -64.04 132.04 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 119.909 1.232 . . . . 0.0 110.438 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.37 0.1 OUTLIER -94.9 -35.14 12.14 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 164.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -146.47 150.4 35.53 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.567 1.547 . . . . 0.0 112.417 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.405 ' CG2' HG21 ' A' ' 60' ' ' ILE . 22.4 p -140.25 -179.38 5.96 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.911 1.684 . . . . 0.0 109.709 -166.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -74.15 133.2 42.77 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 120.307 -1.496 . . . . 0.0 110.06 -164.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.36 179.49 16.09 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.12 1.343 . . . . 0.0 114.874 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -53.64 143.88 19.11 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -66.73 -179.53 0.89 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 168.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -57.4 159.18 4.97 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.252 1.021 . . . . 0.0 112.126 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -83.05 36.29 0.5 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -154.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -57.77 156.11 19.58 Favored Pre-proline 0 N--CA 1.472 0.668 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.16 -25.28 79.53 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.138 2.559 . . . . 0.0 112.323 169.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.26 3.0 p90 -76.64 122.18 24.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 159.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.71 149.91 37.97 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.28 144.78 7.96 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.295 1.426 . . . . 0.0 113.382 173.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -122.29 137.4 54.86 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.776 1.23 . . . . 0.0 111.82 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -94.25 125.53 38.95 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.477 1.111 . . . . 0.0 110.027 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.285 97.1 m-85 -107.14 15.33 25.28 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -170.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.96 -164.77 12.26 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.12 -0.987 . . . . 0.0 115.027 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.21 137.09 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 127.477 2.311 . . . . 0.0 109.384 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.9 97.17 5.49 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -77.67 108.49 10.91 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.03 117.95 5.71 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.313 1.045 . . . . 0.0 111.051 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -133.93 148.76 69.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.147 0.979 . . . . 0.0 111.089 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.36 139.46 65.44 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.234 1.956 . . . . 0.0 110.635 163.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -51.92 136.73 28.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 110.184 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.86 -4.73 78.67 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.537 -1.702 . . . . 0.0 116.19 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 m -53.1 123.5 34.15 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 120.431 2.116 . . . . 0.0 112.343 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.54 ' HB2' HD12 ' A' ' 142' ' ' ILE . 10.7 Cg_endo -68.46 127.95 16.47 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.654 1.569 . . . . 0.0 110.907 174.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 mm -84.38 129.01 38.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.876 1.27 . . . . 0.0 107.797 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -99.03 152.41 19.85 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.656 1.183 . . . . 0.0 109.983 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.01 124.72 90.25 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 118.39 -0.815 . . . . 0.0 110.085 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.26 -36.42 21.17 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.582 2.855 . . . . 0.0 112.835 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.573 2.349 . . . . 0.0 108.989 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.97 147.73 49.8 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.058 -1.026 . . . . 0.0 108.988 155.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.15 -159.4 19.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.916 0.77 . . . . 0.0 113.607 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -148.35 144.46 27.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.874 1.27 . . . . 0.0 112.397 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.21 125.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.91 -44.87 8.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.942 1.697 . . . . 0.0 115.101 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -157.06 147.48 21.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.012 1.325 . . . . 0.0 111.105 -168.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.411 HG23 ' CE1' ' A' ' 129' ' ' TYR . 47.0 mt -140.79 118.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.716 1.206 . . . . 0.0 109.513 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -160.2 -168.47 2.2 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.26 146.33 42.41 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.232 1.413 . . . . 0.0 113.428 173.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -101.33 145.03 29.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.267 1.827 . . . . 0.0 111.729 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -66.2 -18.32 65.28 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -161.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 pp -138.85 -14.45 1.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.042 1.337 . . . . 0.0 113.495 167.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.16 -18.57 79.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.375 0.988 . . . . 0.0 115.172 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.5 -159.22 29.37 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 119.462 1.631 . . . . 0.0 113.739 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -70.61 148.38 48.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.489 HG13 HD22 ' A' ' 124' ' ' LEU . 8.8 t -131.92 137.18 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 126.188 1.795 . . . . 0.0 114.61 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.66 137.52 51.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.75 1.62 . . . . 0.0 109.618 165.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.53 125.28 51.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.676 0.79 . . . . 0.0 112.266 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.69 153.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.295 1.438 . . . . 0.0 111.906 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.63 55.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.857 2.063 . . . . 0.0 111.636 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -86.59 161.34 18.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.587 1.155 . . . . 0.0 113.016 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.405 34.8 p-10 -69.64 -8.48 47.96 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 119.854 3.279 . . . . 0.0 119.854 -165.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -77.86 -12.61 59.99 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.791 1.632 . . . . 0.0 112.936 163.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.97 18.99 71.33 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.283 1.421 . . . . 0.0 114.954 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -113.73 -25.83 8.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.108 1.454 . . . . 0.0 112.581 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.273 55.5 m-85 -102.07 128.37 48.56 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 171.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -104.23 157.08 17.38 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.465 1.906 . . . . 0.0 111.139 170.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -138.36 105.13 5.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.098 2.159 . . . . 0.0 110.501 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -85.81 147.74 26.16 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.19 109.78 8.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.947 1.699 . . . . 0.0 107.875 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 HG13 ' A' ' 109' ' ' VAL . 1.9 mm? -103.8 157.02 17.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.809 1.643 . . . . 0.0 110.562 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 67.1 59.11 0.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.113 1.765 . . . . 0.0 113.253 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 mt -104.82 151.23 24.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.691 1.597 . . . . 0.0 111.058 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.75 -42.67 6.4 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.487 . . . . 0.0 111.298 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -146.58 147.08 30.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.652 1.581 . . . . 0.0 112.265 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.411 ' CE1' HG23 ' A' ' 100' ' ' ILE . 90.1 m-85 -94.04 141.69 28.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 112.647 176.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -106.89 -5.77 18.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.808 1.243 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.29 166.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.341 1.456 . . . . 0.0 110.225 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -122.19 165.17 16.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.05 1.34 . . . . 0.0 110.265 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.69 131.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.978 0.911 . . . . 0.0 108.771 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.87 8.14 73.34 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.929 1.252 . . . . 0.0 115.278 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -84.19 119.22 24.75 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.01 1.405 . . . . 0.0 112.862 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -65.83 142.02 58.08 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.231 163.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.99 159.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.307 1.843 . . . . 0.0 109.195 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.66 142.7 50.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.449 1.9 . . . . 0.0 108.848 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.58 123.01 4.56 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.948 0.899 . . . . 0.0 113.326 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.39 3.73 64.74 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.582 1.087 . . . . 0.0 114.804 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.88 133.61 38.09 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.666 1.186 . . . . 0.0 112.487 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 88' ' ' PRO . 13.7 mm -67.73 129.31 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.721 0.691 . . . . 0.0 109.992 172.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.1 pt -112.87 -22.09 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.201 1.001 . . . . 0.0 113.266 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.93 -179.18 2.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.429 1.491 . . . . 0.0 110.322 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.18 132.17 45.91 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.0 t -77.24 146.53 36.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.08 159.69 28.66 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.98 1.276 . . . . 0.0 111.448 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -77.73 37.89 0.24 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 118.905 1.352 . . . . 0.0 113.635 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.253 6.7 p -64.67 125.16 23.86 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.742 -1.224 . . . . 0.0 111.006 164.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.72 10.93 84.83 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 -170.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.73 165.52 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 119.78 1.79 . . . . 0.0 113.582 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -81.35 162.26 23.48 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.186 1.395 . . . . 0.0 114.283 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.254 0.3 OUTLIER -62.59 -1.59 0.86 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 173.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -64.45 -30.18 71.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.462 1.505 . . . . 0.0 110.018 167.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 160.93 155.19 7.71 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 119.488 1.04 . . . . 0.0 115.268 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -87.73 152.79 21.86 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.903 1.681 . . . . 0.0 111.852 169.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -151.99 128.44 10.67 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 168.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.15 114.07 7.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.173 0.989 . . . . 0.0 110.744 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -91.9 99.04 11.97 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.597 0.759 . . . . 0.0 111.343 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 43.3 t80 -90.97 120.07 31.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.153 1.381 . . . . 0.0 114.679 172.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -130.0 108.36 10.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.987 1.315 . . . . 0.0 111.01 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -96.45 135.78 37.85 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.144 1.378 . . . . 0.0 111.386 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 41.0 mtm -136.11 143.22 44.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.332 1.453 . . . . 0.0 112.065 -166.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -111.62 132.62 54.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.948 1.299 . . . . 0.0 112.988 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.66 1.0 64.95 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.575 1.56 . . . . 0.0 115.17 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 161.64 -169.99 37.25 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 127.856 2.646 . . . . 0.0 109.438 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.87 138.26 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 122.269 1.033 . . . . 0.0 111.006 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.59 161.69 10.67 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 128.757 3.075 . . . . 0.0 109.595 -171.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -57.51 -42.29 82.51 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.704 -1.468 . . . . 0.0 113.44 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.16 -20.63 66.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -78.33 -16.0 58.16 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.8 147.46 45.47 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.36 1.064 . . . . 0.0 112.353 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.36 -61.35 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.409 1.084 . . . . 0.0 113.825 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.4 t0 178.42 123.07 0.2 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 130.557 3.543 . . . . 0.0 108.309 160.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.6 -21.63 21.91 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.78 2.986 . . . . 0.0 116.099 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -51.9 -56.22 23.47 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 120.658 1.572 . . . . 0.0 114.699 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.87 -24.89 60.58 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.618 2.879 . . . . 0.0 112.937 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.275 3.5 t80 -64.26 -45.11 89.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 169.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.5 mt -66.63 -28.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.854 -1.154 . . . . 0.0 111.357 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.22 -4.4 10.39 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -118.09 -10.15 10.39 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.1 mt -66.31 149.66 97.71 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.371 1.068 . . . . 0.0 112.423 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.75 -41.68 10.36 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.789 2.326 . . . . 0.0 113.597 -166.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.67 9.91 34.99 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.11 -133.98 45.93 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 120.866 -1.146 . . . . 0.0 112.441 -172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -54.21 -30.87 51.53 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.907 -0.76 . . . . 0.0 112.772 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -71.43 -5.47 33.04 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.09 1.356 . . . . 0.0 112.456 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.7 m -83.67 -6.91 59.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.968 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.9 -14.81 15.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.992 1.317 . . . . 0.0 113.0 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -146.41 159.12 43.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.535 1.516 . . . . 0.0 115.018 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -104.13 96.42 6.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 122.363 1.078 . . . . 0.0 112.777 -179.444 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.139 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.4 t -161.38 151.09 16.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.501 1.52 . . . . 0.0 113.199 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -53.5 -38.2 63.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.619 1.168 . . . . 0.0 113.368 171.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -153.33 123.59 7.05 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.698 1.199 . . . . 0.0 110.34 165.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mp0 -71.75 -31.76 67.01 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.998 155.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -152.87 125.88 8.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.392 1.477 . . . . 0.0 114.763 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.267 1.9 p90 -67.1 156.36 36.32 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.321 39.3 t80 -133.33 140.82 47.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.47 148.44 34.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.485 1.514 . . . . 0.0 112.087 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.85 2.86 22.18 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.267 1.889 . . . . 0.0 114.692 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.3 t -164.52 154.03 13.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.609 1.564 . . . . 0.0 111.544 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -87.37 14.28 8.29 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.6 mt -71.12 138.62 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 120.062 1.301 . . . . 0.0 113.112 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.8 t -107.0 -28.19 10.19 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.181 1.792 . . . . 0.0 114.781 166.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -146.73 123.92 11.51 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.64 1.576 . . . . 0.0 111.178 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -82.3 177.63 8.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.703 1.201 . . . . 0.0 113.889 166.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -68.26 121.32 15.98 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.14 -139.18 5.62 Favored Glycine 0 N--CA 1.469 0.853 0 O-C-N 121.185 -0.947 . . . . 0.0 112.714 -170.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 157.87 40.52 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 117.857 0.829 . . . . 0.0 113.216 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.257 41.7 m-85 -69.15 -42.28 76.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -148.71 161.09 42.46 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -63.14 -11.66 21.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 127.015 2.126 . . . . 0.0 115.377 170.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.1 m -68.91 155.99 92.28 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.138 1.775 . . . . 0.0 114.538 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.13 -27.21 49.41 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.928 2.419 . . . . 0.0 113.652 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -66.94 138.82 57.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.461 1.504 . . . . 0.0 108.142 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -72.45 130.22 40.17 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.783 1.233 . . . . 0.0 111.96 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.16 80.49 0.08 OUTLIER Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.456 1.503 . . . . 0.0 113.037 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.73 163.57 16.44 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.653 1.581 . . . . 0.0 114.15 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -128.76 128.84 44.79 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.572 2.349 . . . . 0.0 109.36 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.358 93.7 m-85 -106.08 18.96 21.28 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -169.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.72 -172.25 19.03 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.032 -1.042 . . . . 0.0 113.788 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.63 132.92 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.44 1.896 . . . . 0.0 109.039 172.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -111.01 102.01 10.52 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -85.23 115.82 23.22 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 76.1 4.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.862 1.665 . . . . 0.0 112.267 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.49 152.8 41.23 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.37 142.72 91.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.523 2.149 . . . . 0.0 111.001 158.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -59.98 136.3 57.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.935 1.294 . . . . 0.0 110.28 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.68 1.78 90.3 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -57.14 124.67 67.26 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.597 1.698 . . . . 0.0 111.654 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HB2' HD12 ' A' ' 142' ' ' ILE . 89.0 Cg_endo -71.28 125.31 11.22 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.037 1.158 . . . . 0.0 110.031 176.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 146' ' ' SER . 30.8 mm -80.76 129.38 37.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.356 1.462 . . . . 0.0 107.577 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -101.35 152.8 20.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.689 1.196 . . . . 0.0 109.954 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.62 131.54 87.89 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.766 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.75 -34.56 18.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.328 2.685 . . . . 0.0 112.833 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.0 p -129.59 163.4 26.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.547 1.939 . . . . 0.0 108.587 -173.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.93 141.84 58.09 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 121.256 -0.903 . . . . 0.0 108.988 158.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.12 -159.98 21.51 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.068 0.842 . . . . 0.0 113.418 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -151.05 140.91 21.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.228 1.514 . . . . 0.0 111.267 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 t -55.1 137.87 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.108 0.963 . . . . 0.0 113.419 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.97 -44.14 5.58 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -159.27 148.49 18.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.681 1.593 . . . . 0.0 109.776 -167.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.402 HG23 ' CE2' ' A' ' 129' ' ' TYR . 59.2 mt -139.8 128.0 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.447 1.099 . . . . 0.0 108.391 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -160.23 173.33 15.89 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -127.98 158.39 38.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.066 -1.021 . . . . 0.0 111.506 168.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -132.24 128.61 38.25 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.356 1.862 . . . . 0.0 108.732 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -68.46 -20.03 64.59 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.461 -1.4 . . . . 0.0 113.567 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.45 -19.57 23.74 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.449 1.5 . . . . 0.0 113.412 169.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.29 -16.76 5.98 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.688 1.137 . . . . 0.0 115.808 -162.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.23 44.85 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 118.418 1.109 . . . . 0.0 113.236 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.89 147.9 42.79 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.897 -0.767 . . . . 0.0 112.344 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 t -134.82 137.79 50.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 126.268 1.827 . . . . 0.0 114.616 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.1 tp -117.39 133.04 56.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.138 1.775 . . . . 0.0 108.819 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.27 125.65 53.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.778 1.231 . . . . 0.0 110.279 172.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.78 141.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.552 1.141 . . . . 0.0 110.809 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.52 137.82 36.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.021 1.329 . . . . 0.0 109.593 168.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -68.95 164.54 22.01 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.183 -0.323 . . . . 0.0 111.055 166.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -61.21 -31.89 71.66 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -75.76 -13.31 60.3 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.99 7.65 76.59 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 117.631 1.812 . . . . 0.0 117.631 168.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -98.16 -40.56 8.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.342 1.571 . . . . 0.0 110.979 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -74.59 131.52 41.02 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -118.42 150.75 39.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.321 1.848 . . . . 0.0 111.094 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -133.92 103.86 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.563 1.945 . . . . 0.0 110.082 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -85.35 145.47 27.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.341 0.656 . . . . 0.0 111.73 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.06 87.99 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.441 2.296 . . . . 0.0 110.057 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.18 154.16 19.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.851 0.861 . . . . 0.0 110.953 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.254 52.2 m-70 70.82 55.62 0.24 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.768 2.027 . . . . 0.0 113.734 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.9 149.05 23.81 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.68 1.592 . . . . 0.0 111.015 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.6 -48.58 10.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 113.024 166.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -145.21 152.09 39.44 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.282 1.833 . . . . 0.0 110.812 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.402 ' CE2' HG23 ' A' ' 100' ' ' ILE . 75.6 m-85 -85.18 159.89 20.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.572 0.749 . . . . 0.0 109.988 169.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -112.16 -25.28 9.4 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.174 0.99 . . . . 0.0 111.126 164.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.92 168.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.983 1.713 . . . . 0.0 111.423 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -119.73 167.44 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.346 1.458 . . . . 0.0 111.122 166.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.01 130.23 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.544 1.138 . . . . 0.0 108.766 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.06 1.2 76.44 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.989 1.281 . . . . 0.0 115.709 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -81.68 129.79 34.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.457 1.628 . . . . 0.0 112.416 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -68.62 143.94 54.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.784 0.802 . . . . 0.0 110.422 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.3 m -128.71 157.76 41.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.877 1.671 . . . . 0.0 109.036 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.71 143.81 50.99 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.118 1.767 . . . . 0.0 109.427 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.02 125.27 7.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.669 0.747 . . . . 0.0 112.105 174.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.98 -3.77 82.91 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.15 1.357 . . . . 0.0 115.837 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.4 142.26 37.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.469 1.635 . . . . 0.0 112.978 170.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.6 mm -72.88 131.19 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.931 0.872 . . . . 0.0 111.545 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -114.63 -24.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.565 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -168.62 -178.94 3.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.163 1.385 . . . . 0.0 110.566 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -129.28 134.1 47.79 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 89' ' ' ILE . 99.0 p -62.49 145.94 52.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 112.329 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -156.56 160.17 30.05 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -85.82 34.82 0.61 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.426 1.09 . . . . 0.0 113.267 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.7 p -84.32 134.16 34.52 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.815 1.246 . . . . 0.0 111.987 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 76.78 -38.87 1.51 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.789 1.662 . . . . 0.0 114.961 -174.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.3 mt -69.93 166.49 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 126.116 1.767 . . . . 0.0 110.22 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -57.14 152.7 13.02 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.355 -1.466 . . . . 0.0 111.162 159.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.1 t -54.51 -22.22 12.31 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -175.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.3 p -81.48 -12.81 58.74 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -120.65 146.76 17.67 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 124.638 1.113 . . . . 0.0 113.121 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.426 ' H ' ' CE1' ' A' ' 157' ' ' HIS . . . -149.18 34.65 0.73 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -165.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.426 ' CE1' ' H ' ' A' ' 156' ' ' ALA . 8.5 m-70 -100.6 124.05 45.65 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.208 -0.932 . . . . 0.0 111.708 -153.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.74 116.72 7.96 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 111.881 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -94.67 99.99 12.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.145 0.978 . . . . 0.0 110.168 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 46.5 t80 -89.55 113.08 24.44 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.161 1.384 . . . . 0.0 114.332 171.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -118.27 115.26 24.38 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 111.301 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -95.29 128.47 42.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.303 1.441 . . . . 0.0 110.7 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.3 mtm -131.91 157.83 42.98 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.792 1.637 . . . . 0.0 110.819 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -135.12 133.24 39.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.165 0.986 . . . . 0.0 111.813 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.88 5.81 76.29 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.936 1.255 . . . . 0.0 115.089 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 162.63 -170.47 38.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.342 1.449 . . . . 0.0 112.739 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.47 121.15 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -173.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.32 171.89 17.68 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.974 1.749 . . . . 0.0 113.411 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -51.1 -48.75 61.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.382 1.473 . . . . 0.0 112.916 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.93 -13.29 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.238 1.415 . . . . 0.0 114.662 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -92.05 -16.86 25.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.99 135.12 53.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.036 0.934 . . . . 0.0 113.047 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -103.33 -92.06 0.35 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.317 1.447 . . . . 0.0 112.827 -171.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -168.5 100.97 0.53 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.46 -39.71 3.51 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.169 1.913 . . . . 0.0 113.276 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -54.62 -53.03 64.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.2 -23.5 28.71 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.918 3.079 . . . . 0.0 112.458 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -69.3 -39.46 78.28 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 56.9 mt -71.09 -38.71 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 122.979 0.512 . . . . 0.0 110.95 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.52 -15.58 11.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -110.68 -12.06 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.952 1.301 . . . . 0.0 112.778 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.3 154.1 33.83 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.721 1.208 . . . . 0.0 112.394 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.56 -50.57 13.39 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.445 3.43 . . . . 0.0 114.386 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -107.52 9.41 29.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.45 -139.02 43.38 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 120.51 -1.369 . . . . 0.0 112.651 -171.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.27 -21.79 66.72 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.058 -1.26 . . . . 0.0 112.993 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -64.11 -8.58 12.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.91 1.284 . . . . 0.0 112.895 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.8 t -88.56 -1.86 58.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.809 1.244 . . . . 0.0 112.751 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.47 -15.25 12.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.666 1.586 . . . . 0.0 112.417 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -145.67 164.6 31.27 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.56 -1.337 . . . . 0.0 112.912 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -114.53 86.62 2.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.472 0.631 0 C-N-CA 125.06 1.344 . . . . 0.0 110.424 174.754 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.041 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.3 m -61.59 153.88 26.5 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HE2' ' CE2' ' A' ' 54' ' ' PHE . 50.5 pttt -143.11 -179.84 6.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.093 2.157 . . . . 0.0 110.567 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -130.05 -15.16 3.82 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.883 1.273 . . . . 0.0 114.062 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.74 153.89 27.1 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.965 1.306 . . . . 0.0 112.384 162.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -76.4 148.54 37.27 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.457 ' CE2' ' HE2' ' A' ' 50' ' ' LYS 0.343 47.4 m-85 -72.56 51.44 0.26 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 173.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -47.01 141.42 4.18 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -150.07 140.23 22.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.392 1.477 . . . . 0.0 108.999 163.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.48 -42.85 47.08 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 118.497 0.59 . . . . 0.0 112.89 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -74.36 158.32 34.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.631 1.205 . . . . 0.0 112.969 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.5 mtt-85 -76.51 4.33 9.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.7 mt -74.01 131.13 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 119.552 1.069 . . . . 0.0 111.986 -172.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 p -93.66 -35.17 12.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.367 1.867 . . . . 0.0 115.145 167.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -143.7 116.19 8.59 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.609 1.964 . . . . 0.0 109.139 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 p -74.23 171.07 14.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 122.859 1.314 . . . . 0.0 108.365 163.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -67.72 132.82 48.19 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.62 -134.49 4.39 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.563 -0.711 . . . . 0.0 112.765 -174.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -127.47 153.03 46.8 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.493 1.117 . . . . 0.0 112.371 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -72.72 133.99 44.82 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -77.15 -17.05 58.87 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -58.91 -29.02 66.74 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -167.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 p -158.87 170.42 8.96 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.311 1.444 . . . . 0.0 108.918 168.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.87 -21.18 28.68 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 121.682 1.588 . . . . 0.0 113.08 168.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -84.9 -31.92 23.43 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.149 1.38 . . . . 0.0 109.521 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -60.21 135.6 57.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.646 1.578 . . . . 0.0 114.314 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.0 -139.24 6.94 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 116.72 1.448 . . . . 0.0 116.72 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -99.72 155.69 17.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -164.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -114.38 116.9 29.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.386 1.875 . . . . 0.0 110.024 172.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.291 98.3 m-85 -95.99 23.04 6.76 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -172.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.96 -162.91 12.74 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.88 -1.137 . . . . 0.0 113.266 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.49 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -119.18 133.31 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.472 1.909 . . . . 0.0 108.488 175.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -109.51 97.0 6.65 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.67 107.87 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.29 123.7 18.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.416 1.007 . . . . 0.0 110.941 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 mt -138.85 146.67 51.03 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.274 0.63 . . . . 0.0 111.733 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.81 137.85 79.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.295 1.997 . . . . 0.0 110.747 163.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.39 135.18 56.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 111.434 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.25 -7.22 81.9 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.273 -1.293 . . . . 0.0 114.944 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.2 m -53.73 126.13 48.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-N 120.069 1.934 . . . . 0.0 113.362 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.578 ' HB2' HD12 ' A' ' 142' ' ' ILE . 9.5 Cg_endo -68.17 136.66 38.22 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.486 2.124 . . . . 0.0 112.883 171.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.7 mm -92.39 132.45 36.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.566 1.946 . . . . 0.0 108.186 173.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -103.73 151.01 23.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.768 1.227 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.3 129.25 90.63 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.241 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.27 -33.18 11.68 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.675 2.917 . . . . 0.0 113.396 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.0 p -140.78 156.59 46.13 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.397 1.479 . . . . 0.0 107.872 -169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -65.56 129.58 40.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.685 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -153.19 7.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.268 0.461 . . . . 0.0 112.795 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.35 28.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.285 1.834 . . . . 0.0 109.776 176.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.17 136.87 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.125 -0.985 . . . . 0.0 113.211 171.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.22 -38.84 5.87 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.612 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -150.82 142.55 23.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.707 0.803 . . . . 0.0 111.137 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -139.64 123.81 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.348 1.459 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -160.86 169.29 22.98 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -102.01 144.11 31.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.132 1.373 . . . . 0.0 111.546 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -106.78 139.74 40.73 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.146 1.778 . . . . 0.0 109.642 170.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -68.16 -27.36 66.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.4 mt -89.34 -48.62 7.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.708 1.203 . . . . 0.0 110.873 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -88.5 -5.42 75.3 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.202 1.382 . . . . 0.0 116.271 -161.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.73 -148.99 40.9 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.091 1.446 . . . . 0.0 111.539 -174.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -66.28 144.32 56.66 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.49 HG13 HD22 ' A' ' 124' ' ' LEU . 21.2 t -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.024 2.13 . . . . 0.0 112.884 173.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.97 136.04 51.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.388 1.475 . . . . 0.0 109.386 166.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.29 123.11 41.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 111.881 177.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -120.23 144.58 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.899 1.28 . . . . 0.0 110.784 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.59 141.72 41.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.368 1.867 . . . . 0.0 109.829 169.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -74.06 29.03 0.08 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.301 65.0 m-20 59.95 -31.11 0.05 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.579 2.352 . . . . 0.0 117.204 -166.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -62.63 -37.03 84.73 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.895 -1.128 . . . . 0.0 112.811 167.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.83 7.8 66.73 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.026 -0.875 . . . . 0.0 114.88 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -80.85 -46.84 14.68 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.548 1.674 . . . . 0.0 107.547 165.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -86.57 126.52 34.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -120.97 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.509 1.524 . . . . 0.0 111.41 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -119.09 123.52 44.65 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 126.078 1.751 . . . . 0.0 108.394 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -96.93 146.5 24.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.531 0.733 . . . . 0.0 112.463 161.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -130.9 104.03 6.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.806 2.442 . . . . 0.0 110.01 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.49 HD22 HG13 ' A' ' 109' ' ' VAL . 1.5 mm? -105.59 155.69 18.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.648 1.179 . . . . 0.0 111.992 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 63.8 59.83 1.11 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.629 1.972 . . . . 0.0 112.32 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.32 145.78 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.647 1.579 . . . . 0.0 111.187 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -89.86 -41.86 11.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.011 1.324 . . . . 0.0 108.692 171.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -148.21 150.9 34.56 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.478 1.511 . . . . 0.0 113.273 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -97.29 141.32 30.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 112.281 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -103.07 -21.45 13.91 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.253 1.021 . . . . 0.0 112.172 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.95 168.68 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.28 1.832 . . . . 0.0 111.193 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -113.96 171.32 7.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.365 1.866 . . . . 0.0 110.813 168.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.86 137.05 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.527 -1.358 . . . . 0.0 108.786 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.88 10.53 85.56 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.08 1.324 . . . . 0.0 114.143 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -93.22 129.45 39.25 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.92 138.79 48.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.479 0.711 . . . . 0.0 112.548 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.36 160.21 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.8 140.53 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.577 1.951 . . . . 0.0 109.482 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.17 112.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.285 1.834 . . . . 0.0 112.414 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.15 9.3 54.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.637 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -94.37 145.3 24.85 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.586 1.954 . . . . 0.0 114.239 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 88' ' ' PRO . 20.6 mm -70.76 132.89 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.553 1.07 . . . . 0.0 112.566 176.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.1 -22.67 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.399 1.48 . . . . 0.0 113.426 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.08 -176.04 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.255 1.422 . . . . 0.0 110.865 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -136.67 135.42 38.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.2 t -80.94 143.58 32.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -151.65 153.44 24.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.114 1.34 . . . . 0.0 111.275 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -72.82 20.42 0.08 Allowed 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.5 p -54.44 -32.96 58.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.119 2.167 . . . . 0.0 114.028 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.18 25.81 6.92 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.097 1.332 . . . . 0.0 115.251 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 59.3 mt -118.22 146.88 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 118.723 1.262 . . . . 0.0 109.874 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -81.71 16.96 1.59 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.12 -179.62 6.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.968 2.907 . . . . 0.0 112.047 174.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -8.37 55.99 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.12 94.67 1.91 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.235 1.398 . . . . 0.0 113.194 -171.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.09 146.03 49.49 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.026 0.93 . . . . 0.0 113.479 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -147.47 145.97 29.36 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.246 1.018 . . . . 0.0 110.814 167.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.43 115.34 22.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.628 0.771 . . . . 0.0 110.156 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -90.13 98.79 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.85 0.86 . . . . 0.0 110.067 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.276 38.5 t80 -88.86 110.95 21.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.835 1.254 . . . . 0.0 114.341 171.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -113.3 114.59 26.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.874 0.869 . . . . 0.0 111.687 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -97.02 120.71 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.731 1.612 . . . . 0.0 110.854 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.3 mtm -123.05 152.39 41.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.354 1.861 . . . . 0.0 111.266 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -131.51 133.18 44.83 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 111.772 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.61 52.63 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.66 1.6 . . . . 0.0 116.12 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.78 -175.28 45.84 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.086 1.803 . . . . 0.0 111.89 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.16 111.34 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.37 171.43 29.6 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 126.511 2.005 . . . . 0.0 112.408 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -58.8 -44.68 90.82 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.773 -1.427 . . . . 0.0 113.549 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -74.56 -1.07 19.83 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -93.62 -17.17 23.59 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 165.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.18 144.53 57.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.737 0.815 . . . . 0.0 111.931 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -126.78 -75.43 0.58 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -164.52 109.17 0.86 Allowed Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.33 -27.76 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.241 1.96 . . . . 0.0 114.356 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.49 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -54.29 -55.68 34.39 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 121.253 1.842 . . . . 0.0 114.443 -177.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 -21.37 57.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.689 2.926 . . . . 0.0 112.814 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.53 -37.93 59.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.98 -30.26 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.62 0.368 . . . . 0.0 110.79 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.75 -9.62 4.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -112.63 -9.71 13.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.035 2.134 . . . . 0.0 113.666 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.7 mt -69.95 151.57 96.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -170.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.49 -41.86 50.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.817 3.678 . . . . 0.0 114.755 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -119.0 16.64 13.36 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.903 1.281 . . . . 0.0 112.418 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.09 -132.52 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 120.814 -1.179 . . . . 0.0 112.723 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.15 -25.03 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.261 -1.14 . . . . 0.0 112.617 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -70.18 -6.73 36.41 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.074 -1.016 . . . . 0.0 113.004 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.2 m -81.59 -3.91 54.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 0.986 . . . . 0.0 113.17 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.13 -18.01 15.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.17 1.388 . . . . 0.0 111.889 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -144.14 164.04 31.83 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.498 -1.376 . . . . 0.0 114.657 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.46 89.72 3.08 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.395 0.998 . . . . 0.0 113.027 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 124.469 1.108 . . . . 0.0 110.276 173.147 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.007 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -74.0 -37.6 64.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.644 0.777 . . . . 0.0 111.875 -172.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -65.67 170.09 5.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.188 1.395 . . . . 0.0 112.635 174.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.5 m95 63.02 15.62 8.59 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -64.49 -41.12 96.64 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.013 0.824 . . . . 0.0 112.858 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -86.61 123.63 32.01 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.604 1.162 . . . . 0.0 112.837 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.255 6.3 m-85 -63.59 145.21 56.12 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.345 29.2 t80 -70.9 138.83 50.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -150.52 -27.19 0.23 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.113 2.165 . . . . 0.0 114.019 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.93 -69.42 0.06 OUTLIER Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.588 1.566 . . . . 0.0 113.451 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.9 p -68.87 154.44 42.01 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -115.72 15.05 16.49 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 mp -68.66 132.66 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 120.577 1.535 . . . . 0.0 112.416 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -93.82 -44.84 7.92 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.281 1.832 . . . . 0.0 115.396 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -139.78 134.41 31.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.465 1.506 . . . . 0.0 111.875 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.7 p -97.25 178.38 5.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.689 1.996 . . . . 0.0 113.186 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -81.37 134.94 35.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.243 1.017 . . . . 0.0 111.161 -167.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.18 -156.49 16.88 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.594 1.569 . . . . 0.0 115.068 168.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -60.87 159.59 11.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.085 1.354 . . . . 0.0 113.5 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.73 156.5 47.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 173.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 68.84 37.22 2.4 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.411 1.884 . . . . 0.0 115.983 172.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 58.57 34.37 23.82 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 162.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.8 m -139.86 167.12 19.51 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.547 1.539 . . . . 0.0 114.086 -163.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -90.46 -8.78 3.7 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.365 2.71 . . . . 0.0 115.236 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -74.82 163.4 27.71 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.874 -1.141 . . . . 0.0 111.296 -166.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.19 -15.54 3.96 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 118.927 2.936 . . . . 0.0 118.927 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -53.94 117.04 6.81 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.751 1.167 . . . . 0.0 113.967 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -145.01 140.62 28.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.894 1.678 . . . . 0.0 112.819 -176.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -101.82 111.8 24.19 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.747 1.619 . . . . 0.0 110.286 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.303 88.4 m-85 -91.14 26.93 2.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -167.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.93 -167.66 22.7 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.717 -1.239 . . . . 0.0 114.9 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 136.81 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.783 2.033 . . . . 0.0 108.874 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -113.6 115.54 28.08 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -97.84 117.47 32.24 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.06 112.82 2.78 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.624 1.102 . . . . 0.0 111.616 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -139.4 140.4 25.58 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.207 0.603 . . . . 0.0 112.333 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 139.47 57.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.993 2.462 . . . . 0.0 111.446 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.69 129.52 29.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.744 1.218 . . . . 0.0 109.972 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.17 81.29 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.178 -1.345 . . . . 0.0 115.982 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.0 m -54.23 125.18 49.59 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 120.169 1.984 . . . . 0.0 112.364 163.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.567 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.1 Cg_endo -71.43 133.22 22.11 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.956 1.771 . . . . 0.0 111.701 174.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.2 mm -89.21 129.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 108.504 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -102.56 149.17 24.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.936 1.294 . . . . 0.0 109.528 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.73 126.93 93.21 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.566 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.34 -38.47 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.359 2.706 . . . . 0.0 112.291 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.3 p -126.13 161.9 26.58 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.873 2.069 . . . . 0.0 111.693 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -69.58 136.01 50.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -160.91 13.08 Favored Glycine 0 N--CA 1.473 1.12 0 O-C-N 121.777 -0.577 . . . . 0.0 113.768 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.49 145.75 28.06 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.345 1.073 . . . . 0.0 112.412 172.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.36 126.01 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -40.3 9.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.189 1.796 . . . . 0.0 115.657 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -155.51 145.59 21.62 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.154 1.382 . . . . 0.0 110.292 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -137.66 125.44 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.012 1.325 . . . . 0.0 109.083 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -158.36 -176.21 5.77 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -145.04 142.71 29.98 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.68 1.192 . . . . 0.0 111.062 171.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -126.01 169.07 13.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.102 1.361 . . . . 0.0 113.137 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -66.03 -24.56 66.77 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -165.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.64 -12.8 0.88 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.622 1.169 . . . . 0.0 113.878 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.83 -7.63 75.72 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.388 0.994 . . . . 0.0 114.478 169.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.73 -151.74 50.82 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 118.097 0.948 . . . . 0.0 112.847 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.26 146.6 45.29 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.189 0.596 . . . . 0.0 112.12 167.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.16 138.67 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.78 136.43 49.86 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.634 1.574 . . . . 0.0 109.579 166.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 124.52 51.98 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.252 0.621 . . . . 0.0 112.108 167.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.6 mt -118.59 144.05 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.323 1.049 . . . . 0.0 111.879 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.87 138.41 36.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.825 2.05 . . . . 0.0 110.608 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -81.07 144.61 31.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -58.85 -12.08 4.01 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 161.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -67.83 -15.03 63.43 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 120.594 -1.316 . . . . 0.0 114.44 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.84 -0.81 84.81 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.931 1.253 . . . . 0.0 115.977 166.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -151.48 2.53 0.4 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -110.64 150.57 28.82 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -128.65 159.18 36.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.053 2.141 . . . . 0.0 111.503 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -141.62 103.89 4.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.435 1.894 . . . . 0.0 110.849 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -87.36 143.28 27.32 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.919 0.487 . . . . 0.0 111.571 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -130.06 96.48 4.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.052 1.741 . . . . 0.0 107.558 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.71 155.37 19.26 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 0.0 110.142 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 68.42 64.43 0.34 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.798 2.039 . . . . 0.0 113.699 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.5 mt -104.56 154.27 20.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.867 1.667 . . . . 0.0 111.171 172.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -97.99 -44.08 6.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.206 1.802 . . . . 0.0 106.931 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -162.12 159.09 25.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.389 2.276 . . . . 0.0 110.548 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -97.95 162.94 12.99 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.002 1.721 . . . . 0.0 114.454 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -124.17 -8.78 7.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.874 1.27 . . . . 0.0 112.721 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.2 m -134.06 168.03 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.56 1.944 . . . . 0.0 111.187 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -120.36 166.79 13.05 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.97 2.108 . . . . 0.0 111.783 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.95 132.43 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.37 7.59 72.46 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.45 1.024 . . . . 0.0 115.175 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -86.48 115.06 23.73 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.128 1.464 . . . . 0.0 112.256 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -65.87 135.15 54.43 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.289 0.235 . . . . 0.0 110.592 164.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -127.33 163.86 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 126.522 1.929 . . . . 0.0 110.555 -176.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.24 140.07 47.31 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.421 1.488 . . . . 0.0 109.526 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.08 126.81 13.29 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.15 -4.93 74.97 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.124 1.821 . . . . 0.0 114.742 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.8 141.69 36.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.664 1.186 . . . . 0.0 112.145 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 88' ' ' PRO . 18.6 mm -70.63 130.1 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.519 -0.738 . . . . 0.0 111.579 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.4 pt -113.86 -21.42 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.725 1.21 . . . . 0.0 113.363 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.76 -176.53 1.77 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 110.729 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -132.71 134.67 45.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.1 t -78.1 145.97 35.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -156.28 153.55 24.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.672 1.606 . . . . 0.0 111.713 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -77.77 26.68 0.18 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.0 p -58.87 140.21 55.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.532 1.133 . . . . 0.0 110.477 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 78.63 -38.64 1.91 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.183 1.373 . . . . 0.0 115.208 -170.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.0 mt -73.81 144.76 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.16 1.384 . . . . 0.0 112.337 -174.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -74.85 -148.19 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.597 1.959 . . . . 0.0 110.794 167.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.65 4.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 119.263 3.06 . . . . 0.0 119.263 -173.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -19.26 59.86 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 -169.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 73.39 163.63 8.35 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.238 0.923 . . . . 0.0 113.459 -168.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.43 150.01 42.0 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.348 -1.09 . . . . 0.0 113.901 -171.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.63 145.8 26.95 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.641 1.176 . . . . 0.0 110.011 162.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.97 115.2 18.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.692 0.678 . . . . 0.0 110.154 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -91.51 100.05 12.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.826 0.85 . . . . 0.0 110.462 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -92.89 116.52 29.11 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -122.13 112.05 17.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.687 1.195 . . . . 0.0 111.381 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -94.56 129.06 41.53 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.636 1.174 . . . . 0.0 110.536 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.7 mtm -127.24 150.65 49.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.654 1.582 . . . . 0.0 110.856 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -120.05 135.91 54.76 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.027 1.331 . . . . 0.0 110.831 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.02 -15.98 1.69 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.169 1.843 . . . . 0.0 116.525 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.19 -168.78 35.52 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.56 1.553 . . . . 0.0 112.057 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.24 131.26 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.393 1.477 . . . . 0.0 112.747 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.56 166.6 10.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.727 1.632 . . . . 0.0 112.048 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -57.84 -43.74 86.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.426 -1.044 . . . . 0.0 113.487 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.76 -14.24 50.86 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -92.58 -15.88 26.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.59 1.156 . . . . 0.0 114.055 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.41 137.86 58.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.774 1.23 . . . . 0.0 112.836 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -101.5 -90.86 0.33 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.588 1.155 . . . . 0.0 113.805 -173.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -170.15 108.21 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 129.36 3.064 . . . . 0.0 110.591 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.97 -23.06 14.24 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.126 1.884 . . . . 0.0 114.587 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -52.26 -53.83 48.29 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 120.582 1.537 . . . . 0.0 115.085 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.74 -20.03 40.53 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.646 2.898 . . . . 0.0 112.931 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.273 3.8 t80 -70.68 -47.59 59.11 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.5 mt -67.47 -24.29 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.833 -1.167 . . . . 0.0 111.79 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.32 -18.14 64.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -109.28 -7.31 15.27 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.866 -1.146 . . . . 0.0 114.03 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 32.0 mt -69.34 147.72 97.15 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.952 1.301 . . . . 0.0 112.894 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.23 -27.99 34.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.209 2.606 . . . . 0.0 114.164 -166.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.86 2.51 17.07 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.84 -144.06 37.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.84 0.733 . . . . 0.0 112.793 -166.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.97 -24.6 66.23 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.455 -1.027 . . . . 0.0 112.553 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -65.31 -9.89 28.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.481 1.512 . . . . 0.0 111.986 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.6 t -82.52 -3.21 55.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.091 1.356 . . . . 0.0 112.575 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -110.46 -13.11 14.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.517 1.527 . . . . 0.0 112.701 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -146.63 163.52 35.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.705 1.593 . . . . 0.0 115.196 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -115.25 79.06 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 109.998 175.301 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -98.56 25.06 6.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.74 -162.65 11.86 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.872 -1.143 . . . . 0.0 114.824 -173.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.53 134.85 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.415 2.286 . . . . 0.0 108.833 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -109.67 91.73 3.76 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.93 106.78 11.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 125.87 26.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.045 0.839 . . . . 0.0 110.337 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.7 mt -137.14 151.4 71.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.66 0.784 . . . . 0.0 112.094 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.55 138.65 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.582 2.188 . . . . 0.0 111.528 165.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.63 128.77 38.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.442 0.697 . . . . 0.0 110.978 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.49 63.98 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.047 1.308 . . . . 0.0 115.285 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.3 m -57.72 126.38 75.83 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-N 119.583 1.692 . . . . 0.0 112.714 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.532 ' HB2' HD12 ' A' ' 142' ' ' ILE . 17.6 Cg_endo -69.26 133.27 26.06 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.211 1.941 . . . . 0.0 112.412 172.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -89.58 130.0 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.561 1.944 . . . . 0.0 107.964 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -102.75 152.73 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.665 1.586 . . . . 0.0 109.834 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.49 124.0 90.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.936 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.39 -40.3 19.33 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.083 2.522 . . . . 0.0 112.456 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.3 p -130.23 164.12 25.22 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.543 1.937 . . . . 0.0 110.382 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.27 137.61 50.89 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 166.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.08 -161.93 17.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.576 0.608 . . . . 0.0 113.167 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -145.72 144.5 30.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 112.008 174.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.81 129.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -40.06 8.62 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -157.76 146.49 19.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.144 1.378 . . . . 0.0 111.007 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 129' ' ' TYR . 59.7 mt -141.13 120.31 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.85 1.26 . . . . 0.0 109.425 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 p90 . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.236 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 mttm . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.99 123.26 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.35 131.86 48.71 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.341 1.456 . . . . 0.0 110.187 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.13 125.44 53.78 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.114 1.365 . . . . 0.0 111.384 171.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.7 mt -121.39 149.26 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.241 1.416 . . . . 0.0 111.807 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.05 139.84 48.35 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 111.376 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 124.529 1.132 . . . . 0.0 113.363 176.134 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -117.87 159.44 23.08 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.651 1.98 . . . . 0.0 111.907 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -143.45 104.4 4.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.951 2.1 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 148.52 24.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.34 0.656 . . . . 0.0 112.503 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -136.17 89.76 2.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.586 2.355 . . . . 0.0 109.92 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.01 160.51 16.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.666 1.186 . . . . 0.0 111.216 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 62.44 57.1 1.96 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.559 1.944 . . . . 0.0 114.032 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.85 145.46 26.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.322 1.049 . . . . 0.0 111.555 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -87.44 -43.72 11.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.108 1.363 . . . . 0.0 108.045 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -147.45 144.77 28.86 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.186 1.794 . . . . 0.0 112.473 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 100' ' ' ILE . 84.0 m-85 -86.83 149.71 24.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.146 0.978 . . . . 0.0 111.927 171.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -117.18 -4.43 11.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.243 1.017 . . . . 0.0 112.607 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.25 162.82 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.179 1.392 . . . . 0.0 111.529 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -111.66 161.52 16.16 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.583 1.153 . . . . 0.0 111.29 168.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.39 128.04 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.123 1.369 . . . . 0.0 107.641 170.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.66 16.05 66.8 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.179 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -87.23 123.52 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.067 1.434 . . . . 0.0 112.871 167.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -69.02 137.8 53.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.199 0.523 . . . . 0.0 111.718 160.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.83 164.14 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.011 2.125 . . . . 0.0 110.67 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -133.83 142.32 47.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.882 1.273 . . . . 0.0 108.677 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.38 132.35 10.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.337 1.055 . . . . 0.0 113.392 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.88 -7.54 81.83 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.446 1.974 . . . . 0.0 115.011 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -77.37 140.92 40.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.1 1.45 . . . . 0.0 113.148 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.9 mm -67.78 129.4 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.76 -0.587 . . . . 0.0 110.997 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.0 pt -114.45 -20.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.762 1.225 . . . . 0.0 113.304 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.02 -177.07 2.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.137 1.775 . . . . 0.0 110.415 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -132.3 130.85 41.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.4 t -79.05 146.39 33.32 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.559 0.695 . . . . 0.0 112.645 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 C-N-CA 124.758 1.17 . . . . 0.0 111.108 -179.893 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.7 p80 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.15 115.32 8.3 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 109.663 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -95.16 99.88 11.78 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.739 0.816 . . . . 0.0 110.24 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 51.8 t80 -89.09 114.44 25.69 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.025 1.33 . . . . 0.0 114.508 172.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -118.21 116.83 27.61 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.708 1.203 . . . . 0.0 111.908 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.3 ttt-85 -100.64 124.74 46.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.909 1.684 . . . . 0.0 111.567 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 32.9 mtm -130.44 157.27 43.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.96 1.304 . . . . 0.0 112.338 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -131.5 135.96 47.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.403 1.481 . . . . 0.0 111.52 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.7 -7.66 57.83 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 126.368 1.937 . . . . 0.0 115.363 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 171.14 -166.65 39.79 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.689 2.566 . . . . 0.0 109.806 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.57 131.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 122.483 1.135 . . . . 0.0 110.555 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.43 168.98 14.89 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 128.466 2.936 . . . . 0.0 109.896 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -56.22 -41.96 76.5 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.849 1.325 . . . . 0.0 112.852 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.69 64.91 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.055 -1.028 . . . . 0.0 112.505 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.0 -15.1 58.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.954 1.301 . . . . 0.0 113.44 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.88 56.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.927 0.891 . . . . 0.0 112.763 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.96 -85.57 0.55 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.635 1.174 . . . . 0.0 113.66 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -166.97 126.89 1.14 Allowed Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 127.386 2.274 . . . . 0.0 106.109 167.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.0 -28.71 8.94 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.277 2.652 . . . . 0.0 114.601 171.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -53.24 -53.51 55.22 Favored Pre-proline 0 N--CA 1.478 0.971 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.53 -19.5 32.39 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.704 2.936 . . . . 0.0 112.584 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -72.36 -44.87 61.96 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 24.2 mt -66.68 -29.43 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.432 0.693 . . . . 0.0 111.056 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.86 -15.8 5.48 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.85 -3.23 9.71 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.437 1.495 . . . . 0.0 114.27 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.61 147.62 98.03 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.088 0.955 . . . . 0.0 112.097 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -51.35 -44.72 41.61 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.747 3.631 . . . . 0.0 114.626 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -111.71 12.96 21.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.898 1.279 . . . . 0.0 113.686 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.04 -135.39 46.07 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 120.821 -1.174 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.12 -25.85 64.2 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.308 -1.113 . . . . 0.0 113.319 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -70.18 -5.77 29.62 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.563 -1.336 . . . . 0.0 113.373 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.9 m -77.98 -4.05 45.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.987 0.812 . . . . 0.0 111.991 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.51 -15.55 12.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.735 1.614 . . . . 0.0 113.825 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -148.95 158.14 43.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 121.635 2.016 . . . . 0.0 115.037 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -110.06 79.42 1.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.47 0.544 0 C-N-CA 124.584 1.154 . . . . 0.0 109.523 174.516 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 97.8 m-85 -120.54 25.21 9.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -168.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.81 -178.63 25.83 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.97 -1.081 . . . . 0.0 113.354 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.37 146.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.823 1.649 . . . . 0.0 108.109 163.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.8 142.06 48.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.987 0.812 . . . . 0.0 112.177 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -116.43 122.6 45.27 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.338 1.455 . . . . 0.0 114.538 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.79 114.6 17.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.026 0.93 . . . . 0.0 110.864 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.3 mt -126.66 151.26 73.0 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.77 136.9 47.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.612 2.208 . . . . 0.0 110.373 152.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -54.22 138.65 38.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.802 1.241 . . . . 0.0 110.847 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.18 -1.62 84.4 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.589 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 36.2 m -50.25 124.94 18.7 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 119.938 1.869 . . . . 0.0 111.273 166.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HB2' HD12 ' A' ' 142' ' ' ILE . 37.5 Cg_endo -71.31 129.32 15.78 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.798 1.665 . . . . 0.0 110.896 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.34 131.46 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 108.738 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -106.13 155.74 19.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.119 1.367 . . . . 0.0 110.224 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.96 75.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 O-C-N 121.521 -0.737 . . . . 0.0 111.707 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.51 -36.79 10.78 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.283 2.655 . . . . 0.0 113.24 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 p -134.62 163.18 30.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.148 1.779 . . . . 0.0 107.05 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.66 139.69 53.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.73 22.74 Favored Glycine 0 N--CA 1.467 0.702 0 O-C-N 121.433 -0.792 . . . . 0.0 113.219 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -148.02 144.87 28.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.372 1.069 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.51 128.22 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.3 -38.81 7.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.203 1.001 . . . . 0.0 112.045 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -148.62 141.35 24.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.49 1.516 . . . . 0.0 111.778 -168.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -139.76 127.29 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.142 1.377 . . . . 0.0 110.381 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 p90 . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -178.833 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.79 137.18 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.885 2.474 . . . . 0.0 113.394 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.68 135.92 53.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.016 1.326 . . . . 0.0 110.237 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 124.6 44.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.11 147.1 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 125.187 1.395 . . . . 0.0 111.796 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.98 138.13 51.2 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.34 2.256 . . . . 0.0 111.764 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.735 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 39.6 m-85 . . . . . 0 C--O 1.235 0.305 0 N-CA-C 118.28 2.696 . . . . 0.0 118.28 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -130.0 150.36 51.31 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.154 1.781 . . . . 0.0 111.847 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -118.61 131.84 56.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.846 1.658 . . . . 0.0 108.763 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -105.43 150.69 25.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.377 1.071 . . . . 0.0 111.856 157.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -135.19 112.56 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.585 1.954 . . . . 0.0 106.35 171.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -106.7 159.9 15.87 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 111.25 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 68.74 55.3 0.47 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.484 1.913 . . . . 0.0 113.282 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.82 158.03 16.27 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 111.382 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -40.42 5.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.638 1.175 . . . . 0.0 112.557 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -144.64 147.9 33.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.034 1.734 . . . . 0.0 111.782 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -94.32 145.99 24.36 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.037 1.335 . . . . 0.0 112.397 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -106.73 -16.44 14.49 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.47 1.108 . . . . 0.0 112.012 170.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.35 167.21 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.149 1.38 . . . . 0.0 111.499 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -124.19 165.4 17.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 111.939 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.5 t -56.22 123.78 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.36 1.064 . . . . 0.0 108.931 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.34 61.01 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.209 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -97.92 135.83 39.09 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.032 1.916 . . . . 0.0 109.419 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -76.49 145.17 39.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.456 1.102 . . . . 0.0 113.254 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.99 161.04 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 127.013 2.125 . . . . 0.0 111.293 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -123.93 144.09 49.99 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.498 2.319 . . . . 0.0 108.552 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -45.44 112.73 0.49 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.014 1.326 . . . . 0.0 112.308 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.39 -3.2 34.76 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.946 1.736 . . . . 0.0 115.51 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.15 144.54 26.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 88' ' ' PRO . 19.2 mm -70.9 130.82 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.763 0.71 . . . . 0.0 111.924 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.6 pt -115.96 -22.94 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.712 1.205 . . . . 0.0 113.298 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.44 -178.33 2.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.938 1.295 . . . . 0.0 111.278 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -129.73 135.44 48.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.68 146.65 53.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.933 0.893 . . . . 0.0 112.27 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 CA-C-O 121.52 0.511 . . . . 0.0 112.751 176.03 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 115.77 12.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.482 0.713 . . . . 0.0 110.478 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -92.12 98.78 11.75 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.79 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.288 50.6 t80 -89.07 109.67 20.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.66 117.49 33.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.447 1.099 . . . . 0.0 111.467 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -102.53 126.37 49.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.012 1.325 . . . . 0.0 111.059 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.5 mtm -129.49 149.11 51.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.573 1.549 . . . . 0.0 111.451 -170.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -124.32 131.08 53.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.47 1.508 . . . . 0.0 110.759 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.25 -1.27 35.18 Favored Glycine 0 CA--C 1.545 1.914 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.42 -169.74 41.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.997 1.284 . . . . 0.0 112.521 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.76 115.73 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.28 1.432 . . . . 0.0 112.781 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.52 15.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.395 1.95 . . . . 0.0 111.347 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -57.84 -40.5 80.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.607 1.204 . . . . 0.0 112.832 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.49 -17.61 64.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -88.65 -11.8 44.31 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 151.09 34.08 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -130.57 -89.12 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.517 1.527 . . . . 0.0 113.98 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -160.22 95.89 1.53 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -167.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.4 -34.94 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.15 1.9 . . . . 0.0 114.206 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -54.95 -55.36 39.7 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 121.098 1.772 . . . . 0.0 115.53 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.46 -26.51 40.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.362 2.708 . . . . 0.0 112.099 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.17 -38.3 81.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.44 -40.8 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.887 0.475 . . . . 0.0 110.861 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.45 -5.05 13.09 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -114.12 -4.79 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.018 2.127 . . . . 0.0 113.225 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.84 156.04 48.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.53 1.132 . . . . 0.0 112.327 171.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.65 -49.51 16.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.868 3.045 . . . . 0.0 113.148 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.41 5.21 36.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.454 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.37 -143.76 47.61 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.033 -1.042 . . . . 0.0 112.181 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.44 61.93 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -64.7 -10.08 24.57 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -86.72 5.46 36.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 171.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.1 -18.56 9.35 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.624 1.57 . . . . 0.0 112.709 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -149.1 157.73 43.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.363 -1.461 . . . . 0.0 111.701 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.69 89.02 2.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.241 0.65 0 C-N-CA 124.978 1.311 . . . . 0.0 110.796 173.126 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.49 22.63 11.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.571 1.548 . . . . 0.0 114.675 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.59 -158.05 8.93 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 121.206 -0.934 . . . . 0.0 113.56 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.593 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -125.92 133.31 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.867 2.067 . . . . 0.0 108.796 178.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.45 96.08 5.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.48 110.44 14.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 114.17 4.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.267 0.94 . . . . 0.0 111.351 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -129.82 147.27 64.76 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.22 0.608 . . . . 0.0 112.057 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.47 135.43 49.58 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.04 1.827 . . . . 0.0 110.346 162.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -60.67 130.3 45.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.769 0.827 . . . . 0.0 111.129 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.58 -7.92 68.56 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.737 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -51.32 126.65 28.75 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-N 120.121 1.961 . . . . 0.0 113.101 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.606 ' HB2' HD12 ' A' ' 142' ' ' ILE . 6.4 Cg_endo -67.73 136.07 37.73 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.638 2.226 . . . . 0.0 112.151 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.67 127.6 44.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.484 1.514 . . . . 0.0 107.888 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -96.91 148.8 22.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.087 1.355 . . . . 0.0 109.643 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.1 125.06 88.5 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.692 -0.671 . . . . 0.0 110.277 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.64 -39.93 14.58 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.314 2.676 . . . . 0.0 111.72 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.2 p -120.34 166.44 13.52 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.736 2.414 . . . . 0.0 110.089 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -67.36 144.92 55.56 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 154.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.95 -157.68 16.18 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.407 1.003 . . . . 0.0 114.345 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.14 143.96 25.38 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.044 1.738 . . . . 0.0 112.09 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.32 127.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -42.7 8.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 -159.19 143.72 15.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.2 1.0 . . . . 0.0 110.85 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.429 HG23 ' CE2' ' A' ' 129' ' ' TYR . 53.1 mt -141.78 122.31 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.486 1.514 . . . . 0.0 109.101 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -177.316 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 mttm . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.4 139.36 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.656 1.982 . . . . 0.0 114.208 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.298 1.439 . . . . 0.0 109.821 171.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 126.5 55.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.391 0.676 . . . . 0.0 112.57 171.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.14 145.18 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.829 1.252 . . . . 0.0 112.218 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.94 132.25 52.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.701 2.4 . . . . 0.0 112.182 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.422 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.264 50.0 m-85 . . . . . 0 C--O 1.238 0.468 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -126.48 155.71 41.85 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.646 2.378 . . . . 0.0 111.332 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -137.8 105.3 5.54 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.473 1.909 . . . . 0.0 110.625 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -88.52 146.03 25.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.156 0.582 . . . . 0.0 111.225 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -132.21 109.52 9.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.689 1.596 . . . . 0.0 108.218 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.08 162.49 12.9 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.939 1.296 . . . . 0.0 111.112 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 59.32 61.76 1.97 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.203 2.201 . . . . 0.0 112.798 -174.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.03 140.49 36.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.973 1.309 . . . . 0.0 111.998 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -80.86 -48.75 11.97 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 0.0 108.716 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -152.42 149.21 28.34 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.536 1.935 . . . . 0.0 111.152 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.429 ' CE2' HG23 ' A' ' 100' ' ' ILE . 97.9 m-85 -98.06 143.27 28.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.728 1.211 . . . . 0.0 113.032 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -103.45 -29.36 11.23 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.524 -0.735 . . . . 0.0 111.812 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.6 m -111.03 172.61 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.737 1.615 . . . . 0.0 112.208 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -128.55 162.94 26.08 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.734 1.614 . . . . 0.0 111.681 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -56.04 130.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 122.37 1.081 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.29 5.42 67.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.476 1.512 . . . . 0.0 114.995 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -95.21 136.8 35.11 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.24 1.52 . . . . 0.0 114.061 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.1 mmm-85 -86.49 133.93 33.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.94 159.21 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.423 1.489 . . . . 0.0 110.863 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.19 143.54 51.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.216 1.806 . . . . 0.0 108.462 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.65 128.99 13.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.23 1.012 . . . . 0.0 113.06 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.45 -2.69 78.22 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.33 1.443 . . . . 0.0 114.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -79.31 139.74 37.74 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.754 1.277 . . . . 0.0 113.692 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.6 mm -69.82 126.81 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 118.846 0.748 . . . . 0.0 111.544 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -108.8 -26.06 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.125 1.37 . . . . 0.0 113.133 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.11 -176.81 2.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 110.389 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.47 136.34 41.21 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -82.48 143.87 30.83 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 C-N-CA 124.601 1.096 . . . . 0.0 113.27 -176.111 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.0 p80 . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.08 118.08 19.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.857 0.753 . . . . 0.0 110.587 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -94.95 100.91 12.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.51 113.14 25.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.015 1.326 . . . . 0.0 113.953 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -117.7 112.41 20.44 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 110.088 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 ttt-85 -99.93 127.26 46.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.122 0.969 . . . . 0.0 110.603 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.1 mtm -127.37 154.09 45.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.622 1.569 . . . . 0.0 111.731 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -130.07 131.92 45.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.419 1.087 . . . . 0.0 112.246 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.54 6.11 75.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.053 0.835 . . . . 0.0 114.68 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.83 -161.1 31.23 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.116 1.817 . . . . 0.0 111.374 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.48 135.6 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.63 1.172 . . . . 0.0 111.838 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 138.71 171.72 12.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.084 1.802 . . . . 0.0 112.578 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -54.23 -51.29 64.96 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.75 1.22 . . . . 0.0 113.569 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.15 -17.12 63.17 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.712 -1.243 . . . . 0.0 114.279 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -80.23 -18.2 50.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.07 145.87 55.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.667 0.787 . . . . 0.0 111.602 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -122.8 -81.0 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -166.92 97.37 0.68 Allowed Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.27 -26.35 5.13 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.127 1.884 . . . . 0.0 114.51 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.593 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -56.3 -51.91 77.18 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-N 121.622 2.01 . . . . 0.0 113.821 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.48 -25.75 24.95 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.512 2.141 . . . . 0.0 112.379 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.67 -32.7 74.26 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -80.71 -26.37 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.341 0.657 . . . . 0.0 111.717 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -59.46 -10.44 3.29 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -117.39 -5.84 11.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.887 2.075 . . . . 0.0 113.616 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.04 148.76 91.91 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.367 -0.833 . . . . 0.0 111.8 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -36.95 52.87 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.306 2.671 . . . . 0.0 114.066 -166.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -109.64 0.13 18.9 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.265 -0.897 . . . . 0.0 110.864 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 78.3 -143.2 26.96 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.613 1.097 . . . . 0.0 112.083 -164.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.54 -25.97 64.96 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.916 -1.344 . . . . 0.0 114.14 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -63.25 -8.88 9.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.01 1.324 . . . . 0.0 114.485 173.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -83.05 -5.44 59.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.397 1.079 . . . . 0.0 112.952 170.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -104.2 -14.61 15.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.903 1.681 . . . . 0.0 113.184 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -143.51 160.16 41.11 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.834 1.652 . . . . 0.0 114.7 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -108.07 78.16 1.16 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 124.315 1.046 . . . . 0.0 112.354 -176.693 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.279 69.9 m-85 -90.07 43.76 1.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.56 -175.91 38.44 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.506 -1.371 . . . . 0.0 115.055 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.32 146.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.152 1.781 . . . . 0.0 107.866 165.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 137.44 50.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.518 1.054 . . . . 0.0 113.13 167.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.08 118.96 38.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.005 1.722 . . . . 0.0 113.93 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.82 110.47 4.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.585 0.754 . . . . 0.0 110.199 171.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.7 mt -125.34 150.42 67.35 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 111.466 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.6 138.21 73.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.637 2.225 . . . . 0.0 110.578 161.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -56.76 121.61 10.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.185 1.394 . . . . 0.0 111.291 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.37 1.65 66.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.1 m -52.18 125.46 33.38 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 120.407 2.104 . . . . 0.0 112.436 166.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.601 ' HB2' HD12 ' A' ' 142' ' ' ILE . 9.0 Cg_endo -68.22 135.66 35.04 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.095 1.863 . . . . 0.0 111.841 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.3 mm -91.51 130.51 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.716 1.606 . . . . 0.0 107.428 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -101.25 150.19 23.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.995 1.318 . . . . 0.0 109.246 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 93.13 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.936 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.03 -30.53 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.317 2.678 . . . . 0.0 113.345 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.7 p -132.43 163.73 28.12 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.724 2.41 . . . . 0.0 112.225 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.54 135.94 42.14 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.71 -159.26 11.54 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.403 1.001 . . . . 0.0 114.057 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -150.9 145.55 25.71 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.681 1.593 . . . . 0.0 111.174 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.59 125.66 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.83 -41.35 7.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.822 1.249 . . . . 0.0 111.075 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -149.32 142.93 25.46 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.724 1.21 . . . . 0.0 111.654 -166.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.9 mt -140.99 134.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.446 1.098 . . . . 0.0 109.386 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.5 p90 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.3 mttt . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -134.53 138.89 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.137 1.775 . . . . 0.0 113.851 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -115.21 134.27 55.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.566 1.946 . . . . 0.0 109.784 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.44 123.62 46.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.755 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.2 mt -119.48 142.67 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 0.0 111.373 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.09 138.93 37.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.534 1.934 . . . . 0.0 110.89 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 112.241 169.779 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.296 38.5 m-85 . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -131.8 150.38 52.17 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.387 1.075 . . . . 0.0 112.598 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -125.53 121.4 33.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.693 1.997 . . . . 0.0 108.184 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -97.49 150.41 21.1 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.27 91.77 2.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.829 2.452 . . . . 0.0 108.823 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.47 162.91 13.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.472 0.709 . . . . 0.0 111.838 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 65.26 53.63 1.29 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.352 1.861 . . . . 0.0 111.721 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.7 mt -96.75 140.95 30.58 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.266 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.53 -50.83 12.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.376 1.87 . . . . 0.0 107.802 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -147.78 146.84 29.33 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.884 1.673 . . . . 0.0 111.322 -163.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -91.09 151.03 21.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.059 0.543 . . . . 0.0 111.728 171.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -118.12 -7.11 10.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.437 1.095 . . . . 0.0 112.657 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.81 166.8 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.294 1.838 . . . . 0.0 111.219 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -122.16 165.96 15.31 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.718 1.607 . . . . 0.0 111.135 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.5 t -52.64 125.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.782 1.233 . . . . 0.0 107.993 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.1 13.72 61.65 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.42 126.37 35.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.749 1.774 . . . . 0.0 112.603 168.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -71.2 135.22 47.43 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.981 0.512 . . . . 0.0 111.371 167.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.51 156.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.91 1.684 . . . . 0.0 110.348 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -136.13 140.73 43.89 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.988 1.715 . . . . 0.0 109.336 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.25 131.62 16.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.265 1.031 . . . . 0.0 113.488 -171.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.22 -6.68 83.31 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.861 2.172 . . . . 0.0 115.128 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -79.23 140.75 37.58 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.036 1.418 . . . . 0.0 114.017 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.0 mm -70.42 129.63 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.688 0.795 . . . . 0.0 111.603 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -115.5 -23.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.966 1.307 . . . . 0.0 113.089 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.67 -175.92 1.67 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.879 1.672 . . . . 0.0 110.386 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -136.85 138.18 40.48 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.5 t -79.92 143.24 34.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.048 0.84 . . . . 0.0 113.236 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 C-N-CA 124.953 1.264 . . . . 0.0 112.977 -176.213 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.65 117.09 13.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.082 0.953 . . . . 0.0 110.702 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -90.9 106.07 18.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.219 0.918 . . . . 0.0 111.865 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.251 41.5 t80 -95.28 115.04 26.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.409 1.484 . . . . 0.0 114.563 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -113.85 120.43 40.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.822 0.849 . . . . 0.0 111.755 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -92.95 124.0 36.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.078 1.751 . . . . 0.0 111.35 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.3 mtm -126.07 161.32 27.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.984 1.714 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -134.16 141.96 47.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 111.353 169.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.35 -5.26 60.52 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.252 1.406 . . . . 0.0 115.867 167.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.59 -175.12 47.45 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.751 2.596 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.25 121.76 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.637 1.175 . . . . 0.0 112.544 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.93 163.75 10.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.28 1.419 . . . . 0.0 112.356 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -48.23 -46.13 35.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.736 1.214 . . . . 0.0 113.468 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.34 69.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -81.46 -14.24 57.26 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.1 131.83 49.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.614 1.166 . . . . 0.0 112.119 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -103.28 -80.48 0.52 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.778 0.831 . . . . 0.0 112.681 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -166.78 101.34 0.66 Allowed Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.397 1.479 . . . . 0.0 114.046 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.02 -32.29 1.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.866 1.711 . . . . 0.0 114.097 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -57.83 -53.84 61.55 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 120.976 1.717 . . . . 0.0 115.475 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.24 -25.97 49.6 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.241 2.627 . . . . 0.0 112.122 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -61.13 -27.56 68.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 166.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.21 -31.52 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.836 0.854 . . . . 0.0 111.998 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.4 -4.7 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -114.81 -5.75 12.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.807 2.043 . . . . 0.0 113.652 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.9 mt -77.72 148.1 75.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.743 1.217 . . . . 0.0 112.532 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.65 -21.31 22.13 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.811 3.007 . . . . 0.0 115.2 -164.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -119.01 9.44 11.86 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.106 1.363 . . . . 0.0 113.921 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.02 -141.24 34.1 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.252 0.93 . . . . 0.0 112.975 -169.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.63 -25.25 52.8 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.313 -1.11 . . . . 0.0 113.414 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -64.89 -9.11 18.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 113.753 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.3 m -81.74 -7.96 59.65 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.08 0.952 . . . . 0.0 112.76 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.36 -18.69 14.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.624 1.17 . . . . 0.0 113.346 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -144.17 159.42 42.68 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.378 -1.451 . . . . 0.0 113.441 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -104.78 93.11 4.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.241 0.631 0 C-N-CA 123.658 0.783 . . . . 0.0 111.824 177.196 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 121.454 0.645 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.453 68.5 m-85 -93.41 28.07 2.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.43 -168.97 23.09 Favored Glycine 0 CA--C 1.532 1.097 0 O-C-N 121.109 -0.994 . . . . 0.0 114.766 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.27 144.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.977 2.111 . . . . 0.0 108.859 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -123.47 129.88 51.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -102.62 118.77 37.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.106 1.762 . . . . 0.0 113.804 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HA ' ' CD2' ' A' ' 157' ' ' HIS . . . -72.76 78.14 1.12 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.356 1.062 . . . . 0.0 112.421 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.6 mt -95.77 150.17 37.02 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.099 0.959 . . . . 0.0 112.484 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.07 151.52 83.6 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.864 2.376 . . . . 0.0 112.214 162.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -54.74 139.68 38.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.325 1.45 . . . . 0.0 111.054 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.77 -9.56 59.21 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.028 -1.429 . . . . 0.0 115.818 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 m -50.62 122.47 16.19 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.707 1.754 . . . . 0.0 113.938 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.568 ' HB2' HD12 ' A' ' 142' ' ' ILE . 14.7 Cg_endo -67.31 129.3 20.03 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.165 1.243 . . . . 0.0 111.662 172.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.426 HD11 ' HB2' ' A' ' 146' ' ' SER . 45.6 mm -87.94 127.68 40.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.267 1.827 . . . . 0.0 107.771 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -99.25 154.38 18.2 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.482 1.513 . . . . 0.0 109.77 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.9 123.95 90.16 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.939 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -35.79 51.61 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.148 2.565 . . . . 0.0 112.716 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -138.58 154.89 48.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.725 1.61 . . . . 0.0 107.137 -169.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.29 134.33 55.65 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.494 0.718 . . . . 0.0 110.926 169.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.01 -157.92 11.58 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.937 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 146.47 25.65 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.438 1.895 . . . . 0.0 111.911 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.03 129.23 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 -44.91 7.09 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -158.62 143.73 16.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.049 1.34 . . . . 0.0 111.104 -166.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -141.1 118.75 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.761 1.224 . . . . 0.0 109.637 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.0 p90 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.577 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.8 mttp . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.81 140.93 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 127.005 2.122 . . . . 0.0 114.451 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.86 132.53 56.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.302 1.841 . . . . 0.0 108.683 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.99 124.49 51.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.586 1.155 . . . . 0.0 110.403 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.76 144.43 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.455 1.102 . . . . 0.0 111.153 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.76 127.09 53.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.362 1.865 . . . . 0.0 110.35 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 . . . . . 0 N--CA 1.473 0.689 0 O-C-N 121.006 -1.059 . . . . 0.0 111.428 169.328 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.312 35.1 m-85 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -120.13 155.32 33.28 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.316 2.246 . . . . 0.0 110.843 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -140.97 103.17 4.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.245 1.818 . . . . 0.0 109.994 -168.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -85.06 142.72 29.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.685 0.394 . . . . 0.0 111.38 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -130.78 89.94 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.872 2.469 . . . . 0.0 109.979 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mp -93.27 157.06 16.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.342 0.657 . . . . 0.0 111.346 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 71.18 58.56 0.19 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.269 1.827 . . . . 0.0 113.187 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -103.72 148.86 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.024 1.33 . . . . 0.0 111.288 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.42 -52.68 6.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.412 1.885 . . . . 0.0 107.618 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -150.98 157.79 43.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 127.168 2.187 . . . . 0.0 110.921 -165.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -98.77 154.29 18.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.94 0.896 . . . . 0.0 112.076 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -117.18 -14.28 10.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.677 1.191 . . . . 0.0 112.934 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.93 163.17 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.067 1.347 . . . . 0.0 110.397 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -117.88 163.84 15.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.4 t -54.52 135.43 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.57 3.72 83.7 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.561 1.077 . . . . 0.0 115.263 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -79.67 124.57 28.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 119.326 1.563 . . . . 0.0 111.863 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -74.19 140.95 45.46 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.77 160.92 40.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.617 1.567 . . . . 0.0 110.298 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -129.2 145.06 51.41 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.605 1.562 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.0 116.56 2.05 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.558 1.143 . . . . 0.0 112.732 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.68 -1.33 42.19 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 126.203 1.859 . . . . 0.0 115.305 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -86.34 142.58 28.39 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.407 1.883 . . . . 0.0 114.958 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 88' ' ' PRO . 13.4 mm -69.01 129.05 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.109 0.868 . . . . 0.0 112.01 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.77 -23.97 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.707 1.603 . . . . 0.0 113.312 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.77 3.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.469 1.108 . . . . 0.0 110.54 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.66 132.08 46.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 89' ' ' ILE . 1.6 t -69.06 137.52 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.704 1.601 . . . . 0.0 110.43 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.502 0 CA-C-O 122.893 1.274 . . . . 0.0 115.027 -169.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.436 ' CD2' ' HA ' ' A' ' 82' ' ' ALA . 25.1 m170 . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.48 128.53 36.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.292 1.437 . . . . 0.0 112.089 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -106.23 105.9 16.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.798 0.839 . . . . 0.0 112.109 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.287 33.7 t80 -95.4 111.98 23.77 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.882 1.673 . . . . 0.0 114.941 175.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -116.7 114.0 23.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.621 1.168 . . . . 0.0 111.282 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.94 122.63 43.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.415 1.486 . . . . 0.0 110.808 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.0 mtm -128.64 156.46 43.38 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.618 1.567 . . . . 0.0 111.415 -172.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -127.76 128.29 45.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 110.669 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.3 -15.2 12.7 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 125.886 1.708 . . . . 0.0 116.623 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.53 40.31 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.049 1.309 . . . . 0.0 112.179 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.93 91.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 173.03 173.21 39.28 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.872 1.701 . . . . 0.0 112.86 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -48.58 -48.65 38.77 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.1 -14.62 62.74 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.19 -16.34 38.12 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 143.49 52.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.564 1.146 . . . . 0.0 112.823 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -125.23 -79.94 0.61 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -164.79 110.51 0.84 Allowed Pre-proline 0 N--CA 1.47 0.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -29.99 4.13 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.257 1.971 . . . . 0.0 114.151 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -51.35 -59.98 6.72 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.6 -28.62 69.73 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.689 2.926 . . . . 0.0 111.695 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -66.72 -39.17 87.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.22 -34.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.775 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.51 -16.84 17.12 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.93 1.12 11.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.144 1.778 . . . . 0.0 114.692 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.23 154.39 87.36 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.44 1.096 . . . . 0.0 111.848 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -47.2 -54.69 4.7 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.921 3.748 . . . . 0.0 114.028 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -106.99 10.84 30.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.272 1.029 . . . . 0.0 112.727 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.32 -139.1 30.15 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.711 -1.243 . . . . 0.0 112.332 -169.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.97 -26.4 62.28 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.706 -1.467 . . . . 0.0 112.807 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -69.55 -3.37 14.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.983 1.313 . . . . 0.0 113.067 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.6 m -80.54 -8.04 59.44 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.31 1.044 . . . . 0.0 113.013 166.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.57 -13.47 15.05 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.854 1.662 . . . . 0.0 112.687 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.16 161.47 42.67 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -106.04 90.15 3.29 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.849 1.26 . . . . 0.0 109.806 170.272 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 119.767 -0.159 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.96 23.0 14.27 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -170.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.0 -166.97 14.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 120.696 -1.252 . . . . 0.0 114.579 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.01 130.36 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.828 2.051 . . . . 0.0 109.291 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -109.64 89.15 2.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.15 108.1 12.4 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.17 126.83 30.43 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.417 1.008 . . . . 0.0 111.776 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.45 159.17 71.64 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.137 0.975 . . . . 0.0 113.325 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.19 145.8 73.91 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.234 2.623 . . . . 0.0 111.22 161.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -65.87 131.71 46.91 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.345 -0.847 . . . . 0.0 111.149 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.27 84.24 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.586 -1.675 . . . . 0.0 115.415 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -47.72 121.93 8.58 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.923 1.862 . . . . 0.0 112.459 171.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.594 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.6 Cg_endo -68.2 129.25 18.94 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.424 1.416 . . . . 0.0 111.589 175.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -86.23 128.1 39.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.73 1.612 . . . . 0.0 108.482 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -100.4 149.81 23.27 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 109.644 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.76 133.37 90.46 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 121.777 -0.577 . . . . 0.0 110.861 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.59 -32.39 6.11 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.193 2.595 . . . . 0.0 112.667 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.3 p -140.22 160.92 38.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.34 2.256 . . . . 0.0 107.847 -170.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -74.64 136.78 41.94 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.772 -1.205 . . . . 0.0 109.326 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.56 -159.11 11.81 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.973 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.09 144.68 25.89 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.913 1.285 . . . . 0.0 113.108 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.65 127.26 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.06 -41.95 5.69 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.614 1.166 . . . . 0.0 111.939 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -147.06 140.43 25.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.697 1.199 . . . . 0.0 110.915 -165.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 mt -144.82 110.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.512 1.525 . . . . 0.0 109.42 -173.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 p90 . . . . . 0 N--CA 1.48 1.074 0 C-N-CA 123.461 0.704 . . . . 0.0 112.545 -169.617 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.25 134.79 62.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.528 1.531 . . . . 0.0 115.087 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -111.35 134.97 52.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.135 1.374 . . . . 0.0 109.574 168.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.4 124.34 44.28 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 55.6 mt -119.85 139.91 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.557 1.143 . . . . 0.0 111.193 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.33 131.27 40.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.852 2.061 . . . . 0.0 110.118 166.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.611 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 . . . . . 0 C--O 1.236 0.394 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -121.9 152.77 39.27 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.536 1.534 . . . . 0.0 112.54 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.38 138.95 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.586 1.954 . . . . 0.0 109.153 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -114.0 148.65 36.59 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.977 1.311 . . . . 0.0 112.827 161.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -133.7 99.63 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.896 1.679 . . . . 0.0 106.964 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.41 163.67 13.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.695 1.198 . . . . 0.0 110.508 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 66.25 40.15 3.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.154 2.181 . . . . 0.0 114.937 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -83.98 154.22 23.44 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.312 -1.493 . . . . 0.0 112.827 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.36 -46.75 7.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.799 1.239 . . . . 0.0 108.955 171.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -152.82 160.27 43.09 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -104.0 148.64 25.98 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.646 1.578 . . . . 0.0 111.911 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -107.33 -8.61 16.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.662 1.585 . . . . 0.0 112.25 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 175.39 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.772 1.629 . . . . 0.0 111.464 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -130.82 169.21 16.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.438 1.495 . . . . 0.0 111.424 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.29 132.47 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 122.225 1.012 . . . . 0.0 108.983 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.69 9.16 69.08 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.511 1.053 . . . . 0.0 115.128 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -86.27 124.61 32.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.727 1.264 . . . . 0.0 113.33 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -75.87 139.68 41.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.514 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.4 164.6 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.214 1.805 . . . . 0.0 112.676 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.05 140.14 48.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.254 1.822 . . . . 0.0 110.218 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.1 125.68 3.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.875 1.27 . . . . 0.0 113.402 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.94 -10.14 72.33 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.0 1.762 . . . . 0.0 114.995 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -80.74 145.0 31.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.179 1.489 . . . . 0.0 114.667 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.1 mm -70.82 135.06 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.225 0.61 . . . . 0.0 111.817 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 42.1 pt -121.22 -20.52 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.493 1.117 . . . . 0.0 113.321 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.7 -176.03 1.19 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.896 1.678 . . . . 0.0 111.388 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -132.82 134.46 44.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.2 t -71.01 143.65 50.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.179 0.591 . . . . 0.0 112.231 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.15 0 C-N-CA 124.554 1.073 . . . . 0.0 113.185 -178.016 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 120.727 0.298 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.42 120.88 41.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.167 1.387 . . . . 0.0 110.887 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -98.45 99.41 10.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.301 1.04 . . . . 0.0 110.583 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.283 36.8 t80 -88.75 116.66 27.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -122.29 116.95 24.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.323 1.049 . . . . 0.0 111.886 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -95.29 131.39 41.42 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.747 1.619 . . . . 0.0 110.93 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.8 mtm -132.43 155.09 49.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.681 1.593 . . . . 0.0 111.498 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -128.76 136.7 50.91 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.304 1.442 . . . . 0.0 111.235 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.39 2.75 43.85 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.75 -175.81 43.78 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.6 2.048 . . . . 0.0 111.0 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.56 123.29 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 122.438 1.114 . . . . 0.0 108.266 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.07 159.58 9.94 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.724 2.583 . . . . 0.0 110.685 -165.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.61 -46.68 83.78 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.774 1.287 . . . . 0.0 113.534 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.72 -15.98 63.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -76.28 -15.07 60.08 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.27 152.31 42.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.51 1.124 . . . . 0.0 113.861 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -119.97 -90.49 0.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.37 1.468 . . . . 0.0 112.409 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -160.91 118.13 1.44 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.371 1.469 . . . . 0.0 108.385 165.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -20.9 29.96 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.096 2.531 . . . . 0.0 115.512 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -50.86 -55.32 28.28 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.98 -28.2 42.09 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.905 3.07 . . . . 0.0 112.873 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.46 -34.51 78.46 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.2 mt -79.14 -32.66 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.107 0.563 . . . . 0.0 111.37 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.81 -5.59 2.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -117.45 -9.05 10.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.964 1.706 . . . . 0.0 113.804 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 58.7 mt -63.98 152.53 87.15 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.198 1.399 . . . . 0.0 113.078 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.97 -32.71 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.539 2.826 . . . . 0.0 114.603 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.64 13.43 19.93 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.108 1.363 . . . . 0.0 113.09 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.06 -135.73 48.67 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.98 0.8 . . . . 0.0 112.197 -167.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.23 -26.92 53.07 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.91 -10.28 56.29 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.7 t -78.66 0.62 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.211 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.7 mt -111.13 -16.23 13.51 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.726 1.61 . . . . 0.0 112.834 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -146.24 153.87 41.08 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.771 1.623 . . . . 0.0 114.558 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -107.75 76.53 1.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.399 1.095 . . . . 0.0 113.317 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 C--O 1.239 0.543 0 C-N-CA 124.464 1.105 . . . . 0.0 109.454 169.065 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 . . . . . 0 N--CA 1.473 0.706 0 CA-C-O 119.897 -0.097 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -122.47 27.22 7.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.155 0.982 . . . . 0.0 113.627 -166.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.99 -169.47 17.5 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.888 -1.132 . . . . 0.0 113.588 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.585 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -113.68 132.8 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.995 2.118 . . . . 0.0 108.617 173.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.96 93.76 4.61 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -79.82 111.19 15.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 121.55 17.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.729 0.695 . . . . 0.0 111.307 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.8 mt -135.99 156.78 76.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.373 1.469 . . . . 0.0 110.653 -173.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.29 137.68 67.11 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.56 2.174 . . . . 0.0 110.774 160.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -60.21 133.37 56.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 0.0 111.063 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.29 5.25 89.02 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.24 -1.311 . . . . 0.0 115.07 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.5 m -55.12 125.55 57.75 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.179 1.99 . . . . 0.0 110.506 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.579 ' HB2' HD12 ' A' ' 142' ' ' ILE . 10.9 Cg_endo -68.02 132.31 26.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.968 1.779 . . . . 0.0 111.851 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.46 126.22 41.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.208 1.803 . . . . 0.0 107.665 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -95.99 153.61 17.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.216 1.007 . . . . 0.0 110.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.32 123.71 89.44 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.727 -0.608 . . . . 0.0 110.672 172.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.19 -40.19 20.58 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.992 2.461 . . . . 0.0 111.475 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.1 p -134.82 165.02 26.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.079 2.552 . . . . 0.0 111.309 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -70.94 136.03 48.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.493 1.117 . . . . 0.0 112.056 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.54 -157.32 13.22 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.521 1.058 . . . . 0.0 114.629 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.68 150.42 31.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.557 1.943 . . . . 0.0 110.19 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 t -66.01 133.26 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -41.74 8.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -158.88 145.64 17.17 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.069 1.748 . . . . 0.0 109.372 -169.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.6 mt -137.32 129.87 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.901 1.28 . . . . 0.0 108.864 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.6 p90 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.466 0.371 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.51 137.01 56.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.607 1.563 . . . . 0.0 114.823 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.4 tp -115.95 123.44 48.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.21 125.47 48.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.276 1.03 . . . . 0.0 109.753 171.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.1 mt -121.45 147.46 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.588 1.155 . . . . 0.0 111.606 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.87 136.95 49.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.692 1.997 . . . . 0.0 110.812 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 123.876 0.87 . . . . 0.0 112.773 171.336 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.295 52.4 m-85 . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -115.16 151.86 33.64 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.376 1.87 . . . . 0.0 110.746 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.89 102.85 4.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.123 1.769 . . . . 0.0 110.206 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -85.31 139.83 31.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.384 0.274 . . . . 0.0 111.193 170.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -126.25 91.36 3.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.532 2.333 . . . . 0.0 109.436 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.55 158.36 16.49 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.961 1.304 . . . . 0.0 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 63.54 56.34 1.62 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.503 1.921 . . . . 0.0 114.124 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.2 mt -96.49 147.37 23.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 111.332 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -84.42 -48.49 9.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.63 148.11 30.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.062 1.745 . . . . 0.0 112.076 -169.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -93.66 144.62 25.22 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.938 1.295 . . . . 0.0 113.153 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -104.36 -10.97 17.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.605 0.762 . . . . 0.0 112.288 166.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.53 164.31 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.97 1.708 . . . . 0.0 113.191 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.45 164.37 14.98 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.016 2.126 . . . . 0.0 110.515 168.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.73 128.12 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.74 7.9 74.16 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.634 1.111 . . . . 0.0 115.747 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.27 133.32 35.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.044 1.922 . . . . 0.0 107.276 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -70.5 146.24 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.016 0.527 . . . . 0.0 111.8 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.6 m -129.33 154.06 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 110.007 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -133.5 140.59 47.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.954 1.702 . . . . 0.0 108.736 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.26 125.68 11.39 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.264 1.031 . . . . 0.0 112.751 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.63 -1.37 66.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.829 1.68 . . . . 0.0 115.46 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -88.54 142.29 27.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.125 1.37 . . . . 0.0 114.031 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.1 mm -67.3 132.12 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.084 0.856 . . . . 0.0 111.774 177.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 44.2 pt -116.57 -23.17 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.826 1.25 . . . . 0.0 113.211 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -172.54 -175.49 1.35 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.623 1.969 . . . . 0.0 110.665 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.38 139.14 46.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 0.0 107.505 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.11 144.37 50.29 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.64 0.776 . . . . 0.0 112.126 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 C-N-CA 123.664 0.649 . . . . 0.0 113.004 -175.858 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.54 117.37 14.13 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.08 0.952 . . . . 0.0 111.138 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -92.68 101.54 13.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.713 0.805 . . . . 0.0 110.784 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.281 52.9 t80 -93.28 115.65 28.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 170.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -117.62 116.08 26.36 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.632 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -92.24 121.85 34.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.72 1.608 . . . . 0.0 110.426 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.6 mtm -125.67 153.18 44.22 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.341 1.456 . . . . 0.0 110.756 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.12 128.92 46.97 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.654 1.181 . . . . 0.0 110.817 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.61 1.71 83.53 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.285 1.421 . . . . 0.0 115.812 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.51 -174.7 43.85 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.031 1.777 . . . . 0.0 111.846 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.8 125.3 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.618 1.167 . . . . 0.0 114.126 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 151.81 171.5 19.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.648 1.594 . . . . 0.0 113.037 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -65.06 -34.93 79.6 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.343 -1.093 . . . . 0.0 112.15 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.35 67.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.462 1.505 . . . . 0.0 113.58 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -92.94 -14.85 27.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.77 144.61 57.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.537 1.135 . . . . 0.0 112.329 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -116.24 -82.9 0.63 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.048 0.939 . . . . 0.0 112.24 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -170.4 129.02 0.81 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 128.125 2.57 . . . . 0.0 106.111 160.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.469 ' HG2' HD12 ' A' ' 79' ' ' ILE . 69.7 Cg_endo -71.58 -24.48 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.948 2.432 . . . . 0.0 114.539 171.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.585 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -54.05 -55.08 40.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -171.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.88 -31.09 48.28 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.688 2.925 . . . . 0.0 112.082 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -65.1 -41.62 94.77 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.45 HD12 HD13 ' A' ' 79' ' ' ILE . 29.9 mt -71.58 -35.78 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.391 0.541 . . . . 0.0 111.303 174.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 44.3 m-20 -63.68 -2.85 1.9 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -126.53 -7.59 6.29 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.096 2.158 . . . . 0.0 115.01 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.76 151.12 55.05 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.14 0.976 . . . . 0.0 112.484 170.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.41 -32.87 49.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.537 2.824 . . . . 0.0 114.947 -168.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.98 10.2 24.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.534 1.133 . . . . 0.0 109.61 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.68 -136.26 44.32 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.548 -1.345 . . . . 0.0 111.915 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.7 -25.28 68.08 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.934 -1.333 . . . . 0.0 113.939 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -68.41 -3.28 10.7 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.9 m -77.3 -6.69 54.12 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 111.94 166.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.06 -12.92 12.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.779 1.632 . . . . 0.0 113.854 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.13 161.52 38.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -114.81 87.01 2.55 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 122.228 1.013 . . . . 0.0 111.904 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.203 1.401 . . . . 0.0 110.915 177.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.66 21.29 7.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.17 -172.08 13.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.703 1.144 . . . . 0.0 113.903 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.78 136.8 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.342 2.257 . . . . 0.0 108.549 173.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.07 100.88 7.82 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.49 130.61 36.22 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.32 34.22 0.13 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.968 2.107 . . . . 0.0 115.901 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 148.74 90.33 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.727 -1.233 . . . . 0.0 111.835 -168.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.43 146.54 85.59 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.213 1.942 . . . . 0.0 111.982 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.12 129.0 33.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.967 0.907 . . . . 0.0 110.331 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.62 63.06 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.707 1.146 . . . . 0.0 115.523 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -58.87 126.5 80.97 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-N 119.612 1.706 . . . . 0.0 113.15 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.572 ' HB2' HD12 ' A' ' 142' ' ' ILE . 14.2 Cg_endo -69.66 130.31 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.27 1.98 . . . . 0.0 112.317 172.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 146' ' ' SER . 27.4 mm -85.13 129.6 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.974 1.71 . . . . 0.0 108.532 170.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -100.78 151.98 21.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.164 . . . . 0.0 110.39 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.75 88.98 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.367 0.667 . . . . 0.0 111.621 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.71 -26.02 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.176 3.251 . . . . 0.0 113.249 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.9 p -133.27 164.33 27.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 127.306 2.242 . . . . 0.0 110.263 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.98 145.39 46.32 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.169 -0.957 . . . . 0.0 108.479 151.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.83 -163.92 24.67 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.144 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -147.28 143.75 28.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.58 1.152 . . . . 0.0 111.917 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.16 128.11 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.33 -43.88 7.83 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.426 1.491 . . . . 0.0 114.947 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -159.21 144.1 15.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.048 0.939 . . . . 0.0 110.992 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -140.75 114.85 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.674 1.19 . . . . 0.0 109.88 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 p90 . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -167.339 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.7 mttm . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.13 137.45 55.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 tp -115.95 131.5 56.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.719 2.007 . . . . 0.0 108.582 167.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 125.81 53.54 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.59 1.156 . . . . 0.0 110.316 173.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.17 144.46 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.27 1.028 . . . . 0.0 111.552 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.36 136.27 41.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.654 1.982 . . . . 0.0 110.793 171.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 123.628 0.771 . . . . 0.0 111.619 170.422 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.73 159.08 31.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.556 2.742 . . . . 0.0 112.117 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.62 105.26 4.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.184 2.194 . . . . 0.0 110.96 -171.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -85.79 144.33 27.8 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.472 0.709 . . . . 0.0 112.314 171.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.42 87.12 2.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.136 2.574 . . . . 0.0 108.887 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.39 159.55 19.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.044 1.338 . . . . 0.0 110.918 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 62.87 50.41 3.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.754 2.021 . . . . 0.0 114.455 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.9 mt -89.79 158.41 17.51 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.672 -1.267 . . . . 0.0 112.419 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -98.76 -46.61 5.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 0.0 109.13 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -150.14 149.41 30.21 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.207 1.803 . . . . 0.0 111.888 -171.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -103.39 134.52 46.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 112.108 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -87.43 -27.51 22.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.125 0.57 . . . . 0.0 111.791 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -112.93 166.72 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.023 1.729 . . . . 0.0 112.521 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -116.69 162.22 18.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.801 2.04 . . . . 0.0 111.283 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.2 t -55.99 126.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.401 1.081 . . . . 0.0 109.189 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.34 12.14 61.79 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.453 1.501 . . . . 0.0 115.389 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -96.4 133.69 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.764 1.782 . . . . 0.0 107.657 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -72.97 146.75 45.79 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.011 0.924 . . . . 0.0 111.413 167.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.86 167.12 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.343 1.857 . . . . 0.0 111.879 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.85 134.16 44.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.427 1.891 . . . . 0.0 110.055 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.55 121.78 3.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.045 1.338 . . . . 0.0 112.851 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.81 4.69 69.35 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.523 1.535 . . . . 0.0 115.412 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -90.25 148.97 22.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 114.649 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 88' ' ' PRO . 14.8 mm -70.12 139.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.63 0.729 . . . . 0.0 111.469 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.53 -23.06 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.507 1.123 . . . . 0.0 112.544 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.15 -179.01 2.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.026 1.33 . . . . 0.0 111.368 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.97 138.14 54.76 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.502 ' HB3' HD11 ' A' ' 89' ' ' ILE . 80.0 p -66.43 135.99 55.08 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.651 1.18 . . . . 0.0 112.104 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.038 0 CA-C-O 122.389 0.994 . . . . 0.0 113.318 -176.452 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.19 116.11 16.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.487 -1.383 . . . . 0.0 111.082 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -94.62 102.04 13.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.855 0.752 . . . . 0.0 111.774 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.275 43.9 t80 -93.9 116.81 29.3 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.381 1.473 . . . . 0.0 114.77 171.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -124.6 116.61 22.69 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.757 1.223 . . . . 0.0 111.654 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -101.1 127.08 47.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.517 1.127 . . . . 0.0 111.409 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.2 mtm -128.44 157.33 41.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.792 1.637 . . . . 0.0 111.65 -173.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -136.09 137.17 40.79 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.177 1.391 . . . . 0.0 111.243 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.78 -18.61 8.72 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.167 1.365 . . . . 0.0 115.031 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -176.83 -168.74 37.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.152 1.834 . . . . 0.0 111.273 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.59 112.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 156.49 169.36 20.45 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.895 1.712 . . . . 0.0 111.557 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -61.14 -40.64 94.59 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.361 -1.082 . . . . 0.0 113.245 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.47 -26.95 67.17 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.51 -11.86 55.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.55 141.82 51.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.734 1.214 . . . . 0.0 112.651 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -106.03 -80.09 0.56 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -174.51 123.93 0.38 Allowed Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 128.37 2.668 . . . . 0.0 106.147 160.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.42 -29.49 11.09 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.054 2.503 . . . . 0.0 114.715 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -59.63 -52.84 71.17 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.58 -30.69 70.93 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.926 2.417 . . . . 0.0 111.881 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.17 -45.75 93.32 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 166.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.7 mt -69.53 -32.12 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.767 -1.208 . . . . 0.0 111.719 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.08 0.42 1.95 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.061 1.744 . . . . 0.0 115.07 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -124.74 -8.52 7.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 114.303 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.59 151.31 88.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.927 -1.108 . . . . 0.0 112.82 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.5 -35.2 39.87 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.743 2.962 . . . . 0.0 114.806 -165.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -112.13 16.4 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.923 1.289 . . . . 0.0 112.16 166.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.38 -134.72 48.04 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 121.076 -1.015 . . . . 0.0 112.441 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.34 -22.7 65.16 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.419 -1.048 . . . . 0.0 112.544 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.6 mtt-85 -72.3 -3.36 23.31 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.632 -1.293 . . . . 0.0 112.564 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 75.5 m -84.54 -7.53 59.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.501 1.12 . . . . 0.0 113.054 163.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.94 -19.88 15.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.777 1.631 . . . . 0.0 111.671 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -147.41 160.21 42.82 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -104.9 86.24 2.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.472 0.655 0 C-N-CA 124.604 1.162 . . . . 0.0 109.666 173.5 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -112.71 93.96 4.68 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.78 -172.47 26.45 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.198 0.904 . . . . 0.0 113.444 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.557 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -120.23 134.62 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.705 2.002 . . . . 0.0 108.862 173.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -110.53 92.29 3.99 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -78.37 106.18 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.72 120.24 10.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.341 0.973 . . . . 0.0 110.744 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.8 mt -129.83 152.32 79.67 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 124.012 0.925 . . . . 0.0 111.106 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.58 135.52 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.476 -1.009 . . . . 0.0 109.476 160.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.4 tttt -58.67 139.04 56.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.846 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 -6.46 76.29 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.111 -1.383 . . . . 0.0 115.881 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.4 m -51.76 127.53 34.4 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.693 2.247 . . . . 0.0 112.964 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HB2' HD12 ' A' ' 142' ' ' ILE . 11.7 Cg_endo -68.42 131.26 22.79 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.852 1.701 . . . . 0.0 112.084 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.2 132.2 32.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.152 1.781 . . . . 0.0 107.824 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -104.52 155.65 18.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 109.492 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.04 129.59 82.65 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.263 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.13 -31.87 22.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.382 2.721 . . . . 0.0 113.472 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -140.21 159.97 41.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.957 2.103 . . . . 0.0 107.546 -171.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -77.01 138.48 39.62 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.93 -1.106 . . . . 0.0 111.764 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.7 -157.05 10.05 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.075 1.322 . . . . 0.0 113.651 -173.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.91 146.86 25.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.428 1.491 . . . . 0.0 113.005 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.21 129.3 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -43.11 6.92 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -159.41 141.65 13.61 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.694 1.198 . . . . 0.0 110.983 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 55.5 mt -142.6 113.83 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.785 1.234 . . . . 0.0 110.965 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.8 p90 . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 124.493 1.117 . . . . 0.0 111.823 -168.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.2 mttm . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.13 137.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.777 1.631 . . . . 0.0 115.051 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.9 tp -117.87 126.68 52.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.042 2.137 . . . . 0.0 108.955 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.01 126.38 52.13 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.819 1.248 . . . . 0.0 110.256 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.97 147.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.998 1.319 . . . . 0.0 111.45 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.04 137.3 47.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.696 1.998 . . . . 0.0 110.144 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 . . . . . 0 N--CA 1.472 0.665 0 O-C-N 121.223 -0.923 . . . . 0.0 113.443 175.335 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.297 42.1 m-85 . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -123.22 161.21 24.98 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 112.141 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -143.84 104.13 4.13 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.252 2.221 . . . . 0.0 110.955 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -84.81 145.8 27.68 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 167.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -130.72 93.33 3.4 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.604 2.362 . . . . 0.0 109.837 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.39 157.37 15.92 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.663 1.185 . . . . 0.0 110.839 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.266 94.1 m-70 69.76 49.79 0.51 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.072 2.149 . . . . 0.0 114.484 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.84 143.82 25.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.873 0.869 . . . . 0.0 111.485 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.11 -43.32 15.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.402 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -154.48 151.11 28.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.016 2.526 . . . . 0.0 110.847 -169.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -96.96 159.33 14.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.744 0.818 . . . . 0.0 111.238 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -109.67 -28.58 8.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.448 1.099 . . . . 0.0 112.385 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.78 168.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.165 1.786 . . . . 0.0 110.667 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -128.12 172.1 11.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 111.358 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.98 130.8 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.275 1.03 . . . . 0.0 109.224 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.15 3.46 72.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.783 1.182 . . . . 0.0 115.323 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.75 126.14 31.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.015 1.407 . . . . 0.0 111.877 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.24 124.89 28.19 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.803 0.441 . . . . 0.0 111.488 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -106.94 157.03 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.858 1.663 . . . . 0.0 110.46 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.36 140.54 52.11 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.656 1.582 . . . . 0.0 109.307 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -44.02 123.31 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.446 1.098 . . . . 0.0 112.992 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.96 6.95 86.21 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.246 1.403 . . . . 0.0 115.362 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -91.63 145.88 24.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.374 1.469 . . . . 0.0 112.858 170.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 88' ' ' PRO . 20.2 mm -70.12 137.93 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.081 0.855 . . . . 0.0 112.114 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -123.58 -24.05 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.19 -173.17 1.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.45 1.023 . . . . 0.0 111.629 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.55 137.05 41.64 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.161 1.385 . . . . 0.0 107.3 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.8 t -75.56 142.62 42.72 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 C-N-CA 124.268 0.937 . . . . 0.0 113.157 177.755 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 121.105 0.479 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.81 121.56 42.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 110.485 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -96.11 102.4 14.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.92 0.888 . . . . 0.0 110.524 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.76 112.86 24.8 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.371 1.468 . . . . 0.0 114.65 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.44 118.62 35.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.19 0.596 . . . . 0.0 112.155 174.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -93.84 127.56 39.65 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.639 1.576 . . . . 0.0 111.55 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.1 mtm -132.16 162.43 30.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.475 1.91 . . . . 0.0 111.593 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -132.5 128.91 38.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.39 1.076 . . . . 0.0 112.796 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.87 6.93 74.32 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.254 1.261 . . . . 0.0 116.254 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.63 -179.6 44.04 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 126.439 1.971 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.72 128.9 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.282 1.433 . . . . 0.0 112.336 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.62 156.79 6.97 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.786 1.66 . . . . 0.0 112.056 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -48.2 -42.51 30.15 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.23 62.41 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -92.28 -13.41 30.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.628 1.571 . . . . 0.0 114.537 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.54 148.18 34.26 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.314 1.045 . . . . 0.0 113.508 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -116.99 -96.78 0.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.714 1.606 . . . . 0.0 111.826 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -159.51 118.24 1.65 Allowed Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.603 1.961 . . . . 0.0 113.114 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.439 ' HG2' HD12 ' A' ' 79' ' ' ILE . 89.2 Cg_endo -85.35 -30.97 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.913 1.742 . . . . 0.0 114.296 175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.557 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -52.37 -55.71 29.25 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 121.169 1.804 . . . . 0.0 114.697 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.01 -26.75 21.34 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.778 2.985 . . . . 0.0 112.225 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -67.26 -37.48 83.54 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.05 -44.95 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.093 0.557 . . . . 0.0 110.572 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -67.52 -0.89 4.2 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -173.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -111.92 -9.57 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.212 1.805 . . . . 0.0 113.52 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.28 159.15 42.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.243 1.417 . . . . 0.0 113.378 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.35 -48.06 24.02 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.73 3.62 . . . . 0.0 114.062 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -114.08 8.85 17.13 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.446 1.099 . . . . 0.0 113.356 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.51 -135.79 27.41 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.562 1.077 . . . . 0.0 111.961 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.18 -28.83 19.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.605 1.162 . . . . 0.0 113.6 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -70.72 -7.84 47.78 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.055 -1.028 . . . . 0.0 113.31 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.4 m -81.49 -3.86 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.802 0.841 . . . . 0.0 112.27 167.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.1 mp -111.11 -14.83 13.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.993 1.717 . . . . 0.0 113.322 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -145.03 161.88 38.31 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.234 -1.541 . . . . 0.0 113.76 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -110.14 82.75 1.64 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.015 0.912 . . . . 0.0 113.134 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 125.316 1.446 . . . . 0.0 111.061 174.22 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 . . . . . 0 CA--C 1.538 0.49 0 CA-C-O 120.592 0.234 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.357 83.2 m-85 -108.12 23.43 14.5 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -170.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.28 -164.51 13.44 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.332 0.968 . . . . 0.0 113.266 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.48 133.71 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 126.609 1.963 . . . . 0.0 108.953 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -110.43 96.48 6.22 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -78.64 123.88 27.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.49 56.59 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.703 2.001 . . . . 0.0 113.847 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.6 149.0 63.55 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.288 -0.883 . . . . 0.0 111.112 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.45 146.28 93.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.05 1.833 . . . . 0.0 111.777 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -54.58 135.48 46.26 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 110.678 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.95 68.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.737 1.161 . . . . 0.0 115.63 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 m -52.71 126.14 39.78 Favored Pre-proline 0 N--CA 1.478 0.936 0 CA-C-N 118.75 1.275 . . . . 0.0 112.238 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.495 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.6 Cg_endo -69.49 129.28 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.09 1.86 . . . . 0.0 111.998 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -85.86 130.59 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 108.468 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -103.35 149.94 24.27 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 109.764 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.54 83.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.879 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.4 -46.86 4.96 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.47 2.78 . . . . 0.0 111.574 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -113.98 172.81 6.77 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 128.487 2.715 . . . . 0.0 109.703 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -68.98 149.97 48.22 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.245 -0.91 . . . . 0.0 110.017 155.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 -154.64 12.45 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.475 0.56 . . . . 0.0 114.159 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -151.24 145.84 25.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.574 1.549 . . . . 0.0 111.021 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -66.0 128.12 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.04 -41.34 9.61 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -159.37 145.67 16.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.001 1.72 . . . . 0.0 109.543 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.0 mt -137.99 127.64 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 109.365 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.3 p90 . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.517 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.4 mttp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.14 143.16 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.861 1.665 . . . . 0.0 114.421 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 tt -122.76 136.6 54.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.803 1.641 . . . . 0.0 109.416 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.52 125.83 52.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.311 0.644 . . . . 0.0 111.935 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.02 147.92 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.883 1.273 . . . . 0.0 111.813 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -112.54 141.45 46.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 111.726 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 124.769 1.228 . . . . 0.0 113.062 173.187 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 C--O 1.235 0.328 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -121.14 142.97 49.36 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.954 1.702 . . . . 0.0 111.31 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -123.93 103.68 8.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.762 2.025 . . . . 0.0 110.426 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -86.68 144.01 27.33 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.566 0.346 . . . . 0.0 111.62 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -128.7 97.67 4.75 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.427 1.891 . . . . 0.0 106.892 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.28 151.59 22.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 109.844 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 71.56 63.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.937 2.095 . . . . 0.0 113.95 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.4 mt -101.67 155.7 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.512 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.45 -43.3 6.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.738 1.215 . . . . 0.0 110.939 167.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -145.14 150.29 36.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.614 1.566 . . . . 0.0 112.38 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -92.54 158.31 16.07 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.57 1.148 . . . . 0.0 112.441 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -122.2 -10.63 8.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.05 0.94 . . . . 0.0 113.205 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.3 160.81 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.56 1.144 . . . . 0.0 112.341 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -120.26 155.33 33.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.29 1.836 . . . . 0.0 112.841 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.1 t -55.11 123.14 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 0.0 109.413 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.08 0.7 61.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.078 1.323 . . . . 0.0 115.528 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -88.28 128.95 35.49 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.966 1.883 . . . . 0.0 113.3 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -74.55 139.97 44.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.064 0.546 . . . . 0.0 111.998 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.31 159.86 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 110.373 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -126.67 148.3 49.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.407 1.483 . . . . 0.0 108.658 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.42 121.74 4.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.363 1.065 . . . . 0.0 111.984 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.23 10.25 58.55 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.732 1.158 . . . . 0.0 114.971 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.33 134.75 34.09 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.966 1.306 . . . . 0.0 112.676 167.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 88' ' ' PRO . 15.4 mm -65.57 131.41 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 118.888 0.767 . . . . 0.0 110.372 172.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.4 pt -114.98 -21.96 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.479 1.112 . . . . 0.0 113.231 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.44 -179.82 1.96 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 110.904 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -129.63 135.0 48.0 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t -80.27 144.54 32.77 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.217 0 C-N-CA 125.312 1.434 . . . . 0.0 112.361 -179.076 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.0 p80 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.85 115.49 19.47 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.159 170.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -93.75 101.29 13.41 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.29 0.636 . . . . 0.0 110.943 172.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.66 117.21 29.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.948 1.299 . . . . 0.0 114.128 171.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -122.6 114.44 20.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.348 1.059 . . . . 0.0 111.888 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -92.51 121.94 34.46 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.208 1.803 . . . . 0.0 110.828 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.1 mtm -127.38 160.86 30.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.238 1.815 . . . . 0.0 111.189 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -140.26 133.96 30.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.11 6.96 81.21 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.722 1.153 . . . . 0.0 115.125 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.29 179.46 38.48 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 127.57 2.51 . . . . 0.0 110.086 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.1 125.07 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.76 168.86 15.45 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.607 1.575 . . . . 0.0 112.875 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -60.3 -36.9 78.95 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.184 -1.186 . . . . 0.0 113.523 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.08 -17.36 63.22 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.795 -1.191 . . . . 0.0 114.05 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.23 -12.55 43.43 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.47 137.11 52.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.567 1.147 . . . . 0.0 112.986 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -103.13 -89.86 0.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -161.91 115.9 1.23 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.575 2.35 . . . . 0.0 113.585 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 -31.76 2.08 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.103 1.869 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -54.37 -53.39 59.93 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.78 -22.56 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.886 3.058 . . . . 0.0 112.052 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -65.52 -42.67 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 167.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 49.0 mt -72.21 -25.62 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.297 -0.877 . . . . 0.0 112.206 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -59.76 -14.2 13.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -118.13 -1.14 11.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.431 1.092 . . . . 0.0 113.641 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.89 148.65 92.23 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.517 0.727 . . . . 0.0 112.632 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.58 -26.45 23.71 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.609 2.873 . . . . 0.0 114.932 -168.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -112.82 -7.86 13.76 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.83 -137.81 13.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.413 1.482 . . . . 0.0 112.535 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -55.09 -30.78 60.39 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.727 1.263 . . . . 0.0 111.694 170.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.0 mtp-105 -63.97 -12.25 36.04 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.476 1.51 . . . . 0.0 113.899 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 71.6 m -79.77 -7.85 58.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.472 1.033 . . . . 0.0 112.565 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.06 -14.0 15.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.106 1.363 . . . . 0.0 112.948 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -149.98 162.3 40.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -111.72 80.57 1.34 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--O 1.24 0.555 0 C-N-CA 124.888 1.275 . . . . 0.0 110.123 173.59 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 121.739 0.781 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.526 12.1 m-30 -90.74 39.44 0.98 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -173.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.91 -179.55 26.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.82 1.2 . . . . 0.0 112.897 170.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.58 127.48 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.687 1.595 . . . . 0.0 109.501 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -99.26 90.0 4.41 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -74.1 107.24 6.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.97 123.95 20.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.056 0.844 . . . . 0.0 110.294 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 mt -138.35 151.98 70.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.61 0.764 . . . . 0.0 111.228 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.2 136.5 44.26 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.36 2.04 . . . . 0.0 110.033 162.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.02 134.61 52.58 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.207 1.003 . . . . 0.0 109.949 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.32 -8.35 79.32 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.237 -1.313 . . . . 0.0 115.824 -175.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.6 m -53.77 123.81 40.23 Favored Pre-proline 0 N--CA 1.481 1.114 0 CA-C-N 120.219 2.009 . . . . 0.0 112.331 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.556 ' HB2' HD12 ' A' ' 142' ' ' ILE . 32.2 Cg_endo -70.03 130.85 19.71 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.726 1.617 . . . . 0.0 111.161 175.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -85.74 131.2 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.463 1.505 . . . . 0.0 108.216 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -101.32 149.8 23.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.31 1.044 . . . . 0.0 109.84 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.19 130.85 87.45 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.76 -0.588 . . . . 0.0 110.835 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.62 -27.42 15.33 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.923 3.082 . . . . 0.0 112.724 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 p -129.94 161.67 30.36 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.039 2.535 . . . . 0.0 112.905 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -63.92 138.83 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 157.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.52 -155.95 11.37 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -151.99 148.78 28.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.187 1.395 . . . . 0.0 111.584 171.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.66 129.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -41.92 7.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.003 1.721 . . . . 0.0 115.244 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -157.9 143.25 16.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.467 1.107 . . . . 0.0 111.464 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.4 mt -136.42 125.73 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.381 1.072 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.8 p90 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.967 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 mttm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 111.649 0.241 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.42 138.39 53.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.689 1.595 . . . . 0.0 114.743 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -119.46 127.09 52.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.959 2.104 . . . . 0.0 108.605 171.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 126.76 52.22 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.365 1.066 . . . . 0.0 110.464 171.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.8 mt -123.12 147.78 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.952 1.301 . . . . 0.0 111.927 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.22 141.96 42.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.201 2.2 . . . . 0.0 111.737 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 173.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 42.4 m-85 . . . . . 0 C--O 1.237 0.447 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -125.81 152.51 45.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.541 1.936 . . . . 0.0 111.431 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.74 104.03 6.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.846 2.059 . . . . 0.0 109.986 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.95 139.99 29.95 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.527 0.331 . . . . 0.0 111.63 170.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -125.57 92.93 3.71 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.621 2.368 . . . . 0.0 108.759 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.23 163.29 14.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.889 1.276 . . . . 0.0 110.914 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 64.71 38.08 7.15 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.489 1.916 . . . . 0.0 114.966 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.54 154.25 27.62 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.496 -1.378 . . . . 0.0 112.848 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.53 -49.43 6.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.73 1.612 . . . . 0.0 109.272 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -152.18 149.33 28.63 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.641 1.976 . . . . 0.0 111.387 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -94.47 141.35 28.69 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.503 1.121 . . . . 0.0 111.913 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -95.43 -15.51 22.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.058 0.943 . . . . 0.0 111.878 167.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.94 165.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.27 1.828 . . . . 0.0 113.154 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -120.79 164.34 16.76 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.744 2.018 . . . . 0.0 111.2 172.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.07 129.72 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.32 4.58 68.28 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.531 1.062 . . . . 0.0 115.713 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.62 130.27 35.22 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.623 1.712 . . . . 0.0 112.912 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -65.0 143.87 57.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.407 0.622 . . . . 0.0 110.795 163.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 161.62 21.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.514 1.526 . . . . 0.0 110.535 167.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -133.86 143.29 48.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.576 1.55 . . . . 0.0 109.88 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.14 117.61 2.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.966 0.889 . . . . 0.0 111.904 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.83 74.88 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.547 1.546 . . . . 0.0 115.205 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -85.36 145.14 27.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.519 1.66 . . . . 0.0 114.487 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 88' ' ' PRO . 15.9 mm -70.82 136.46 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.854 0.835 . . . . 0.0 111.969 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 49.1 pt -122.79 -23.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.69 1.196 . . . . 0.0 112.903 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.32 -176.57 1.91 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.527 1.531 . . . . 0.0 110.853 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -129.44 136.63 50.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.8 t -66.08 137.07 56.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.981 0 C-N-CA 125.575 1.56 . . . . 0.0 111.885 179.169 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.46 123.13 47.38 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.588 1.555 . . . . 0.0 109.812 165.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -98.38 103.62 15.58 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.472 0.709 . . . . 0.0 110.867 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.272 36.0 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 172.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -116.26 115.28 25.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.436 1.094 . . . . 0.0 111.851 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -95.31 125.25 39.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.804 1.642 . . . . 0.0 111.149 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.9 mtm -131.0 153.0 49.69 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.494 1.518 . . . . 0.0 111.372 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.24 130.51 52.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.227 1.411 . . . . 0.0 111.898 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.99 36.15 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.39 -179.73 48.0 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.549 2.023 . . . . 0.0 111.9 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 125.9 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.579 1.552 . . . . 0.0 112.891 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.98 164.85 10.08 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.888 . . . . 0.0 112.325 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -56.79 -36.95 70.47 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.038 -1.272 . . . . 0.0 113.155 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.45 -12.37 56.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -97.59 -8.82 28.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 173.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.29 142.12 55.65 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.212 1.405 . . . . 0.0 113.087 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.13 -79.7 0.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.354 1.062 . . . . 0.0 112.335 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -170.07 123.57 0.64 Allowed Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.843 2.057 . . . . 0.0 113.054 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.25 -35.4 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.535 2.156 . . . . 0.0 114.102 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -54.41 -54.69 45.53 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.11 -18.9 39.83 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.879 3.053 . . . . 0.0 113.14 -175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.06 -44.18 66.27 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.76 -31.25 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.707 0.803 . . . . 0.0 111.634 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.82 -3.77 3.69 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -123.53 -1.99 8.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.685 1.594 . . . . 0.0 114.374 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.7 mt -69.25 151.22 97.07 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.292 1.037 . . . . 0.0 112.292 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.08 -36.17 71.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.174 2.583 . . . . 0.0 115.063 -165.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -111.51 9.59 21.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.896 0.878 . . . . 0.0 113.366 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 71.51 -134.06 22.16 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.026 -1.046 . . . . 0.0 112.241 -171.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.69 -26.0 65.23 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.341 -1.094 . . . . 0.0 112.94 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -70.91 -3.9 21.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.407 1.483 . . . . 0.0 114.171 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 68.9 m -82.13 -6.08 58.92 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.14 0.976 . . . . 0.0 113.122 165.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.85 -13.25 14.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.307 1.443 . . . . 0.0 113.114 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.92 163.1 36.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.448 1.476 . . . . 0.0 113.896 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -111.35 89.67 3.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 124.531 1.132 . . . . 0.0 110.682 170.987 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.285 97.1 m-85 -107.14 15.33 25.28 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -170.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.96 -164.77 12.26 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.12 -0.987 . . . . 0.0 115.027 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.21 137.09 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 127.477 2.311 . . . . 0.0 109.384 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.9 97.17 5.49 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -77.67 108.49 10.91 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.03 117.95 5.71 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.313 1.045 . . . . 0.0 111.051 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -133.93 148.76 69.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.147 0.979 . . . . 0.0 111.089 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.36 139.46 65.44 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.234 1.956 . . . . 0.0 110.635 163.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -51.92 136.73 28.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 110.184 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.86 -4.73 78.67 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.537 -1.702 . . . . 0.0 116.19 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 m -53.1 123.5 34.15 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 120.431 2.116 . . . . 0.0 112.343 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.54 ' HB2' HD12 ' A' ' 142' ' ' ILE . 10.7 Cg_endo -68.46 127.95 16.47 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.654 1.569 . . . . 0.0 110.907 174.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 mm -84.38 129.01 38.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.876 1.27 . . . . 0.0 107.797 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -99.03 152.41 19.85 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.656 1.183 . . . . 0.0 109.983 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.01 124.72 90.25 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 118.39 -0.815 . . . . 0.0 110.085 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.26 -36.42 21.17 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.582 2.855 . . . . 0.0 112.835 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.573 2.349 . . . . 0.0 108.989 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.97 147.73 49.8 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.058 -1.026 . . . . 0.0 108.988 155.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.15 -159.4 19.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.916 0.77 . . . . 0.0 113.607 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -148.35 144.46 27.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.874 1.27 . . . . 0.0 112.397 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.21 125.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.91 -44.87 8.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.942 1.697 . . . . 0.0 115.101 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -157.06 147.48 21.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.012 1.325 . . . . 0.0 111.105 -168.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.411 HG23 ' CE1' ' A' ' 129' ' ' TYR . 47.0 mt -140.79 118.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.716 1.206 . . . . 0.0 109.513 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 p90 . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.724 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.489 HG13 HD22 ' A' ' 124' ' ' LEU . 8.8 t -131.92 137.18 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 126.188 1.795 . . . . 0.0 114.61 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.66 137.52 51.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.75 1.62 . . . . 0.0 109.618 165.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.53 125.28 51.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.676 0.79 . . . . 0.0 112.266 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.69 153.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.295 1.438 . . . . 0.0 111.906 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.63 55.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.857 2.063 . . . . 0.0 111.636 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 . . . . . 0 N--CA 1.481 1.095 0 C-N-CA 124.587 1.155 . . . . 0.0 113.016 177.619 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.273 55.5 m-85 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -104.23 157.08 17.38 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.465 1.906 . . . . 0.0 111.139 170.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -138.36 105.13 5.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.098 2.159 . . . . 0.0 110.501 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -85.81 147.74 26.16 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.19 109.78 8.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.947 1.699 . . . . 0.0 107.875 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 HG13 ' A' ' 109' ' ' VAL . 1.9 mm? -103.8 157.02 17.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.809 1.643 . . . . 0.0 110.562 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 67.1 59.11 0.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.113 1.765 . . . . 0.0 113.253 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 mt -104.82 151.23 24.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.691 1.597 . . . . 0.0 111.058 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.75 -42.67 6.4 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.487 . . . . 0.0 111.298 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -146.58 147.08 30.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.652 1.581 . . . . 0.0 112.265 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.411 ' CE1' HG23 ' A' ' 100' ' ' ILE . 90.1 m-85 -94.04 141.69 28.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 112.647 176.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -106.89 -5.77 18.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.808 1.243 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.29 166.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.341 1.456 . . . . 0.0 110.225 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -122.19 165.17 16.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.05 1.34 . . . . 0.0 110.265 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.69 131.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.978 0.911 . . . . 0.0 108.771 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.87 8.14 73.34 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.929 1.252 . . . . 0.0 115.278 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -84.19 119.22 24.75 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.01 1.405 . . . . 0.0 112.862 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -65.83 142.02 58.08 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.231 163.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.99 159.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.307 1.843 . . . . 0.0 109.195 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.66 142.7 50.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.449 1.9 . . . . 0.0 108.848 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.58 123.01 4.56 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.948 0.899 . . . . 0.0 113.326 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.39 3.73 64.74 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.582 1.087 . . . . 0.0 114.804 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.88 133.61 38.09 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.666 1.186 . . . . 0.0 112.487 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 88' ' ' PRO . 13.7 mm -67.73 129.31 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.721 0.691 . . . . 0.0 109.992 172.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.1 pt -112.87 -22.09 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.201 1.001 . . . . 0.0 113.266 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.93 -179.18 2.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.429 1.491 . . . . 0.0 110.322 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.18 132.17 45.91 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.0 t -77.24 146.53 36.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.094 0 C-N-CA 124.98 1.276 . . . . 0.0 111.448 -179.757 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.15 114.07 7.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.173 0.989 . . . . 0.0 110.744 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -91.9 99.04 11.97 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.597 0.759 . . . . 0.0 111.343 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 43.3 t80 -90.97 120.07 31.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.153 1.381 . . . . 0.0 114.679 172.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -130.0 108.36 10.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.987 1.315 . . . . 0.0 111.01 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -96.45 135.78 37.85 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.144 1.378 . . . . 0.0 111.386 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 41.0 mtm -136.11 143.22 44.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.332 1.453 . . . . 0.0 112.065 -166.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -111.62 132.62 54.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.948 1.299 . . . . 0.0 112.988 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.66 1.0 64.95 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.575 1.56 . . . . 0.0 115.17 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 161.64 -169.99 37.25 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 127.856 2.646 . . . . 0.0 109.438 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.87 138.26 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 122.269 1.033 . . . . 0.0 111.006 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.59 161.69 10.67 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 128.757 3.075 . . . . 0.0 109.595 -171.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -57.51 -42.29 82.51 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.704 -1.468 . . . . 0.0 113.44 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.16 -20.63 66.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -78.33 -16.0 58.16 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.8 147.46 45.47 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.36 1.064 . . . . 0.0 112.353 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.36 -61.35 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.409 1.084 . . . . 0.0 113.825 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.4 t0 178.42 123.07 0.2 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 130.557 3.543 . . . . 0.0 108.309 160.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.6 -21.63 21.91 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.78 2.986 . . . . 0.0 116.099 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -51.9 -56.22 23.47 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 120.658 1.572 . . . . 0.0 114.699 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.87 -24.89 60.58 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.618 2.879 . . . . 0.0 112.937 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.275 3.5 t80 -64.26 -45.11 89.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 169.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.5 mt -66.63 -28.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.854 -1.154 . . . . 0.0 111.357 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.22 -4.4 10.39 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -118.09 -10.15 10.39 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.1 mt -66.31 149.66 97.71 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.371 1.068 . . . . 0.0 112.423 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.75 -41.68 10.36 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.789 2.326 . . . . 0.0 113.597 -166.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.67 9.91 34.99 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.11 -133.98 45.93 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 120.866 -1.146 . . . . 0.0 112.441 -172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -54.21 -30.87 51.53 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.907 -0.76 . . . . 0.0 112.772 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -71.43 -5.47 33.04 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.09 1.356 . . . . 0.0 112.456 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.7 m -83.67 -6.91 59.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.968 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.9 -14.81 15.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.992 1.317 . . . . 0.0 113.0 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -146.41 159.12 43.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.535 1.516 . . . . 0.0 115.018 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -104.13 96.42 6.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 122.363 1.078 . . . . 0.0 112.777 -179.444 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.358 93.7 m-85 -106.08 18.96 21.28 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -169.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.72 -172.25 19.03 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.032 -1.042 . . . . 0.0 113.788 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.63 132.92 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.44 1.896 . . . . 0.0 109.039 172.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -111.01 102.01 10.52 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -85.23 115.82 23.22 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 76.1 4.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.862 1.665 . . . . 0.0 112.267 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.49 152.8 41.23 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.37 142.72 91.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.523 2.149 . . . . 0.0 111.001 158.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -59.98 136.3 57.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.935 1.294 . . . . 0.0 110.28 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.68 1.78 90.3 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -57.14 124.67 67.26 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.597 1.698 . . . . 0.0 111.654 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HB2' HD12 ' A' ' 142' ' ' ILE . 89.0 Cg_endo -71.28 125.31 11.22 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.037 1.158 . . . . 0.0 110.031 176.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 146' ' ' SER . 30.8 mm -80.76 129.38 37.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.356 1.462 . . . . 0.0 107.577 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -101.35 152.8 20.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.689 1.196 . . . . 0.0 109.954 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.62 131.54 87.89 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.766 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.75 -34.56 18.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.328 2.685 . . . . 0.0 112.833 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.0 p -129.59 163.4 26.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.547 1.939 . . . . 0.0 108.587 -173.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.93 141.84 58.09 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 121.256 -0.903 . . . . 0.0 108.988 158.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.12 -159.98 21.51 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.068 0.842 . . . . 0.0 113.418 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -151.05 140.91 21.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.228 1.514 . . . . 0.0 111.267 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 t -55.1 137.87 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.108 0.963 . . . . 0.0 113.419 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.97 -44.14 5.58 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -159.27 148.49 18.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.681 1.593 . . . . 0.0 109.776 -167.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.402 HG23 ' CE2' ' A' ' 129' ' ' TYR . 59.2 mt -139.8 128.0 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.447 1.099 . . . . 0.0 108.391 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.299 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 t -134.82 137.79 50.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 126.268 1.827 . . . . 0.0 114.616 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.1 tp -117.39 133.04 56.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.138 1.775 . . . . 0.0 108.819 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.27 125.65 53.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.778 1.231 . . . . 0.0 110.279 172.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.78 141.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.552 1.141 . . . . 0.0 110.809 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.52 137.82 36.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.021 1.329 . . . . 0.0 109.593 168.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 . . . . . 0 CA--C 1.543 0.674 0 O-C-N 122.183 -0.323 . . . . 0.0 111.055 166.306 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -118.42 150.75 39.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.321 1.848 . . . . 0.0 111.094 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -133.92 103.86 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.563 1.945 . . . . 0.0 110.082 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -85.35 145.47 27.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.341 0.656 . . . . 0.0 111.73 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.06 87.99 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.441 2.296 . . . . 0.0 110.057 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.18 154.16 19.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.851 0.861 . . . . 0.0 110.953 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.254 52.2 m-70 70.82 55.62 0.24 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.768 2.027 . . . . 0.0 113.734 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.9 149.05 23.81 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.68 1.592 . . . . 0.0 111.015 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.6 -48.58 10.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 113.024 166.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -145.21 152.09 39.44 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.282 1.833 . . . . 0.0 110.812 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.402 ' CE2' HG23 ' A' ' 100' ' ' ILE . 75.6 m-85 -85.18 159.89 20.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.572 0.749 . . . . 0.0 109.988 169.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -112.16 -25.28 9.4 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.174 0.99 . . . . 0.0 111.126 164.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.92 168.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.983 1.713 . . . . 0.0 111.423 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -119.73 167.44 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.346 1.458 . . . . 0.0 111.122 166.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.01 130.23 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.544 1.138 . . . . 0.0 108.766 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.06 1.2 76.44 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.989 1.281 . . . . 0.0 115.709 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -81.68 129.79 34.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.457 1.628 . . . . 0.0 112.416 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -68.62 143.94 54.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.784 0.802 . . . . 0.0 110.422 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.3 m -128.71 157.76 41.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.877 1.671 . . . . 0.0 109.036 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.71 143.81 50.99 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.118 1.767 . . . . 0.0 109.427 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.02 125.27 7.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.669 0.747 . . . . 0.0 112.105 174.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.98 -3.77 82.91 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.15 1.357 . . . . 0.0 115.837 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.4 142.26 37.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.469 1.635 . . . . 0.0 112.978 170.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.6 mm -72.88 131.19 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.931 0.872 . . . . 0.0 111.545 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -114.63 -24.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.565 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -168.62 -178.94 3.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.163 1.385 . . . . 0.0 110.566 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -129.28 134.1 47.79 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 89' ' ' ILE . 99.0 p -62.49 145.94 52.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 112.329 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.556 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 -172.767 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.3 m170 . . . . . 0 CA--C 1.546 0.824 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.74 116.72 7.96 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 111.881 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -94.67 99.99 12.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.145 0.978 . . . . 0.0 110.168 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 46.5 t80 -89.55 113.08 24.44 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.161 1.384 . . . . 0.0 114.332 171.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -118.27 115.26 24.38 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 111.301 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -95.29 128.47 42.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.303 1.441 . . . . 0.0 110.7 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.3 mtm -131.91 157.83 42.98 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.792 1.637 . . . . 0.0 110.819 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -135.12 133.24 39.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.165 0.986 . . . . 0.0 111.813 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.88 5.81 76.29 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.936 1.255 . . . . 0.0 115.089 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 162.63 -170.47 38.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.342 1.449 . . . . 0.0 112.739 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.47 121.15 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -173.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.32 171.89 17.68 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.974 1.749 . . . . 0.0 113.411 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -51.1 -48.75 61.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.382 1.473 . . . . 0.0 112.916 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.93 -13.29 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.238 1.415 . . . . 0.0 114.662 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -92.05 -16.86 25.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.99 135.12 53.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.036 0.934 . . . . 0.0 113.047 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -103.33 -92.06 0.35 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.317 1.447 . . . . 0.0 112.827 -171.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -168.5 100.97 0.53 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.46 -39.71 3.51 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.169 1.913 . . . . 0.0 113.276 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -54.62 -53.03 64.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.2 -23.5 28.71 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.918 3.079 . . . . 0.0 112.458 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -69.3 -39.46 78.28 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 56.9 mt -71.09 -38.71 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 122.979 0.512 . . . . 0.0 110.95 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.52 -15.58 11.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -110.68 -12.06 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.952 1.301 . . . . 0.0 112.778 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.3 154.1 33.83 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.721 1.208 . . . . 0.0 112.394 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.56 -50.57 13.39 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.445 3.43 . . . . 0.0 114.386 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -107.52 9.41 29.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.45 -139.02 43.38 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 120.51 -1.369 . . . . 0.0 112.651 -171.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.27 -21.79 66.72 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.058 -1.26 . . . . 0.0 112.993 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -64.11 -8.58 12.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.91 1.284 . . . . 0.0 112.895 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.8 t -88.56 -1.86 58.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.809 1.244 . . . . 0.0 112.751 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.47 -15.25 12.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.666 1.586 . . . . 0.0 112.417 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -145.67 164.6 31.27 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.56 -1.337 . . . . 0.0 112.912 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -114.53 86.62 2.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.472 0.631 0 C-N-CA 125.06 1.344 . . . . 0.0 110.424 174.754 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.291 98.3 m-85 -95.99 23.04 6.76 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -172.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.96 -162.91 12.74 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.88 -1.137 . . . . 0.0 113.266 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.49 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -119.18 133.31 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.472 1.909 . . . . 0.0 108.488 175.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -109.51 97.0 6.65 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.67 107.87 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.29 123.7 18.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.416 1.007 . . . . 0.0 110.941 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 mt -138.85 146.67 51.03 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.274 0.63 . . . . 0.0 111.733 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.81 137.85 79.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.295 1.997 . . . . 0.0 110.747 163.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.39 135.18 56.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 111.434 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.25 -7.22 81.9 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.273 -1.293 . . . . 0.0 114.944 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.2 m -53.73 126.13 48.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-N 120.069 1.934 . . . . 0.0 113.362 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.578 ' HB2' HD12 ' A' ' 142' ' ' ILE . 9.5 Cg_endo -68.17 136.66 38.22 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.486 2.124 . . . . 0.0 112.883 171.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.7 mm -92.39 132.45 36.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.566 1.946 . . . . 0.0 108.186 173.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -103.73 151.01 23.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.768 1.227 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.3 129.25 90.63 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.241 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.27 -33.18 11.68 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.675 2.917 . . . . 0.0 113.396 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.0 p -140.78 156.59 46.13 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.397 1.479 . . . . 0.0 107.872 -169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -65.56 129.58 40.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.685 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -153.19 7.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.268 0.461 . . . . 0.0 112.795 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.35 28.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.285 1.834 . . . . 0.0 109.776 176.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.17 136.87 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.125 -0.985 . . . . 0.0 113.211 171.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.22 -38.84 5.87 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.612 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -150.82 142.55 23.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.707 0.803 . . . . 0.0 111.137 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -139.64 123.81 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.348 1.459 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.5 p90 . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.215 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 mttm . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.49 HG13 HD22 ' A' ' 124' ' ' LEU . 21.2 t -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.024 2.13 . . . . 0.0 112.884 173.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.97 136.04 51.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.388 1.475 . . . . 0.0 109.386 166.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.29 123.11 41.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 111.881 177.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -120.23 144.58 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.899 1.28 . . . . 0.0 110.784 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.59 141.72 41.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.368 1.867 . . . . 0.0 109.829 169.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 . . . . . 0 N--CA 1.481 1.118 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 177.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -120.97 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.509 1.524 . . . . 0.0 111.41 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -119.09 123.52 44.65 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 126.078 1.751 . . . . 0.0 108.394 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -96.93 146.5 24.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.531 0.733 . . . . 0.0 112.463 161.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -130.9 104.03 6.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.806 2.442 . . . . 0.0 110.01 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.49 HD22 HG13 ' A' ' 109' ' ' VAL . 1.5 mm? -105.59 155.69 18.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.648 1.179 . . . . 0.0 111.992 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 63.8 59.83 1.11 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.629 1.972 . . . . 0.0 112.32 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.32 145.78 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.647 1.579 . . . . 0.0 111.187 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -89.86 -41.86 11.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.011 1.324 . . . . 0.0 108.692 171.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -148.21 150.9 34.56 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.478 1.511 . . . . 0.0 113.273 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -97.29 141.32 30.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 112.281 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -103.07 -21.45 13.91 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.253 1.021 . . . . 0.0 112.172 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.95 168.68 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.28 1.832 . . . . 0.0 111.193 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -113.96 171.32 7.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.365 1.866 . . . . 0.0 110.813 168.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.86 137.05 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.527 -1.358 . . . . 0.0 108.786 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.88 10.53 85.56 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.08 1.324 . . . . 0.0 114.143 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -93.22 129.45 39.25 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.92 138.79 48.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.479 0.711 . . . . 0.0 112.548 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.36 160.21 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.8 140.53 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.577 1.951 . . . . 0.0 109.482 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.17 112.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.285 1.834 . . . . 0.0 112.414 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.15 9.3 54.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.637 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -94.37 145.3 24.85 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.586 1.954 . . . . 0.0 114.239 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 88' ' ' PRO . 20.6 mm -70.76 132.89 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.553 1.07 . . . . 0.0 112.566 176.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.1 -22.67 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.399 1.48 . . . . 0.0 113.426 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.08 -176.04 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.255 1.422 . . . . 0.0 110.865 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -136.67 135.42 38.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.2 t -80.94 143.58 32.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.067 0 C-N-CA 125.114 1.34 . . . . 0.0 111.275 179.862 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 110.814 -0.069 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.43 115.34 22.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.628 0.771 . . . . 0.0 110.156 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -90.13 98.79 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.85 0.86 . . . . 0.0 110.067 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.276 38.5 t80 -88.86 110.95 21.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.835 1.254 . . . . 0.0 114.341 171.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -113.3 114.59 26.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.874 0.869 . . . . 0.0 111.687 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -97.02 120.71 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.731 1.612 . . . . 0.0 110.854 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.3 mtm -123.05 152.39 41.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.354 1.861 . . . . 0.0 111.266 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -131.51 133.18 44.83 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 111.772 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.61 52.63 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.66 1.6 . . . . 0.0 116.12 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.78 -175.28 45.84 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.086 1.803 . . . . 0.0 111.89 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.16 111.34 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.37 171.43 29.6 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 126.511 2.005 . . . . 0.0 112.408 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -58.8 -44.68 90.82 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.773 -1.427 . . . . 0.0 113.549 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -74.56 -1.07 19.83 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -93.62 -17.17 23.59 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 165.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.18 144.53 57.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.737 0.815 . . . . 0.0 111.931 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -126.78 -75.43 0.58 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -164.52 109.17 0.86 Allowed Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.33 -27.76 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.241 1.96 . . . . 0.0 114.356 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.49 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -54.29 -55.68 34.39 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 121.253 1.842 . . . . 0.0 114.443 -177.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 -21.37 57.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.689 2.926 . . . . 0.0 112.814 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.53 -37.93 59.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.98 -30.26 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.62 0.368 . . . . 0.0 110.79 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.75 -9.62 4.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -112.63 -9.71 13.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.035 2.134 . . . . 0.0 113.666 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.7 mt -69.95 151.57 96.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -170.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.49 -41.86 50.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.817 3.678 . . . . 0.0 114.755 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -119.0 16.64 13.36 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.903 1.281 . . . . 0.0 112.418 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.09 -132.52 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 120.814 -1.179 . . . . 0.0 112.723 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.15 -25.03 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.261 -1.14 . . . . 0.0 112.617 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -70.18 -6.73 36.41 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.074 -1.016 . . . . 0.0 113.004 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.2 m -81.59 -3.91 54.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 0.986 . . . . 0.0 113.17 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.13 -18.01 15.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.17 1.388 . . . . 0.0 111.889 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -144.14 164.04 31.83 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.498 -1.376 . . . . 0.0 114.657 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.46 89.72 3.08 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.395 0.998 . . . . 0.0 113.027 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 124.469 1.108 . . . . 0.0 110.276 173.147 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.303 88.4 m-85 -91.14 26.93 2.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -167.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.93 -167.66 22.7 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.717 -1.239 . . . . 0.0 114.9 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 136.81 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.783 2.033 . . . . 0.0 108.874 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -113.6 115.54 28.08 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -97.84 117.47 32.24 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.06 112.82 2.78 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.624 1.102 . . . . 0.0 111.616 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -139.4 140.4 25.58 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.207 0.603 . . . . 0.0 112.333 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 139.47 57.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.993 2.462 . . . . 0.0 111.446 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.69 129.52 29.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.744 1.218 . . . . 0.0 109.972 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.17 81.29 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.178 -1.345 . . . . 0.0 115.982 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.0 m -54.23 125.18 49.59 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 120.169 1.984 . . . . 0.0 112.364 163.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.567 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.1 Cg_endo -71.43 133.22 22.11 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.956 1.771 . . . . 0.0 111.701 174.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.2 mm -89.21 129.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 108.504 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -102.56 149.17 24.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.936 1.294 . . . . 0.0 109.528 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.73 126.93 93.21 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.566 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.34 -38.47 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.359 2.706 . . . . 0.0 112.291 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.3 p -126.13 161.9 26.58 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.873 2.069 . . . . 0.0 111.693 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -69.58 136.01 50.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -160.91 13.08 Favored Glycine 0 N--CA 1.473 1.12 0 O-C-N 121.777 -0.577 . . . . 0.0 113.768 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.49 145.75 28.06 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.345 1.073 . . . . 0.0 112.412 172.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.36 126.01 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -40.3 9.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.189 1.796 . . . . 0.0 115.657 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -155.51 145.59 21.62 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.154 1.382 . . . . 0.0 110.292 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -137.66 125.44 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.012 1.325 . . . . 0.0 109.083 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.6 p90 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.986 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.16 138.67 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.78 136.43 49.86 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.634 1.574 . . . . 0.0 109.579 166.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 124.52 51.98 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.252 0.621 . . . . 0.0 112.108 167.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.6 mt -118.59 144.05 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.323 1.049 . . . . 0.0 111.879 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.87 138.41 36.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.825 2.05 . . . . 0.0 110.608 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 178.477 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -128.65 159.18 36.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.053 2.141 . . . . 0.0 111.503 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -141.62 103.89 4.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.435 1.894 . . . . 0.0 110.849 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -87.36 143.28 27.32 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.919 0.487 . . . . 0.0 111.571 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -130.06 96.48 4.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.052 1.741 . . . . 0.0 107.558 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.71 155.37 19.26 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 0.0 110.142 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 68.42 64.43 0.34 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.798 2.039 . . . . 0.0 113.699 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.5 mt -104.56 154.27 20.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.867 1.667 . . . . 0.0 111.171 172.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -97.99 -44.08 6.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.206 1.802 . . . . 0.0 106.931 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -162.12 159.09 25.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.389 2.276 . . . . 0.0 110.548 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -97.95 162.94 12.99 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.002 1.721 . . . . 0.0 114.454 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -124.17 -8.78 7.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.874 1.27 . . . . 0.0 112.721 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.2 m -134.06 168.03 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.56 1.944 . . . . 0.0 111.187 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -120.36 166.79 13.05 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.97 2.108 . . . . 0.0 111.783 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.95 132.43 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.37 7.59 72.46 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.45 1.024 . . . . 0.0 115.175 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -86.48 115.06 23.73 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.128 1.464 . . . . 0.0 112.256 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -65.87 135.15 54.43 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.289 0.235 . . . . 0.0 110.592 164.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -127.33 163.86 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 126.522 1.929 . . . . 0.0 110.555 -176.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.24 140.07 47.31 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.421 1.488 . . . . 0.0 109.526 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.08 126.81 13.29 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.15 -4.93 74.97 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.124 1.821 . . . . 0.0 114.742 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.8 141.69 36.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.664 1.186 . . . . 0.0 112.145 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 88' ' ' PRO . 18.6 mm -70.63 130.1 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.519 -0.738 . . . . 0.0 111.579 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.4 pt -113.86 -21.42 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.725 1.21 . . . . 0.0 113.363 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.76 -176.53 1.77 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 110.729 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -132.71 134.67 45.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.1 t -78.1 145.97 35.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.15 0 C-N-CA 125.672 1.606 . . . . 0.0 111.713 -177.876 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.97 115.2 18.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.692 0.678 . . . . 0.0 110.154 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -91.51 100.05 12.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.826 0.85 . . . . 0.0 110.462 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -92.89 116.52 29.11 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -122.13 112.05 17.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.687 1.195 . . . . 0.0 111.381 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -94.56 129.06 41.53 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.636 1.174 . . . . 0.0 110.536 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.7 mtm -127.24 150.65 49.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.654 1.582 . . . . 0.0 110.856 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -120.05 135.91 54.76 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.027 1.331 . . . . 0.0 110.831 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.02 -15.98 1.69 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.169 1.843 . . . . 0.0 116.525 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.19 -168.78 35.52 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.56 1.553 . . . . 0.0 112.057 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.24 131.26 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.393 1.477 . . . . 0.0 112.747 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.56 166.6 10.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.727 1.632 . . . . 0.0 112.048 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -57.84 -43.74 86.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.426 -1.044 . . . . 0.0 113.487 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.76 -14.24 50.86 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -92.58 -15.88 26.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.59 1.156 . . . . 0.0 114.055 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.41 137.86 58.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.774 1.23 . . . . 0.0 112.836 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -101.5 -90.86 0.33 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.588 1.155 . . . . 0.0 113.805 -173.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -170.15 108.21 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 129.36 3.064 . . . . 0.0 110.591 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.97 -23.06 14.24 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.126 1.884 . . . . 0.0 114.587 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -52.26 -53.83 48.29 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 120.582 1.537 . . . . 0.0 115.085 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.74 -20.03 40.53 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.646 2.898 . . . . 0.0 112.931 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.273 3.8 t80 -70.68 -47.59 59.11 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.5 mt -67.47 -24.29 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.833 -1.167 . . . . 0.0 111.79 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.32 -18.14 64.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -109.28 -7.31 15.27 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.866 -1.146 . . . . 0.0 114.03 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 32.0 mt -69.34 147.72 97.15 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.952 1.301 . . . . 0.0 112.894 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.23 -27.99 34.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.209 2.606 . . . . 0.0 114.164 -166.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.86 2.51 17.07 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.84 -144.06 37.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.84 0.733 . . . . 0.0 112.793 -166.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.97 -24.6 66.23 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.455 -1.027 . . . . 0.0 112.553 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -65.31 -9.89 28.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.481 1.512 . . . . 0.0 111.986 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.6 t -82.52 -3.21 55.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.091 1.356 . . . . 0.0 112.575 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -110.46 -13.11 14.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.517 1.527 . . . . 0.0 112.701 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -146.63 163.52 35.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.705 1.593 . . . . 0.0 115.196 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -115.25 79.06 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 109.998 175.301 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.951 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -61.6 -41.94 98.16 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.273 1.429 . . . . 0.0 113.703 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -100.1 116.7 32.73 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -173.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -154.28 -12.79 0.13 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 pm0 -60.3 146.08 45.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.447 1.899 . . . . 0.0 115.085 -165.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.01 137.39 41.48 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.376 9.8 p90 -79.6 42.98 0.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 164.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.84 141.74 58.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.521 1.528 . . . . 0.0 112.242 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -155.87 121.25 4.86 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.034 0.834 . . . . 0.0 111.974 163.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.14 -175.04 14.7 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.567 1.556 . . . . 0.0 114.801 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.3 m -75.05 168.86 19.15 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -76.24 -4.94 44.59 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -171.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.5 125.24 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 119.339 0.972 . . . . 0.0 110.784 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.282 0.7 OUTLIER -76.46 -51.15 12.33 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 169.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -146.73 139.46 25.17 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.411 1.884 . . . . 0.0 112.132 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.8 p -98.69 -170.91 2.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.768 2.027 . . . . 0.0 111.015 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -76.45 124.05 26.96 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.683 -1.261 . . . . 0.0 107.935 -170.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.84 173.58 19.71 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 124.241 0.924 . . . . 0.0 115.379 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -62.64 147.95 47.82 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.348 -1.089 . . . . 0.0 113.612 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.294 33.8 m-85 -70.53 -40.15 73.62 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 118.476 2.769 . . . . 0.0 118.476 174.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -151.26 173.82 14.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.095 1.358 . . . . 0.0 111.493 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -59.38 165.86 2.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.838 0.855 . . . . 0.0 111.861 164.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.1 m 67.56 161.31 0.14 Allowed Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.26 1.824 . . . . 0.0 114.045 -167.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.28 5.9 5.72 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.007 2.471 . . . . 0.0 114.744 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -95.14 -35.6 11.82 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.2 0.909 . . . . 0.0 110.773 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -87.5 94.54 9.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.816 1.647 . . . . 0.0 112.417 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.96 -164.22 9.99 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.459 1.504 . . . . 0.0 115.772 -167.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -85.16 140.24 31.07 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.789 1.236 . . . . 0.0 113.329 -173.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -82.03 122.23 27.54 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.929 1.692 . . . . 0.0 108.348 158.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -98.56 25.06 6.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -157.74 -162.65 11.86 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.872 -1.143 . . . . 0.0 114.824 -173.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.53 134.85 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.415 2.286 . . . . 0.0 108.833 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -109.67 91.73 3.76 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -78.93 106.78 11.19 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 125.87 26.12 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.045 0.839 . . . . 0.0 110.337 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.7 mt -137.14 151.4 71.73 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 123.66 0.784 . . . . 0.0 112.094 -175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.55 138.65 66.04 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.582 2.188 . . . . 0.0 111.528 165.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -58.63 128.77 38.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.442 0.697 . . . . 0.0 110.978 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.3 -3.49 63.98 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.047 1.308 . . . . 0.0 115.285 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.3 m -57.72 126.38 75.83 Favored Pre-proline 0 N--CA 1.478 0.95 0 CA-C-N 119.583 1.692 . . . . 0.0 112.714 171.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.532 ' HB2' HD12 ' A' ' 142' ' ' ILE . 17.6 Cg_endo -69.26 133.27 26.06 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.211 1.941 . . . . 0.0 112.412 172.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.5 mm -89.58 130.0 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.561 1.944 . . . . 0.0 107.964 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -102.75 152.73 20.9 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.665 1.586 . . . . 0.0 109.834 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.49 124.0 90.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.936 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.39 -40.3 19.33 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.083 2.522 . . . . 0.0 112.456 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.3 p -130.23 164.12 25.22 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.543 1.937 . . . . 0.0 110.382 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.27 137.61 50.89 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 166.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.08 -161.93 17.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.576 0.608 . . . . 0.0 113.167 -177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -145.72 144.5 30.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.66 1.184 . . . . 0.0 112.008 174.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -69.81 129.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -40.06 8.62 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -157.76 146.49 19.37 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.144 1.378 . . . . 0.0 111.007 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 129' ' ' TYR . 59.7 mt -141.13 120.31 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.85 1.26 . . . . 0.0 109.425 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -155.04 165.55 36.36 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -129.44 119.46 23.83 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.783 0.801 . . . . 0.0 111.211 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -100.9 140.44 35.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.794 2.038 . . . . 0.0 111.269 -172.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -67.04 -17.63 64.99 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.92 -23.31 3.67 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.915 1.286 . . . . 0.0 114.317 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.5 -5.57 57.81 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 126.364 1.935 . . . . 0.0 114.518 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.89 -157.09 48.39 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 117.944 0.872 . . . . 0.0 113.004 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -67.19 144.01 56.23 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.845 -0.797 . . . . 0.0 112.389 174.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.99 123.26 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.35 131.86 48.71 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.341 1.456 . . . . 0.0 110.187 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.13 125.44 53.78 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.114 1.365 . . . . 0.0 111.384 171.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 56.7 mt -121.39 149.26 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.241 1.416 . . . . 0.0 111.807 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.05 139.84 48.35 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 111.376 173.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -80.19 162.67 24.56 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.529 1.132 . . . . 0.0 113.363 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -64.54 -23.77 67.38 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -169.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -80.18 -6.32 57.57 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.52 3.0 90.73 Favored Glycine 0 CA--C 1.538 1.512 0 N-CA-C 117.188 1.635 . . . . 0.0 117.188 167.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -109.91 -40.07 4.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.198 1.499 . . . . 0.0 111.868 -172.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -77.74 134.69 38.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 117.42 2.378 . . . . 0.0 117.42 170.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -117.87 159.44 23.08 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.651 1.98 . . . . 0.0 111.907 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -143.45 104.4 4.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.951 2.1 . . . . 0.0 110.376 -171.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.12 148.52 24.4 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.34 0.656 . . . . 0.0 112.503 171.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -136.17 89.76 2.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.586 2.355 . . . . 0.0 109.92 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.01 160.51 16.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.666 1.186 . . . . 0.0 111.216 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 62.44 57.1 1.96 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.559 1.944 . . . . 0.0 114.032 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.85 145.46 26.4 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.322 1.049 . . . . 0.0 111.555 173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -87.44 -43.72 11.86 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.108 1.363 . . . . 0.0 108.045 171.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -147.45 144.77 28.86 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.186 1.794 . . . . 0.0 112.473 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 100' ' ' ILE . 84.0 m-85 -86.83 149.71 24.64 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.146 0.978 . . . . 0.0 111.927 171.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -117.18 -4.43 11.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.243 1.017 . . . . 0.0 112.607 169.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.9 m -127.25 162.82 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.179 1.392 . . . . 0.0 111.529 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -111.66 161.52 16.16 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.583 1.153 . . . . 0.0 111.29 168.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.2 t -53.39 128.04 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.123 1.369 . . . . 0.0 107.641 170.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.66 16.05 66.8 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-O 118.544 -1.142 . . . . 0.0 115.179 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -87.23 123.52 32.33 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.067 1.434 . . . . 0.0 112.871 167.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -69.02 137.8 53.94 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.199 0.523 . . . . 0.0 111.718 160.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.83 164.14 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 127.011 2.125 . . . . 0.0 110.67 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -133.83 142.32 47.79 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.882 1.273 . . . . 0.0 108.677 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.38 132.35 10.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.337 1.055 . . . . 0.0 113.392 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.88 -7.54 81.83 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.446 1.974 . . . . 0.0 115.011 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -77.37 140.92 40.04 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.1 1.45 . . . . 0.0 113.148 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.532 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.9 mm -67.78 129.4 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.76 -0.587 . . . . 0.0 110.997 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.0 pt -114.45 -20.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.762 1.225 . . . . 0.0 113.304 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.02 -177.07 2.47 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.137 1.775 . . . . 0.0 110.415 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -132.3 130.85 41.37 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 173.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.4 t -79.05 146.39 33.32 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.559 0.695 . . . . 0.0 112.645 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -156.57 160.97 30.64 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.758 1.17 . . . . 0.0 111.108 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -76.31 35.57 0.14 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.212 1.005 . . . . 0.0 113.702 -174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.251 7.5 p -66.59 145.89 55.11 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.678 1.191 . . . . 0.0 112.619 171.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.97 -41.43 1.07 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.335 1.445 . . . . 0.0 114.51 -166.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 19.3 mt -65.5 131.07 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.975 1.31 . . . . 0.0 111.488 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -72.08 -47.88 48.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 112.857 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.254 0.6 OUTLIER -134.21 -32.45 1.06 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.869 2.174 . . . . 0.0 116.869 176.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.08 157.96 23.99 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.47 159.83 47.54 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.716 1.151 . . . . 0.0 113.781 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.39 146.7 53.79 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -170.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -145.05 124.11 12.82 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.916 0.886 . . . . 0.0 112.364 169.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.15 115.32 8.3 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 109.663 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -95.16 99.88 11.78 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.739 0.816 . . . . 0.0 110.24 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 51.8 t80 -89.09 114.44 25.69 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.025 1.33 . . . . 0.0 114.508 172.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -118.21 116.83 27.61 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.708 1.203 . . . . 0.0 111.908 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.3 ttt-85 -100.64 124.74 46.64 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.909 1.684 . . . . 0.0 111.567 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 32.9 mtm -130.44 157.27 43.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.96 1.304 . . . . 0.0 112.338 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -131.5 135.96 47.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.403 1.481 . . . . 0.0 111.52 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.7 -7.66 57.83 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 126.368 1.937 . . . . 0.0 115.363 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 171.14 -166.65 39.79 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.689 2.566 . . . . 0.0 109.806 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.57 131.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 122.483 1.135 . . . . 0.0 110.555 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.43 168.98 14.89 Favored Glycine 0 CA--C 1.541 1.687 0 C-N-CA 128.466 2.936 . . . . 0.0 109.896 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -56.22 -41.96 76.5 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.849 1.325 . . . . 0.0 112.852 -176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.24 -26.69 64.91 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.055 -1.028 . . . . 0.0 112.505 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -79.0 -15.1 58.73 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.954 1.301 . . . . 0.0 113.44 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.91 143.88 56.58 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.927 0.891 . . . . 0.0 112.763 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -110.96 -85.57 0.55 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.635 1.174 . . . . 0.0 113.66 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -166.97 126.89 1.14 Allowed Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 127.386 2.274 . . . . 0.0 106.109 167.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -75.0 -28.71 8.94 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.277 2.652 . . . . 0.0 114.601 171.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -53.24 -53.51 55.22 Favored Pre-proline 0 N--CA 1.478 0.971 0 N-CA-C 115.651 1.722 . . . . 0.0 115.651 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.53 -19.5 32.39 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.704 2.936 . . . . 0.0 112.584 -177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -72.36 -44.87 61.96 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 24.2 mt -66.68 -29.43 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.432 0.693 . . . . 0.0 111.056 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.86 -15.8 5.48 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 116.844 2.165 . . . . 0.0 116.844 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -120.85 -3.23 9.71 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.437 1.495 . . . . 0.0 114.27 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.61 147.62 98.03 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.088 0.955 . . . . 0.0 112.097 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -51.35 -44.72 41.61 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 124.747 3.631 . . . . 0.0 114.626 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -111.71 12.96 21.12 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.898 1.279 . . . . 0.0 113.686 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.04 -135.39 46.07 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 120.821 -1.174 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.12 -25.85 64.2 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.308 -1.113 . . . . 0.0 113.319 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -70.18 -5.77 29.62 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 120.563 -1.336 . . . . 0.0 113.373 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 74.9 m -77.98 -4.05 45.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.987 0.812 . . . . 0.0 111.991 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 mp -113.51 -15.55 12.55 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.735 1.614 . . . . 0.0 113.825 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -148.95 158.14 43.95 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 121.635 2.016 . . . . 0.0 115.037 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -110.06 79.42 1.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.47 0.544 0 C-N-CA 124.584 1.154 . . . . 0.0 109.523 174.516 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.944 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.5 t -150.71 -34.69 0.15 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.099 0.949 . . . . 0.0 113.129 166.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -75.0 143.87 43.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.389 1.075 . . . . 0.0 111.37 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -104.32 159.03 16.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.855 1.262 . . . . 0.0 112.964 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -63.88 132.2 50.06 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.568 -0.708 . . . . 0.0 110.64 171.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.42 107.81 2.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.64 0.776 . . . . 0.0 112.056 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.338 18.2 p90 -69.44 132.63 46.64 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 116.987 2.218 . . . . 0.0 116.987 -170.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.283 8.0 t80 -68.61 132.7 47.35 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 116.858 2.169 . . . . 0.0 116.858 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.466 ' HE ' ' HB3' ' A' ' 58' ' ' SER . 39.2 ttt180 -79.9 105.52 11.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.407 1.083 . . . . 0.0 111.859 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.83 43.3 0.94 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.709 1.623 . . . . 0.0 114.346 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.466 ' HB3' ' HE ' ' A' ' 56' ' ' ARG . 78.9 p -80.77 163.52 23.43 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.366 1.466 . . . . 0.0 114.408 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -136.78 40.65 2.55 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.182 1.793 . . . . 0.0 113.364 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -70.36 114.78 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 121.259 -0.9 . . . . 0.0 110.397 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -40.76 75.24 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.956 1.702 . . . . 0.0 115.508 172.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -148.11 135.98 20.98 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.394 1.878 . . . . 0.0 109.52 -176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.1 p -96.31 169.54 9.86 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.197 0.998 . . . . 0.0 110.22 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -74.29 138.33 43.49 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.153 -0.967 . . . . 0.0 108.775 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.55 -68.11 0.38 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 124.351 0.977 . . . . 0.0 112.745 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.59 160.97 35.08 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.681 1.193 . . . . 0.0 113.216 -171.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.33 56.8 m-85 -65.3 42.12 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 160.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 62.72 -70.24 0.06 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 128.195 2.598 . . . . 0.0 114.791 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -73.4 -29.11 62.38 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 116.431 2.012 . . . . 0.0 116.431 -152.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -158.96 152.15 18.65 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.762 1.225 . . . . 0.0 111.822 -174.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.11 -33.78 3.35 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.824 2.349 . . . . 0.0 113.476 174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.5 116.83 7.19 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -164.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.315 3.1 m-20 58.22 16.11 3.75 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -113.32 23.0 14.47 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 -165.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -63.4 145.2 56.09 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.156 1.978 . . . . 0.0 114.347 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -146.73 136.87 23.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.625 1.97 . . . . 0.0 110.127 -173.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 97.8 m-85 -120.54 25.21 9.91 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -168.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.81 -178.63 25.83 Favored Glycine 0 CA--C 1.527 0.815 0 O-C-N 120.97 -1.081 . . . . 0.0 113.354 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.37 146.37 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.823 1.649 . . . . 0.0 108.109 163.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -119.8 142.06 48.94 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.987 0.812 . . . . 0.0 112.177 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -116.43 122.6 45.27 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.338 1.455 . . . . 0.0 114.538 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.79 114.6 17.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.026 0.93 . . . . 0.0 110.864 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.3 mt -126.66 151.26 73.0 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -65.77 136.9 47.45 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.612 2.208 . . . . 0.0 110.373 152.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -54.22 138.65 38.1 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.802 1.241 . . . . 0.0 110.847 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.18 -1.62 84.4 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.392 -1.227 . . . . 0.0 115.589 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 36.2 m -50.25 124.94 18.7 Favored Pre-proline 0 N--CA 1.479 1.009 0 CA-C-N 119.938 1.869 . . . . 0.0 111.273 166.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HB2' HD12 ' A' ' 142' ' ' ILE . 37.5 Cg_endo -71.31 129.32 15.78 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.798 1.665 . . . . 0.0 110.896 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.34 131.46 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.459 1.504 . . . . 0.0 108.738 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -106.13 155.74 19.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.119 1.367 . . . . 0.0 110.224 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.42 130.96 75.68 Favored Pre-proline 0 CA--C 1.554 1.097 0 O-C-N 121.521 -0.737 . . . . 0.0 111.707 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.51 -36.79 10.78 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.283 2.655 . . . . 0.0 113.24 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 p -134.62 163.18 30.32 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.148 1.779 . . . . 0.0 107.05 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.66 139.69 53.54 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.93 -162.73 22.74 Favored Glycine 0 N--CA 1.467 0.702 0 O-C-N 121.433 -0.792 . . . . 0.0 113.219 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -148.02 144.87 28.24 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.372 1.069 . . . . 0.0 111.268 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.51 128.22 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.3 -38.81 7.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.203 1.001 . . . . 0.0 112.045 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -148.62 141.35 24.56 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.49 1.516 . . . . 0.0 111.778 -168.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -139.76 127.29 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.142 1.377 . . . . 0.0 110.381 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -159.49 167.44 28.65 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -111.6 164.65 12.77 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.635 1.174 . . . . 0.0 109.31 158.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -144.02 170.09 16.59 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.324 -0.86 . . . . 0.0 112.598 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -55.44 -31.79 62.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.043 1.737 . . . . 0.0 115.171 -165.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.52 -14.03 1.49 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.98 -8.81 87.28 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.47 -149.46 36.99 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 119.006 1.403 . . . . 0.0 112.178 -169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -72.34 150.68 43.28 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.249 -0.56 . . . . 0.0 112.442 164.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.0 t -134.79 137.18 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.885 2.474 . . . . 0.0 113.394 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.7 tt -115.68 135.92 53.57 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.016 1.326 . . . . 0.0 110.237 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -121.51 124.6 44.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.11 147.1 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 125.187 1.395 . . . . 0.0 111.796 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.98 138.13 51.2 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.34 2.256 . . . . 0.0 111.764 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -90.52 159.55 16.44 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -65.83 -10.92 42.27 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -76.34 -15.84 59.88 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.146 0.979 . . . . 0.0 113.627 167.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.78 -2.2 25.91 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.108 1.337 . . . . 0.0 115.976 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -99.35 -45.67 5.77 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.716 1.758 . . . . 0.0 110.475 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 39.6 m-85 -81.57 145.91 30.4 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 118.28 2.696 . . . . 0.0 118.28 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -130.0 150.36 51.31 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.154 1.781 . . . . 0.0 111.847 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -118.61 131.84 56.19 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.846 1.658 . . . . 0.0 108.763 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.1 m0 -105.43 150.69 25.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.377 1.071 . . . . 0.0 111.856 157.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -135.19 112.56 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.585 1.954 . . . . 0.0 106.35 171.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -106.7 159.9 15.87 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 111.25 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 68.74 55.3 0.47 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.484 1.913 . . . . 0.0 113.282 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.82 158.03 16.27 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 111.382 173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -40.42 5.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.638 1.175 . . . . 0.0 112.557 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -144.64 147.9 33.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.034 1.734 . . . . 0.0 111.782 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -94.32 145.99 24.36 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.037 1.335 . . . . 0.0 112.397 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -106.73 -16.44 14.49 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.47 1.108 . . . . 0.0 112.012 170.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.35 167.21 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.149 1.38 . . . . 0.0 111.499 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -124.19 165.4 17.66 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 111.939 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 69.5 t -56.22 123.78 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.36 1.064 . . . . 0.0 108.931 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.11 15.34 61.01 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.273 -1.293 . . . . 0.0 115.209 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -97.92 135.83 39.09 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.032 1.916 . . . . 0.0 109.419 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -76.49 145.17 39.36 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.456 1.102 . . . . 0.0 113.254 171.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 m -132.99 161.04 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 127.013 2.125 . . . . 0.0 111.293 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -123.93 144.09 49.99 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.498 2.319 . . . . 0.0 108.552 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -45.44 112.73 0.49 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.014 1.326 . . . . 0.0 112.308 172.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.39 -3.2 34.76 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.946 1.736 . . . . 0.0 115.51 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.15 144.54 26.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 88' ' ' PRO . 19.2 mm -70.9 130.82 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.763 0.71 . . . . 0.0 111.924 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.6 pt -115.96 -22.94 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.712 1.205 . . . . 0.0 113.298 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.44 -178.33 2.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.938 1.295 . . . . 0.0 111.278 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -129.73 135.44 48.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.68 146.65 53.41 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.933 0.893 . . . . 0.0 112.27 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.02 150.65 22.34 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 121.52 0.511 . . . . 0.0 112.751 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -77.73 34.6 0.18 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.491 1.116 . . . . 0.0 112.761 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.7 p -81.52 -15.18 55.69 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 117.203 2.297 . . . . 0.0 117.203 -165.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -133.5 32.28 2.74 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.652 1.596 . . . . 0.0 113.752 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 6.0 mt -126.26 136.33 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.961 1.304 . . . . 0.0 111.834 -164.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -61.15 -34.49 75.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.639 1.976 . . . . 0.0 114.544 -173.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.5 p -140.34 -153.53 0.47 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.915 2.486 . . . . 0.0 109.693 169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.272 0.8 OUTLIER -77.66 149.95 34.62 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 175.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 158.09 -18.3 0.33 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.226 -1.319 . . . . 0.0 115.878 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 51.58 20.45 1.06 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 127.065 2.146 . . . . 0.0 116.373 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -70.87 133.44 46.48 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -164.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 115.77 12.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.482 0.713 . . . . 0.0 110.478 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -92.12 98.78 11.75 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 110.79 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.288 50.6 t80 -89.07 109.67 20.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 172.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.66 117.49 33.06 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.447 1.099 . . . . 0.0 111.467 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -102.53 126.37 49.57 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.012 1.325 . . . . 0.0 111.059 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.5 mtm -129.49 149.11 51.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.573 1.549 . . . . 0.0 111.451 -170.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -124.32 131.08 53.5 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.47 1.508 . . . . 0.0 110.759 -174.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.25 -1.27 35.18 Favored Glycine 0 CA--C 1.545 1.914 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.42 -169.74 41.99 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.997 1.284 . . . . 0.0 112.521 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.76 115.73 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.28 1.432 . . . . 0.0 112.781 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.41 166.52 15.16 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.395 1.95 . . . . 0.0 111.347 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -57.84 -40.5 80.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.607 1.204 . . . . 0.0 112.832 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.49 -17.61 64.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -88.65 -11.8 44.31 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 151.09 34.08 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -130.57 -89.12 0.48 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.517 1.527 . . . . 0.0 113.98 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -160.22 95.89 1.53 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -167.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.4 -34.94 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.15 1.9 . . . . 0.0 114.206 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -54.95 -55.36 39.7 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 121.098 1.772 . . . . 0.0 115.53 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.46 -26.51 40.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.362 2.708 . . . . 0.0 112.099 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -68.17 -38.3 81.93 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.44 -40.8 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.887 0.475 . . . . 0.0 110.861 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.45 -5.05 13.09 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -114.12 -4.79 13.09 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.018 2.127 . . . . 0.0 113.225 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.84 156.04 48.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.53 1.132 . . . . 0.0 112.327 171.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -54.65 -49.51 16.55 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.868 3.045 . . . . 0.0 113.148 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -103.41 5.21 36.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.299 1.04 . . . . 0.0 112.454 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.37 -143.76 47.61 Favored Glycine 0 CA--C 1.533 1.157 0 O-C-N 121.033 -1.042 . . . . 0.0 112.181 -170.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -20.44 61.93 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -64.7 -10.08 24.57 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 171.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -86.72 5.46 36.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.558 0.743 . . . . 0.0 112.235 171.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.1 -18.56 9.35 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.624 1.57 . . . . 0.0 112.709 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -149.1 157.73 43.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.363 -1.461 . . . . 0.0 111.701 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.69 89.02 2.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.241 0.65 0 C-N-CA 124.978 1.311 . . . . 0.0 110.796 173.126 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.944 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.0 p -70.75 -15.02 62.65 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -110.95 -38.33 5.13 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.784 1.634 . . . . 0.0 113.391 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -153.8 166.0 34.26 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.649 1.58 . . . . 0.0 112.3 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -76.73 126.1 30.4 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.254 -0.904 . . . . 0.0 113.316 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -81.7 91.74 6.49 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.021 0.929 . . . . 0.0 112.433 166.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.331 45.4 m-85 -75.41 171.41 14.29 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 116.99 2.218 . . . . 0.0 116.99 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.317 3.8 p90 -61.56 21.87 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 120.598 3.555 . . . . 0.0 120.598 -174.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -57.75 129.52 42.24 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.644 -1.285 . . . . 0.0 111.944 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.37 -24.1 24.99 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.676 1.131 . . . . 0.0 113.687 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 m -96.96 123.9 40.79 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.954 1.377 . . . . 0.0 112.786 170.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -83.1 4.74 25.09 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -163.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.1 mt -71.81 123.23 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -167.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 15.3 p -77.24 -42.26 37.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.113 1.365 . . . . 0.0 114.135 168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -145.91 135.79 23.49 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.506 1.522 . . . . 0.0 112.718 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 p -104.74 -164.95 1.09 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.981 1.713 . . . . 0.0 108.135 174.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -87.32 140.57 29.4 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 119.88 -1.762 . . . . 0.0 109.721 -160.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 104.99 -159.33 15.75 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.076 1.798 . . . . 0.0 112.811 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -58.4 153.98 14.63 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 118.419 1.11 . . . . 0.0 112.63 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.35 147.39 29.87 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.0 mp0 -76.71 -46.38 25.68 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.719 -0.613 . . . . 0.0 112.382 172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -154.24 120.94 5.52 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.647 1.979 . . . . 0.0 109.838 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.2 p -165.03 169.12 7.83 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 124.87 1.268 . . . . 0.0 110.358 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -79.23 1.81 8.86 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.083 2.522 . . . . 0.0 114.323 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -84.66 147.32 27.0 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 120.483 -1.386 . . . . 0.0 114.599 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -89.7 -34.25 16.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 162.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.65 -175.4 40.94 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 122.031 0.795 . . . . 0.0 114.072 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -90.47 166.69 13.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.006 1.322 . . . . 0.0 111.677 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -87.27 139.65 30.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.696 1.198 . . . . 0.0 110.0 161.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.49 22.63 11.19 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.571 1.548 . . . . 0.0 114.675 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.59 -158.05 8.93 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 121.206 -0.934 . . . . 0.0 113.56 -173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.593 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -125.92 133.31 69.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.867 2.067 . . . . 0.0 108.796 178.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -111.45 96.08 5.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 116.388 1.995 . . . . 0.0 116.388 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -79.48 110.44 14.79 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 114.17 4.62 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.267 0.94 . . . . 0.0 111.351 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -129.82 147.27 64.76 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 123.22 0.608 . . . . 0.0 112.057 -172.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -63.47 135.43 49.58 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.04 1.827 . . . . 0.0 110.346 162.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -60.67 130.3 45.82 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.769 0.827 . . . . 0.0 111.129 -175.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.58 -7.92 68.56 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 117.806 -1.552 . . . . 0.0 115.737 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -51.32 126.65 28.75 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-N 120.121 1.961 . . . . 0.0 113.101 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.606 ' HB2' HD12 ' A' ' 142' ' ' ILE . 6.4 Cg_endo -67.73 136.07 37.73 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.638 2.226 . . . . 0.0 112.151 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.67 127.6 44.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.484 1.514 . . . . 0.0 107.888 172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt -96.91 148.8 22.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.087 1.355 . . . . 0.0 109.643 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.1 125.06 88.5 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.692 -0.671 . . . . 0.0 110.277 173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -66.64 -39.93 14.58 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.314 2.676 . . . . 0.0 111.72 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.2 p -120.34 166.44 13.52 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.736 2.414 . . . . 0.0 110.089 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -67.36 144.92 55.56 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.292 -0.88 . . . . 0.0 110.5 154.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.95 -157.68 16.18 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.407 1.003 . . . . 0.0 114.345 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.14 143.96 25.38 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.044 1.738 . . . . 0.0 112.09 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.32 127.08 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -42.7 8.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.8 ttm-85 -159.19 143.72 15.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.2 1.0 . . . . 0.0 110.85 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.429 HG23 ' CE2' ' A' ' 129' ' ' TYR . 53.1 mt -141.78 122.31 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.486 1.514 . . . . 0.0 109.101 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -154.7 166.2 34.17 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 116.385 1.994 . . . . 0.0 116.385 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -118.84 142.19 47.95 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.508 1.123 . . . . 0.0 109.757 161.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -101.96 129.75 48.31 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.041 1.736 . . . . 0.0 111.288 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.67 -23.05 66.91 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.19 31.28 6.82 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.683 1.593 . . . . 0.0 111.992 173.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.09 -128.39 1.48 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.98 1.752 . . . . 0.0 109.958 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.73 -157.84 7.99 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.839 1.209 . . . . 0.0 112.029 172.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -66.98 146.61 54.19 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -140.4 139.36 35.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.656 1.982 . . . . 0.0 114.208 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.5 tt -117.15 134.28 54.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.298 1.439 . . . . 0.0 109.821 171.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.58 126.5 55.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.391 0.676 . . . . 0.0 112.57 171.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.3 mt -121.14 145.18 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.829 1.252 . . . . 0.0 112.218 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -105.94 132.25 52.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.701 2.4 . . . . 0.0 112.182 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -81.51 157.81 24.7 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.38 -37.74 81.71 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 118.585 2.809 . . . . 0.0 118.585 -170.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -73.22 -9.92 59.21 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.92 17.95 57.02 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 116.901 1.52 . . . . 0.0 116.901 165.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -125.49 -31.66 2.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.365 1.583 . . . . 0.0 112.846 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.264 50.0 m-85 -83.47 141.79 31.41 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -126.48 155.71 41.85 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.646 2.378 . . . . 0.0 111.332 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -137.8 105.3 5.54 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.473 1.909 . . . . 0.0 110.625 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -88.52 146.03 25.4 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.156 0.582 . . . . 0.0 111.225 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -132.21 109.52 9.99 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.689 1.596 . . . . 0.0 108.218 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.08 162.49 12.9 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.939 1.296 . . . . 0.0 111.112 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 59.32 61.76 1.97 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.203 2.201 . . . . 0.0 112.798 -174.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.2 mt -102.03 140.49 36.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.973 1.309 . . . . 0.0 111.998 176.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -80.86 -48.75 11.97 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 0.0 108.716 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -152.42 149.21 28.34 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.536 1.935 . . . . 0.0 111.152 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.429 ' CE2' HG23 ' A' ' 100' ' ' ILE . 97.9 m-85 -98.06 143.27 28.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.728 1.211 . . . . 0.0 113.032 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -103.45 -29.36 11.23 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.524 -0.735 . . . . 0.0 111.812 171.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 19.6 m -111.03 172.61 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.737 1.615 . . . . 0.0 112.208 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -128.55 162.94 26.08 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.734 1.614 . . . . 0.0 111.681 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -56.04 130.18 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 122.37 1.081 . . . . 0.0 109.358 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.29 5.42 67.47 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.476 1.512 . . . . 0.0 114.995 174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -95.21 136.8 35.11 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 119.24 1.52 . . . . 0.0 114.061 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.1 mmm-85 -86.49 133.93 33.71 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.574 1.15 . . . . 0.0 112.266 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 m -122.94 159.21 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.423 1.489 . . . . 0.0 110.863 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.19 143.54 51.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.216 1.806 . . . . 0.0 108.462 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.65 128.99 13.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.23 1.012 . . . . 0.0 113.06 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.45 -2.69 78.22 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 125.33 1.443 . . . . 0.0 114.849 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -79.31 139.74 37.74 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.754 1.277 . . . . 0.0 113.692 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.6 mm -69.82 126.81 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 118.846 0.748 . . . . 0.0 111.544 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -108.8 -26.06 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.125 1.37 . . . . 0.0 113.133 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.11 -176.81 2.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 110.389 -175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -135.47 136.34 41.21 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -82.48 143.87 30.83 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.25 165.73 37.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.601 1.096 . . . . 0.0 113.27 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -77.97 15.6 0.86 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -165.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.9 p -60.62 -17.21 45.54 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 117.352 2.352 . . . . 0.0 117.352 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -122.84 29.8 5.27 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.745 1.64 . . . . 0.0 113.015 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.3 146.89 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.185 1.794 . . . . 0.0 109.536 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -74.61 101.43 4.23 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.693 0.797 . . . . 0.0 110.688 174.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.322 0.2 OUTLIER 64.41 -68.58 0.1 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 119.672 3.212 . . . . 0.0 119.672 176.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.73 126.77 43.24 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -159.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.86 174.55 8.03 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.688 1.137 . . . . 0.0 115.45 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -139.14 146.33 40.5 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.521 1.128 . . . . 0.0 112.257 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -150.54 135.44 17.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.991 0.916 . . . . 0.0 111.693 172.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -77.08 118.08 19.28 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.857 0.753 . . . . 0.0 110.587 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -94.95 100.91 12.67 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.06 0.944 . . . . 0.0 110.361 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -91.51 113.14 25.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.015 1.326 . . . . 0.0 113.953 172.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -117.7 112.41 20.44 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 110.088 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 46.4 ttt-85 -99.93 127.26 46.14 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.122 0.969 . . . . 0.0 110.603 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.1 mtm -127.37 154.09 45.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.622 1.569 . . . . 0.0 111.731 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -130.07 131.92 45.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.419 1.087 . . . . 0.0 112.246 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.54 6.11 75.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.053 0.835 . . . . 0.0 114.68 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 157.83 -161.1 31.23 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.116 1.817 . . . . 0.0 111.374 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.5 t -134.48 135.6 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.63 1.172 . . . . 0.0 111.838 -170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 138.71 171.72 12.28 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.084 1.802 . . . . 0.0 112.578 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -54.23 -51.29 64.96 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.75 1.22 . . . . 0.0 113.569 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.15 -17.12 63.17 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.712 -1.243 . . . . 0.0 114.279 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -80.23 -18.2 50.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 169.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.07 145.87 55.34 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.667 0.787 . . . . 0.0 111.602 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -122.8 -81.0 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -166.92 97.37 0.68 Allowed Pre-proline 0 N--CA 1.473 0.71 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -172.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.27 -26.35 5.13 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.127 1.884 . . . . 0.0 114.51 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.593 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -56.3 -51.91 77.18 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-N 121.622 2.01 . . . . 0.0 113.821 -178.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.48 -25.75 24.95 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.512 2.141 . . . . 0.0 112.379 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -63.67 -32.7 74.26 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 168.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 45.9 mt -80.71 -26.37 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.341 0.657 . . . . 0.0 111.717 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -59.46 -10.44 3.29 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 174.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -117.39 -5.84 11.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.887 2.075 . . . . 0.0 113.616 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 25.9 mt -72.04 148.76 91.91 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.367 -0.833 . . . . 0.0 111.8 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -36.95 52.87 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.306 2.671 . . . . 0.0 114.066 -166.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -109.64 0.13 18.9 Favored 'General case' 0 CA--C 1.548 0.886 0 O-C-N 121.265 -0.897 . . . . 0.0 110.864 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 78.3 -143.2 26.96 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 119.613 1.097 . . . . 0.0 112.083 -164.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -59.54 -25.97 64.96 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.916 -1.344 . . . . 0.0 114.14 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -63.25 -8.88 9.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.01 1.324 . . . . 0.0 114.485 173.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m -83.05 -5.44 59.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.397 1.079 . . . . 0.0 112.952 170.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -104.2 -14.61 15.78 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.903 1.681 . . . . 0.0 113.184 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -143.51 160.16 41.11 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.834 1.652 . . . . 0.0 114.7 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -108.07 78.16 1.16 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 124.315 1.046 . . . . 0.0 112.354 -176.693 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 71.7 m -68.4 124.26 23.04 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.439 1.496 . . . . 0.0 112.035 -178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -60.11 155.64 16.74 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.301 1.44 . . . . 0.0 112.977 172.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -152.34 155.99 38.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.935 1.294 . . . . 0.0 111.593 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -141.28 151.05 43.34 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.26 1.824 . . . . 0.0 110.528 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -97.41 126.49 42.69 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.283 9.2 p90 -145.33 156.98 44.12 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.393 77.2 t80 -127.01 154.92 44.01 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -65.53 155.45 35.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.918 2.087 . . . . 0.0 115.405 -160.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.94 -48.93 2.43 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.333 1.444 . . . . 0.0 114.095 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.1 p -69.46 167.03 17.53 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.758 1.623 . . . . 0.0 113.394 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -110.42 0.76 17.98 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.502 1.668 . . . . 0.0 115.502 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.51 ' H ' HD12 ' A' ' 60' ' ' ILE . 1.2 mp -65.44 138.37 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 120.36 1.436 . . . . 0.0 110.085 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 t -128.5 -26.89 2.7 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.843 2.057 . . . . 0.0 115.415 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -130.81 151.37 51.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.468 1.507 . . . . 0.0 110.821 167.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.4 p -138.24 164.94 27.94 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.862 1.265 . . . . 0.0 110.305 -170.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -76.23 158.54 31.51 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.391 -0.818 . . . . 0.0 108.986 -168.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.47 -155.74 23.58 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.623 1.106 . . . . 0.0 112.462 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 157.54 17.95 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.199 -1.177 . . . . 0.0 111.708 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -55.85 140.21 43.2 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -64.24 -20.94 66.38 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.824 -1.172 . . . . 0.0 114.025 -174.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -104.37 9.49 35.77 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.348 1.859 . . . . 0.0 113.681 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.7 m -147.42 142.23 16.61 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -171.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -95.74 -9.78 1.09 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.29 3.327 . . . . 0.0 114.192 171.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -71.72 171.98 10.57 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.438 1.895 . . . . 0.0 109.674 -169.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -69.45 118.84 12.84 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.868 -1.145 . . . . 0.0 113.801 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.32 120.91 0.82 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.248 1.404 . . . . 0.0 111.234 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -121.81 146.06 47.45 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -166.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -103.59 113.97 27.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.23 2.212 . . . . 0.0 109.474 172.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.279 69.9 m-85 -90.07 43.76 1.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -169.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.56 -175.91 38.44 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.506 -1.371 . . . . 0.0 115.055 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.32 146.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 126.152 1.781 . . . . 0.0 107.866 165.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.01 137.44 50.27 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.518 1.054 . . . . 0.0 113.13 167.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -102.08 118.96 38.01 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.005 1.722 . . . . 0.0 113.93 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.82 110.47 4.98 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.585 0.754 . . . . 0.0 110.199 171.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.7 mt -125.34 150.42 67.35 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.328 1.051 . . . . 0.0 111.466 -176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.6 138.21 73.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.637 2.225 . . . . 0.0 110.578 161.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -56.76 121.61 10.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.185 1.394 . . . . 0.0 111.291 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.37 1.65 66.38 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.1 m -52.18 125.46 33.38 Favored Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 120.407 2.104 . . . . 0.0 112.436 166.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.601 ' HB2' HD12 ' A' ' 142' ' ' ILE . 9.0 Cg_endo -68.22 135.66 35.04 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.095 1.863 . . . . 0.0 111.841 173.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 18.3 mm -91.51 130.51 40.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.716 1.606 . . . . 0.0 107.428 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -101.25 150.19 23.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.995 1.318 . . . . 0.0 109.246 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.45 128.02 93.13 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.936 171.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.03 -30.53 16.29 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.317 2.678 . . . . 0.0 113.345 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.7 p -132.43 163.73 28.12 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.724 2.41 . . . . 0.0 112.225 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.54 135.94 42.14 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 164.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.71 -159.26 11.54 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.403 1.001 . . . . 0.0 114.057 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tmmt? -150.9 145.55 25.71 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.681 1.593 . . . . 0.0 111.174 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.59 125.66 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.83 -41.35 7.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.822 1.249 . . . . 0.0 111.075 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -149.32 142.93 25.46 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.724 1.21 . . . . 0.0 111.654 -166.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.9 mt -140.99 134.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.446 1.098 . . . . 0.0 109.386 174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -157.52 177.76 11.05 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -120.47 161.8 20.64 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.881 1.272 . . . . 0.0 111.918 164.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -132.29 145.92 51.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.031 1.733 . . . . 0.0 111.491 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -63.97 -30.35 71.44 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -173.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -97.95 -38.71 9.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.263 1.425 . . . . 0.0 112.429 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.4 -9.23 55.53 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.317 1.437 . . . . 0.0 115.519 -162.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.54 -149.11 36.37 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 118.341 1.07 . . . . 0.0 112.934 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.4 146.57 45.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.8 t -134.53 138.89 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.137 1.775 . . . . 0.0 113.851 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.3 tp -115.21 134.27 55.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.566 1.946 . . . . 0.0 109.784 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.44 123.62 46.83 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.698 1.199 . . . . 0.0 112.755 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.2 mt -119.48 142.67 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.062 1.345 . . . . 0.0 111.373 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.09 138.93 37.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.534 1.934 . . . . 0.0 110.89 169.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -76.92 168.0 20.86 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 112.241 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -65.81 -22.26 66.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -61.45 -21.45 64.16 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 127.46 2.304 . . . . 0.0 113.992 -175.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.68 10.7 78.81 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.468 1.509 . . . . 0.0 115.088 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -149.55 -25.33 0.28 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.296 38.5 m-85 -80.36 140.39 36.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 173.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -131.8 150.38 52.17 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.387 1.075 . . . . 0.0 112.598 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -125.53 121.4 33.59 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.693 1.997 . . . . 0.0 108.184 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -97.49 150.41 21.1 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -136.27 91.77 2.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.829 2.452 . . . . 0.0 108.823 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 mp -95.47 162.91 13.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.472 0.709 . . . . 0.0 111.838 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 65.26 53.63 1.29 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.352 1.861 . . . . 0.0 111.721 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.7 mt -96.75 140.95 30.58 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.266 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.53 -50.83 12.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.376 1.87 . . . . 0.0 107.802 170.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -147.78 146.84 29.33 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.884 1.673 . . . . 0.0 111.322 -163.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -91.09 151.03 21.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.059 0.543 . . . . 0.0 111.728 171.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -118.12 -7.11 10.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.437 1.095 . . . . 0.0 112.657 169.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.81 166.8 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.294 1.838 . . . . 0.0 111.219 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -122.16 165.96 15.31 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.718 1.607 . . . . 0.0 111.135 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 43.5 t -52.64 125.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.782 1.233 . . . . 0.0 107.993 172.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.1 13.72 61.65 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.42 126.37 35.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.749 1.774 . . . . 0.0 112.603 168.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -71.2 135.22 47.43 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.981 0.512 . . . . 0.0 111.371 167.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.5 m -121.51 156.46 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.91 1.684 . . . . 0.0 110.348 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -136.13 140.73 43.89 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.988 1.715 . . . . 0.0 109.336 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.25 131.62 16.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.265 1.031 . . . . 0.0 113.488 -171.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 89.22 -6.68 83.31 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.861 2.172 . . . . 0.0 115.128 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -79.23 140.75 37.58 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.036 1.418 . . . . 0.0 114.017 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.0 mm -70.42 129.63 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.688 0.795 . . . . 0.0 111.603 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -115.5 -23.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.966 1.307 . . . . 0.0 113.089 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.67 -175.92 1.67 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.879 1.672 . . . . 0.0 110.386 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -136.85 138.18 40.48 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.5 t -79.92 143.24 34.4 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.048 0.84 . . . . 0.0 113.236 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.28 167.74 30.19 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.953 1.264 . . . . 0.0 112.977 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -82.77 16.83 2.06 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.6 p -62.48 1.87 0.32 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 118.052 2.612 . . . . 0.0 118.052 -168.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.64 51.12 0.14 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.298 0.952 . . . . 0.0 113.243 176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mt -135.91 122.68 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.912 0.863 . . . . 0.0 111.161 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -67.95 -21.16 65.11 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.053 1.341 . . . . 0.0 114.05 -170.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.8 p -66.55 -12.95 60.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.932 1.693 . . . . 0.0 115.357 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.397 0.2 OUTLIER 68.07 12.25 8.7 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -164.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -95.4 166.07 25.3 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.94 1.257 . . . . 0.0 113.197 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -110.9 131.79 54.75 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.614 1.166 . . . . 0.0 110.8 169.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -154.91 132.31 11.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.681 0.792 . . . . 0.0 111.971 169.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.65 117.09 13.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.082 0.953 . . . . 0.0 110.702 -177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -90.9 106.07 18.27 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.219 0.918 . . . . 0.0 111.865 172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.251 41.5 t80 -95.28 115.04 26.89 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.409 1.484 . . . . 0.0 114.563 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -113.85 120.43 40.7 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.822 0.849 . . . . 0.0 111.755 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -92.95 124.0 36.61 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.078 1.751 . . . . 0.0 111.35 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.3 mtm -126.07 161.32 27.87 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.984 1.714 . . . . 0.0 111.293 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -134.16 141.96 47.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 111.353 169.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.35 -5.26 60.52 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.252 1.406 . . . . 0.0 115.867 167.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.59 -175.12 47.45 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 127.751 2.596 . . . . 0.0 110.146 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.25 121.76 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.637 1.175 . . . . 0.0 112.544 -174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.93 163.75 10.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.28 1.419 . . . . 0.0 112.356 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -48.23 -46.13 35.03 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.736 1.214 . . . . 0.0 113.468 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.18 -29.34 69.74 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -81.46 -14.24 57.26 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.1 131.83 49.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.614 1.166 . . . . 0.0 112.119 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -103.28 -80.48 0.52 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.778 0.831 . . . . 0.0 112.681 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.5 p30 -166.78 101.34 0.66 Allowed Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.397 1.479 . . . . 0.0 114.046 -171.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -80.02 -32.29 1.49 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.866 1.711 . . . . 0.0 114.097 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -57.83 -53.84 61.55 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 120.976 1.717 . . . . 0.0 115.475 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.24 -25.97 49.6 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.241 2.627 . . . . 0.0 112.122 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -61.13 -27.56 68.47 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 117.214 2.301 . . . . 0.0 117.214 166.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.6 mt -82.21 -31.52 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.836 0.854 . . . . 0.0 111.998 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -63.4 -4.7 2.87 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -114.81 -5.75 12.64 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.807 2.043 . . . . 0.0 113.652 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.9 mt -77.72 148.1 75.63 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.743 1.217 . . . . 0.0 112.532 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.65 -21.31 22.13 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.811 3.007 . . . . 0.0 115.2 -164.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -119.01 9.44 11.86 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.106 1.363 . . . . 0.0 113.921 169.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.02 -141.24 34.1 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.252 0.93 . . . . 0.0 112.975 -169.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -56.63 -25.25 52.8 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.313 -1.11 . . . . 0.0 113.414 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -64.89 -9.11 18.57 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 113.753 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.3 m -81.74 -7.96 59.65 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.08 0.952 . . . . 0.0 112.76 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.36 -18.69 14.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.624 1.17 . . . . 0.0 113.346 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -144.17 159.42 42.68 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.378 -1.451 . . . . 0.0 113.441 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -104.78 93.11 4.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.241 0.631 0 C-N-CA 123.658 0.783 . . . . 0.0 111.824 177.196 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.179 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.4 p -82.43 -15.37 52.86 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.56 156.17 35.29 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.042 1.292 . . . . 0.0 113.536 -171.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -153.06 150.85 29.58 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.239 1.416 . . . . 0.0 113.011 -172.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.41 -24.32 57.13 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -165.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -91.41 138.36 31.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.439 1.496 . . . . 0.0 113.682 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -62.11 129.0 38.79 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 168.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -68.13 134.33 50.37 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 117.346 2.35 . . . . 0.0 117.346 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -89.81 -26.55 20.5 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.43 -123.22 4.15 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.444 1.973 . . . . 0.0 111.729 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.1 m -67.76 149.64 49.68 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -127.47 21.48 6.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -166.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.26 127.94 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 120.198 1.363 . . . . 0.0 110.969 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.1 t -107.9 -27.14 10.38 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.264 1.825 . . . . 0.0 115.724 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -142.53 153.99 44.08 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.59 1.156 . . . . 0.0 111.242 162.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 p -128.64 176.43 7.8 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.53 1.532 . . . . 0.0 107.613 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -69.99 158.62 35.3 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 -172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.52 -135.99 12.5 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.297 -0.877 . . . . 0.0 112.245 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.75 154.13 42.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.97 1.385 . . . . 0.0 112.867 174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -61.73 -64.97 0.77 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -160.04 -177.01 6.0 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.714 2.006 . . . . 0.0 111.025 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -63.42 18.68 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 128.219 2.608 . . . . 0.0 116.742 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.7 p -76.31 161.91 73.13 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.954 2.501 . . . . 0.0 115.09 -172.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.1 -28.04 11.28 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.026 2.484 . . . . 0.0 112.192 162.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.276 1.2 p90 -66.43 128.67 37.08 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 163.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -155.59 96.48 1.77 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -112.49 -1.31 26.19 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.443 1.497 . . . . 0.0 114.455 171.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm 59.35 159.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.572 2.349 . . . . 0.0 115.926 -171.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -134.0 111.15 10.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.435 1.894 . . . . 0.0 110.099 -162.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.453 68.5 m-85 -93.41 28.07 2.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 117.911 2.56 . . . . 0.0 117.911 -167.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.43 -168.97 23.09 Favored Glycine 0 CA--C 1.532 1.097 0 O-C-N 121.109 -0.994 . . . . 0.0 114.766 -175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.27 144.57 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.977 2.111 . . . . 0.0 108.859 175.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -123.47 129.88 51.88 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -102.62 118.77 37.58 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.106 1.762 . . . . 0.0 113.804 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.436 ' HA ' ' CD2' ' A' ' 157' ' ' HIS . . . -72.76 78.14 1.12 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.356 1.062 . . . . 0.0 112.421 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.6 mt -95.77 150.17 37.02 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.099 0.959 . . . . 0.0 112.484 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.07 151.52 83.6 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.864 2.376 . . . . 0.0 112.214 162.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -54.74 139.68 38.49 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.325 1.45 . . . . 0.0 111.054 174.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.77 -9.56 59.21 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.028 -1.429 . . . . 0.0 115.818 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.6 m -50.62 122.47 16.19 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-N 119.707 1.754 . . . . 0.0 113.938 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.568 ' HB2' HD12 ' A' ' 142' ' ' ILE . 14.7 Cg_endo -67.31 129.3 20.03 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 121.165 1.243 . . . . 0.0 111.662 172.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.426 HD11 ' HB2' ' A' ' 146' ' ' SER . 45.6 mm -87.94 127.68 40.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.267 1.827 . . . . 0.0 107.771 173.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -99.25 154.38 18.2 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.482 1.513 . . . . 0.0 109.77 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.9 123.95 90.16 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.939 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.08 -35.79 51.61 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.148 2.565 . . . . 0.0 112.716 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -138.58 154.89 48.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.725 1.61 . . . . 0.0 107.137 -169.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.29 134.33 55.65 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.494 0.718 . . . . 0.0 110.926 169.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.01 -157.92 11.58 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.937 -173.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 146.47 25.65 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.438 1.895 . . . . 0.0 111.911 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.03 129.23 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 -44.91 7.09 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -158.62 143.73 16.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.049 1.34 . . . . 0.0 111.104 -166.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -141.1 118.75 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.761 1.224 . . . . 0.0 109.637 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -159.68 174.46 14.52 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -129.9 156.38 44.49 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.982 1.313 . . . . 0.0 110.172 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -124.97 132.92 53.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.702 1.601 . . . . 0.0 108.785 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -52.16 -31.52 31.67 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -155.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.0 pp -130.72 6.22 4.7 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.87 1.668 . . . . 0.0 113.682 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -98.62 -20.21 20.18 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 126.167 1.842 . . . . 0.0 115.605 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.06 -173.05 21.23 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.495 1.521 . . . . 0.0 114.547 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -72.08 152.16 42.56 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.09 -0.653 . . . . 0.0 112.543 167.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.81 140.93 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 127.005 2.122 . . . . 0.0 114.451 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.86 132.53 56.67 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.302 1.841 . . . . 0.0 108.683 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.99 124.49 51.52 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.586 1.155 . . . . 0.0 110.403 173.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.9 mt -120.76 144.43 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.455 1.102 . . . . 0.0 111.153 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.76 127.09 53.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.362 1.865 . . . . 0.0 110.35 172.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -64.94 144.59 57.18 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.006 -1.059 . . . . 0.0 111.428 169.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -69.2 -12.84 62.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.08 -20.67 65.57 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 165.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.69 1.83 63.51 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 116.131 1.213 . . . . 0.0 116.131 164.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -124.79 -30.56 3.27 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.09 1.445 . . . . 0.0 113.639 -175.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.312 35.1 m-85 -83.95 136.47 34.06 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 117.335 2.346 . . . . 0.0 117.335 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -120.13 155.32 33.28 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.316 2.246 . . . . 0.0 110.843 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -140.97 103.17 4.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.245 1.818 . . . . 0.0 109.994 -168.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -85.06 142.72 29.36 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.685 0.394 . . . . 0.0 111.38 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -130.78 89.94 2.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 127.872 2.469 . . . . 0.0 109.979 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mp -93.27 157.06 16.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.342 0.657 . . . . 0.0 111.346 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 71.18 58.56 0.19 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.269 1.827 . . . . 0.0 113.187 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.1 mt -103.72 148.86 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.024 1.33 . . . . 0.0 111.288 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.42 -52.68 6.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.412 1.885 . . . . 0.0 107.618 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -150.98 157.79 43.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 127.168 2.187 . . . . 0.0 110.921 -165.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -98.77 154.29 18.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.94 0.896 . . . . 0.0 112.076 175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -117.18 -14.28 10.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.677 1.191 . . . . 0.0 112.934 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.93 163.17 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.067 1.347 . . . . 0.0 110.397 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -117.88 163.84 15.94 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.415 1.486 . . . . 0.0 109.453 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.4 t -54.52 135.43 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.57 3.72 83.7 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.561 1.077 . . . . 0.0 115.263 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -79.67 124.57 28.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 119.326 1.563 . . . . 0.0 111.863 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -74.19 140.95 45.46 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.77 160.92 40.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.617 1.567 . . . . 0.0 110.298 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -129.2 145.06 51.41 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.605 1.562 . . . . 0.0 110.46 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.0 116.56 2.05 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.558 1.143 . . . . 0.0 112.732 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.68 -1.33 42.19 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 126.203 1.859 . . . . 0.0 115.305 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -86.34 142.58 28.39 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.407 1.883 . . . . 0.0 114.958 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 88' ' ' PRO . 13.4 mm -69.01 129.05 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.109 0.868 . . . . 0.0 112.01 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.2 pt -115.77 -23.97 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.707 1.603 . . . . 0.0 113.312 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.77 3.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.469 1.108 . . . . 0.0 110.54 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -129.66 132.08 46.59 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.426 ' HB2' HD11 ' A' ' 89' ' ' ILE . 1.6 t -69.06 137.52 53.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.704 1.601 . . . . 0.0 110.43 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.87 163.36 34.16 Favored Glycine 0 N--CA 1.464 0.502 0 CA-C-O 122.893 1.274 . . . . 0.0 115.027 -169.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -81.3 34.24 0.36 Allowed 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -163.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.0 p -88.21 113.81 24.2 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.327 1.451 . . . . 0.0 112.248 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.14 17.8 74.23 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 118.891 2.317 . . . . 0.0 118.891 168.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.41 145.94 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 120.182 1.991 . . . . 0.0 111.468 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -75.13 -43.57 51.86 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.16 132.21 31.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 174.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.413 2.3 p 66.96 -128.59 0.17 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -170.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.8 166.58 38.84 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 121.168 1.803 . . . . 0.0 116.212 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 67.2 -9.68 0.38 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 119.467 3.136 . . . . 0.0 119.467 172.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.436 ' CD2' ' HA ' ' A' ' 82' ' ' ALA . 25.1 m170 -74.61 124.94 27.6 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.106 1.362 . . . . 0.0 113.99 -171.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.48 128.53 36.55 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.292 1.437 . . . . 0.0 112.089 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -106.23 105.9 16.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.798 0.839 . . . . 0.0 112.109 171.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.287 33.7 t80 -95.4 111.98 23.77 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.882 1.673 . . . . 0.0 114.941 175.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -116.7 114.0 23.41 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.621 1.168 . . . . 0.0 111.282 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.94 122.63 43.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.415 1.486 . . . . 0.0 110.808 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.0 mtm -128.64 156.46 43.38 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.618 1.567 . . . . 0.0 111.415 -172.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -127.76 128.29 45.09 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.91 1.284 . . . . 0.0 110.669 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.3 -15.2 12.7 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 125.886 1.708 . . . . 0.0 116.623 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.17 -174.53 40.31 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.049 1.309 . . . . 0.0 112.179 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -127.93 91.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -167.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 173.03 173.21 39.28 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.872 1.701 . . . . 0.0 112.86 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -48.58 -48.65 38.77 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.1 -14.62 62.74 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.19 -16.34 38.12 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 172.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.1 143.49 52.38 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.564 1.146 . . . . 0.0 112.823 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -125.23 -79.94 0.61 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.243 1.017 . . . . 0.0 113.412 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -164.79 110.51 0.84 Allowed Pre-proline 0 N--CA 1.47 0.546 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -29.99 4.13 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.257 1.971 . . . . 0.0 114.151 173.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.7 mmtt -51.35 -59.98 6.72 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.6 -28.62 69.73 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.689 2.926 . . . . 0.0 111.695 -172.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -66.72 -39.17 87.9 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 172.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.1 mt -72.22 -34.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.775 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.51 -16.84 17.12 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.93 1.12 11.47 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.144 1.778 . . . . 0.0 114.692 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.8 mt -65.23 154.39 87.36 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.44 1.096 . . . . 0.0 111.848 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -47.2 -54.69 4.7 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.921 3.748 . . . . 0.0 114.028 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -106.99 10.84 30.29 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.272 1.029 . . . . 0.0 112.727 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.32 -139.1 30.15 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 120.711 -1.243 . . . . 0.0 112.332 -169.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -57.97 -26.4 62.28 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.706 -1.467 . . . . 0.0 112.807 175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -69.55 -3.37 14.51 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.983 1.313 . . . . 0.0 113.067 176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.6 m -80.54 -8.04 59.44 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.31 1.044 . . . . 0.0 113.013 166.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.57 -13.47 15.05 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.854 1.662 . . . . 0.0 112.687 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -151.16 161.47 42.67 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -106.04 90.15 3.29 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.849 1.26 . . . . 0.0 109.806 170.272 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.747 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.1 p -56.46 128.49 36.34 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.12 155.34 21.52 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.882 1.673 . . . . 0.0 111.483 165.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -136.31 159.64 41.12 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.695 1.198 . . . . 0.0 113.358 -174.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.07 158.43 31.11 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.76 1.267 . . . . 0.0 112.883 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -151.94 161.85 41.99 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.625 1.97 . . . . 0.0 113.861 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -88.03 124.82 34.14 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 167.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.261 16.2 t80 -66.68 156.58 34.89 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 169.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -47.58 104.93 0.06 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.692 1.597 . . . . 0.0 112.982 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.97 -11.1 0.29 Allowed Glycine 0 CA--C 1.544 1.871 0 N-CA-C 118.045 1.978 . . . . 0.0 118.045 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 m -148.72 153.46 38.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.425 2.112 . . . . 0.0 113.909 -162.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -84.83 16.02 3.58 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 mt -87.49 125.98 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 120.937 -1.102 . . . . 0.0 113.548 -167.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.1 p -88.1 -36.78 16.72 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -141.0 122.88 15.4 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.173 1.389 . . . . 0.0 111.641 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.0 p -85.43 -176.69 6.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.622 1.169 . . . . 0.0 110.412 164.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -68.66 134.89 50.55 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.34 -120.5 1.01 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.351 0.501 . . . . 0.0 112.092 -171.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 149.56 35.06 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.667 1.587 . . . . 0.0 112.813 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -62.48 160.04 14.43 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.155 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -59.69 156.44 13.79 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.454 -0.779 . . . . 0.0 112.431 166.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.2 m170 63.12 52.76 2.44 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.87 1.668 . . . . 0.0 113.825 -171.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.8 m 68.66 160.9 0.14 Allowed Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 128.525 2.73 . . . . 0.0 117.409 169.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -86.09 1.45 7.87 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.067 3.178 . . . . 0.0 115.257 -172.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -76.14 109.67 10.0 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.31 25.5 m-20 55.12 36.09 26.21 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -166.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.46 20.96 1.87 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.895 1.236 . . . . 0.0 115.782 -165.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -83.87 144.74 29.03 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 120.006 1.903 . . . . 0.0 112.908 176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -115.28 129.04 56.51 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.335 1.854 . . . . 0.0 110.688 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -111.96 23.0 14.27 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -170.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.0 -166.97 14.21 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 120.696 -1.252 . . . . 0.0 114.579 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.01 130.36 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.828 2.051 . . . . 0.0 109.291 174.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -109.64 89.15 2.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -79.15 108.1 12.4 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.17 126.83 30.43 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.417 1.008 . . . . 0.0 111.776 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.45 159.17 71.64 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.137 0.975 . . . . 0.0 113.325 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.19 145.8 73.91 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.234 2.623 . . . . 0.0 111.22 161.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -65.87 131.71 46.91 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.345 -0.847 . . . . 0.0 111.149 -174.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.18 -3.27 84.24 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 117.586 -1.675 . . . . 0.0 115.415 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -47.72 121.93 8.58 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-N 119.923 1.862 . . . . 0.0 112.459 171.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.594 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.6 Cg_endo -68.2 129.25 18.94 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.424 1.416 . . . . 0.0 111.589 175.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mm -86.23 128.1 39.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.73 1.612 . . . . 0.0 108.482 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -100.4 149.81 23.27 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 109.644 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.76 133.37 90.46 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 121.777 -0.577 . . . . 0.0 110.861 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.59 -32.39 6.11 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.193 2.595 . . . . 0.0 112.667 175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.3 p -140.22 160.92 38.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.34 2.256 . . . . 0.0 107.847 -170.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -74.64 136.78 41.94 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 120.772 -1.205 . . . . 0.0 109.326 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.56 -159.11 11.81 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-O 119.357 -0.691 . . . . 0.0 113.973 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -150.09 144.68 25.89 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.913 1.285 . . . . 0.0 113.108 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.65 127.26 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.06 -41.95 5.69 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.614 1.166 . . . . 0.0 111.939 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -147.06 140.43 25.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.697 1.199 . . . . 0.0 110.915 -165.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 mt -144.82 110.51 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.512 1.525 . . . . 0.0 109.42 -173.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -154.81 -175.23 5.32 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.461 0.704 . . . . 0.0 112.545 -169.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.51 32.6 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.697 1.199 . . . . 0.0 112.456 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -143.65 153.98 43.06 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.906 2.082 . . . . 0.0 112.023 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -63.55 -31.16 72.24 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.67 -19.02 5.04 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.955 1.302 . . . . 0.0 113.692 -174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.21 -8.32 75.26 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.809 1.671 . . . . 0.0 114.326 169.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.2 -152.39 49.82 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 118.02 0.91 . . . . 0.0 113.074 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -73.33 148.07 43.82 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.684 -0.892 . . . . 0.0 112.498 170.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.25 134.79 62.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.528 1.531 . . . . 0.0 115.087 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -111.35 134.97 52.54 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.135 1.374 . . . . 0.0 109.574 168.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.4 124.34 44.28 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 55.6 mt -119.85 139.91 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.557 1.143 . . . . 0.0 111.193 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.33 131.27 40.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.852 2.061 . . . . 0.0 110.118 166.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -77.34 155.53 31.9 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -68.48 -12.43 61.21 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.417 1.887 . . . . 0.0 111.564 -174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -71.04 -13.35 61.95 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 167.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.32 -2.28 57.78 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -114.75 -35.56 4.79 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.581 1.69 . . . . 0.0 112.517 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -88.99 143.31 26.94 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 -176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -121.9 152.77 39.27 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.536 1.534 . . . . 0.0 112.54 174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -120.38 138.95 53.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.586 1.954 . . . . 0.0 109.153 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -114.0 148.65 36.59 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.977 1.311 . . . . 0.0 112.827 161.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -133.7 99.63 4.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.896 1.679 . . . . 0.0 106.964 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.1 mp -92.41 163.67 13.77 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.695 1.198 . . . . 0.0 110.508 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 66.25 40.15 3.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.154 2.181 . . . . 0.0 114.937 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -83.98 154.22 23.44 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.312 -1.493 . . . . 0.0 112.827 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -92.36 -46.75 7.53 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.799 1.239 . . . . 0.0 108.955 171.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.2 mttp -152.82 160.27 43.09 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -104.0 148.64 25.98 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.646 1.578 . . . . 0.0 111.911 176.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -107.33 -8.61 16.28 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.662 1.585 . . . . 0.0 112.25 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 175.39 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 125.772 1.629 . . . . 0.0 111.464 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -130.82 169.21 16.03 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.438 1.495 . . . . 0.0 111.424 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.29 132.47 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 122.225 1.012 . . . . 0.0 108.983 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.69 9.16 69.08 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.511 1.053 . . . . 0.0 115.128 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -86.27 124.61 32.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.727 1.264 . . . . 0.0 113.33 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -75.87 139.68 41.81 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.871 0.367 . . . . 0.0 111.514 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.4 164.6 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.214 1.805 . . . . 0.0 112.676 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.05 140.14 48.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.254 1.822 . . . . 0.0 110.218 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -43.1 125.68 3.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.875 1.27 . . . . 0.0 113.402 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.94 -10.14 72.33 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.0 1.762 . . . . 0.0 114.995 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -80.74 145.0 31.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.179 1.489 . . . . 0.0 114.667 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.594 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.1 mm -70.82 135.06 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.225 0.61 . . . . 0.0 111.817 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 42.1 pt -121.22 -20.52 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.493 1.117 . . . . 0.0 113.321 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.7 -176.03 1.19 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.896 1.678 . . . . 0.0 111.388 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -132.82 134.46 44.7 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.2 t -71.01 143.65 50.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.179 0.591 . . . . 0.0 112.231 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.88 175.06 21.07 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.554 1.073 . . . . 0.0 113.185 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -87.38 17.34 4.52 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.218 -1.166 . . . . 0.0 112.98 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.269 5.6 p -65.98 137.67 57.29 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.34 -34.06 2.91 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 125.326 1.441 . . . . 0.0 115.094 -174.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.7 144.97 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.3 1.44 . . . . 0.0 112.331 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -75.41 -37.61 60.35 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -170.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.269 1.3 m -127.13 -70.61 0.71 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 117.218 2.303 . . . . 0.0 117.218 -169.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.8 p -145.13 146.0 31.62 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 103.19 134.61 8.37 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.979 1.752 . . . . 0.0 113.736 171.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -97.84 150.38 21.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.856 1.662 . . . . 0.0 111.87 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -156.97 171.12 21.03 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.569 -0.707 . . . . 0.0 111.684 175.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -115.42 120.88 41.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.167 1.387 . . . . 0.0 110.887 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -98.45 99.41 10.58 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.301 1.04 . . . . 0.0 110.583 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.283 36.8 t80 -88.75 116.66 27.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 172.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -122.29 116.95 24.98 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.323 1.049 . . . . 0.0 111.886 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -95.29 131.39 41.42 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.747 1.619 . . . . 0.0 110.93 178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.8 mtm -132.43 155.09 49.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.681 1.593 . . . . 0.0 111.498 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -128.76 136.7 50.91 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.304 1.442 . . . . 0.0 111.235 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.39 2.75 43.85 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.518 0.967 . . . . 0.0 115.518 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.75 -175.81 43.78 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.6 2.048 . . . . 0.0 111.0 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.56 123.29 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 122.438 1.114 . . . . 0.0 108.266 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.07 159.58 9.94 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 127.724 2.583 . . . . 0.0 110.685 -165.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -57.61 -46.68 83.78 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.774 1.287 . . . . 0.0 113.534 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.72 -15.98 63.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -76.28 -15.07 60.08 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.27 152.31 42.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.51 1.124 . . . . 0.0 113.861 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -119.97 -90.49 0.58 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.37 1.468 . . . . 0.0 112.409 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -160.91 118.13 1.44 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.371 1.469 . . . . 0.0 108.385 165.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.67 -20.9 29.96 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.096 2.531 . . . . 0.0 115.512 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -50.86 -55.32 28.28 Favored Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.98 -28.2 42.09 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.905 3.07 . . . . 0.0 112.873 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -65.46 -34.51 78.46 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 170.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.2 mt -79.14 -32.66 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.107 0.563 . . . . 0.0 111.37 173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.81 -5.59 2.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.811 2.152 . . . . 0.0 116.811 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -117.45 -9.05 10.93 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.964 1.706 . . . . 0.0 113.804 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 58.7 mt -63.98 152.53 87.15 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.198 1.399 . . . . 0.0 113.078 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.97 -32.71 17.19 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.539 2.826 . . . . 0.0 114.603 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.64 13.43 19.93 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.108 1.363 . . . . 0.0 113.09 170.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.06 -135.73 48.67 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.98 0.8 . . . . 0.0 112.197 -167.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.23 -26.92 53.07 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -68.91 -10.28 56.29 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.7 t -78.66 0.62 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.639 -0.696 . . . . 0.0 112.211 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.7 mt -111.13 -16.23 13.51 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.726 1.61 . . . . 0.0 112.834 174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -146.24 153.87 41.08 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.771 1.623 . . . . 0.0 114.558 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -107.75 76.53 1.07 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.399 1.095 . . . . 0.0 113.317 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 C--O 1.239 0.543 0 C-N-CA 124.464 1.105 . . . . 0.0 109.454 169.065 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.1 m -66.15 155.61 36.43 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.099 1.36 . . . . 0.0 114.302 -175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -94.01 -31.89 14.05 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.375 1.47 . . . . 0.0 112.21 161.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.7 p-90 -147.22 161.87 40.04 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.126 1.77 . . . . 0.0 112.656 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -138.88 -178.45 5.33 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.899 1.679 . . . . 0.0 113.135 -176.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.356 4.4 p30 -68.85 51.9 0.08 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 128.001 2.52 . . . . 0.0 117.645 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.274 12.8 m-85 -93.24 135.71 34.19 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 120.015 3.339 . . . . 0.0 120.015 -172.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -111.31 149.46 31.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 128.262 2.625 . . . . 0.0 116.275 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.0 mtm-85 -138.5 60.9 1.6 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.93 -39.73 95.06 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 159.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 75.0 m -84.92 135.46 34.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.186 0.995 . . . . 0.0 109.952 156.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -71.3 -9.57 58.34 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 -166.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -79.73 126.11 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 119.569 1.077 . . . . 0.0 111.488 -170.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.251 0.7 OUTLIER -74.95 -42.19 58.16 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 167.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.49 122.22 10.54 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.486 1.514 . . . . 0.0 109.801 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.0 p -82.51 170.82 14.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.177 1.391 . . . . 0.0 112.434 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -67.39 131.18 45.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.19 -90.4 0.18 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.116 0.865 . . . . 0.0 112.439 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -137.21 163.07 31.76 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.988 1.315 . . . . 0.0 113.533 -164.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.85 172.03 8.74 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 164.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -88.42 -0.88 57.67 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.313 1.045 . . . . 0.0 113.047 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -62.59 -29.85 70.9 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.737 1.215 . . . . 0.0 114.163 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.4 p -158.09 162.25 27.3 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.482 1.113 . . . . 0.0 111.038 168.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -74.85 -8.61 20.4 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.01 2.474 . . . . 0.0 113.449 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -89.62 -63.6 1.26 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -171.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.08 168.83 26.04 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-O 122.498 1.142 . . . . 0.0 109.547 -168.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.39 110.67 2.36 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 127.558 2.504 . . . . 0.0 110.821 -171.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -122.25 137.59 54.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.027 1.331 . . . . 0.0 113.954 -165.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -122.18 136.99 54.98 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.105 1.762 . . . . 0.0 110.847 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -122.47 27.22 7.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.155 0.982 . . . . 0.0 113.627 -166.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -151.99 -169.47 17.5 Favored Glycine 0 CA--C 1.531 1.08 0 O-C-N 120.888 -1.132 . . . . 0.0 113.588 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.585 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -113.68 132.8 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 126.995 2.118 . . . . 0.0 108.617 173.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -111.96 93.76 4.61 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -79.82 111.19 15.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 121.55 17.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.729 0.695 . . . . 0.0 111.307 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.8 mt -135.99 156.78 76.87 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.373 1.469 . . . . 0.0 110.653 -173.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.29 137.68 67.11 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.56 2.174 . . . . 0.0 110.774 160.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -60.21 133.37 56.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.773 0.829 . . . . 0.0 111.063 -176.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.29 5.25 89.02 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 118.24 -1.311 . . . . 0.0 115.07 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.5 m -55.12 125.55 57.75 Favored Pre-proline 0 N--CA 1.477 0.916 0 CA-C-N 120.179 1.99 . . . . 0.0 110.506 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.579 ' HB2' HD12 ' A' ' 142' ' ' ILE . 10.9 Cg_endo -68.02 132.31 26.0 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 121.968 1.779 . . . . 0.0 111.851 174.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.46 126.22 41.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 126.208 1.803 . . . . 0.0 107.665 174.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -95.99 153.61 17.68 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.216 1.007 . . . . 0.0 110.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.32 123.71 89.44 Favored Pre-proline 0 CA--C 1.551 1.003 0 O-C-N 121.727 -0.608 . . . . 0.0 110.672 172.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.19 -40.19 20.58 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.992 2.461 . . . . 0.0 111.475 174.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.1 p -134.82 165.02 26.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.079 2.552 . . . . 0.0 111.309 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -70.94 136.03 48.27 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.493 1.117 . . . . 0.0 112.056 169.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.54 -157.32 13.22 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.521 1.058 . . . . 0.0 114.629 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -150.68 150.42 31.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.557 1.943 . . . . 0.0 110.19 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 t -66.01 133.26 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 -41.74 8.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -158.88 145.64 17.17 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.069 1.748 . . . . 0.0 109.372 -169.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.6 mt -137.32 129.87 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.901 1.28 . . . . 0.0 108.864 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -157.53 173.38 16.97 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -128.54 152.73 47.96 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.119 0.967 . . . . 0.0 111.141 170.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -145.16 143.03 30.12 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.281 1.432 . . . . 0.0 112.68 -174.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -66.22 -21.91 66.32 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.06 -37.85 9.19 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.888 1.275 . . . . 0.0 112.156 171.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -91.54 -9.5 62.91 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.855 1.217 . . . . 0.0 115.917 -168.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.0 -154.98 52.56 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.021 0.91 . . . . 0.0 112.455 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -69.29 144.17 53.64 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.857 -0.79 . . . . 0.0 111.438 165.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.51 137.01 56.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.607 1.563 . . . . 0.0 114.823 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.4 tp -115.95 123.44 48.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.649 1.98 . . . . 0.0 108.573 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.21 125.47 48.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.276 1.03 . . . . 0.0 109.753 171.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.1 mt -121.45 147.46 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.588 1.155 . . . . 0.0 111.606 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.87 136.95 49.13 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.692 1.997 . . . . 0.0 110.812 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -76.42 154.93 34.4 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.876 0.87 . . . . 0.0 112.773 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -58.21 -28.71 65.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -175.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -85.68 0.36 52.93 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.85 5.13 90.04 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 117.157 1.623 . . . . 0.0 117.157 160.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.23 -31.54 7.05 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.54 1.67 . . . . 0.0 112.209 -174.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.295 52.4 m-85 -88.03 131.07 34.79 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 172.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -115.16 151.86 33.64 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.376 1.87 . . . . 0.0 110.746 174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.89 102.85 4.99 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.123 1.769 . . . . 0.0 110.206 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.4 m0 -85.31 139.83 31.29 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.384 0.274 . . . . 0.0 111.193 170.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -126.25 91.36 3.36 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.532 2.333 . . . . 0.0 109.436 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.55 158.36 16.49 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.961 1.304 . . . . 0.0 110.638 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 63.54 56.34 1.62 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.503 1.921 . . . . 0.0 114.124 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.2 mt -96.49 147.37 23.91 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.421 1.088 . . . . 0.0 111.332 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -84.42 -48.49 9.6 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.63 148.11 30.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.062 1.745 . . . . 0.0 112.076 -169.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -93.66 144.62 25.22 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.938 1.295 . . . . 0.0 113.153 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -104.36 -10.97 17.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.605 0.762 . . . . 0.0 112.288 166.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.2 m -118.53 164.31 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.97 1.708 . . . . 0.0 113.191 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -117.45 164.37 14.98 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.016 2.126 . . . . 0.0 110.515 168.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.73 128.12 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.74 7.9 74.16 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.634 1.111 . . . . 0.0 115.747 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -90.27 133.32 35.01 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 120.044 1.922 . . . . 0.0 107.276 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -70.5 146.24 50.36 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.016 0.527 . . . . 0.0 111.8 172.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.6 m -129.33 154.06 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 110.007 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -133.5 140.59 47.33 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.954 1.702 . . . . 0.0 108.736 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.26 125.68 11.39 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 122.264 1.031 . . . . 0.0 112.751 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.63 -1.37 66.12 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 125.829 1.68 . . . . 0.0 115.46 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -88.54 142.29 27.82 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.125 1.37 . . . . 0.0 114.031 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.579 HD12 ' HB2' ' A' ' 88' ' ' PRO . 16.1 mm -67.3 132.12 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.084 0.856 . . . . 0.0 111.774 177.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 44.2 pt -116.57 -23.17 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.826 1.25 . . . . 0.0 113.211 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -172.54 -175.49 1.35 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.623 1.969 . . . . 0.0 110.665 -177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -133.38 139.14 46.63 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.036 1.335 . . . . 0.0 107.505 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.11 144.37 50.29 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.64 0.776 . . . . 0.0 112.126 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.93 156.23 26.89 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 123.664 0.649 . . . . 0.0 113.004 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -82.36 31.45 0.4 Allowed 'General case' 0 CA--C 1.549 0.932 0 O-C-N 121.05 -1.265 . . . . 0.0 113.685 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 48.3 p -67.21 134.25 51.33 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.055 0.942 . . . . 0.0 110.93 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 72.67 -20.78 1.0 Allowed Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.314 1.435 . . . . 0.0 116.319 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.5 140.79 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.635 1.717 . . . . 0.0 111.617 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -74.95 -0.8 19.89 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.158 1.783 . . . . 0.0 115.376 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.3 t -153.56 140.46 19.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.017 2.127 . . . . 0.0 110.806 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.334 4.8 p -72.34 21.44 0.06 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.802 2.89 . . . . 0.0 118.802 -164.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.51 -9.19 81.81 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 116.789 1.476 . . . . 0.0 116.789 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 56.89 28.15 14.13 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 117.689 2.477 . . . . 0.0 117.689 163.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -76.46 134.47 39.53 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -169.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.54 117.37 14.13 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.08 0.952 . . . . 0.0 111.138 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -92.68 101.54 13.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.713 0.805 . . . . 0.0 110.784 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.281 52.9 t80 -93.28 115.65 28.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 170.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -117.62 116.08 26.36 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 111.632 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -92.24 121.85 34.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.72 1.608 . . . . 0.0 110.426 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.6 mtm -125.67 153.18 44.22 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.341 1.456 . . . . 0.0 110.756 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.12 128.92 46.97 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.654 1.181 . . . . 0.0 110.817 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.61 1.71 83.53 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.285 1.421 . . . . 0.0 115.812 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 169.51 -174.7 43.85 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.031 1.777 . . . . 0.0 111.846 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.8 125.3 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.618 1.167 . . . . 0.0 114.126 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 151.81 171.5 19.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.648 1.594 . . . . 0.0 113.037 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -65.06 -34.93 79.6 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.343 -1.093 . . . . 0.0 112.15 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.93 -25.35 67.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.462 1.505 . . . . 0.0 113.58 170.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -92.94 -14.85 27.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.77 144.61 57.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.537 1.135 . . . . 0.0 112.329 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -116.24 -82.9 0.63 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.048 0.939 . . . . 0.0 112.24 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -170.4 129.02 0.81 Allowed Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 128.125 2.57 . . . . 0.0 106.111 160.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.469 ' HG2' HD12 ' A' ' 79' ' ' ILE . 69.7 Cg_endo -71.58 -24.48 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.948 2.432 . . . . 0.0 114.539 171.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.585 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -54.05 -55.08 40.17 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -171.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.88 -31.09 48.28 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.688 2.925 . . . . 0.0 112.082 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -65.1 -41.62 94.77 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 170.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.45 HD12 HD13 ' A' ' 79' ' ' ILE . 29.9 mt -71.58 -35.78 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.391 0.541 . . . . 0.0 111.303 174.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 44.3 m-20 -63.68 -2.85 1.9 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -126.53 -7.59 6.29 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.096 2.158 . . . . 0.0 115.01 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.76 151.12 55.05 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.14 0.976 . . . . 0.0 112.484 170.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.41 -32.87 49.18 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.537 2.824 . . . . 0.0 114.947 -168.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.98 10.2 24.26 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.534 1.133 . . . . 0.0 109.61 173.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.68 -136.26 44.32 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.548 -1.345 . . . . 0.0 111.915 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.7 -25.28 68.08 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.934 -1.333 . . . . 0.0 113.939 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -68.41 -3.28 10.7 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.9 m -77.3 -6.69 54.12 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.28 0.632 . . . . 0.0 111.94 166.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.06 -12.92 12.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.779 1.632 . . . . 0.0 113.854 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -144.13 161.52 38.63 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -114.81 87.01 2.55 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 122.228 1.013 . . . . 0.0 111.904 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.203 1.401 . . . . 0.0 110.915 177.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 CA-C-O 120.781 0.101 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -113.34 154.55 26.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.855 1.262 . . . . 0.0 110.665 165.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -108.42 162.6 13.96 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.627 1.571 . . . . 0.0 111.005 171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -134.29 133.21 40.5 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.708 1.203 . . . . 0.0 112.832 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -68.02 142.16 55.99 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.017 0.913 . . . . 0.0 112.129 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -117.07 147.84 42.03 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.087 1.755 . . . . 0.0 114.73 171.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.262 21.9 t80 -56.58 136.71 54.45 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 116.542 2.052 . . . . 0.0 116.542 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.281 1.1 p90 -141.43 147.74 38.43 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 117.743 2.497 . . . . 0.0 117.743 179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -130.84 152.22 50.41 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.484 1.914 . . . . 0.0 111.094 166.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.24 -107.85 2.0 Allowed Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -167.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.7 m -64.58 152.1 42.93 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -126.17 34.81 4.78 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.89 138.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 O-C-N 120.05 -1.656 . . . . 0.0 112.671 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.3 p -107.41 -27.11 10.65 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 127.294 2.238 . . . . 0.0 116.379 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -146.51 149.92 34.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.979 1.712 . . . . 0.0 110.39 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.1 p -135.94 169.17 18.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.852 1.661 . . . . 0.0 109.484 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -68.27 126.23 28.92 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.38 -142.57 8.56 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.427 0.537 . . . . 0.0 113.739 -174.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -132.9 146.76 52.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.408 1.483 . . . . 0.0 111.067 179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -67.0 138.9 57.58 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -72.56 -49.84 29.68 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.375 0.67 . . . . 0.0 109.763 169.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -144.44 131.34 20.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.841 1.656 . . . . 0.0 110.752 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 p -162.55 164.99 16.04 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.118 0.967 . . . . 0.0 111.971 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.58 -6.76 11.69 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.262 2.641 . . . . 0.0 113.143 167.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -93.33 -174.41 3.51 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.683 1.593 . . . . 0.0 109.984 -167.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.293 8.7 p30 -64.5 -14.13 55.71 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 173.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.21 13.96 27.44 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.475 1.512 . . . . 0.0 116.226 167.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -130.74 144.56 51.53 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 120.259 2.029 . . . . 0.0 113.178 -167.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -147.07 131.47 17.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.579 -0.701 . . . . 0.0 112.832 -170.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -125.66 21.29 7.74 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -142.17 -172.08 13.42 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.703 1.144 . . . . 0.0 113.903 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.78 136.8 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.342 2.257 . . . . 0.0 108.549 173.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.07 100.88 7.82 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.49 130.61 36.22 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.32 34.22 0.13 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.968 2.107 . . . . 0.0 115.901 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.64 148.74 90.33 Favored Pre-proline 0 CA--C 1.547 0.827 0 O-C-N 120.727 -1.233 . . . . 0.0 111.835 -168.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.43 146.54 85.59 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.213 1.942 . . . . 0.0 111.982 169.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.12 129.0 33.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.967 0.907 . . . . 0.0 110.331 174.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.5 -10.62 63.06 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.707 1.146 . . . . 0.0 115.523 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -58.87 126.5 80.97 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-N 119.612 1.706 . . . . 0.0 113.15 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.572 ' HB2' HD12 ' A' ' 142' ' ' ILE . 14.2 Cg_endo -69.66 130.31 19.24 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.27 1.98 . . . . 0.0 112.317 172.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 146' ' ' SER . 27.4 mm -85.13 129.6 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.974 1.71 . . . . 0.0 108.532 170.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -100.78 151.98 21.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.164 . . . . 0.0 110.39 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.75 88.98 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 123.367 0.667 . . . . 0.0 111.621 175.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.71 -26.02 14.08 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.176 3.251 . . . . 0.0 113.249 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.9 p -133.27 164.33 27.33 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 127.306 2.242 . . . . 0.0 110.263 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -59.98 145.39 46.32 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.169 -0.957 . . . . 0.0 108.479 151.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -169.83 -163.92 24.67 Favored Glycine 0 N--CA 1.47 0.912 0 CA-C-O 119.686 -0.508 . . . . 0.0 113.144 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -147.28 143.75 28.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.58 1.152 . . . . 0.0 111.917 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -69.16 128.11 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.33 -43.88 7.83 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.426 1.491 . . . . 0.0 114.947 178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -159.21 144.1 15.69 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.048 0.939 . . . . 0.0 110.992 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.1 mt -140.75 114.85 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.674 1.19 . . . . 0.0 109.88 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -154.24 -177.27 6.33 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -167.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -139.65 150.54 45.05 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.981 -1.074 . . . . 0.0 111.828 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -123.84 162.18 23.79 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.108 1.763 . . . . 0.0 111.215 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.5 pm0 -66.14 -40.92 90.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 -169.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.2 -11.19 6.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.796 1.238 . . . . 0.0 113.842 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.14 -6.53 88.83 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 125.826 1.679 . . . . 0.0 114.006 163.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.24 -156.39 53.54 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.95 0.786 . . . . 0.0 113.49 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -69.11 145.86 53.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.048 -0.678 . . . . 0.0 111.958 171.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.13 137.45 55.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 115.446 1.646 . . . . 0.0 115.446 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.6 tp -115.95 131.5 56.92 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.719 2.007 . . . . 0.0 108.582 167.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 125.81 53.54 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.59 1.156 . . . . 0.0 110.316 173.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.17 144.46 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.27 1.028 . . . . 0.0 111.552 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -101.36 136.27 41.48 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.654 1.982 . . . . 0.0 110.793 171.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -79.16 159.69 27.3 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.628 0.771 . . . . 0.0 111.619 170.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -74.66 -10.62 59.7 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 120.318 -1.489 . . . . 0.0 114.367 174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -58.65 -24.17 60.64 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.602 1.561 . . . . 0.0 112.454 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 99.72 2.08 56.33 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.648 1.594 . . . . 0.0 115.226 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -142.65 -28.0 0.59 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -86.28 141.53 29.19 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -124.73 159.08 31.71 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.556 2.742 . . . . 0.0 112.117 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -140.62 105.26 4.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.184 2.194 . . . . 0.0 110.96 -171.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -85.79 144.33 27.8 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.472 0.709 . . . . 0.0 112.314 171.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.42 87.12 2.39 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 128.136 2.574 . . . . 0.0 108.887 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.39 159.55 19.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.044 1.338 . . . . 0.0 110.918 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 62.87 50.41 3.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.754 2.021 . . . . 0.0 114.455 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.9 mt -89.79 158.41 17.51 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.672 -1.267 . . . . 0.0 112.419 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -98.76 -46.61 5.61 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.945 1.298 . . . . 0.0 109.13 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -150.14 149.41 30.21 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.207 1.803 . . . . 0.0 111.888 -171.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -103.39 134.52 46.63 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.077 1.351 . . . . 0.0 112.108 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -87.43 -27.51 22.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.125 0.57 . . . . 0.0 111.791 172.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 m -112.93 166.72 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.023 1.729 . . . . 0.0 112.521 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -116.69 162.22 18.0 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.801 2.04 . . . . 0.0 111.283 173.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.2 t -55.99 126.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.401 1.081 . . . . 0.0 109.189 172.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.34 12.14 61.79 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.453 1.501 . . . . 0.0 115.389 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -96.4 133.69 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.764 1.782 . . . . 0.0 107.657 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -72.97 146.75 45.79 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.011 0.924 . . . . 0.0 111.413 167.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 m -130.86 167.12 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.343 1.857 . . . . 0.0 111.879 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.85 134.16 44.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.427 1.891 . . . . 0.0 110.055 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.55 121.78 3.71 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.045 1.338 . . . . 0.0 112.851 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 90.81 4.69 69.35 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.523 1.535 . . . . 0.0 115.412 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -90.25 148.97 22.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.532 1.533 . . . . 0.0 114.649 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 88' ' ' PRO . 14.8 mm -70.12 139.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.63 0.729 . . . . 0.0 111.469 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.4 pt -124.53 -23.06 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.507 1.123 . . . . 0.0 112.544 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.15 -179.01 2.99 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.026 1.33 . . . . 0.0 111.368 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -122.97 138.14 54.76 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 172.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.502 ' HB3' HD11 ' A' ' 89' ' ' ILE . 80.0 p -66.43 135.99 55.08 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.651 1.18 . . . . 0.0 112.104 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -126.52 168.56 18.63 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 122.389 0.994 . . . . 0.0 113.318 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -85.56 1.28 49.72 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.095 1.358 . . . . 0.0 112.802 174.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.0 p -57.37 130.1 44.74 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.714 1.605 . . . . 0.0 114.183 -173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.3 -20.89 1.16 Allowed Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.151 1.358 . . . . 0.0 116.35 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 mt -87.14 -70.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.889 1.845 . . . . 0.0 111.425 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -154.42 166.02 34.55 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.103 1.761 . . . . 0.0 108.758 -167.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.346 0.6 OUTLIER -67.22 -25.52 66.14 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 176.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.267 0.7 OUTLIER -132.32 -26.12 1.9 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 174.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -76.18 142.09 27.88 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.677 1.132 . . . . 0.0 114.437 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.65 152.13 38.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.983 1.313 . . . . 0.0 113.811 -166.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -160.21 133.96 7.09 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 125.477 1.511 . . . . 0.0 112.157 169.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.19 116.11 16.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.487 -1.383 . . . . 0.0 111.082 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -94.62 102.04 13.94 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.855 0.752 . . . . 0.0 111.774 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.275 43.9 t80 -93.9 116.81 29.3 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.381 1.473 . . . . 0.0 114.77 171.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -124.6 116.61 22.69 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.757 1.223 . . . . 0.0 111.654 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -101.1 127.08 47.81 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.517 1.127 . . . . 0.0 111.409 -176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.2 mtm -128.44 157.33 41.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.792 1.637 . . . . 0.0 111.65 -173.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -136.09 137.17 40.79 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.177 1.391 . . . . 0.0 111.243 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.78 -18.61 8.72 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.167 1.365 . . . . 0.0 115.031 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -176.83 -168.74 37.22 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.152 1.834 . . . . 0.0 111.273 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 t -128.59 112.76 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 156.49 169.36 20.45 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.895 1.712 . . . . 0.0 111.557 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -61.14 -40.64 94.59 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.361 -1.082 . . . . 0.0 113.245 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.47 -26.95 67.17 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 173.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -84.51 -11.86 55.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 115.614 1.709 . . . . 0.0 115.614 175.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.55 141.82 51.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.734 1.214 . . . . 0.0 112.651 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -106.03 -80.09 0.56 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -170.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -174.51 123.93 0.38 Allowed Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 128.37 2.668 . . . . 0.0 106.147 160.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.42 -29.49 11.09 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.054 2.503 . . . . 0.0 114.715 176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -59.63 -52.84 71.17 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -172.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.58 -30.69 70.93 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.926 2.417 . . . . 0.0 111.881 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.17 -45.75 93.32 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 166.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 39.7 mt -69.53 -32.12 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 O-C-N 120.767 -1.208 . . . . 0.0 111.719 174.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.08 0.42 1.95 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.061 1.744 . . . . 0.0 115.07 175.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -124.74 -8.52 7.32 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.938 1.695 . . . . 0.0 114.303 170.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.59 151.31 88.49 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 120.927 -1.108 . . . . 0.0 112.82 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.5 -35.2 39.87 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.743 2.962 . . . . 0.0 114.806 -165.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -112.13 16.4 20.16 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.923 1.289 . . . . 0.0 112.16 166.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 61.38 -134.72 48.04 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 121.076 -1.015 . . . . 0.0 112.441 -171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -61.34 -22.7 65.16 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.419 -1.048 . . . . 0.0 112.544 175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.6 mtt-85 -72.3 -3.36 23.31 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.632 -1.293 . . . . 0.0 112.564 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 75.5 m -84.54 -7.53 59.23 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.501 1.12 . . . . 0.0 113.054 163.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.94 -19.88 15.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.777 1.631 . . . . 0.0 111.671 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -147.41 160.21 42.82 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -104.9 86.24 2.43 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.472 0.655 0 C-N-CA 124.604 1.162 . . . . 0.0 109.666 173.5 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 54.7 m -97.37 -13.58 21.77 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -76.68 153.07 35.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.265 1.426 . . . . 0.0 111.353 171.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -65.63 119.98 12.12 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 118.137 0.426 . . . . 0.0 111.542 166.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -64.83 148.46 51.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.376 1.07 . . . . 0.0 112.73 -177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -78.17 143.69 37.01 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.163 1.385 . . . . 0.0 112.073 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -84.57 166.04 17.51 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 116.681 2.104 . . . . 0.0 116.681 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.288 56.0 m-85 -108.8 -21.73 12.54 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 117.777 2.51 . . . . 0.0 117.777 171.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -141.2 167.17 22.83 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.609 1.964 . . . . 0.0 110.912 173.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.42 147.01 48.09 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 123.844 0.735 . . . . 0.0 113.351 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.8 t -148.09 151.48 35.72 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -81.35 -11.13 59.4 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 127.209 2.204 . . . . 0.0 113.679 170.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.1 mt -79.69 116.65 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 120.336 1.425 . . . . 0.0 112.158 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.273 1.3 p -64.64 -52.71 55.96 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.315 1.046 . . . . 0.0 113.663 169.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -143.89 128.15 17.75 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.884 1.674 . . . . 0.0 110.939 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.1 p -83.27 -172.25 4.03 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.403 1.481 . . . . 0.0 108.451 171.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -70.26 122.92 20.45 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 175.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.07 -155.09 18.59 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 121.491 -0.755 . . . . 0.0 112.716 -172.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -136.98 148.8 47.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.398 1.099 . . . . 0.0 113.179 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.27 48.8 m-85 -67.88 -36.3 80.0 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 119.3 3.074 . . . . 0.0 119.3 -160.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.6 mp0 -133.84 156.59 47.79 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.288 1.435 . . . . 0.0 111.696 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -64.95 4.89 0.38 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.036 1.734 . . . . 0.0 115.664 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.0 p -56.81 166.52 1.32 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 128.301 2.64 . . . . 0.0 112.788 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.11 -15.18 35.69 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.648 2.232 . . . . 0.0 113.921 173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -73.59 159.0 33.75 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.993 1.317 . . . . 0.0 114.165 -167.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -84.71 37.3 0.64 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 125.947 1.699 . . . . 0.0 110.725 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.48 59.76 2.43 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 127.436 2.446 . . . . 0.0 114.477 -170.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -79.38 146.37 32.87 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 -167.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -97.54 125.32 42.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.875 1.67 . . . . 0.0 109.491 155.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -112.71 93.96 4.68 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 145.78 -172.47 26.45 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.198 0.904 . . . . 0.0 113.444 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.557 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -120.23 134.62 63.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 126.705 2.002 . . . . 0.0 108.862 173.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -110.53 92.29 3.99 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.664 2.098 . . . . 0.0 116.664 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -78.37 106.18 10.13 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.72 120.24 10.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.341 0.973 . . . . 0.0 110.744 171.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.8 mt -129.83 152.32 79.67 Favored Pre-proline 0 N--CA 1.467 0.399 0 C-N-CA 124.012 0.925 . . . . 0.0 111.106 -174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.58 135.52 57.36 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 N-CA-C 109.476 -1.009 . . . . 0.0 109.476 160.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.4 tttt -58.67 139.04 56.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.916 0.887 . . . . 0.0 110.846 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.32 -6.46 76.29 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.111 -1.383 . . . . 0.0 115.881 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 34.4 m -51.76 127.53 34.4 Favored Pre-proline 0 N--CA 1.479 1.019 0 CA-C-N 120.693 2.247 . . . . 0.0 112.964 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.559 ' HB2' HD12 ' A' ' 142' ' ' ILE . 11.7 Cg_endo -68.42 131.26 22.79 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.852 1.701 . . . . 0.0 112.084 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.2 132.2 32.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.152 1.781 . . . . 0.0 107.824 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -104.52 155.65 18.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.215 1.406 . . . . 0.0 109.492 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.04 129.59 82.65 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.263 171.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.13 -31.87 22.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.382 2.721 . . . . 0.0 113.472 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -140.21 159.97 41.0 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.957 2.103 . . . . 0.0 107.546 -171.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -77.01 138.48 39.62 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.93 -1.106 . . . . 0.0 111.764 171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.7 -157.05 10.05 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.075 1.322 . . . . 0.0 113.651 -173.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.91 146.86 25.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.428 1.491 . . . . 0.0 113.005 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.21 129.3 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -43.11 6.92 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -159.41 141.65 13.61 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.694 1.198 . . . . 0.0 110.983 -166.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 55.5 mt -142.6 113.83 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.785 1.234 . . . . 0.0 110.965 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -157.2 -173.36 4.4 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.493 1.117 . . . . 0.0 111.823 -168.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.85 132.71 47.79 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.091 -1.005 . . . . 0.0 111.054 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -76.95 130.25 37.26 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -70.4 -18.36 63.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.2 mt -87.47 -3.43 59.0 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.215 1.006 . . . . 0.0 112.806 168.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -150.03 -154.63 6.5 Favored Glycine 0 N--CA 1.438 -1.172 0 CA-C-O 122.801 1.223 . . . . 0.0 112.579 -147.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -108.44 -166.81 21.1 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.799 1.666 . . . . 0.0 113.7 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -66.29 148.01 52.48 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.416 -0.461 . . . . 0.0 111.909 170.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.13 137.94 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.777 1.631 . . . . 0.0 115.051 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.9 tp -117.87 126.68 52.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.042 2.137 . . . . 0.0 108.955 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.01 126.38 52.13 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.819 1.248 . . . . 0.0 110.256 171.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.4 mt -121.97 147.1 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.998 1.319 . . . . 0.0 111.45 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.04 137.3 47.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.696 1.998 . . . . 0.0 110.144 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -74.43 146.17 43.07 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.223 -0.923 . . . . 0.0 113.443 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -66.6 -20.67 66.06 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.61 -26.06 67.66 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 121.497 -0.752 . . . . 0.0 112.491 168.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 106.93 18.81 10.16 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 117.994 1.957 . . . . 0.0 117.994 157.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -143.8 -25.09 0.56 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.34 2.07 . . . . 0.0 115.873 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.297 42.1 m-85 -79.26 146.65 32.9 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.96 2.207 . . . . 0.0 116.96 172.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -123.22 161.21 24.98 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.465 1.906 . . . . 0.0 112.141 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -143.84 104.13 4.13 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.252 2.221 . . . . 0.0 110.955 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -84.81 145.8 27.68 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 167.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -130.72 93.33 3.4 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.604 2.362 . . . . 0.0 109.837 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -95.39 157.37 15.92 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.663 1.185 . . . . 0.0 110.839 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.266 94.1 m-70 69.76 49.79 0.51 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.072 2.149 . . . . 0.0 114.484 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.0 mt -93.84 143.82 25.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.873 0.869 . . . . 0.0 111.485 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.11 -43.32 15.15 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.402 173.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -154.48 151.11 28.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.016 2.526 . . . . 0.0 110.847 -169.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -96.96 159.33 14.97 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.744 0.818 . . . . 0.0 111.238 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -109.67 -28.58 8.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.448 1.099 . . . . 0.0 112.385 167.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -111.78 168.43 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.165 1.786 . . . . 0.0 110.667 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -128.12 172.1 11.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.212 1.405 . . . . 0.0 111.358 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.3 t -56.98 130.8 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.275 1.03 . . . . 0.0 109.224 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.15 3.46 72.83 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.783 1.182 . . . . 0.0 115.323 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -81.75 126.14 31.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.015 1.407 . . . . 0.0 111.877 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.24 124.89 28.19 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 122.803 0.441 . . . . 0.0 111.488 172.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.0 m -106.94 157.03 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 125.858 1.663 . . . . 0.0 110.46 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -127.36 140.54 52.11 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.656 1.582 . . . . 0.0 109.307 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -44.02 123.31 3.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.446 1.098 . . . . 0.0 112.992 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 83.96 6.95 86.21 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.246 1.403 . . . . 0.0 115.362 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -91.63 145.88 24.23 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.374 1.469 . . . . 0.0 112.858 170.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.559 HD12 ' HB2' ' A' ' 88' ' ' PRO . 20.2 mm -70.12 137.93 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.081 0.855 . . . . 0.0 112.114 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -123.58 -24.05 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.142 1.377 . . . . 0.0 112.577 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.19 -173.17 1.44 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.45 1.023 . . . . 0.0 111.629 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -135.55 137.05 41.64 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.161 1.385 . . . . 0.0 107.3 175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.8 t -75.56 142.62 42.72 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.71 163.9 28.52 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.268 0.937 . . . . 0.0 113.157 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -79.97 30.72 0.26 Allowed 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.092 -1.24 . . . . 0.0 112.526 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.284 6.7 p -66.07 127.39 31.91 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.818 1.247 . . . . 0.0 112.153 178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 80.17 6.04 89.38 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 117.658 -1.634 . . . . 0.0 116.822 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mt -123.13 135.96 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.285 2.043 . . . . 0.0 112.395 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -74.48 8.32 2.35 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.613 1.965 . . . . 0.0 114.762 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.0 p -129.55 151.95 49.61 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -171.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.314 0.9 OUTLIER -83.41 152.8 24.84 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.027 1.331 . . . . 0.0 113.721 171.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 84.7 167.09 42.45 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -152.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -148.82 168.15 23.75 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.189 1.396 . . . . 0.0 111.82 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -150.99 171.59 17.05 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.309 0.644 . . . . 0.0 111.714 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -115.81 121.56 42.77 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.245 1.418 . . . . 0.0 110.485 170.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -96.11 102.4 14.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.92 0.888 . . . . 0.0 110.524 172.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -93.76 112.86 24.8 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.371 1.468 . . . . 0.0 114.65 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -113.44 118.62 35.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.19 0.596 . . . . 0.0 112.155 174.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -93.84 127.56 39.65 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.639 1.576 . . . . 0.0 111.55 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.1 mtm -132.16 162.43 30.91 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.475 1.91 . . . . 0.0 111.593 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -132.5 128.91 38.38 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.39 1.076 . . . . 0.0 112.796 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.87 6.93 74.32 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 116.254 1.261 . . . . 0.0 116.254 171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.63 -179.6 44.04 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 126.439 1.971 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.72 128.9 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.282 1.433 . . . . 0.0 112.336 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.62 156.79 6.97 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.786 1.66 . . . . 0.0 112.056 -176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -48.2 -42.51 30.15 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.8 -14.23 62.41 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -92.28 -13.41 30.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.628 1.571 . . . . 0.0 114.537 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.54 148.18 34.26 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.314 1.045 . . . . 0.0 113.508 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -116.99 -96.78 0.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.714 1.606 . . . . 0.0 111.826 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -159.51 118.24 1.65 Allowed Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.603 1.961 . . . . 0.0 113.114 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.439 ' HG2' HD12 ' A' ' 79' ' ' ILE . 89.2 Cg_endo -85.35 -30.97 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.913 1.742 . . . . 0.0 114.296 175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.557 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -52.37 -55.71 29.25 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-N 121.169 1.804 . . . . 0.0 114.697 -172.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.01 -26.75 21.34 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.778 2.985 . . . . 0.0 112.225 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -67.26 -37.48 83.54 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.05 -44.95 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 123.093 0.557 . . . . 0.0 110.572 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -67.52 -0.89 4.2 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -173.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -111.92 -9.57 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.212 1.805 . . . . 0.0 113.52 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.28 159.15 42.03 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 125.243 1.417 . . . . 0.0 113.378 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.35 -48.06 24.02 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.73 3.62 . . . . 0.0 114.062 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -114.08 8.85 17.13 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.446 1.099 . . . . 0.0 113.356 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.51 -135.79 27.41 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.562 1.077 . . . . 0.0 111.961 -175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -52.18 -28.83 19.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.605 1.162 . . . . 0.0 113.6 171.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -70.72 -7.84 47.78 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.055 -1.028 . . . . 0.0 113.31 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.4 m -81.49 -3.86 54.27 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.802 0.841 . . . . 0.0 112.27 167.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.1 mp -111.11 -14.83 13.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.993 1.717 . . . . 0.0 113.322 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -145.03 161.88 38.31 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.234 -1.541 . . . . 0.0 113.76 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -110.14 82.75 1.64 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.015 0.912 . . . . 0.0 113.134 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 125.316 1.446 . . . . 0.0 111.061 174.22 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 CA-C-O 120.969 0.205 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.2 t -77.28 139.58 39.85 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.969 1.708 . . . . 0.0 114.682 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -80.67 -43.63 20.09 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.191 1.796 . . . . 0.0 112.764 172.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 t-105 -163.04 148.56 11.81 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.197 1.799 . . . . 0.0 110.724 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.64 -13.56 0.5 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 172.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -65.72 146.18 55.1 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 118.11 2.633 . . . . 0.0 118.11 -175.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -59.6 -36.31 76.03 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -140.89 164.79 29.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.918 2.087 . . . . 0.0 114.677 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -98.23 124.47 42.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.553 1.541 . . . . 0.0 112.187 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.57 -32.3 78.39 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 123.51 0.576 . . . . 0.0 113.084 168.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.4 p -152.44 156.57 39.74 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.048 1.739 . . . . 0.0 112.856 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 62.3 mtt85 -77.33 16.38 0.62 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.9 mt -77.62 122.74 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 121.072 -1.017 . . . . 0.0 111.371 -172.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 p -75.49 -45.73 36.57 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.466 0.914 . . . . 0.0 113.466 165.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -134.92 119.12 17.66 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.796 1.638 . . . . 0.0 110.503 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 p -81.48 176.63 9.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.549 1.14 . . . . 0.0 107.94 166.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -67.14 137.93 56.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.94 -173.47 30.45 Favored Glycine 0 N--CA 1.474 1.178 0 O-C-N 121.136 -0.978 . . . . 0.0 112.879 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -67.12 154.64 40.74 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.442 1.621 . . . . 0.0 111.526 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -67.01 138.16 57.02 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 163.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -152.1 154.75 36.51 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.713 0.805 . . . . 0.0 111.456 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 65.52 -38.79 0.27 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.511 2.325 . . . . 0.0 115.852 -177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.7 p -83.87 167.31 28.84 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.152 2.181 . . . . 0.0 111.951 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.94 1.99 5.28 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.66 2.907 . . . . 0.0 114.84 173.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.263 90.4 m-85 -68.95 145.9 53.23 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -124.47 147.94 48.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.48 1.912 . . . . 0.0 114.693 -171.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.85 -141.79 20.4 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.785 0.707 . . . . 0.0 111.55 -170.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -129.92 151.76 50.14 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.039 0.919 . . . . 0.0 112.064 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -89.79 125.66 35.39 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.261 1.824 . . . . 0.0 110.46 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.357 83.2 m-85 -108.12 23.43 14.5 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -170.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.28 -164.51 13.44 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.332 0.968 . . . . 0.0 113.266 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.48 133.71 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 126.609 1.963 . . . . 0.0 108.953 175.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -110.43 96.48 6.22 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -78.64 123.88 27.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.49 56.59 1.12 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.703 2.001 . . . . 0.0 113.847 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.6 149.0 63.55 Favored Pre-proline 0 CA--C 1.545 0.772 0 O-C-N 121.288 -0.883 . . . . 0.0 111.112 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.45 146.28 93.0 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.05 1.833 . . . . 0.0 111.777 166.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -54.58 135.48 46.26 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.738 1.215 . . . . 0.0 110.678 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.95 68.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.737 1.161 . . . . 0.0 115.63 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.5 m -52.71 126.14 39.78 Favored Pre-proline 0 N--CA 1.478 0.936 0 CA-C-N 118.75 1.275 . . . . 0.0 112.238 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.495 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.6 Cg_endo -69.49 129.28 17.59 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.09 1.86 . . . . 0.0 111.998 173.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.7 mm -85.86 130.59 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 108.468 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -103.35 149.94 24.27 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 109.764 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.54 83.61 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.879 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.4 -46.86 4.96 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.47 2.78 . . . . 0.0 111.574 177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -113.98 172.81 6.77 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 128.487 2.715 . . . . 0.0 109.703 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -68.98 149.97 48.22 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.245 -0.91 . . . . 0.0 110.017 155.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -177.47 -154.64 12.45 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 123.475 0.56 . . . . 0.0 114.159 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -151.24 145.84 25.65 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.574 1.549 . . . . 0.0 111.021 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -66.0 128.12 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -94.04 -41.34 9.61 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -159.37 145.67 16.44 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.001 1.72 . . . . 0.0 109.543 -167.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.0 mt -137.99 127.64 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.089 0.956 . . . . 0.0 109.365 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -155.22 164.09 39.29 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -129.52 147.26 51.31 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.84 0.856 . . . . 0.0 110.257 161.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -101.81 128.7 48.05 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.663 1.185 . . . . 0.0 111.311 -174.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -57.25 -19.14 19.68 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.689 1.996 . . . . 0.0 115.537 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 pp -129.35 19.56 5.8 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.404 1.882 . . . . 0.0 113.251 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.37 -132.58 3.45 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.445 1.498 . . . . 0.0 111.294 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -131.65 -164.75 11.21 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.964 1.269 . . . . 0.0 113.224 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -76.31 145.95 39.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.286 0.635 . . . . 0.0 112.064 166.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.14 143.16 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.861 1.665 . . . . 0.0 114.421 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.5 tt -122.76 136.6 54.92 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.803 1.641 . . . . 0.0 109.416 172.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.52 125.83 52.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.311 0.644 . . . . 0.0 111.935 175.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.02 147.92 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.883 1.273 . . . . 0.0 111.813 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -112.54 141.45 46.29 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.876 2.07 . . . . 0.0 111.726 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -80.82 179.2 7.93 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.769 1.228 . . . . 0.0 113.062 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -48.78 -46.22 41.17 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 118.682 2.845 . . . . 0.0 118.682 -171.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -83.42 -19.1 36.59 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.874 1.27 . . . . 0.0 113.671 171.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.35 27.2 71.97 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.798 1.19 . . . . 0.0 114.649 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -94.18 -36.62 11.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.635 1.717 . . . . 0.0 110.83 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -79.75 130.62 35.49 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 168.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -121.14 142.97 49.36 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.954 1.702 . . . . 0.0 111.31 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -123.93 103.68 8.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.762 2.025 . . . . 0.0 110.426 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -86.68 144.01 27.33 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.566 0.346 . . . . 0.0 111.62 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -128.7 97.67 4.75 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.427 1.891 . . . . 0.0 106.892 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.28 151.59 22.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 109.844 172.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 71.56 63.9 0.15 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.937 2.095 . . . . 0.0 113.95 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.4 mt -101.67 155.7 17.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.103 -1.862 . . . . 0.0 110.512 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.45 -43.3 6.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.738 1.215 . . . . 0.0 110.939 167.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -145.14 150.29 36.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.614 1.566 . . . . 0.0 112.38 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -92.54 158.31 16.07 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.57 1.148 . . . . 0.0 112.441 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -122.2 -10.63 8.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.05 0.94 . . . . 0.0 113.205 167.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.3 160.81 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.56 1.144 . . . . 0.0 112.341 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -120.26 155.33 33.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.29 1.836 . . . . 0.0 112.841 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.1 t -55.11 123.14 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 0.0 109.413 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.08 0.7 61.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.078 1.323 . . . . 0.0 115.528 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -88.28 128.95 35.49 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.966 1.883 . . . . 0.0 113.3 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -74.55 139.97 44.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.064 0.546 . . . . 0.0 111.998 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.0 m -128.31 159.86 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 127.472 2.309 . . . . 0.0 110.373 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -126.67 148.3 49.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.407 1.483 . . . . 0.0 108.658 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.42 121.74 4.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.363 1.065 . . . . 0.0 111.984 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.23 10.25 58.55 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.732 1.158 . . . . 0.0 114.971 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.33 134.75 34.09 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.966 1.306 . . . . 0.0 112.676 167.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 88' ' ' PRO . 15.4 mm -65.57 131.41 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 118.888 0.767 . . . . 0.0 110.372 172.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.4 pt -114.98 -21.96 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.479 1.112 . . . . 0.0 113.231 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -173.44 -179.82 1.96 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.428 1.491 . . . . 0.0 110.904 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -129.63 135.0 48.0 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.0 t -80.27 144.54 32.77 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.71 155.76 26.97 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.312 1.434 . . . . 0.0 112.361 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.251 34.1 p30 -81.7 47.95 1.14 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 -172.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 35.5 p -65.38 117.58 8.13 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 164.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.77 25.85 68.64 Favored Glycine 0 CA--C 1.54 1.616 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 -175.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.14 165.91 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 119.627 1.714 . . . . 0.0 113.44 172.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -51.7 141.59 16.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.972 1.709 . . . . 0.0 113.727 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.287 1.0 OUTLIER -66.2 5.5 0.53 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 171.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 27.6 p -75.39 -17.39 60.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.014 1.726 . . . . 0.0 114.778 173.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 157.1 -170.28 34.33 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.334 1.445 . . . . 0.0 111.919 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -133.25 169.15 17.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.682 1.193 . . . . 0.0 112.918 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -151.13 141.04 21.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.803 0.841 . . . . 0.0 112.656 169.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.85 115.49 19.47 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.159 170.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -93.75 101.29 13.41 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.29 0.636 . . . . 0.0 110.943 172.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -90.66 117.21 29.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.948 1.299 . . . . 0.0 114.128 171.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -122.6 114.44 20.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.348 1.059 . . . . 0.0 111.888 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -92.51 121.94 34.46 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.208 1.803 . . . . 0.0 110.828 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.1 mtm -127.38 160.86 30.13 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.238 1.815 . . . . 0.0 111.189 -175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -140.26 133.96 30.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.11 6.96 81.21 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.722 1.153 . . . . 0.0 115.125 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 164.29 179.46 38.48 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 127.57 2.51 . . . . 0.0 110.086 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -123.1 125.07 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -174.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.76 168.86 15.45 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.607 1.575 . . . . 0.0 112.875 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -60.3 -36.9 78.95 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.184 -1.186 . . . . 0.0 113.523 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -70.08 -17.36 63.22 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.795 -1.191 . . . . 0.0 114.05 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.23 -12.55 43.43 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 173.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.47 137.11 52.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.567 1.147 . . . . 0.0 112.986 -175.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -103.13 -89.86 0.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.724 1.21 . . . . 0.0 112.302 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -161.91 115.9 1.23 Allowed Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.575 2.35 . . . . 0.0 113.585 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 -31.76 2.08 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.103 1.869 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -54.37 -53.39 59.93 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.78 -22.56 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.886 3.058 . . . . 0.0 112.052 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -65.52 -42.67 91.78 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 167.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 49.0 mt -72.21 -25.62 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.297 -0.877 . . . . 0.0 112.206 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -59.76 -14.2 13.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -118.13 -1.14 11.44 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.431 1.092 . . . . 0.0 113.641 -178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 50.8 mt -71.89 148.65 92.23 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.517 0.727 . . . . 0.0 112.632 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.58 -26.45 23.71 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.609 2.873 . . . . 0.0 114.932 -168.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -112.82 -7.86 13.76 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 165.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 92.83 -137.81 13.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.413 1.482 . . . . 0.0 112.535 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -55.09 -30.78 60.39 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.727 1.263 . . . . 0.0 111.694 170.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 43.0 mtp-105 -63.97 -12.25 36.04 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.476 1.51 . . . . 0.0 113.899 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 71.6 m -79.77 -7.85 58.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.472 1.033 . . . . 0.0 112.565 172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.06 -14.0 15.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.106 1.363 . . . . 0.0 112.948 175.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -149.98 162.3 40.64 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -111.72 80.57 1.34 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--O 1.24 0.555 0 C-N-CA 124.888 1.275 . . . . 0.0 110.123 173.59 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -62.39 160.83 12.66 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.021 1.328 . . . . 0.0 114.491 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -57.81 139.22 54.56 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.505 0.722 . . . . 0.0 111.367 168.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -76.31 139.77 41.21 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.191 0.519 . . . . 0.0 111.381 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -135.9 129.71 32.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.099 1.36 . . . . 0.0 110.873 167.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -70.95 176.01 4.68 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.325 1.05 . . . . 0.0 113.056 167.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -149.2 162.41 40.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.733 -1.229 . . . . 0.0 111.393 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.275 21.2 t80 -66.46 141.34 57.94 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 118.038 2.607 . . . . 0.0 118.038 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -137.55 146.53 44.21 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.208 1.803 . . . . 0.0 110.493 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.66 -12.58 79.86 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.702 1.144 . . . . 0.0 114.179 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.6 p -63.74 161.71 14.67 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.923 1.689 . . . . 0.0 114.062 172.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.2 mtp85 -103.62 -18.58 14.68 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.462 HG21 HG23 ' A' ' 63' ' ' THR . 59.5 mt -67.05 104.24 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 121.144 1.793 . . . . 0.0 110.999 176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.26 1.2 t -79.88 -24.23 41.32 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 178.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -153.84 130.62 10.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.797 1.239 . . . . 0.0 109.748 164.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.462 HG23 HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -88.02 174.54 8.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -174.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -67.13 134.54 51.99 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.129 -0.982 . . . . 0.0 110.918 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.65 -137.05 9.57 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.273 0.94 . . . . 0.0 113.052 176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -76.7 155.11 33.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.265 0.626 . . . . 0.0 111.888 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.1 157.9 45.4 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 -173.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -59.32 154.24 17.04 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -42.29 132.07 3.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.743 2.017 . . . . 0.0 112.901 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 p -171.53 163.68 4.8 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.316 1.846 . . . . 0.0 110.348 -165.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -68.91 -25.65 32.43 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.431 2.087 . . . . 0.0 113.489 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -75.59 151.73 37.8 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.83 1.252 . . . . 0.0 109.903 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -97.55 167.97 10.65 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.959 1.703 . . . . 0.0 115.312 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.3 -125.96 7.2 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.09 1.196 . . . . 0.0 116.09 162.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.458 ' HE2' ' CZ ' ' A' ' 77' ' ' TYR . 1.7 ptmt -126.88 165.91 18.47 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 126.332 1.853 . . . . 0.0 112.107 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -118.41 93.61 4.18 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.211 1.404 . . . . 0.0 110.89 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CZ ' ' HE2' ' A' ' 75' ' ' LYS 0.526 12.1 m-30 -90.74 39.44 0.98 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -173.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.91 -179.55 26.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.82 1.2 . . . . 0.0 112.897 170.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.58 127.48 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 125.687 1.595 . . . . 0.0 109.501 176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -99.26 90.0 4.41 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -74.1 107.24 6.18 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.97 123.95 20.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.056 0.844 . . . . 0.0 110.294 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 mt -138.35 151.98 70.47 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.61 0.764 . . . . 0.0 111.228 -173.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.2 136.5 44.26 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.36 2.04 . . . . 0.0 110.033 162.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -56.02 134.61 52.58 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.207 1.003 . . . . 0.0 109.949 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.32 -8.35 79.32 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.237 -1.313 . . . . 0.0 115.824 -175.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.6 m -53.77 123.81 40.23 Favored Pre-proline 0 N--CA 1.481 1.114 0 CA-C-N 120.219 2.009 . . . . 0.0 112.331 169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.556 ' HB2' HD12 ' A' ' 142' ' ' ILE . 32.2 Cg_endo -70.03 130.85 19.71 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.726 1.617 . . . . 0.0 111.161 175.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.6 mm -85.74 131.2 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.463 1.505 . . . . 0.0 108.216 172.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -101.32 149.8 23.65 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.31 1.044 . . . . 0.0 109.84 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.19 130.85 87.45 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.76 -0.588 . . . . 0.0 110.835 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.62 -27.42 15.33 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.923 3.082 . . . . 0.0 112.724 176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 p -129.94 161.67 30.36 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.039 2.535 . . . . 0.0 112.905 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -63.92 138.83 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 157.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.52 -155.95 11.37 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 114.985 0.754 . . . . 0.0 114.985 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -151.99 148.78 28.14 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.187 1.395 . . . . 0.0 111.584 171.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 t -65.66 129.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.12 -41.92 7.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.003 1.721 . . . . 0.0 115.244 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -157.9 143.25 16.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.467 1.107 . . . . 0.0 111.464 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.4 mt -136.42 125.73 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.381 1.072 . . . . 0.0 110.738 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -158.82 176.99 11.65 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -127.61 157.48 40.11 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.899 1.28 . . . . 0.0 112.588 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -144.68 144.14 31.08 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.779 1.232 . . . . 0.0 113.681 -165.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -58.44 -30.08 66.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.393 1.477 . . . . 0.0 114.344 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 mt -112.63 -31.39 6.78 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.765 1.226 . . . . 0.0 112.857 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -86.83 -8.29 76.55 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.751 1.167 . . . . 0.0 115.034 -169.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.12 -150.58 47.61 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 117.696 0.748 . . . . 0.0 112.2 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -71.39 143.73 50.06 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.887 -0.772 . . . . 0.0 111.649 165.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.6 t -131.42 138.39 53.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.689 1.595 . . . . 0.0 114.743 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.0 tp -119.46 127.09 52.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.959 2.104 . . . . 0.0 108.605 171.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.82 126.76 52.22 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.365 1.066 . . . . 0.0 110.464 171.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 53.8 mt -123.12 147.78 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.952 1.301 . . . . 0.0 111.927 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.22 141.96 42.45 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.201 2.2 . . . . 0.0 111.737 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.06 160.89 27.95 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -50.44 -38.47 43.57 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 166.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -86.09 -8.34 57.96 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.469 1.508 . . . . 0.0 114.412 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.66 66.98 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 117.604 1.802 . . . . 0.0 117.604 166.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -90.91 -43.9 9.71 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.758 2.279 . . . . 0.0 110.85 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.253 42.4 m-85 -82.95 145.22 29.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 116.77 2.137 . . . . 0.0 116.77 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -125.81 152.51 45.35 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.541 1.936 . . . . 0.0 111.431 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -133.74 104.03 6.14 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.846 2.059 . . . . 0.0 109.986 -172.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -87.95 139.99 29.95 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.527 0.331 . . . . 0.0 111.63 170.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -125.57 92.93 3.71 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.621 2.368 . . . . 0.0 108.759 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -91.23 163.29 14.3 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.889 1.276 . . . . 0.0 110.914 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 64.71 38.08 7.15 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.489 1.916 . . . . 0.0 114.966 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 mt -80.54 154.25 27.62 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.496 -1.378 . . . . 0.0 112.848 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.53 -49.43 6.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.73 1.612 . . . . 0.0 109.272 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -152.18 149.33 28.63 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.641 1.976 . . . . 0.0 111.387 -170.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -94.47 141.35 28.69 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.503 1.121 . . . . 0.0 111.913 178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -95.43 -15.51 22.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.058 0.943 . . . . 0.0 111.878 167.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.94 165.91 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 126.27 1.828 . . . . 0.0 113.154 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -120.79 164.34 16.76 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.744 2.018 . . . . 0.0 111.2 172.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.07 129.72 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.32 4.58 68.28 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.531 1.062 . . . . 0.0 115.713 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -79.62 130.27 35.22 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 119.623 1.712 . . . . 0.0 112.912 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -65.0 143.87 57.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.407 0.622 . . . . 0.0 110.795 163.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.3 161.62 21.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 125.514 1.526 . . . . 0.0 110.535 167.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -133.86 143.29 48.22 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.576 1.55 . . . . 0.0 109.88 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.14 117.61 2.91 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.966 0.889 . . . . 0.0 111.904 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.98 -1.83 74.88 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.547 1.546 . . . . 0.0 115.205 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -85.36 145.14 27.63 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.519 1.66 . . . . 0.0 114.487 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 88' ' ' PRO . 15.9 mm -70.82 136.46 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.854 0.835 . . . . 0.0 111.969 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 49.1 pt -122.79 -23.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.69 1.196 . . . . 0.0 112.903 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.32 -176.57 1.91 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.527 1.531 . . . . 0.0 110.853 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -129.44 136.63 50.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 18.8 t -66.08 137.07 56.81 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.599 0.76 . . . . 0.0 111.914 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -125.53 -169.88 12.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.575 1.56 . . . . 0.0 111.885 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.259 41.2 p30 -111.03 16.94 20.9 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 168.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.8 p -57.85 131.56 50.74 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.224 1.009 . . . . 0.0 111.958 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.6 -16.65 3.0 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.26 1.409 . . . . 0.0 115.835 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 4.6 mt -78.61 146.85 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.769 1.785 . . . . 0.0 110.652 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -111.09 -46.64 3.29 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.637 1.175 . . . . 0.0 111.749 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.8 157.57 30.02 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.303 0.7 OUTLIER -63.17 142.83 58.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -172.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 83.81 149.26 9.31 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.885 1.707 . . . . 0.0 114.731 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -85.22 156.58 20.92 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.973 1.309 . . . . 0.0 112.814 177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -149.56 165.6 31.76 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.814 0.846 . . . . 0.0 112.834 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.46 123.13 47.38 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.588 1.555 . . . . 0.0 109.812 165.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -98.38 103.62 15.58 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.472 0.709 . . . . 0.0 110.867 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.272 36.0 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 172.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -116.26 115.28 25.68 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.436 1.094 . . . . 0.0 111.851 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.0 ttt-85 -95.31 125.25 39.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.804 1.642 . . . . 0.0 111.149 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.9 mtm -131.0 153.0 49.69 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.494 1.518 . . . . 0.0 111.372 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.24 130.51 52.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.227 1.411 . . . . 0.0 111.898 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.99 36.15 Favored Glycine 0 CA--C 1.544 1.848 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 172.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.39 -179.73 48.0 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 126.549 2.023 . . . . 0.0 111.9 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.2 t -119.75 125.9 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.579 1.552 . . . . 0.0 112.891 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.98 164.85 10.08 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.266 1.888 . . . . 0.0 112.325 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -56.79 -36.95 70.47 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.038 -1.272 . . . . 0.0 113.155 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.45 -12.37 56.87 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 175.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -97.59 -8.82 28.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 173.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.29 142.12 55.65 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.212 1.405 . . . . 0.0 113.087 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -116.13 -79.7 0.59 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.354 1.062 . . . . 0.0 112.335 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -170.07 123.57 0.64 Allowed Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.843 2.057 . . . . 0.0 113.054 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.25 -35.4 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.535 2.156 . . . . 0.0 114.102 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -54.41 -54.69 45.53 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.11 -18.9 39.83 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.879 3.053 . . . . 0.0 113.14 -175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.06 -44.18 66.27 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 164.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 59.5 mt -67.76 -31.25 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.707 0.803 . . . . 0.0 111.634 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -64.82 -3.77 3.69 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -123.53 -1.99 8.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.685 1.594 . . . . 0.0 114.374 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.7 mt -69.25 151.22 97.07 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.292 1.037 . . . . 0.0 112.292 174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.08 -36.17 71.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.174 2.583 . . . . 0.0 115.063 -165.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -111.51 9.59 21.28 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.896 0.878 . . . . 0.0 113.366 169.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 71.51 -134.06 22.16 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.026 -1.046 . . . . 0.0 112.241 -171.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.69 -26.0 65.23 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.341 -1.094 . . . . 0.0 112.94 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -70.91 -3.9 21.66 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.407 1.483 . . . . 0.0 114.171 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 68.9 m -82.13 -6.08 58.92 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.14 0.976 . . . . 0.0 113.122 165.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.85 -13.25 14.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.307 1.443 . . . . 0.0 113.114 177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -145.92 163.1 36.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 120.448 1.476 . . . . 0.0 113.896 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -111.35 89.67 3.12 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 124.531 1.132 . . . . 0.0 110.682 170.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.11 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.2 p -136.15 -27.91 1.07 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -88.98 -174.61 4.54 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.199 1.799 . . . . 0.0 111.679 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -64.09 132.11 49.54 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.404 0.681 . . . . 0.0 110.989 171.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -139.85 160.99 38.65 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.21 1.404 . . . . 0.0 112.533 -169.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -64.89 161.87 17.49 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 173.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -142.49 167.62 21.67 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -65.03 152.2 44.05 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.67 157.77 40.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.443 1.497 . . . . 0.0 112.683 173.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.17 -121.0 5.75 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.848 0.737 . . . . 0.0 113.552 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t -60.82 139.35 57.97 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.606 1.162 . . . . 0.0 112.763 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -69.58 -15.95 63.32 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.405 HG21 ' CG2' ' A' ' 63' ' ' THR . 76.3 mt -64.04 132.04 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 119.909 1.232 . . . . 0.0 110.438 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.37 0.1 OUTLIER -94.9 -35.14 12.14 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 164.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -146.47 150.4 35.53 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.567 1.547 . . . . 0.0 112.417 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.405 ' CG2' HG21 ' A' ' 60' ' ' ILE . 22.4 p -140.25 -179.38 5.96 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.911 1.684 . . . . 0.0 109.709 -166.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -74.15 133.2 42.77 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 120.307 -1.496 . . . . 0.0 110.06 -164.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.36 179.49 16.09 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.12 1.343 . . . . 0.0 114.874 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -53.64 143.88 19.11 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -66.73 -179.53 0.89 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 168.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -57.4 159.18 4.97 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.252 1.021 . . . . 0.0 112.126 171.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -83.05 36.29 0.5 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -154.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -57.77 156.11 19.58 Favored Pre-proline 0 N--CA 1.472 0.668 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -60.16 -25.28 79.53 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.138 2.559 . . . . 0.0 112.323 169.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.26 3.0 p90 -76.64 122.18 24.29 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 159.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -75.71 149.91 37.97 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 171.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.28 144.78 7.96 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.295 1.426 . . . . 0.0 113.382 173.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -122.29 137.4 54.86 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.776 1.23 . . . . 0.0 111.82 177.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -94.25 125.53 38.95 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.477 1.111 . . . . 0.0 110.027 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.285 97.1 m-85 -107.14 15.33 25.28 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -170.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.96 -164.77 12.26 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.12 -0.987 . . . . 0.0 115.027 -173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.21 137.09 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 127.477 2.311 . . . . 0.0 109.384 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.9 97.17 5.49 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -77.67 108.49 10.91 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.03 117.95 5.71 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.313 1.045 . . . . 0.0 111.051 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.1 mt -133.93 148.76 69.53 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.147 0.979 . . . . 0.0 111.089 -175.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.36 139.46 65.44 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.234 1.956 . . . . 0.0 110.635 163.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -51.92 136.73 28.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.565 1.146 . . . . 0.0 110.184 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.86 -4.73 78.67 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.537 -1.702 . . . . 0.0 116.19 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.1 m -53.1 123.5 34.15 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-N 120.431 2.116 . . . . 0.0 112.343 168.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.54 ' HB2' HD12 ' A' ' 142' ' ' ILE . 10.7 Cg_endo -68.46 127.95 16.47 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.654 1.569 . . . . 0.0 110.907 174.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.4 mm -84.38 129.01 38.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.876 1.27 . . . . 0.0 107.797 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -99.03 152.41 19.85 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.656 1.183 . . . . 0.0 109.983 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.01 124.72 90.25 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-O 118.39 -0.815 . . . . 0.0 110.085 168.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.26 -36.42 21.17 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.582 2.855 . . . . 0.0 112.835 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -124.09 170.28 10.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.573 2.349 . . . . 0.0 108.989 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.97 147.73 49.8 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.058 -1.026 . . . . 0.0 108.988 155.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.15 -159.4 19.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.916 0.77 . . . . 0.0 113.607 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -148.35 144.46 27.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.874 1.27 . . . . 0.0 112.397 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.21 125.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.91 -44.87 8.24 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.942 1.697 . . . . 0.0 115.101 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -157.06 147.48 21.24 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.012 1.325 . . . . 0.0 111.105 -168.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.411 HG23 ' CE1' ' A' ' 129' ' ' TYR . 47.0 mt -140.79 118.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.716 1.206 . . . . 0.0 109.513 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -160.2 -168.47 2.2 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.26 146.33 42.41 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.232 1.413 . . . . 0.0 113.428 173.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -101.33 145.03 29.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.267 1.827 . . . . 0.0 111.729 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -66.2 -18.32 65.28 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -161.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 pp -138.85 -14.45 1.2 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.042 1.337 . . . . 0.0 113.495 167.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.16 -18.57 79.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.375 0.988 . . . . 0.0 115.172 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.5 -159.22 29.37 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 119.462 1.631 . . . . 0.0 113.739 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -70.61 148.38 48.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.489 HG13 HD22 ' A' ' 124' ' ' LEU . 8.8 t -131.92 137.18 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 126.188 1.795 . . . . 0.0 114.61 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.66 137.52 51.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.75 1.62 . . . . 0.0 109.618 165.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.53 125.28 51.67 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.676 0.79 . . . . 0.0 112.266 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.7 mt -122.69 153.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.295 1.438 . . . . 0.0 111.906 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.63 55.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.857 2.063 . . . . 0.0 111.636 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -86.59 161.34 18.57 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.587 1.155 . . . . 0.0 113.016 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.405 34.8 p-10 -69.64 -8.48 47.96 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 119.854 3.279 . . . . 0.0 119.854 -165.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -77.86 -12.61 59.99 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.791 1.632 . . . . 0.0 112.936 163.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.97 18.99 71.33 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.283 1.421 . . . . 0.0 114.954 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -113.73 -25.83 8.49 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.108 1.454 . . . . 0.0 112.581 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.273 55.5 m-85 -102.07 128.37 48.56 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 171.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -104.23 157.08 17.38 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.465 1.906 . . . . 0.0 111.139 170.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -138.36 105.13 5.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.098 2.159 . . . . 0.0 110.501 -174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -85.81 147.74 26.16 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 169.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -135.19 109.78 8.55 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.947 1.699 . . . . 0.0 107.875 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.489 HD22 HG13 ' A' ' 109' ' ' VAL . 1.9 mm? -103.8 157.02 17.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.809 1.643 . . . . 0.0 110.562 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 67.1 59.11 0.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.113 1.765 . . . . 0.0 113.253 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 mt -104.82 151.23 24.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.691 1.597 . . . . 0.0 111.058 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.75 -42.67 6.4 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.419 1.487 . . . . 0.0 111.298 173.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -146.58 147.08 30.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.652 1.581 . . . . 0.0 112.265 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.411 ' CE1' HG23 ' A' ' 100' ' ' ILE . 90.1 m-85 -94.04 141.69 28.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.168 0.987 . . . . 0.0 112.647 176.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -106.89 -5.77 18.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.808 1.243 . . . . 0.0 113.463 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.29 166.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.341 1.456 . . . . 0.0 110.225 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -122.19 165.17 16.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.05 1.34 . . . . 0.0 110.265 175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.69 131.86 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.978 0.911 . . . . 0.0 108.771 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.87 8.14 73.34 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.929 1.252 . . . . 0.0 115.278 178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -84.19 119.22 24.75 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 119.01 1.405 . . . . 0.0 112.862 175.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -65.83 142.02 58.08 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.231 163.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.99 159.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.307 1.843 . . . . 0.0 109.195 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.66 142.7 50.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 126.449 1.9 . . . . 0.0 108.848 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.58 123.01 4.56 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.948 0.899 . . . . 0.0 113.326 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.39 3.73 64.74 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.582 1.087 . . . . 0.0 114.804 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.88 133.61 38.09 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.666 1.186 . . . . 0.0 112.487 169.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 88' ' ' PRO . 13.7 mm -67.73 129.31 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 118.721 0.691 . . . . 0.0 109.992 172.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.1 pt -112.87 -22.09 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.201 1.001 . . . . 0.0 113.266 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.93 -179.18 2.35 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.429 1.491 . . . . 0.0 110.322 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -130.18 132.17 45.91 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.0 t -77.24 146.53 36.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.08 159.69 28.66 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 124.98 1.276 . . . . 0.0 111.448 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -77.73 37.89 0.24 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 118.905 1.352 . . . . 0.0 113.635 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.253 6.7 p -64.67 125.16 23.86 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.742 -1.224 . . . . 0.0 111.006 164.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.72 10.93 84.83 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 116.033 1.173 . . . . 0.0 116.033 -170.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.73 165.52 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 119.78 1.79 . . . . 0.0 113.582 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -81.35 162.26 23.48 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.186 1.395 . . . . 0.0 114.283 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.254 0.3 OUTLIER -62.59 -1.59 0.86 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 173.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -64.45 -30.18 71.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.462 1.505 . . . . 0.0 110.018 167.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 160.93 155.19 7.71 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 119.488 1.04 . . . . 0.0 115.268 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -87.73 152.79 21.86 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.903 1.681 . . . . 0.0 111.852 169.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -151.99 128.44 10.67 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 168.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.15 114.07 7.08 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.173 0.989 . . . . 0.0 110.744 177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -91.9 99.04 11.97 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.597 0.759 . . . . 0.0 111.343 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 43.3 t80 -90.97 120.07 31.67 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.153 1.381 . . . . 0.0 114.679 172.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -130.0 108.36 10.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.987 1.315 . . . . 0.0 111.01 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -96.45 135.78 37.85 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.144 1.378 . . . . 0.0 111.386 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 41.0 mtm -136.11 143.22 44.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.332 1.453 . . . . 0.0 112.065 -166.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -111.62 132.62 54.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.948 1.299 . . . . 0.0 112.988 -173.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.66 1.0 64.95 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.575 1.56 . . . . 0.0 115.17 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 161.64 -169.99 37.25 Favored Glycine 0 CA--C 1.533 1.156 0 C-N-CA 127.856 2.646 . . . . 0.0 109.438 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.87 138.26 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 122.269 1.033 . . . . 0.0 111.006 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.59 161.69 10.67 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 128.757 3.075 . . . . 0.0 109.595 -171.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -57.51 -42.29 82.51 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.704 -1.468 . . . . 0.0 113.44 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.16 -20.63 66.2 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -78.33 -16.0 58.16 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.8 147.46 45.47 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.36 1.064 . . . . 0.0 112.353 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.36 -61.35 1.74 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.409 1.084 . . . . 0.0 113.825 -176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 64.4 t0 178.42 123.07 0.2 Allowed Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 130.557 3.543 . . . . 0.0 108.309 160.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.6 -21.63 21.91 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.78 2.986 . . . . 0.0 116.099 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -51.9 -56.22 23.47 Favored Pre-proline 0 N--CA 1.483 1.176 0 CA-C-N 120.658 1.572 . . . . 0.0 114.699 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.87 -24.89 60.58 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.618 2.879 . . . . 0.0 112.937 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.275 3.5 t80 -64.26 -45.11 89.53 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 169.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 35.5 mt -66.63 -28.47 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 120.854 -1.154 . . . . 0.0 111.357 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.22 -4.4 10.39 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -118.09 -10.15 10.39 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 172.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 30.1 mt -66.31 149.66 97.71 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.371 1.068 . . . . 0.0 112.423 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.75 -41.68 10.36 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.789 2.326 . . . . 0.0 113.597 -166.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -104.67 9.91 34.99 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 171.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.11 -133.98 45.93 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 120.866 -1.146 . . . . 0.0 112.441 -172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -54.21 -30.87 51.53 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.907 -0.76 . . . . 0.0 112.772 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -71.43 -5.47 33.04 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.09 1.356 . . . . 0.0 112.456 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.7 m -83.67 -6.91 59.56 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.968 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.9 -14.81 15.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.992 1.317 . . . . 0.0 113.0 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -146.41 159.12 43.8 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.535 1.516 . . . . 0.0 115.018 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -104.13 96.42 6.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 175.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 122.363 1.078 . . . . 0.0 112.777 -179.444 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.139 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.4 t -161.38 151.09 16.82 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.501 1.52 . . . . 0.0 113.199 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -53.5 -38.2 63.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.619 1.168 . . . . 0.0 113.368 171.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -153.33 123.59 7.05 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.698 1.199 . . . . 0.0 110.34 165.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.1 mp0 -71.75 -31.76 67.01 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.998 155.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -152.87 125.88 8.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.392 1.477 . . . . 0.0 114.763 169.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.267 1.9 p90 -67.1 156.36 36.32 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.321 39.3 t80 -133.33 140.82 47.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 177.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.47 148.44 34.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.485 1.514 . . . . 0.0 112.087 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.85 2.86 22.18 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.267 1.889 . . . . 0.0 114.692 -172.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.3 t -164.52 154.03 13.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.609 1.564 . . . . 0.0 111.544 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -87.37 14.28 8.29 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.6 mt -71.12 138.62 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 120.062 1.301 . . . . 0.0 113.112 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.8 t -107.0 -28.19 10.19 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.181 1.792 . . . . 0.0 114.781 166.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -146.73 123.92 11.51 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.64 1.576 . . . . 0.0 111.178 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -82.3 177.63 8.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.703 1.201 . . . . 0.0 113.889 166.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -68.26 121.32 15.98 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 174.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.14 -139.18 5.62 Favored Glycine 0 N--CA 1.469 0.853 0 O-C-N 121.185 -0.947 . . . . 0.0 112.714 -170.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.06 157.87 40.52 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 117.857 0.829 . . . . 0.0 113.216 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.257 41.7 m-85 -69.15 -42.28 76.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -148.71 161.09 42.46 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -63.14 -11.66 21.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 127.015 2.126 . . . . 0.0 115.377 170.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.1 m -68.91 155.99 92.28 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.138 1.775 . . . . 0.0 114.538 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.13 -27.21 49.41 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.928 2.419 . . . . 0.0 113.652 -178.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -66.94 138.82 57.56 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.461 1.504 . . . . 0.0 108.142 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -72.45 130.22 40.17 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.783 1.233 . . . . 0.0 111.96 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.16 80.49 0.08 OUTLIER Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.456 1.503 . . . . 0.0 113.037 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.73 163.57 16.44 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.653 1.581 . . . . 0.0 114.15 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -128.76 128.84 44.79 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.572 2.349 . . . . 0.0 109.36 175.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.358 93.7 m-85 -106.08 18.96 21.28 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -169.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.72 -172.25 19.03 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.032 -1.042 . . . . 0.0 113.788 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.63 132.92 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.44 1.896 . . . . 0.0 109.039 172.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -111.01 102.01 10.52 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -85.23 115.82 23.22 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.12 76.1 4.65 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.862 1.665 . . . . 0.0 112.267 -174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.49 152.8 41.23 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.767 -170.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.37 142.72 91.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.523 2.149 . . . . 0.0 111.001 158.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 tttp -59.98 136.3 57.97 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.935 1.294 . . . . 0.0 110.28 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.68 1.78 90.3 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 116.244 1.258 . . . . 0.0 116.244 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.6 m -57.14 124.67 67.26 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.597 1.698 . . . . 0.0 111.654 166.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HB2' HD12 ' A' ' 142' ' ' ILE . 89.0 Cg_endo -71.28 125.31 11.22 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.037 1.158 . . . . 0.0 110.031 176.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 146' ' ' SER . 30.8 mm -80.76 129.38 37.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.356 1.462 . . . . 0.0 107.577 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -101.35 152.8 20.28 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.689 1.196 . . . . 0.0 109.954 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.62 131.54 87.89 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.766 170.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.75 -34.56 18.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.328 2.685 . . . . 0.0 112.833 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.0 p -129.59 163.4 26.09 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 126.547 1.939 . . . . 0.0 108.587 -173.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.93 141.84 58.09 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 121.256 -0.903 . . . . 0.0 108.988 158.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.12 -159.98 21.51 Favored Glycine 0 N--CA 1.477 1.395 0 C-N-CA 124.068 0.842 . . . . 0.0 113.418 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -151.05 140.91 21.91 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.228 1.514 . . . . 0.0 111.267 176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 t -55.1 137.87 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.108 0.963 . . . . 0.0 113.419 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.97 -44.14 5.58 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 174.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -159.27 148.49 18.41 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.681 1.593 . . . . 0.0 109.776 -167.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.402 HG23 ' CE2' ' A' ' 129' ' ' TYR . 59.2 mt -139.8 128.0 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.447 1.099 . . . . 0.0 108.391 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -160.23 173.33 15.89 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -177.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -127.98 158.39 38.0 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.066 -1.021 . . . . 0.0 111.506 168.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -132.24 128.61 38.25 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.356 1.862 . . . . 0.0 108.732 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -68.46 -20.03 64.59 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.461 -1.4 . . . . 0.0 113.567 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.45 -19.57 23.74 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.449 1.5 . . . . 0.0 113.412 169.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.29 -16.76 5.98 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.688 1.137 . . . . 0.0 115.808 -162.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.23 44.85 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 118.418 1.109 . . . . 0.0 113.236 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -73.89 147.9 42.79 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.897 -0.767 . . . . 0.0 112.344 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 t -134.82 137.79 50.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 126.268 1.827 . . . . 0.0 114.616 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.1 tp -117.39 133.04 56.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.138 1.775 . . . . 0.0 108.819 168.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.27 125.65 53.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.778 1.231 . . . . 0.0 110.279 172.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.0 mt -119.78 141.57 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.552 1.141 . . . . 0.0 110.809 174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -98.52 137.82 36.62 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.021 1.329 . . . . 0.0 109.593 168.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -68.95 164.54 22.01 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 122.183 -0.323 . . . . 0.0 111.055 166.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -61.21 -31.89 71.66 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -75.76 -13.31 60.3 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 170.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 73.99 7.65 76.59 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 117.631 1.812 . . . . 0.0 117.631 168.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -98.16 -40.56 8.33 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.342 1.571 . . . . 0.0 110.979 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -74.59 131.52 41.02 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -118.42 150.75 39.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.321 1.848 . . . . 0.0 111.094 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -133.92 103.86 6.02 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.563 1.945 . . . . 0.0 110.082 -172.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.5 m0 -85.35 145.47 27.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.341 0.656 . . . . 0.0 111.73 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -133.06 87.99 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.441 2.296 . . . . 0.0 110.057 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.18 154.16 19.51 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.851 0.861 . . . . 0.0 110.953 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . 0.254 52.2 m-70 70.82 55.62 0.24 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.768 2.027 . . . . 0.0 113.734 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.1 mt -99.9 149.05 23.81 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.68 1.592 . . . . 0.0 111.015 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.6 -48.58 10.07 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 113.024 166.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -145.21 152.09 39.44 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.282 1.833 . . . . 0.0 110.812 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.402 ' CE2' HG23 ' A' ' 100' ' ' ILE . 75.6 m-85 -85.18 159.89 20.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.572 0.749 . . . . 0.0 109.988 169.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -112.16 -25.28 9.4 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.174 0.99 . . . . 0.0 111.126 164.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.92 168.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.983 1.713 . . . . 0.0 111.423 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -119.73 167.44 12.05 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.346 1.458 . . . . 0.0 111.122 166.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.01 130.23 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.544 1.138 . . . . 0.0 108.766 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.06 1.2 76.44 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.989 1.281 . . . . 0.0 115.709 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -81.68 129.79 34.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 119.457 1.628 . . . . 0.0 112.416 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -68.62 143.94 54.67 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.784 0.802 . . . . 0.0 110.422 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.3 m -128.71 157.76 41.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.877 1.671 . . . . 0.0 109.036 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.71 143.81 50.99 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.118 1.767 . . . . 0.0 109.427 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -47.02 125.27 7.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.669 0.747 . . . . 0.0 112.105 174.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.98 -3.77 82.91 Favored Glycine 0 CA--C 1.541 1.673 0 C-N-CA 125.15 1.357 . . . . 0.0 115.837 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -78.4 142.26 37.73 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.469 1.635 . . . . 0.0 112.978 170.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 88' ' ' PRO . 17.6 mm -72.88 131.19 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.931 0.872 . . . . 0.0 111.545 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 46.7 pt -114.63 -24.32 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.565 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -168.62 -178.94 3.63 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.163 1.385 . . . . 0.0 110.566 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -129.28 134.1 47.79 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 89' ' ' ILE . 99.0 p -62.49 145.94 52.91 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 112.329 -178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -156.56 160.17 30.05 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 -172.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -85.82 34.82 0.61 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.426 1.09 . . . . 0.0 113.267 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.7 p -84.32 134.16 34.52 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.815 1.246 . . . . 0.0 111.987 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 76.78 -38.87 1.51 Allowed Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.789 1.662 . . . . 0.0 114.961 -174.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 16.3 mt -69.93 166.49 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 126.116 1.767 . . . . 0.0 110.22 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -57.14 152.7 13.02 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.355 -1.466 . . . . 0.0 111.162 159.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.1 t -54.51 -22.22 12.31 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -175.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.3 p -81.48 -12.81 58.74 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -120.65 146.76 17.67 Favored Glycine 0 N--CA 1.475 1.259 0 C-N-CA 124.638 1.113 . . . . 0.0 113.121 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.514 ' H ' ' CD2' ' A' ' 157' ' ' HIS . . . -149.18 34.65 0.73 Allowed 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 -165.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.514 ' CD2' ' H ' ' A' ' 156' ' ' ALA . 12.3 m170 -100.6 124.05 45.65 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.208 -0.932 . . . . 0.0 111.708 -153.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.74 116.72 7.96 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.845 1.258 . . . . 0.0 111.881 -171.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -94.67 99.99 12.01 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.145 0.978 . . . . 0.0 110.168 172.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.263 46.5 t80 -89.55 113.08 24.44 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.161 1.384 . . . . 0.0 114.332 171.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -118.27 115.26 24.38 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 111.301 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -95.29 128.47 42.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.303 1.441 . . . . 0.0 110.7 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.3 mtm -131.91 157.83 42.98 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.792 1.637 . . . . 0.0 110.819 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -135.12 133.24 39.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.165 0.986 . . . . 0.0 111.813 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.88 5.81 76.29 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.936 1.255 . . . . 0.0 115.089 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 162.63 -170.47 38.2 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.342 1.449 . . . . 0.0 112.739 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -129.47 121.15 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -173.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 148.32 171.89 17.68 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.974 1.749 . . . . 0.0 113.411 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -51.1 -48.75 61.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.382 1.473 . . . . 0.0 112.916 175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.93 -13.29 62.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.238 1.415 . . . . 0.0 114.662 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -92.05 -16.86 25.85 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.99 135.12 53.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.036 0.934 . . . . 0.0 113.047 -172.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -103.33 -92.06 0.35 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.317 1.447 . . . . 0.0 112.827 -171.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -168.5 100.97 0.53 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 126.79 2.036 . . . . 0.0 112.95 -172.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.46 -39.71 3.51 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.169 1.913 . . . . 0.0 113.276 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -54.62 -53.03 64.75 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -172.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.2 -23.5 28.71 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.918 3.079 . . . . 0.0 112.458 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -69.3 -39.46 78.28 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 165.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 56.9 mt -71.09 -38.71 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 122.979 0.512 . . . . 0.0 110.95 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -58.52 -15.58 11.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -110.68 -12.06 14.36 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.952 1.301 . . . . 0.0 112.778 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.3 154.1 33.83 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.721 1.208 . . . . 0.0 112.394 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.56 -50.57 13.39 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 124.445 3.43 . . . . 0.0 114.386 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -107.52 9.41 29.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.676 0.79 . . . . 0.0 112.762 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.45 -139.02 43.38 Favored Glycine 0 CA--C 1.537 1.423 0 O-C-N 120.51 -1.369 . . . . 0.0 112.651 -171.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.27 -21.79 66.72 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.058 -1.26 . . . . 0.0 112.993 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -64.11 -8.58 12.54 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.91 1.284 . . . . 0.0 112.895 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.8 t -88.56 -1.86 58.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.809 1.244 . . . . 0.0 112.751 171.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.47 -15.25 12.08 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.666 1.586 . . . . 0.0 112.417 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -145.67 164.6 31.27 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.56 -1.337 . . . . 0.0 112.912 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -114.53 86.62 2.47 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.472 0.631 0 C-N-CA 125.06 1.344 . . . . 0.0 110.424 174.754 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.041 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.3 m -61.59 153.88 26.5 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HE2' ' CE2' ' A' ' 54' ' ' PHE . 50.5 pttt -143.11 -179.84 6.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.093 2.157 . . . . 0.0 110.567 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -130.05 -15.16 3.82 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.883 1.273 . . . . 0.0 114.062 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.74 153.89 27.1 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.965 1.306 . . . . 0.0 112.384 162.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -76.4 148.54 37.27 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.457 ' CE2' ' HE2' ' A' ' 50' ' ' LYS 0.343 47.4 m-85 -72.56 51.44 0.26 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 173.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -47.01 141.42 4.18 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 118.231 2.678 . . . . 0.0 118.231 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -150.07 140.23 22.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.392 1.477 . . . . 0.0 108.999 163.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.48 -42.85 47.08 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 118.497 0.59 . . . . 0.0 112.89 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.6 p -74.36 158.32 34.16 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 122.631 1.205 . . . . 0.0 112.969 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.5 mtt-85 -76.51 4.33 9.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.7 mt -74.01 131.13 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 119.552 1.069 . . . . 0.0 111.986 -172.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 p -93.66 -35.17 12.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.367 1.867 . . . . 0.0 115.145 167.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -143.7 116.19 8.59 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.609 1.964 . . . . 0.0 109.139 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.7 p -74.23 171.07 14.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 122.859 1.314 . . . . 0.0 108.365 163.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -67.72 132.82 48.19 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 153.62 -134.49 4.39 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 121.563 -0.711 . . . . 0.0 112.765 -174.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -127.47 153.03 46.8 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.493 1.117 . . . . 0.0 112.371 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -72.72 133.99 44.82 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -77.15 -17.05 58.87 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -58.91 -29.02 66.74 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -167.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.7 p -158.87 170.42 8.96 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.311 1.444 . . . . 0.0 108.918 168.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.87 -21.18 28.68 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 121.682 1.588 . . . . 0.0 113.08 168.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -84.9 -31.92 23.43 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.149 1.38 . . . . 0.0 109.521 -173.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -60.21 135.6 57.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.646 1.578 . . . . 0.0 114.314 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.0 -139.24 6.94 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 116.72 1.448 . . . . 0.0 116.72 -172.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -99.72 155.69 17.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -164.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -114.38 116.9 29.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.386 1.875 . . . . 0.0 110.024 172.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.291 98.3 m-85 -95.99 23.04 6.76 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 -172.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.96 -162.91 12.74 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 120.88 -1.137 . . . . 0.0 113.266 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.49 HD11 ' HD2' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -119.18 133.31 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.472 1.909 . . . . 0.0 108.488 175.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -109.51 97.0 6.65 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.67 107.87 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.29 123.7 18.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.416 1.007 . . . . 0.0 110.941 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.7 mt -138.85 146.67 51.03 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 123.274 0.63 . . . . 0.0 111.733 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.81 137.85 79.15 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.295 1.997 . . . . 0.0 110.747 163.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -57.39 135.18 56.53 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.217 1.007 . . . . 0.0 111.434 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.25 -7.22 81.9 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.273 -1.293 . . . . 0.0 114.944 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.2 m -53.73 126.13 48.35 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-N 120.069 1.934 . . . . 0.0 113.362 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.578 ' HB2' HD12 ' A' ' 142' ' ' ILE . 9.5 Cg_endo -68.17 136.66 38.22 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.486 2.124 . . . . 0.0 112.883 171.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.7 mm -92.39 132.45 36.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.566 1.946 . . . . 0.0 108.186 173.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -103.73 151.01 23.52 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.768 1.227 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.3 129.25 90.63 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.241 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.27 -33.18 11.68 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.675 2.917 . . . . 0.0 113.396 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.0 p -140.78 156.59 46.13 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.397 1.479 . . . . 0.0 107.872 -169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -65.56 129.58 40.25 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.685 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -153.19 7.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 123.268 0.461 . . . . 0.0 112.795 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.01 149.35 28.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.285 1.834 . . . . 0.0 109.776 176.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.17 136.87 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.125 -0.985 . . . . 0.0 113.211 171.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.22 -38.84 5.87 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.535 1.134 . . . . 0.0 111.612 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -150.82 142.55 23.72 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.707 0.803 . . . . 0.0 111.137 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -139.64 123.81 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.348 1.459 . . . . 0.0 108.277 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -160.86 169.29 22.98 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -102.01 144.11 31.02 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.132 1.373 . . . . 0.0 111.546 169.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -106.78 139.74 40.73 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.146 1.778 . . . . 0.0 109.642 170.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -68.16 -27.36 66.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.4 mt -89.34 -48.62 7.23 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.708 1.203 . . . . 0.0 110.873 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -88.5 -5.42 75.3 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.202 1.382 . . . . 0.0 116.271 -161.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.73 -148.99 40.9 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.091 1.446 . . . . 0.0 111.539 -174.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -66.28 144.32 56.66 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.49 HG13 HD22 ' A' ' 124' ' ' LEU . 21.2 t -127.76 135.78 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 127.024 2.13 . . . . 0.0 112.884 173.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.97 136.04 51.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.388 1.475 . . . . 0.0 109.386 166.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.29 123.11 41.39 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 111.881 177.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 71.9 mt -120.23 144.58 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.899 1.28 . . . . 0.0 110.784 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -109.59 141.72 41.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.368 1.867 . . . . 0.0 109.829 169.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -74.06 29.03 0.08 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.301 65.0 m-20 59.95 -31.11 0.05 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 127.579 2.352 . . . . 0.0 117.204 -166.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -62.63 -37.03 84.73 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.895 -1.128 . . . . 0.0 112.811 167.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.83 7.8 66.73 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.026 -0.875 . . . . 0.0 114.88 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -80.85 -46.84 14.68 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.548 1.674 . . . . 0.0 107.547 165.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -86.57 126.52 34.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -120.97 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.509 1.524 . . . . 0.0 111.41 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -119.09 123.52 44.65 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 126.078 1.751 . . . . 0.0 108.394 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -96.93 146.5 24.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.531 0.733 . . . . 0.0 112.463 161.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -130.9 104.03 6.9 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.806 2.442 . . . . 0.0 110.01 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.49 HD22 HG13 ' A' ' 109' ' ' VAL . 1.5 mm? -105.59 155.69 18.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.648 1.179 . . . . 0.0 111.992 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 63.8 59.83 1.11 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.629 1.972 . . . . 0.0 112.32 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -100.32 145.78 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.647 1.579 . . . . 0.0 111.187 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -89.86 -41.86 11.57 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.011 1.324 . . . . 0.0 108.692 171.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -148.21 150.9 34.56 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.478 1.511 . . . . 0.0 113.273 -172.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -97.29 141.32 30.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.656 1.582 . . . . 0.0 112.281 173.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -103.07 -21.45 13.91 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.253 1.021 . . . . 0.0 112.172 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 m -112.95 168.68 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.28 1.832 . . . . 0.0 111.193 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -113.96 171.32 7.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.365 1.866 . . . . 0.0 110.813 168.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.86 137.05 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 120.527 -1.358 . . . . 0.0 108.786 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.88 10.53 85.56 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.08 1.324 . . . . 0.0 114.143 177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -93.22 129.45 39.25 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -170.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -71.92 138.79 48.38 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.479 0.711 . . . . 0.0 112.548 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.36 160.21 42.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 125.444 1.497 . . . . 0.0 110.942 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.8 140.53 42.57 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.577 1.951 . . . . 0.0 109.482 -174.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.17 112.53 0.64 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.285 1.834 . . . . 0.0 112.414 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.15 9.3 54.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 118.616 -1.102 . . . . 0.0 115.637 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -94.37 145.3 24.85 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.586 1.954 . . . . 0.0 114.239 170.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 88' ' ' PRO . 20.6 mm -70.76 132.89 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.553 1.07 . . . . 0.0 112.566 176.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 39.8 pt -119.1 -22.67 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.399 1.48 . . . . 0.0 113.426 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.08 -176.04 1.86 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.255 1.422 . . . . 0.0 110.865 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -136.67 135.42 38.23 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.2 t -80.94 143.58 32.52 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -151.65 153.44 24.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.114 1.34 . . . . 0.0 111.275 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -72.82 20.42 0.08 Allowed 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.5 p -54.44 -32.96 58.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.119 2.167 . . . . 0.0 114.028 -174.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.18 25.81 6.92 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.097 1.332 . . . . 0.0 115.251 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 59.3 mt -118.22 146.88 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 118.723 1.262 . . . . 0.0 109.874 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -81.71 16.96 1.59 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -173.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.12 -179.62 6.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.968 2.907 . . . . 0.0 112.047 174.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -8.37 55.99 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 166.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -85.12 94.67 1.91 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.235 1.398 . . . . 0.0 113.194 -171.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -71.09 146.03 49.49 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.026 0.93 . . . . 0.0 113.479 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -147.47 145.97 29.36 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.246 1.018 . . . . 0.0 110.814 167.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.43 115.34 22.49 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.628 0.771 . . . . 0.0 110.156 171.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -90.13 98.79 11.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.85 0.86 . . . . 0.0 110.067 171.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.276 38.5 t80 -88.86 110.95 21.49 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.835 1.254 . . . . 0.0 114.341 171.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -113.3 114.59 26.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.874 0.869 . . . . 0.0 111.687 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -97.02 120.71 37.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.731 1.612 . . . . 0.0 110.854 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.3 mtm -123.05 152.39 41.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.354 1.861 . . . . 0.0 111.266 -174.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -131.51 133.18 44.83 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.73 1.212 . . . . 0.0 111.772 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.61 52.63 Favored Glycine 0 CA--C 1.542 1.758 0 C-N-CA 125.66 1.6 . . . . 0.0 116.12 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 172.78 -175.28 45.84 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.086 1.803 . . . . 0.0 111.89 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.16 111.34 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -175.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 163.37 171.43 29.6 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 126.511 2.005 . . . . 0.0 112.408 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -58.8 -44.68 90.82 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.773 -1.427 . . . . 0.0 113.549 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -74.56 -1.07 19.83 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -93.62 -17.17 23.59 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 165.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.18 144.53 57.13 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.737 0.815 . . . . 0.0 111.931 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -126.78 -75.43 0.58 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -164.52 109.17 0.86 Allowed Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -81.33 -27.76 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.241 1.96 . . . . 0.0 114.356 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.49 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -54.29 -55.68 34.39 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 121.253 1.842 . . . . 0.0 114.443 -177.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 -21.37 57.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.689 2.926 . . . . 0.0 112.814 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.53 -37.93 59.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 170.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.98 -30.26 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.62 0.368 . . . . 0.0 110.79 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.75 -9.62 4.27 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -112.63 -9.71 13.72 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.035 2.134 . . . . 0.0 113.666 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.7 mt -69.95 151.57 96.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -170.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.49 -41.86 50.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.817 3.678 . . . . 0.0 114.755 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -119.0 16.64 13.36 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.903 1.281 . . . . 0.0 112.418 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.09 -132.52 42.82 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 120.814 -1.179 . . . . 0.0 112.723 -175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.15 -25.03 66.72 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.261 -1.14 . . . . 0.0 112.617 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -70.18 -6.73 36.41 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.074 -1.016 . . . . 0.0 113.004 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 58.2 m -81.59 -3.91 54.64 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 0.986 . . . . 0.0 113.17 167.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.13 -18.01 15.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.17 1.388 . . . . 0.0 111.889 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -144.14 164.04 31.83 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.498 -1.376 . . . . 0.0 114.657 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -107.46 89.72 3.08 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 119.395 0.998 . . . . 0.0 113.027 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 124.469 1.108 . . . . 0.0 110.276 173.147 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.007 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -74.0 -37.6 64.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.644 0.777 . . . . 0.0 111.875 -172.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -65.67 170.09 5.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.188 1.395 . . . . 0.0 112.635 174.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 58.5 m95 63.02 15.62 8.59 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -64.49 -41.12 96.64 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.013 0.824 . . . . 0.0 112.858 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -86.61 123.63 32.01 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.604 1.162 . . . . 0.0 112.837 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.255 6.3 m-85 -63.59 145.21 56.12 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.345 29.2 t80 -70.9 138.83 50.46 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.2 ptt-85 -150.52 -27.19 0.23 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.113 2.165 . . . . 0.0 114.019 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.93 -69.42 0.06 OUTLIER Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.588 1.566 . . . . 0.0 113.451 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.9 p -68.87 154.44 42.01 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -115.72 15.05 16.49 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 mp -68.66 132.66 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 120.577 1.535 . . . . 0.0 112.416 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -93.82 -44.84 7.92 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.281 1.832 . . . . 0.0 115.396 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -139.78 134.41 31.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.465 1.506 . . . . 0.0 111.875 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.7 p -97.25 178.38 5.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.689 1.996 . . . . 0.0 113.186 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -81.37 134.94 35.64 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.243 1.017 . . . . 0.0 111.161 -167.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.18 -156.49 16.88 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.594 1.569 . . . . 0.0 115.068 168.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -60.87 159.59 11.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.085 1.354 . . . . 0.0 113.5 -177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.73 156.5 47.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 117.428 2.381 . . . . 0.0 117.428 173.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 68.84 37.22 2.4 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.411 1.884 . . . . 0.0 115.983 172.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 58.57 34.37 23.82 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 162.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.8 m -139.86 167.12 19.51 Favored Pre-proline 0 N--CA 1.48 1.035 0 C-N-CA 125.547 1.539 . . . . 0.0 114.086 -163.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -90.46 -8.78 3.7 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.365 2.71 . . . . 0.0 115.236 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -74.82 163.4 27.71 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.874 -1.141 . . . . 0.0 111.296 -166.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.19 -15.54 3.96 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 118.927 2.936 . . . . 0.0 118.927 -174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -53.94 117.04 6.81 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.751 1.167 . . . . 0.0 113.967 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -145.01 140.62 28.28 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.894 1.678 . . . . 0.0 112.819 -176.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -101.82 111.8 24.19 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.747 1.619 . . . . 0.0 110.286 174.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.303 88.4 m-85 -91.14 26.93 2.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.771 2.137 . . . . 0.0 116.771 -167.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.93 -167.66 22.7 Favored Glycine 0 CA--C 1.528 0.884 0 O-C-N 120.717 -1.239 . . . . 0.0 114.9 -172.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.03 136.81 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.783 2.033 . . . . 0.0 108.874 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -113.6 115.54 28.08 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -97.84 117.47 32.24 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.06 112.82 2.78 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.624 1.102 . . . . 0.0 111.616 175.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -139.4 140.4 25.58 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.207 0.603 . . . . 0.0 112.333 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.73 139.47 57.88 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.993 2.462 . . . . 0.0 111.446 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -52.69 129.52 29.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.744 1.218 . . . . 0.0 109.972 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.17 81.29 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.178 -1.345 . . . . 0.0 115.982 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.0 m -54.23 125.18 49.59 Favored Pre-proline 0 N--CA 1.478 0.965 0 CA-C-N 120.169 1.984 . . . . 0.0 112.364 163.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.567 ' HB2' HD12 ' A' ' 142' ' ' ILE . 13.1 Cg_endo -71.43 133.22 22.11 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.956 1.771 . . . . 0.0 111.701 174.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.2 mm -89.21 129.46 40.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.65 1.58 . . . . 0.0 108.504 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -102.56 149.17 24.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.936 1.294 . . . . 0.0 109.528 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.73 126.93 93.21 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-O 118.858 -0.591 . . . . 0.0 110.566 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.34 -38.47 6.48 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.359 2.706 . . . . 0.0 112.291 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.3 p -126.13 161.9 26.58 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.873 2.069 . . . . 0.0 111.693 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -69.58 136.01 50.74 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 165.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.17 -160.91 13.08 Favored Glycine 0 N--CA 1.473 1.12 0 O-C-N 121.777 -0.577 . . . . 0.0 113.768 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.49 145.75 28.06 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.345 1.073 . . . . 0.0 112.412 172.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.36 126.01 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -40.3 9.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.189 1.796 . . . . 0.0 115.657 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -155.51 145.59 21.62 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.154 1.382 . . . . 0.0 110.292 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.6 mt -137.66 125.44 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.012 1.325 . . . . 0.0 109.083 174.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -158.36 -176.21 5.77 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -170.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -145.04 142.71 29.98 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.68 1.192 . . . . 0.0 111.062 171.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -126.01 169.07 13.11 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.102 1.361 . . . . 0.0 113.137 -178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -66.03 -24.56 66.77 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.834 2.161 . . . . 0.0 116.834 -165.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.64 -12.8 0.88 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.622 1.169 . . . . 0.0 113.878 171.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.83 -7.63 75.72 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.388 0.994 . . . . 0.0 114.478 169.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.73 -151.74 50.82 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 118.097 0.948 . . . . 0.0 112.847 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.26 146.6 45.29 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.189 0.596 . . . . 0.0 112.12 167.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.16 138.67 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.78 136.43 49.86 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.634 1.574 . . . . 0.0 109.579 166.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.76 124.52 51.98 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.252 0.621 . . . . 0.0 112.108 167.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.6 mt -118.59 144.05 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.323 1.049 . . . . 0.0 111.879 173.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.87 138.41 36.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.825 2.05 . . . . 0.0 110.608 170.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -81.07 144.61 31.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -58.85 -12.08 4.01 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 161.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -67.83 -15.03 63.43 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 120.594 -1.316 . . . . 0.0 114.44 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.84 -0.81 84.81 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.931 1.253 . . . . 0.0 115.977 166.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -151.48 2.53 0.4 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -110.64 150.57 28.82 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -128.65 159.18 36.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.053 2.141 . . . . 0.0 111.503 175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -141.62 103.89 4.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.435 1.894 . . . . 0.0 110.849 -170.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 1.9 m0 -87.36 143.28 27.32 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.919 0.487 . . . . 0.0 111.571 171.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -130.06 96.48 4.2 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.052 1.741 . . . . 0.0 107.558 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.71 155.37 19.26 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 0.0 110.142 174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 68.42 64.43 0.34 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.798 2.039 . . . . 0.0 113.699 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.5 mt -104.56 154.27 20.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.867 1.667 . . . . 0.0 111.171 172.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -97.99 -44.08 6.81 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.206 1.802 . . . . 0.0 106.931 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -162.12 159.09 25.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 127.389 2.276 . . . . 0.0 110.548 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -97.95 162.94 12.99 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.002 1.721 . . . . 0.0 114.454 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -124.17 -8.78 7.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.874 1.27 . . . . 0.0 112.721 170.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.2 m -134.06 168.03 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.56 1.944 . . . . 0.0 111.187 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -120.36 166.79 13.05 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.97 2.108 . . . . 0.0 111.783 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.95 132.43 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.37 7.59 72.46 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.45 1.024 . . . . 0.0 115.175 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -86.48 115.06 23.73 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 119.128 1.464 . . . . 0.0 112.256 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -65.87 135.15 54.43 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.289 0.235 . . . . 0.0 110.592 164.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 m -127.33 163.86 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 126.522 1.929 . . . . 0.0 110.555 -176.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.24 140.07 47.31 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.421 1.488 . . . . 0.0 109.526 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -49.08 126.81 13.29 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.15 -4.93 74.97 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.124 1.821 . . . . 0.0 114.742 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.8 141.69 36.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.664 1.186 . . . . 0.0 112.145 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 88' ' ' PRO . 18.6 mm -70.63 130.1 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.519 -0.738 . . . . 0.0 111.579 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.4 pt -113.86 -21.42 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.725 1.21 . . . . 0.0 113.363 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.76 -176.53 1.77 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.989 1.316 . . . . 0.0 110.729 -178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -132.71 134.67 45.08 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.1 t -78.1 145.97 35.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -156.28 153.55 24.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.672 1.606 . . . . 0.0 111.713 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -77.77 26.68 0.18 Allowed 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 80.0 p -58.87 140.21 55.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.532 1.133 . . . . 0.0 110.477 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 78.63 -38.64 1.91 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.183 1.373 . . . . 0.0 115.208 -170.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.0 mt -73.81 144.76 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.16 1.384 . . . . 0.0 112.337 -174.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -74.85 -148.19 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.597 1.959 . . . . 0.0 110.794 167.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.65 4.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 119.263 3.06 . . . . 0.0 119.263 -173.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.23 -19.26 59.86 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 -169.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 73.39 163.63 8.35 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 124.238 0.923 . . . . 0.0 113.459 -168.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.43 150.01 42.0 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.348 -1.09 . . . . 0.0 113.901 -171.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.63 145.8 26.95 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.641 1.176 . . . . 0.0 110.011 162.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -78.97 115.2 18.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.692 0.678 . . . . 0.0 110.154 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -91.51 100.05 12.87 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.826 0.85 . . . . 0.0 110.462 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -92.89 116.52 29.11 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 114.611 1.338 . . . . 0.0 114.611 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -122.13 112.05 17.74 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.687 1.195 . . . . 0.0 111.381 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -94.56 129.06 41.53 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.636 1.174 . . . . 0.0 110.536 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.7 mtm -127.24 150.65 49.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.654 1.582 . . . . 0.0 110.856 -173.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -120.05 135.91 54.76 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.027 1.331 . . . . 0.0 110.831 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.02 -15.98 1.69 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.169 1.843 . . . . 0.0 116.525 175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.19 -168.78 35.52 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.56 1.553 . . . . 0.0 112.057 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.1 t -123.24 131.26 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.393 1.477 . . . . 0.0 112.747 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 140.56 166.6 10.74 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.727 1.632 . . . . 0.0 112.048 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -57.84 -43.74 86.05 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.426 -1.044 . . . . 0.0 113.487 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.76 -14.24 50.86 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -92.58 -15.88 26.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.59 1.156 . . . . 0.0 114.055 174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.41 137.86 58.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.774 1.23 . . . . 0.0 112.836 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -101.5 -90.86 0.33 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.588 1.155 . . . . 0.0 113.805 -173.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -170.15 108.21 0.44 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 129.36 3.064 . . . . 0.0 110.591 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.97 -23.06 14.24 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.126 1.884 . . . . 0.0 114.587 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -52.26 -53.83 48.29 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 120.582 1.537 . . . . 0.0 115.085 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.74 -20.03 40.53 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.646 2.898 . . . . 0.0 112.931 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.273 3.8 t80 -70.68 -47.59 59.11 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 26.5 mt -67.47 -24.29 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 120.833 -1.167 . . . . 0.0 111.79 175.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.32 -18.14 64.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 172.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -109.28 -7.31 15.27 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.866 -1.146 . . . . 0.0 114.03 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 32.0 mt -69.34 147.72 97.15 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.952 1.301 . . . . 0.0 112.894 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.23 -27.99 34.31 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.209 2.606 . . . . 0.0 114.164 -166.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.86 2.51 17.07 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.84 -144.06 37.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.84 0.733 . . . . 0.0 112.793 -166.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.97 -24.6 66.23 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.455 -1.027 . . . . 0.0 112.553 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -65.31 -9.89 28.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.481 1.512 . . . . 0.0 111.986 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.6 t -82.52 -3.21 55.54 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.091 1.356 . . . . 0.0 112.575 172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.8 mp -110.46 -13.11 14.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.517 1.527 . . . . 0.0 112.701 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -146.63 163.52 35.59 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.705 1.593 . . . . 0.0 115.196 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -115.25 79.06 1.23 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 124.323 1.049 . . . . 0.0 109.998 175.301 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_